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x AUSFÜHRLICHE DEUTSCHSPRACHIGE ZUSAMMENFASSUNG 
Ausführliche deutschsprachige Zusammenfassung 
Die experimentelle Bestimmung der Struktur und Funktion von Makromolekülen ist von hohem 
biologischen, mikrobiologischen, pharmakologischen und medizinischen Interesse. Die 
erfolgreichste Methode, um biologische Moleküle auf atomarer Ebene zu untersuchen, ist die 
Röntgenbeugung an 3-D Kristallen, durch die Strukturen von Makromolekülen mit hoher 
Auflösung ermittelt werden können. Diese Methode wird durch andere biochemische, genetische 
oder strukturelle Methoden wie Massenspektrometrie, analytische Ultrazentrifugation, Mutagenese, 
Elektronenmikroskopie und verschiedenen spektroskopischen Techniken ideal ergänzt.  
Unter allen biologisch relevanten Makromolekülen stellen Membranproteine eine besondere 
Herausforderung für strukturelle Untersuchungen dar. Es ist schwierig, sie in ausreichenden 
Mengen zu gewinnen, sie sind instabil, nur durch milde amphipatische Detergenzien in Lösungen 
zu halten und neigen wenig dazu, gut geordnete Kristalle zu bilden. Trotzdem sind sie eine überaus 
interessante Proteingruppe, da sie rund 20 – 25 % aller Proteome ausmachen und 60 % aller 
Pharmaka an Membranproteinen angreifen.  
Diese Arbeit beschreibt die strukturellen und funktionellen Eigenschaften eines 
membrangebundenen Enzyms, der Sulfid:Chinon Oxidoreduktase (SQR), die aus den Zellen des 
hyperthermophilen Bakteriums Aquifex aeolicus isoliert wurde.  
SQRs gehören zusammen mit der Glutathion-Reduktase, der Lipoamid-Dehydrogenase, der 
Thioredoxin-Reduktase und der Trypanothion-Reduktase zur Superfamilie der Flavoprotein-
Disulfid-Reduktasen (FDR). Für die ersten Lebensformen war die sulfidabhängige Chinon-
Reduktion durch die SQRs essentiell, um in ihrem sauerstoffarmen, marinen Lebensraum Sulfid 
zur Energiegewinnung zu nutzen. Die Gene dieser Proteine sind durchweg in der Evolution 
erhalten geblieben und heute in allen Domänen des Lebens, auch im Menschen, jedoch nicht in 
Pflanzen, zu finden. Sie spielen eine physiologische Rolle bei der Sulfidentgiftung (in allen 
Organismen), bei der sulfidabhängigen Atmung und Photosynthese (in Bakterien) und bei der 
Schwermetalltoleranz (in Hefen). In Eukaryoten könnten sie an sulfidabhängigen Signalprozessen 
beteiligt sein, da Sulfid in den Zellen produziert wird und als „Gasotransmitter“ wirkt. 
Zu Beginn dieser Arbeit gab es keine der strukturellen Informationen über eine SQR, und nur 
einige wenige Homologe waren funktionell charakterisiert. Darüber hinaus zeigen SQRs eine 
geringe Sequenzähnlichkeit, so dass die Klassifizierung der SQR-Familie nur teilweise möglich 
und auch widersprüchlich war, da die Bestimmung der funktionell relevanten Sequenzbereiche 
ungenau war. Bisher wurde der katalytische Mechanismus auf Basis der Struktur der 
Allochromatium vinosum Flavocytochrom c:Sulfid Dehydrogenase (FCSD) vorhergesagt, ein 
Protein der FDR Familie mit nur 24 % Sequenzidentität zur A. aeolicus SQR. 
 
xiAUSFÜHRLICHE DEUTSCHSPRACHIGE ZUSAMMENFASSUNG 
Die  SQR wurde in den Membranen von A. aeolicus durch denaturierende Polyacrylamid 
Gelelektrophorese (SDS-PAGE), Peptidmassen-Fingerabdruck-Massenspektrometrie (PMF-MS) 
und spektrophotometrische Aktivitätstests identifiziert, mit dem Detergenz Dodecyl-β-D-maltosid 
(DDM) solubilisiert und durch fünf aufeinander folgende chromatographische Schritte mit einer 
abschließenden Ausbeute von 32 % gereinigt. Das Protein hat einen berechneten isoelektrischen 
Punkt von 4,2 - 4,5, und durch Massenspektrometrie wurde für das Proteinmonomer eine Masse 
von 47.388 Da berechnet. Das Absorptionsspektrum im sichtbaren Wellenlängenbereich deutet auf 
ein fest gebundenes Flavin-Adenin-Dinukleotid (FAD) Molekül hin. Überraschenderweise wurde 
der Oligomerzustand der gereinigten SQR mit analytischer Ultrazentrifugation (AUC), 
Crosslinking und Einzelpartikelanalyse als Trimer bestimmt. Die 
Totalreflektionsröntgenfluoreszenz (TXRF) zeigte interessanterweise, dass die SQR eine höhere 
Anzahl an Schwefelatomen besitzt, als man von der Aminosäuresequenz her erwarten würde. 
Experimente mit hoch auflösender Massenspektrometrie deuten darauf hin, dass diese 
Schwefelatome in Ketten von mindestens vier Atomen angeordnet und kovalent an das Protein 
gebunden sind. Der gereinigte Proteinkomplex ist aktiv, zeigt eine mikromolare Affinität zu seinen 
Substraten Sulfid und Ubichinon und kann durch Chinon-Analoge kompetitiv inhibiert werden. Die 
gröβte Aktivität wurde bei der höchsten getesteten Temperatur von 80 °C gemessen. Die 
Aktivierungsenergie des Enzyms beträgt rund 14 kJ/(K·mol). Besonders bemerkenswert ist die 
Stabilität der isolierten SQR bei hoher Temperatur, denn selbst nach 24 Stunden bei 80 °C hat das 
Protein noch immer eine 50%ige Aktivität.  
Die SQR wurde durch 3D Kristallisation und Röntgenbeugung strukturell untersucht. Kristalle 
konnten in hängenden und sitzenden Tropfen in Dampfdiffusion, im Mikroansatz unter Paraffinöl 
und in der so genannten Schwammphase (engl.: sponge phase) erhalten werden. Die erfolgreichste 
Technik war die Dampfdiffusion, durch die zwei verschiedene Kristallformen erhalten wurden, die 
als hexagonale und nadelförmige Kristalle beschrieben werden können und Röntgenstrahlen mit 
einer Auflösung bis zu mehr als 2 Å beugen. In beiden Kristallformen zeigt das Enzym die 
gleichen elektrophoretischen, spektroskopischen, massenspektrometrischen und enzymatischen 
Eigenschaften wie in Lösung. Obwohl beide mit den Präzipitationsmitteln Ammoniumsulfat und 
Polyethylenglykol (PEG) gezüchtet wurden, unterscheiden sie sich jedoch signifikant in den 
Beugungseigenschaften. Das Beugungsbild der hexagonalen Kristalle ist durch eine hohe 
Mosaizität gekennzeichnet und daher für die Datenauswertung unbrauchbar. Dahingegen konnten 
die Nadelkristalle zur Strukturlösung verwendet werden. Sie gehören mit einer Einheitszelle von 
112 x 154 x 178 Å
3 der Raumgruppe P212121 an, enthalten 6 Moleküle in der asymmetrischen 
Einheit und weisen einen Solvensgehalt von 53 % auf. Das Kristallgitter ist aus Molekülschichten 
und dünnen Detergenzschichten aufgebaut und imitiert in gewisser Weise die Anordnung der 
Proteinkomplexe über der zellulären Membran. 
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Die Struktur der SQR wurde mit einer Auflösung von 2,3 Å durch de novo Phasenbestimmung mit 
der Methode des Multiplen-Isomorphen-Ersatzes mit anomaler Streuung von Osmium- und Gold-
Derivaten ermittelt (die MIRAS Methode). Das Modell wurde weitestgehend per Hand gebaut und 
bis zu einem Rfree von 23,5 % (Rwork 19,2 %) verfeinert. Kristalle der SQR wurden mit dem Substrat 
Decylubichinon und mit dem Inhibitor Aurachin C inkubiert und die Strukturen der Substrat- und 
Inhibitorkomplexe mit einer Auflösung von 2,0 Å bzw. 2,9 Å bestimmt. Sie zeigen im Vergleich 
zur Chinon-gebundenen Struktur keine Unterschiede in der Konformation der Polypeptidkette, aber 
sie erlauben die eindeutige Identifizierung der Chinon-Bindestelle, die so zum ersten Mal für SQRs 
bestimmt werden konnte.  
Die sechs SQR Monomere in der asymmetrischen Einheit sind nahezu identisch. Alle enthalten die 
für FDRs typischen zwei FAD-bindenden Rossmann Domänen und eine C-terminale Domäne, die 
für jede FDR Unterfamilie spezifisch ist. Die C-terminale Domäne der SQR besteht aus zwei 
amphipatischen Helices gefolgt von einer Schleife, die aus 18 Aminosäuren besteht, und durch 
zwei Disulfidbrücken stabilisiert wird. Die Existenz der strukturell wichtigen Disulfidbrücken 
deutet auf eine Lokalisation des Proteins im Periplasma hin. Zudem tragen die Disulfide zusammen 
mit dem ausgeprägten Netzwerk an Wasserstoffbrückenbindungen zwischen den Untereinheiten zu 
der groβen „thermischen“ Stabilität des Proteins bei.  
Die sechs Monomere in der asymmetrischen Einheit lagern sich zu zwei homotrimeren Komplexen 
zusammen, jeder mit einer ausgeprägten elliptischen Form und einer starken Polarität. Die Seite, 
welche durch die beiden Rossmann Domänen gebildet wird, ist vorwiegend negativ geladen, 
während die andere Seite durch einen Überschuss an positiver Ladung und hydrophobe Stellen 
charakterisiert ist und deshalb die Interaktionsfläche mit der Membran bildet. Aus der 
Kristallstruktur kann gefolgert werden, dass sich die SQR symmetrisch mit Hilfe der zwei C-
terminalen amphipatischen Helices bis zu einer Tiefe von 12 Å in die Lipiddoppelschicht einlagert. 
Folglich ist die SQR ein integrales monotopisches Membranprotein. Trp 377 und Trp 391 binden 
zwei Sulfatgruppen, welche chemisch analog zu den Phosphatgruppen von Lipiden sind, und 
könnten daher so genannte „Lipidklammern“ (engl.: lipid clamps) darstellen, die eine hohe 
Affinität zu zwitterionischen Phospholipiden besitzen. Die Bindung von zwei weiteren Sulfaten 
zwischen benachbarten Monomeren deutet darauf hin, dass die Membraneinlagerung die 
Oligomerisierung stabilisiert. Diese Verknüpfung von Membraneinlagerung, Trimerisierung und 
enzymatischer Aktivität könnte sicherstellen, dass die SQR ausschließlich hydrophobe Chinone 
reduziert. Vielleicht wird dadurch auch die Abgabe des Polyschwefelproduktes direkt in die 
unpolare Umgebung der Lipiddoppelschicht erleichtert.  
Auch eine ausführliche Beschreibung des aktiven Zentrums, das um die FAD Bindetasche 
lokalisiert ist, wird durch die Struktur ermöglicht. Wie die FCSD bindet auch die SQR FAD 
kovalent. Unerwarteterweise besteht die Verbindung nicht aus einer klassischen Thiol 8-α-Sγ-
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Cysteinylbindung sondern aus einer indirekten 8-α-X-Sγ-Cys124-Bindung, wobei die Gruppe X 
aufgrund einer experimentellen anomalen Differenz-Elektronendichtekarte als Schwefelatom 
interpretiert wurde. Diese ungewöhnliche Art der Bindung könnte das Reduktionspotential des 
FAD beeinflussen, wichtig für die richtige Positionierung des Cofaktors im aktiven Zentrum sein 
oder sogar eine aktive Rolle in der Katalyse spielen. 
Der Isoalloxazinring des FAD trennt die Bindetasche in zwei Hohlräume. Die Chinon-Bindestelle 
liegt auf der si-Seite des FAD. Diese Seite ist von der Membran über einen Kanal zugänglich, der 
von den oben beschriebenen amphipatischen Helices geformt wird. Die kürzeste Entfernung 
zwischen dem Chinon und dem FAD ist etwa 3.5 Å, was einen schnellen Elektronentransfer erlaubt. 
Der aromatische Ring des Substrats ist zwischen der Benzylgruppe von Phe 385 und der 
Seitenkette von Ile 346 gebunden, während Glu 318, Lys 382 und andere Wassermoleküle 
Wasserstoffbrückenbindungen mit dem Chinon bilden und in den Protonentransfer involviert sein 
könnten. Die Struktur der SQR Chinon-Bindestelle ist neu und zeigt keine Ähnlichkeit zu der von 
anderen FDRs. Zum Beispiel hat die chinon-bindende Proteindomäne der FCSD, dem nächsten 
strukturellen Homolog, eine völlig andere Architektur, welche an die Interaktion mit Cytochrom c 
angepasst ist, das anstelle von Chinon der Elektronenakzeptor dieses Proteins ist. Auch die Sulfid-
Oxidationsstelle zeigt neue Eigenschaften und unterscheidet sich deutlich von der der FCSD, 
obwohl beide Proteine die gleiche reduktive Semireaktion katalysieren. Während sich in der FCSD 
die Sulfid-Oxidationsstelle auf der Oberfläche des Proteins befindet, ist diese in der SQR im Innern 
des Proteins auf der re-Seite des FAD verborgen, wo sie mit der umgebenden Flüssigkeit durch 
einen Kanal verbunden ist. Dieser besitzt ein positives elektrostatisches Oberflächenpotential, wird 
von der konservierten essentiellen Aminosäure Val 294 flankiert, und ist desweiteren mit 
Wassermolekülen, welche den Pfad des Substrates H2S imitieren könnten, besetzt. Außerdem 
liegen an der Sulfidoxidationsstelle der SQR drei – und nicht zwei, wie in FCSD – konservierte 
Cysteine. Cys 124 bindet FAD wie oben beschrieben. Cys 156 und Cys 347 entsprechen dem 
aktiven Redoxpaar der FCSD, sind aber, anders als bei der FCSD, nicht durch eine Disulfidbrücke 
verbunden und liegen zu weit entfernt vom FAD, um ein für den Reaktionszyklus der FDR 
typisches kovalentes Intermediat zu bilden. Die Sulfid-Oxidationstasche in der Struktur ist 
unerwarteterweise nicht leer, sondern enthält eine kovalent gebundene Polyschwefelkette, die 
durch TXRF und Massenspektrometrie nachgewiesen wurde und welche vermutlich das Produkt 
der Reaktion darstellt. In den meisten Monomeren, ist die Kette an das Sγ Atom von Cys 156 
gebunden, in Richtung Cys 347 orientiert, umgeben von hydrophoben Aminosäuren und in der 
Nähe des Proton Donor/Akzeptor Paares Tyr 161 – Glu 162 lokalisiert. In manchen Monomeren 
wird eine geschlossene ringförmige Elektronendichte gefunden, die sich mit einem Ring aus acht 
Schwefelatomen (S8) erklären läßt. Die Kette in anderen Monomeren verlängert nicht die 
Seitenkette von Cys 156, sondern von Cys 347. 
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Die Struktur ermöglicht es, eine Hypothese für den katalytischen Mechanismus zu formulieren. 
Entsprechend dieser Hypothese folgt die SQR einer ungewöhnlichen 
Schwefelpolymerisationsreaktion, welche von allen bekannten FDRs abweicht. Im Allgemeinen 
wird das aktive Cystein/Cystin Redoxpaar oxidiert/reduziert und gibt die Elektronen über ein Cys-
Sγ-C4A-FAD Ladungstransfer-Intermediat an FAD ab. Im Gegensatz dazu werden in dieser Arbeit 
zwei unterschiedliche, alternative Mechanismen für die SQR vorgeschlagen, welche im Folgenden 
als „C4A-S“- und „C8M“-Mechanismen bezeichnet werden. Der C4A-S Mechanismus postuliert 
die Bildung eines kovalenten Cys156-Sγ-S-C4A-FAD Zwischenprodukts, ähnlich zu dem 
allgemein angenommenen FDR Zwischenprodukt, aber mit einem zusätzlichen Schwefelatom, 
welches durch das Substrat Sulfid beigesteuert wird und die Protein-FAD Verbindung vermittelt. 
Der C4A-S Mechanismus würde geringe Konformationsänderungen während des Reaktionszyklus 
erfordern, und nur Cys 156 und Cys 347 wären beteiligt. Im Gegensatz dazu würde der C8M 
Mechanismus auch Cys 124 eine aktive Rolle zuordnen und würde die ungewöhnliche Bindung des 
FAD erklären. Dieser Mechanismus schlägt vor, dass Cys 124, durch Sulfid zu der nukleophilen 
Form Cys124-Sγ-S
- aktiviert, das Chinon-Methid-Tautomer von FAD in Position C8M angreift. 
Cys 156 und Cys 347 wären indessen nötig, um die länger werdenden Polyschwefelprodukte zu 
übernehmen und zu beherbergen. Obwohl diese Hypothese mit den strukturellen Beobachtungen 
vereinbar ist, hat der C8M Mechanismus auch Schwachstellen. Erstens spiegeln sich die erwarteten 
weitaus größeren Konformationsänderungen im Vergleich zum C4A-S Mechanismus in der 
Struktur nicht wider, da die niedrigen Temperaturfaktoren eine geringe Flexibilität der 
Polypeptidkette zeigen. Zweitens ist Cys 124 zwar tatsächlich essentiell für einige Arten von SQRs, 
jedoch nicht durchgehend konserviert. 
Unabhängig vom Mechanismus wird der Abbruch der Polymerisierung vermutlich durch den 
limitierenden Platz im aktiven Zentrum ausgelöst. Das tatsächliche Produkt der SQR Reaktion ist 
unbekannt. Trotzdem zeigt die Struktur der A. aeolicus SQR, dass das katalytische Zentrum nur ein 
katalytisch produktives Milieu für Ketten aus bis zu 9-S-Atomen bietet, welche vermutlich 
abschließend zu einem S8 Ring geschnitten werden. Diese Form ist sehr apolar und instabil in 
Wasser und könnte durch einen hydrophoben Kanal abgegeben werden, welcher sich in Richtung 
der in die Membran eingebetteten Region zieht. Auf diesem Weg würde sich der S8 Ring direkt zur 
Membran bewegen und könnte abschließend in so genannten „Schwefelkügelchen“ (engl.: „sulfur 
globules“) eingelagert werden, welche der Zelle, sollte der Nährstoffgehalt in der Umgebung 
abfallen, als Energie Reserve dienen. In A. aeolicus befinden sich diese Kügelchen im Cytoplasma. 
Deshalb könnte die SQR, obwohl sie ein monotopisches und kein polytopisches Membranprotein 
ist, an der zellulären Aufnahme von Schwefel effizient teilnehmen. 
Es sollte erwähnt werden, dass die strukturellen Eigenschaften und die hypothetischen 
Mechanismen, die hier für die SQR von A. aeolicus vorgestellt werden, sich nicht nur von anderen 
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FDR unterscheiden, sondern auch nicht unbedingt universell für alle SQRs gelten. Zum Beispiel 
zeigt die Struktur der SQR des Archaeons Acidianus ambivalens, welche seit kurzem auch zur 
Verfügung steht, signifikante Unterschiede sowohl bei den Schleifen, welche die Sulfid-
Zugangskanäle flankieren, als in der FAD Bindung als auch in der Architektur der Sulfid-
Oxidationsstelle. Diese Daten zeigen eine überraschende und bisher unerwartete Variabilität 
zwischen SQRs, die bisher als homolog angesehen wurden. Deswegen ist es möglich, dass die A. 
ambivalens SQR zumindest in Bezug auf die Sulfid-Oxidation, einem anderen katalytischen 
Mechanismus folgt als die A. aeolicus SQR. Basierend auf dem strukturellen Vergleich, der hohen 
Anzahl an SQR Sequenzen, die nun verfügbar sind, und anhand neuester funktioneller 
Charakterisierung von anderen Mitgliedern der SQR Familie, konnten neue Struktur-basierte SQR 
Sequenzmotive identifiziert werden. Daher wurde die Klassifizierung der SQRs wieder 
aufgegriffen und verbessert.   
Diese Arbeit liefert nach mehr als 20 Jahren weltweiter Forschung an SQRs die erste vollständige 
Struktur einer SQR und eine neue strukturbasierte Klassifizierung für diese Proteinfamilie. Die 
strukturellen Daten liefern zum ersten Mal einen näheren Einblick in die faszinierende, für 
Energieerhaltungs- und Entgiftungsprozesse äußerst wichtige, aber komplexe SQR-Reaktion und 
eröffnen neue Möglichkeiten für die zukünftige Forschung. Einerseits sollte der Mechanismus der 
SQR von A. aeolicus weiter untersucht werden, um zwischen den beiden aktuell vorgeschlagenen 
Hypothesen zu unterscheiden. Andererseits sollten auch die Unterschiede innerhalb der SQR 
Familie näher untersucht werden. Dabei sollte ein besonderer Augenmerk auf die Organismen 
gelegt werden, welche gleichzeitig SQRs unterschiedlicher Art besitzen. Schließlich sollten mit 
Nachdruck eukaryotische SQRs untersucht werden. Diese spielen vermutlich auch im Menschen 
eine Rolle bei der Homöostase von Sulfid, welches ein Vermittler bei der Signalübertragung im 
sympathischen Nervensystem und ein Schlüsselmetabolit bei neurodegenerativen Krankheiten ist. 
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Zusammenfassung 
Diese Arbeit stellt die erste vollständige Röntgenkristallstruktur des Membranproteins 
Sulfid:Chinon Oxidoreduktase (SQR) vor. Die Beschreibung der Struktur, wird durch die 
biochemische und funktionelle Charakterisierung des Enzyms ergänzt.  
SQRs sind ubiquitäre Flavoprotein-Disulfid-Reduktasen (FDRs), die in allen Domänen des Lebens, 
darunter auch im Menschen, vertreten sind. Ihre physiologische Funktion reicht von der 
Sulfidentgiftung bis hin zur sulfidabhängigen Atmung und Photosynthese (in Archaea und 
Bakterien), zur Schwermetalltoleranz (in Hefen) und vermutlich zur sulfidabhängigen 
Signalübertragung (in höheren Eukaryoten). Bis heute war es schwierig, die Funktion der SQRs zu 
verstehen, da diese Familie eine geringe Sequenzidentität aufweist, nur wenig funktionell 
charakterisiert war und keine strukturellen Daten zur Verfügung standen. 
Die SQR wurde in den Plasmamembranen des hyperthermophilen Bakteriums Aquifex aeolicus 
durch einen Peptidmassen Fingerabdruck (PMF) und einen spektrophotometrischen Aktivitätstest 
identifiziert. Das Protein wurde mit dem Detergenz Dodecyl-β-D-maltosid (DDM) solubilisiert und 
in aktiver Form bis zur Homogenität gereinigt. Jedes Monomer bindet ein FAD Molekül, welches 
der einzige Cofaktor ist. Die Struktur der SQR wurde in der „wie-gereinigten“, der Substrat-
gebundenen und der Inhibitor-gebundenen Form mit einer Auflösung von 2,3, 2,0 bzw. 2,9 Å 
bestimmt. Sie besteht aus zwei Rossmann-Domänen und einer Membrankontaktregion. Obwohl die 
Architektur des Monomers derjenigen von FDRs ähnelt, zeigt die Struktur Merkmale, die bisher 
noch nicht beobachtet wurden, jedoch groβe Auswirkungen auf den katalytischen Mechanismus der 
SQRs haben. 
Die SQR von A. aeolicus liegt überraschenderweise im Kristall als Trimer vor, was durch 
analytische Ultrazentrifugation (AUC), Crosslinking und Einzelpartikelanalyse auch als native 
Form in Lösung bestätigt wurde. Das Trimer erzeugt eine passende Oberfläche für die Bindung an 
die Membran und stellt dadurch sicher, dass die SQR ausschließlich membranassoziierte Chinone 
reduziert. Die SQR sitzt als integrales monotopisches Membranprotein bis zu einer Tiefe von etwa 
12 Å in der Membran. Die Interaktion wird durch zwei amphipatische Helices und zwei spezifische 
Lipid-Bindestellen vermittelt. Ein Kanal, der von der Membranbindedomäne zur si-Seite des FAD 
reicht, repräsentiert die Chinon-Bindestelle. Der Chinon-Ring ist zwischen den zwei konservierten 
Aminosäuren Phe 385 und Ile 346 gebunden und wird nach der Reduktion vermutlich von Glu 318, 
Lys 382 und/oder den in der Nähe lokalisierten Wassermolekülen protoniert. Die Sulfid-
Polymerisierung hingegen geschieht auf der re-Seite des FAD. Hier sind die hoch konservierten 
Aminosäuren Cys 156 und Cys 347 kovalent an eine Polyschwefelkette gebunden, die in manchen 
Monomeren die Form eines S8 Rings annimmt und vermutlich das Produkt der Reaktion ist. 
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Schließlich zeigt die Struktur eine ungewöhnliche kovalente Bindung der 8-Methylgruppe von 
FAD zu Cys 124, welche vermutlich eine Disulfidbrücke darstellt.  
Der detaillierte Einblick in das Protein und alle unerwarteten strukturellen Beobachtungen, die hier 
in dieser Arbeit gezeigt werden, deuten auf einen katalytischen Mechanismus der SQRs hin, der 
sich signifikant zu dem der anderen FDRs unterscheidet. In Übereinstimmung mit den strukturellen 
und funktionellen Daten werden zwei Reaktionsmechanismen für SQRs vorgeschlagen. Beide 
erklären wie Sulfid und Chinon in das aktive Zentrum gelangen und binden, wie Elektronen vom 
Sulfid über FAD zum Chinon übertragen werden und wie das Polyschwefelprodukt, das an die 
Polypeptidkette gebunden ist, verlängert und schließlich abgegeben wird. Der Unterschied beider 
Hypothesen liegt in dem kovalenten Protein-FAD Intermediat, das sich während des 
Reaktionszyklus bildet und dessen Struktur experimentell noch nicht bestimmt wurde.  
Interessanterweise zeigt die Struktur der SQR von Acidianus ambivalens, welche seit kurzem auch 
zur Verfügung steht, Unterschiede im aktiven Zentrum und in der FAD-Bindestelle zur SQR von A. 
aeolicus. Diese Variabilität der SQRs deutet darauf hin, dass nicht alle diese Enzyme dem gleichen 
katalytischen Mechanismus folgen, obwohl sie bisher als homolog betrachtet wurden. Folglich, 
wurden die verfügbaren aber widersprüchlichen sequenzbasierten Klassifizierungen der SQR 
Familie wieder aufgegriffen. Da die entscheidenden Sequenzabschnitte nun bekannt waren, erfolgte 
die Einteilung der Gruppen durch einen strukturbasierten Abgleich der steigenden Anzahl an 
verfügbaren Sequenzen und wurde mit den vorhandenen strukturellen und funktionellen Daten in 
Einklang gebracht. 
Diese Arbeit liefert erstmals einen tieferen Einblick in den faszinierenden aber komplexen 
Reaktionen, die SQRs katalysieren, und bietet eine Grundlage für weitere genetische, biochemische 
und strukturelle Untersuchungen. 
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Detailed English Summary 
Experimental determination of the structures and functions of macromolecules is of high 
biochemical, microbiological, pharmacological and medical interest. The most successful approach 
to study biological targets at a molecular level is X-ray diffraction of 3-D crystals, which provides 
high resolution structural information. This method is efficiently complemented by other 
biochemical, genetic or structural tools, such as mass spectrometry, analytical ultracentrifugation, 
mutagenesis, electron microscopy, and a wide variety of spectroscopic techniques. 
Among all biologically relevant macromolecules, membrane proteins are particularly challenging 
targets for structural investigation. It is difficult to express them in high amount and they are 
unstable, soluble only in solutions containing mild amphipathic detergents and not prone to form 
well-ordered crystals. Nonetheless, they are an exceptionally interesting group of proteins, as they 
comprise 20 – 25 % of total proteomes and 60 % of the current drug targets. 
This work describes the structural and functional properties of a membrane enzyme, the 
sulfide:quinone oxidoreductase (SQR) isolated from the native cells of the hyperthermophilic 
bacterium Aquifex aeolicus.  
SQRs belong to the flavoprotein disulfide reductase (FDR) superfamily, together with well-
characterized soluble proteins like glutathione reductase, lipoamide dehydrogenase, thioredoxin 
reductase and trypanothione reductase. At the origin of life, SQRs were essential for catalyzing 
sulfide-dependent quinone reduction, an important reaction that allowed organisms to thrive in the 
sulfidic anoxic conditions of early oceanic environments. They were conserved throughout 
evolution and are currently found in all domains of life, including humans, although being absent in 
plants. They play a physiological role in sulfide detoxification, in sulfide-dependent respiration and 
photosynthesis (in bacteria) and in heavy metal tolerance (in yeast). In eukaryotes, they may be 
involved in sulfide-dependent signalling processes, since sulfide is endogenously produced and acts 
as a “gasotransmitter”. 
At the beginning of this work, no structure was available for any SQR and only few homologues 
had been functionally characterized. Furthermore, sequence conservation among SQRs is very poor, 
so that their classification was partial and contradictory because the determination of the 
functionally relevant sequence fingerprints was uncertain. Until now, their catalytic mechanism had 
been hypothesised on the basis of the structure of Allochromatium vinosum flavocytochrome 
c:sulfide dehydrogenase (FCSD), a protein of the FDR family with only 24 % sequence identity to 
A. aeolicus SQR. 
A. aeolicus SQR was identified in total membrane preparations by denaturing polyacrylamide 
electrophoresis (SDS-PAGE), peptide mass fingerprint mass spectrometry (PMF-MS) and a 
spectrophotometric activity assay. It was solubilized in the detergent dodecyl-β-D-maltoside (DDM) 
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and purified by conventional chromatographic methods in 5 steps, with a final yield of 32 %. The 
protein has a calculated isoelectric point of 4.2 – 4.5, a monomeric molecular mass of 47,388 Da, 
as judged by full-length matrix-assisted laser-desorption ionisation time-of-flight mass 
spectrometry (MALDI-TOF MS) and harbours one tightly-bound flavin adenine dinucleotide 
molecule (FAD), as determined from the absorption spectrum in the visible wavelength range. 
Surprisingly, purified SQR was shown to be trimeric in solution by density-matching analytical 
ultracentrifugation (AUC), crosslinking and single particle electron microscopy. Interestingly, total 
X-ray fluorescence (TXRF) showed that SQR binds a higher number of sulfur atoms than expected 
from the protein sequence. High-resolution mass spectrometric experiments suggest that such 
sulfurs are organised in chains of at least 4 atoms and are covalently attached to the protein. Finally, 
the protein complex is functionally active, possesses micromolar affinity to its substrates, sulfide 
and ubiquinone, and can be competitively inhibited by quinone analogues. The maximal activity 
was detected at 80 °C, the highest temperature tested. The activation energy of the enzyme is of 
about 14 kJ/(K·mol). Particularly remarkable is the stability of the purified complex over time at 
high temperature. Incubated at 80 °C, it retains 50 % activity after 24 h.  
The structure of SQR was studied by 3-D crystallization and X-ray diffraction. Crystals were 
obtained by hanging- and sitting-drop vapour diffusion, by microbatch under paraffin oil and in 
lipidic sponge phase. The hanging-drop vapour diffusion technique was the most successful, 
yielding two crystal forms, hereafter referred to as the hexagonal and the needle crystals, which 
both diffract X-rays at a resolution of better than 2 Å. The protein in both the hexagonal and the 
needle crystals show the same electrophoretic, spectroscopic, mass spectrometric and enzymatic 
properties as the protein in solution and both crystal forms were obtained using ammonium sulfate 
and PEG as precipitating agents. However, their X-ray diffraction properties differ significantly. 
The diffraction of the hexagonal crystals is characterized by high mosaicity and is consequently not 
suitable for data processing, while the needle crystals could be used for structure determination. 
They belong to the space group P212121, with unit cell dimensions of approximately 112 x 154 x 
178 Å
3. They possess 6 molecules in the asymmetric unit and a solvent content of 53 %. The 
molecules are arranged over layers of detergent-filled regions in the crystal lattice, mimicking the 
arrangement of the protein complexes over the cellular membranes. 
The SQR structure was solved to 2.3 Å resolution by de novo phasing using multiple isomorphous 
replacement and anomalous scattering of osmium and gold derivatives (the MIRAS method). 
Model building was done mostly by hand and the initial model was then refined to a final Rfree of 
23.5 % (Rwork is 19.2 %). Soaking with the substrate decylubiquinone and with the inhibitor 
aurachin C was also successful and the corresponding structures were solved by rigid body 
refinement at 2.0 Å and 2.9 Å resolution, respectively. They do not show significant movements of 
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the protein chain, but they do allow unequivocal identification of the SQR quinone binding site, 
which is described for the first time in this work. 
The six SQR monomers in the asymmetric unit are nearly identical. They are each composed of 
two FAD-binding Rossmann-fold domains typical of FDRs and a C-terminal domain distinctive of 
each FDR subfamily. The latter protein region consists of an amphipathic helix-turn-helix motif 
followed by an 18-amino-acid long loop stabilized by two disulfide bridges. The presence of these 
structurally important disulfide bonds suggests that the protein is localized in a periplasmic 
oxidising environment. These disulfides, together with the tight hydrogen-bonding network that 
mediates oligomeric contacts and the large solvent-filled cavities which confer resilience to SQR, 
explain the protein’s high thermal stability.  
The six monomers in the asymmetric unit are associated in two homotrimeric complexes, that have 
a pronounced elliptical shape and a strong polarity. One side, formed by the two Rossmann-fold 
domains, is predominantly negative, while the other side is characterized by clusters of positive 
charges and hydrophobic patches and mediates the interaction with the membrane. From the crystal 
structure, it can be concluded that SQR inserts symmetrically to a depth of about 12 Å into one 
leaflet of the bilayer through the C-terminal amphipathic helices and is therefore classified as an 
integral monotopic membrane protein. Two sulfate ions – chemically analogous to lipidic 
phosphate head groups – are bound to Trp 377 and Trp 391, which might thus represent two clamps 
with affinity for zwitterionic phospholipids. Furthermore, additional sulfates bind between 
neighbouring monomers suggesting that membrane insertion stabilizes oligomerization and, vice 
versa, that the trimer creates an appropriate surface for binding lipids. The coupling between 
membrane insertion, trimerization and enzymatic activity might ensure that SQR exclusively 
reduces hydrophobic quinones and, perhaps, might also facilitate the release of the water-labile 
polysulfur product directly into the apolar lipid bilayer environment. 
The structure also allows a detailed description of the active sites, located around the FAD binding 
pocket. SQR binds FAD covalently, like FCSD. Unexpectedly though, the connection does not 
consist of a classic thiol 8-α-Sγ-cysteinyl bond, but of an indirect 8-α-X-Sγ-Cys124 bond, where 
group X was interpreted as a sulfur atom on the basis of an experimental anomalous difference 
electron density map. This unusual binding mode may affect the reduction potential of FAD, may 
be important for a correct localization of the cofactor in the active site or may even play an active 
role in catalysis. 
The isoalloxazine ring of FAD divides the binding pocket into two cavities. The quinone binding 
site is on the si-face of FAD and is accessible from the membrane through a channel formed 
between the amphipathic helices described above. The shortest distance between quinone and FAD 
is about 3.5 Å, which permits fast electron transfer. The aromatic ring is bound between the 
benzene moiety of Phe 385 and the side chain of Ile 346, while Glu 318, Lys 382 and other water 
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molecules form hydrogen bonds with the quinone and might be involved in proton transfer. The 
fold of the SQR quinone binding site is new and has no similarity with any domain of other FDRs. 
In fact, the corresponding region in FCSD, the closest SQR structural homologue, has a completely 
different architecture, suited for interaction with cytochrome c, the electron acceptor replacing 
quinone in that protein. Moreover, also the SQR sulfide oxidation site shows surprising novel 
features and differs significantly from that of FCSD, despite both proteins catalysing the same 
reductive semireaction. While in FCSD the sulfide oxidation site is exposed to the bulk solvent, in 
SQR it is buried in the protein core on the re-face of FAD. It is accessible through a channel 
characterized by a positive electrostatic surface potential, flanked by the conserved essential 
residue Val 294 and occupied in the structure by four solvent molecules that may mimic the trace 
of the substrate, H2S, approaching the active pocket. Furthermore,  three – and not two, like in 
FCSD – conserved cysteines face the sulfide oxidation site. Cys 124 forms the unprecedented 
indirect bond with FAD, as described above. Instead, Cys 156 and Cys 347 correspond to the redox 
active couple of FCSD, but in contrast to that protein, they are not connected by a disulfide bridge 
and they are too far from FAD to form the covalent intermediate typical of the FDR reaction cycle. 
In fact, the sulfide oxidation pocket is unexpectedly not empty in the structure but contains the 
covalently attached polysulfur chain identified by TXRF and mass spectrometry and presumably 
corresponding to the product of the reaction. In most of the monomers, the chain extends from the 
Sγ atom of Cys 156, is oriented towards Cys 347, is surrounded by hydrophobic amino acids and is 
near the proton donor/acceptor couple Tyr 161 – Glu 162. In some other monomers, it takes the 
form of a ring of 8 sulfur atoms (S8). Finally, in few monomers, it does not extend from Cys 156 
but from Cys 347. 
The structure allows the formulation of detailed hypotheses on the SQR catalytic mechanism and 
suggests that the enzyme performs an unusual sulfur polymerization reaction rather different from 
that of all known FDRs. In general in FDRs, a redox active cystine/cysteine couple is 
reduced/oxidised and transfers electrons to FAD via a Cys-Sγ-C4A-FAD charge-transfer 
intermediate. Instead, two alternative mechanisms are proposed here for SQR and are referred to as 
the “C4A-S” and the “C8M” mechanism, respectively. The C4A-S mechanism postulates the 
formation of a Cys156-Sγ-S-C4A-FAD covalent intermediate, similar to the common FDR 
intermediate, but with an additional sulfur atom contributed by the substrate sulfide to mediate the 
protein-FAD linkage. The C4A-S mechanism would require moderate conformational changes 
during the reaction cycle and would directly involve only Cys 156 and Cys 347. On the contrary, 
the C8M mechanism would attribute an active role also to Cys 124 and would explain its unusual 
linkage to FAD. This mechanism postulates that Cys 124, activated by sulfide to the nucleophilic 
form Cys124-Sγ-S
-, would then attack the quinone methide tautomer of FAD in position C8M. Cys 
156 and Cys 347 would then be necessary to take over and harbour the elongating polysulfur 
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product. Although compatible with all structural observations, the C8M mechanism presents two 
inconsistencies. First, it would require more pronounced conformational changes than the C4A-S 
mechanism, though the structure (low B factors) does not suggest flexibility of any polypeptide 
segment. Second, it is limited by the fact that Cys 124, while essential for some SQR types, is not 
strictly conserved. 
Independent of the mechanism, the termination of the elongation is presumably triggered by the 
limited space of the active site. The true product of the SQR reaction is unknown. Nonetheless, the 
A. aeolicus SQR structure shows that the active site can only provide a catalytically productive 
environment for up to a 9-S-atom chain which is finally most likely cleaved to an S8 ring. The latter 
species is very apolar and water-labile and may be released through a hydrophobic channel 
conducting towards the membrane embedded region. Using this pathway, S8 would move directly 
towards the membrane interior and could finally be incorporated into so called “sulfur globules”, 
particles that the cells may use as reserve when energetic supplies become short. In A. aeolicus 
these particles are accumulated in the cytoplasm so that – while not spanning the bilayer – SQR 
would participate in cellular uptake of sulfur in an efficient manner. 
It must be said that the structural features and the mechanistic hypotheses presented for A. aeolicus 
SQR do not only differ from the other FDRs, but may also not be universal for all SQRs. In 
particular, the structure of the SQR from the archaeon Acidianus ambivalens, which also became 
available recently, shows pronounced differences in the loops that flank the sulfide access channel, 
in the binding mode of FAD and in the architecture of the sulfide oxidation site. These data show 
surprising and previously unexpected variability among SQRs until now considered homologous. 
Therefore, it is possible that A. ambivalens SQR follows a catalytic mechanism different from that 
of A. aeolicus SQR, at least with respect to sulfide oxidation. Based on this structural comparison, 
on the large number of SQR sequences now available and on recent functional characterization of 
other members of the SQR family, new structure-based SQR sequence fingerprints have been 
identified. Consequently, the SQR classification has been revised.  
In conclusion, after more than 20 years of worldwide research, this work contributes the first 
complete structural description of an SQR and a new structure-based classification for this protein 
family. The structural data offer for the first time a detailed look into the intriguing but complicated 
SQR reaction, crucial for energy conservation and detoxification processes and open up new 
possibilities for future research. On one hand, the mechanism of A. aeolicus SQR must be studied 
further in order to discriminate among the currently proposed catalytic hypotheses. On the other 
hand, the variety in the SQR family must be further investigated, with particular emphasis on those 
organisms which possess SQRs of different types. Finally, a high priority is the study of eukaryotic 
SQRs, potentially important in humans for the homeostasis of sulfide, a mediator of sympathetic 
neurotransmission and a key metabolite in neurodegenerative diseases. 
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xxiv ABSTRACT 
Abstract 
This work presents the first complete structure of the membrane protein sulfide:quinone 
oxidoreductase (SQR), obtained by X-ray crystallography. Its description is complemented by the 
results of biochemical and functional experiments. 
SQRs are ubiquitous flavoprotein disulfide reductases (FDRs), present in all domains of life, 
including in humans. Their physiological role extends from sulfide detoxification to sulfide-
dependent respiration and photosynthesis (in archaea and bacteria), to heavy metal tolerance (in 
yeast) and possibly to sulfide signalling (in higher eukaryotes). Until now understanding the 
function of SQRs was difficult because of the poor level of sequence conservation in this enzyme 
family, the limited functional characterization available and the absence of any structural data. 
SQR was identified in the native membranes of the hyperthermophilic bacterium Aquifex aeolicus 
by peptide mass fingerprinting (PMF) and by a spectrophotometric activity assay. The protein was 
solubilized in the detergent dodecyl-β-D-maltoside (DDM) and purified to homogeneity in a 
functionally active state. It binds one FAD molecule per protein monomer and FAD is its only 
cofactor. Its structure was determined in the “as-purified”, substrate-bound and inhibitor-bound 
forms at resolutions of 2.3, 2.0 and 2.9 Å, respectively. It is composed of two Rossmann-fold 
domains and of one membrane-attachment region. Despite the overall monomeric architecture 
being similar to that of FDRs, the structure reveals properties that had not been observed in FDRs 
until now and that have strong implications for the SQR catalytic mechanism. 
Surprisingly, A. aeolicus SQR is trimeric in the crystal structure and in solution, as determined by 
density-matched analytical ultracentrifugation, cross-linking and single particle electron 
microscopy. The trimer creates an appropriate surface for binding lipids and thus ensures that SQR 
exclusively reduces hydrophobic quinones. SQR inserts to a depth of about 12 Å into the 
membrane as an integral monotopic membrane protein. The interaction is mediated by an 
amphipathic helix-turn-helix tripodal motif and two lipid clamps. A channel in the membrane-
binding domain extends towards the si-side of FAD and represents the quinone-binding site. The 
quinone ring is sandwiched between the conserved amino acids Phe 385 and Ile 346 and is possibly 
protonated upon reduction via Glu 318, Lys 382 and/or neighboring solvent molecules. Sulfide 
polymerization occurs on the re-side of FAD, where the highly conserved Cys 156 and Cys 347 
appear to be covalently bound to the putative product of the reaction, a polysulfur chain which 
takes the form of an S8 ring in some monomers. Finally, the structure shows that FAD is covalently 
connected to the protein in an unprecedented way, via a putative disulfide bridge between the 8-
methyl group of the isoalloxazine moiety and Cys 124. 
The high resolution insight into the protein and all unexpected structural observations presented in 
this work suggest that the catalytic mechanism of SQRs is significantly different from that of FDRs. 
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In agreement with the structural and functional data, two reaction schemes are proposed for A. 
aeolicus SQR. They both provide a detailed description of how sulfide and quinones reach and bind 
the active site, how electrons are transferred from sulfide to quinone via FAD and how the 
elongating polysulfur product is attached to the polypeptide and is finally released. The two 
hypotheses differ in defining the structure of the covalent protein-FAD intermediate that forms 
during the reaction cycle and whose identity still remains experimentally undetermined. 
Remarkably, the structure of the active site and the FAD-binding mode of A. aeolicus SQR are not 
conserved in another SQR structure which also became available recently, that of the archaeon 
Acidianus ambivalens. The variability in SQRs suggests that not all of these enzymes follow the 
same catalytic mechanism, despite having been considered homologous. Consequently, the 
currently available but contradictory sequence-based classifications of the SQR family were 
revised. A structure-based alignment calculated on the increasing number of available sequences 
allowed to define new SQR groups and their characteristic sequence fingerprints in agreement with 
the reported structural and functional data.  
In conclusion, the results obtained in this work offer for the first time a detailed look into the 
intriguing but complicated reactions catalysed by SQRs and provide a stimulus for further genetic, 
biochemical and structural investigation. 
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Abbreviations 
The abbreviations used in this work are listed in the following table. 
Table of abbreviations. 
1.  MEASURES AND UNITS DERIVED FROM OR NOT BELONGING TO THE INTERNATIONAL SYSTEM. 
Å angstrom 
°C degrees  celsius 
cal calories 
Da dalton 
ε extinction  coefficient 
eV electron  volt 
h hour 
KM Michaelis-Menten  constant 
L liter 
λ absorption  wavelength 
M molar 
min minute 
Pa pascal 
ppm parts  per  million 
rad radian 
rpm rotations  per  minute 
S svedberg 
U (enzymatic)  unit 
V (as unit)  volt 
V (as measure)  volume 
Vpp  peak power point voltage (also peak-to-peak voltage) 
v/v volume/volume 
w/v weight/volume 
w/w weight/weight 
 
2.  BIOMOLECULES AND NON-CONVENTIONAL CHEMICALS. 
ACN acetonitrile 
AHC  ammonium hydrogen carbonate 
BCA bicinchonin  acid 
BisTris 1,3-bis(tris(hydroxymethyl)methylamino)propane 
CHCA  α-cyano-4-hydroxy-cinnamic acid 
ddH2O  bidistilled water (Millipore) 
DDM (also LM)  n-dodecyl-β-D-maltoside 
EDTA ethylendiaminetetracetic  acid 
FAD flavin  adenine  dinucleotide (oxidised) 
FADH2  flavin adenine dinucleotide (reduced) 
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FCSD flavocytochrome  c:sulfide dehydrogenase 
FDR flavoprotein  disulfide  reductase 
H2S (or HS
- or S
2-) sulfide 
LM see  DDM 
βME 2-mercapto-ethanol 
MES 2-(N-morpholino)-ethanesulfonic  acid 
MPD 2-methyl-2,4-pentanediol 
PEG polyethylene  glycol 
sDHB  super-DHB, mixture of 2,5-dihydroxybenzoic acid and 5-
methoxysalicylic acid 
SDS  sodium dodecyl sulfate 
SQR sulfide:quinone  oxidoreductase 
SQRDL  sulfide:quinone oxidoreductase dehydrogenase-like 
TEMED N,N,N',N'-tetramethylethylenediamine 
TFA trifluoroacetic  acid 
Tris Tris-hydroxymethyl-aminomethane 
UQ ubiquinone 
UQH2 ubiquinol 
Zwittergent N-alkyl-N,N-dimethyl-3-amino-1-alkane  sulfonate 
 
3.  TECHNIQUES AND INSTRUMENTATION. 
AUC analytical  ultracentrifugation 
BN blue-native 
CN clear-native 
HPLC  high performance (pressure) liquid chromatography 
EM electron  microscopy 
ESI electrospray  ionisation 
IEF isoelectric  focusing 
LC liquid  chromatography 
LILBID  laser-induced liquid-beam ionization / desorption 
MALDI  matrix-assisted laser desorption ionisation 
MIRAS  multiple isomorphous replacement with anomalous scattering 
MS mass  spectroscopy 
NCS non-crystallographic  symmetry 
PAGE  polyacrylamide gel electrophoresis 
PMF  peptide mass fingerprint 
SEC size-exclusion  chromatography 
SMART  simple modular architecture research tool 
TLS  translation, libration, screw rotation 
TOF  time of flight 
TXRF  total reflection X-ray fluorescence 
XRD X-ray  diffraction 
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4.  DATABASES AND SOFTWARE. 
3D-PSSM  Three-Dimensional Position-Specific Scoring Matrix 
ARP/wARP  Automated Refinement Procedure 
BLAST Basic  Local  Alignment Search Algorithm 
CCP4  Collaborative Computational Project number 4 
CNS  Crystallography and NMR System 
DM Density  Modification 
EBI  European Bioinformatics Institute 
FASTA FAST-All 
GRASP  Graphical Representation and Analysis of Surface Properties 
NCBI  National Centre for Biotechnology Information 
PDB Protein  Data  Bank 
SCOP  Structural Classification of Proteins 
SHARP Statistical  Heavy-Atom Refinement and Phasing 
T-COFFEE  Tree-based Consistency Objective Function For AlignmEnt 
Evaluation 
TMHMM  Transmembrane Hidden Markov Model 
 
5.  GENERAL ABBREVIATIONS. 
2-D bi-dimensional 
3-D tri-dimensional 
aW water  activity 
CCD charged-coupled  device 
CMC critical  micelle  concentration 
conc concentration 
ED electron  density 
e.g.  exempli gratia (lat., engl.: for example) 
et al.  et alii (lat., engl.: and others) 
eq. equation 
ESRF  European Synchrotron Radiation Facility 
i.e.  in exemplum (lat., engl.: for example) 
LD lethal  dose 
(f)M (fluorescent)  protein  molecular weight marker 
MMP  monotopic membrane protein 
MW molecular  weight 
p.a. per  analysis 
pI isoelectric  point 
RMSD  root mean square deviation 
ROI  region of interest 
SLS  Swiss Light Source 
tR retention  time 
UV/Vis or Vis/UV  ultraviolet/visible 
 
 
xxixABBREVIATIONS 
 
 
 
 
 
 
xxx GLOSSARY 
Glossary 
amphipathic sequence  polypeptide sequence folding as a helix with one polar and 
one apolar face 
assimilatory sulfur metabolism  metabolic pathway involving sulfur compounds and used 
to produce organic S-containing biomolecules (i.e. the 
amino acid cysteine and methionine, coenzyme A, biotin, 
lipoic acid, molybdopterin, thionucleotides and thiamine) 
chemolithoautotrophic organism  organism using only inorganic carbon sources (i.e. CO2) 
for biosynthesis and inorganic chemical energy sources (i.e. 
H2, NH3, NO2
-, Fe
2+, S
2-, S2O3
2- …) 
cyclooctasulfur  the most stable form of zero valent sulfur, taking the 
structure of an orthorhombic S8 ring; it is a very 
hydrophobic molecule, soluble in organic solvents but not 
in water and it has aromatic features because one electron 
pair of each sulfur atom is delocalised across the ring 
dissimilatory sulfur metabolism  metabolic pathway involving sulfur compounds as electron 
donors or acceptors and used to produce cellular energy 
flavoprotein  protein containing an isoalloxazine chromophore 
gasotransmitter  small molecule present in a gaseous state at standard 
temperature and pressure and acting as a tissue hormone 
hyperthermophilic organism  organism thriving at temperatures higher than 80 °C 
isoalloxazine tricyclic  heteronuclear organic molecule derived from 
pteridine and composed of a pyrimidine-2,4-dione, a 
pyrazine and a dimethylbenzyl ring 
integral monotopic membrane protein  membrane  protein constitutively bound to one leaflet of 
biological membranes, but not crossing the lipidic bilayer  
protein  domain  an independently folding part of a protein with defined 
secondary structure 
sulfide  the most reduced form of sulfur, present as a gas at 
standard temperature and pressure in the non-ionised form 
H2S, or as monovalent (HS
-) or divalent anions (S
2-) in 
solution, with pKA values of 6.89 and > 14, respectively 
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1. Introduction 
1.1.  Structure and function of proteins 
Proteins were recognised to be essential macromolecules almost two centuries ago, when G. J. 
Mulders and J. J. Berzelius described in their correspondence the existence of “animal 
substances” formed by a large number of carbon, hydrogen, oxygen and nitrogen atoms and 
containing traces of sulfur and phosphorus (Whitford, 2005). In 1934, it became clear that 
proteins have a regular structure when J.D. Bernal and D. Crowfoot showed that crystals of 
pepsin can diffract X-rays (Bernal and Crowfoot, 1934; Perutz, 1992). It was not earlier than 
1958, though, that the first model of the structural architecture of a protein was obtained, 
thanks to the work of J. C. Kendrew on myoglobin (Kendrew et al., 1958). As of February 23
rd, 
2009, the latest SCOP database release 1.75  (Murzin et al., 1995; Andreeva et al., 2008) 
showed that 38,221 unique entries of protein coordinates were available on the Protein Data 
Bank (PDB)
1. They can be classified in 1,195 folds, 1,962 superfamilies, 3,902 families and 
110,800 domains. 
As John Kendrew and coworkers wrote about the structure of myoglobin, “complexity and lack 
of symmetry” are certainly remarkable in protein structures (Kendrew et al., 1958). These 
features reflect though the requirements for proteins to be endowed with diverse functions 
(Branden and Tooze, 1998). There is a strict interdependence between the amino acid sequence 
of a protein, the structures it can adopt and the functions it performs. While it has to be 
considered that evolution acts on genotypes, in other words on the protein sequences, natural 
selection actually occurs on phenotypes, that is to say on the protein function. Because of this 
discrepancy, the paradigm “similar sequence – similar structure – similar function” does not 
universally hold (Martin et al., 1998) (Table 1.1). 
In general, homologous proteins
2 tend to develop similar folds and functions but exceptions are 
numerous. For instance, human α-lactalbumin and chicken egg-white lysozyme are 
homologous, sharing 40 % sequence identity and the same structural fold, but lactalbumin does 
not possess the hydrolase activity of lysozyme (Kumagai et al., 1992). Even 100 % identical 
protein sequences can possess different functions. This extreme is the case of “moonlighting 
proteins” (Jeffery, 1999) and of “promiscuous enzymes” (Khersonsky et al., 2006). In addition, 
polypeptides with identical amino acid sequences may adopt different tertiary folds and even 
different secondary structures, as is the case for the so called “chameleon sequences” (Minor 
                                                 
1 The total number of PDB entries was 55,842 on Feb 23
rd, 2009 and it has increased to 62,634 until Jan 15
th, 
2010. 
2 Two proteins are defined as homologous if they have a common ancestor (Whitford, 2005). 
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and Kim, 1996) (Figure 1.1).  
The examples mentioned above represent cases of divergent evolution of similar protein 
sequences. The opposite case of non-homologous sequences evolving in a convergent manner 
has also been widely reported. For example, TIM-barrel proteins – named after the 
triosephosphateisomerase (Banner et al., 1975) – are enzymes whose sequences are strongly 
divergent, such that it is unlikely that they descend all from the same ancestor. They also 
catalyse different reactions with representatives in almost 30 different enzyme classes. 
Nonetheless, they all present the same fold, an eight-stranded α/β-barrel, which was probably 
selected during evolution because it constitutes a favourable structural solution in forming a 
closed stable β-barrel (Lesk et al., 1989). A different case of convergent evolution is 
represented by serine proteases (i.e. trypsin and subtilisin) that possess significantly different 
sequences and structures but catalyze their 
enzymatic reaction following a very similar 
mechanism (Robertus et al., 1972). Last but 
not least, proteins may also substantially 
differ in their primary structure but have 
both a similar fold and a similar function, 
like  Vitreoscilla stercoraria and Perkinsus 
marinus haemoglobin that share only 8% 
sequence identity. 
In the absence of a general paradigm that 
relates sequences to structures and to 
functions and given the complication of 
macromolecular folding processes, accurate 
de novo structure prediction is difficult and 
Table 1.1: Sequence-structure-function relationships
a. 
evolution sequence  structure  function examples 
+ + +  general  paradigm 
+ + –  lactalbumin vs lysozyme, moonlighting proteins, 
promiscuous enzymes 
divergent 
+ –  +/–  chameleon  sequences 
– + +  V. stercoraria vs P. marinus haemoglobin 
– + –  TIM  barrels 
– – +  serine  proteases 
convergent 
– – –  general  paradigm 
a + indicates similarity, – indicates difference. 
 
Figure 1.1: Chameleon sequences. Chameleon
sequences represent one of the many exceptions to the
paradigm “similar sequence – similar structure – similar 
function”. The Figure shows a ribbon diagram in blue of
the structure of the IG-binding domain of protein G
(GB1). The same 11-amino-acid sequence
AWTVEKAFKTF (light blue) was alternatively
substituted in two different segments of the native GB1
sequence. Depending on the position, it adopts two
different secondary structure folds. The Figure is 
reproduced from Minor and Kim, 1996. 
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unreliable. Therefore, experimental determination of the structures and functions of biological 
macromolecules remains necessary. Ultimately, the description of structural-functional 
relationships is relevant to many scientific fields. Combined structural and functional data 
contribute to explaining the dynamics of biological and cellular processes. Additionally, they 
reveal a physico-chemical description of natural reactions providing ideas for reproducing 
them artificially. Finally, they are highly valuable from a medical and pharmacological 
perspective, because they provide the basis for the study of pathological states at the molecular 
level, thereby opening up possibilities for rational drug development. 
1.1.1.  Structure and function of enzymes 
Enzymes (from Greek, en + zyme, “in yeast”) are particularly attractive targets in the study 
of structural-functional relationships because specific structural features determine their 
high specificity in substrate binding and their high efficiency in catalysing chemical 
reactions otherwise impossible at standard temperature and pressure (Fersht, 1999). The 
general shape of the active site, the physico-chemical properties of the catalytic residues, 
their spatial localization and in some cases the presence of cofactors offer an optimal 
environment for reactions to occur with lowered activation energy and therefore with 
higher probability and speed. Nonetheless, the number of catalytically important amino 
acids in one enzyme is very low with respect to the total size of the protein. Therefore, 
enzymes, more than other proteins, are likely to represent exceptions to the paradigm 
“similar sequence – similar structure – similar function” (Martin et al., 1998). More often, 
enzymes respect a different paradigm “similar cofactor/ligand – similar structure – similar 
function” (Martin et al., 1998). For instance, the three-layer αβα Rossmann fold 
(Rossmann et al., 1974) is a widely preferred structural motif in proteins binding 
nucleotides (NADH, NADPH, flavins) (Martin et al., 1998). However, this paradigm is by 
far also not universal (see following Chapter 1.1.2). 
Therefore, structural and functional investigation on enzymes is particularly necessary for a 
detailed understanding of their catalytic cycles. Ideally, a comprehensive view would be 
obtained from the structures of the enzyme and of its complexes with substrates, 
intermediates, products and inhibitors. 
Systematic scientific approaches for characterizing enzymes can be said to have started in 
1897 when H. and E. Buchner discovered that cell-free yeast extracts could transform 
sugar into alcohol (Fersht, 1999). Structural investigation was opened in the late 1920s by 
the successful crystallization of urease by J.B. Sumner and of pepsin by J.H. Northrop. The 
first three-dimensional structure of an enzyme, lysozyme, was solved in 1965 by D. C. 
Philips and coworkers (Blake et al., 1965). Starting from the years 1999 – 2000, crystal 
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structures beyond 3 Å resolution became available for ribosomes, the most complex 
protein-RNA catalytic assemblies, thereby achieving a milestone in the field of 
macromolecular crystallography (Ramakrishnan and Moore, 2001). Nonetheless, despite 
the tremendous developments of X-ray crystallography and the increasing number of 
available structural as well as enzymological data, further and deeper investigation is 
required because exciting and often unpredictable properties of enzyme functions are still 
continuously being revealed (De Colibus and Mattevi, 2006). 
1.1.2.  Structure and function of flavoenzymes 
Flavoenzymes are enzymes containing a heterocyclic isoalloxazine chromophore (Figure 
1.2), a remarkably versatile and still poorly understood molecule in terms of chemical 
reactivity and mechanistic properties. 
Flavoenzymes can catalyse a wide variety of 
reactions, including dehydrogenation, one- 
and two-electron transfer reactions, light 
emission, oxygen activation and 
hydroxylation (Fraaije and Mattevi, 2000).  
They display a variety of folds, including 
the (α/β)8 barrel fold, the p-hydroxybenzoate 
hydroxylase (PHBH) fold, the flavodoxin-
like fold, two- or three-(α+β) domains or 
other dinucleotide-binding multidomains 
(Fraaije and Mattevi, 2000) (Figure 1.3). 
Conserved features in the cofactor binding 
pocket of different flavoenzymes are a positive charge or dipole near the N
1-C
2=O
2 flavin 
region and a hydrogen-bond donor near the N
5 isoalloxazine atom (Fraaije and Mattevi, 
2000). However, some flavoenzymes bind their cofactor in a covalent manner, others not. 
In addition, covalent binding may occur in different positions of the isoalloxazine group 
(Heuts et al., 2009). 
 
Figure 1.2: The structure of flavomolecules. The
representation shows the oxidised form of flavin 
adenine dinucleotide (FAD). It is composed of the 
isoalloxazine group, a triciclic aromatic ring (light
yellow), the ribitol-5-phosphate group (dark yellow), the
ribose-5-phosphate group (light brown) and the adenine
group (grey). Other flavomolecules of biological 
relevance are riboflavin, composed of the isoalloxazine
and the ribitol group, and flavin adenine
mononucleotide (FMN), consisting of the isoalloxazine
and the ribitol-5-phosphate group. 
Concerning substrate binding and substrate-flavin interactions some features are conserved 
among flavoenzymes. The location of the atom attacking the flavin is typically located 3.5 
Å from the N
5 atom, forming an angle of 96 – 117° with atoms N
5 and N
10. In addition, 
substrate binding to flavoenzymes quite commonly occurs through a channel and the active 
site is often shielded from the bulk solvent (Fraaije and Mattevi, 2000). However, there are 
exceptions to this rule and the substrates of flavoenzymes are also very different in 
chemistry and size, requiring completely different architectures of the binding pockets. 
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Figure 1.3: Structural folds of flavoenzymes. The proteins are shown as light blue cartoon representations. 
The flavin ligand (FMN or FAD), represented in black sticks, is approximately oriented in the same direction in 
all panels. Old yellow enzyme (PDB id.: 1OYB) possesses the (α/β)8 barrel fold (A), D amino-acid oxidase 
(1DDO) the PHBH fold (B), NAD(P)H quinone reductase (1QRD) the flavodoxin-like fold (C), vanillyl-
alcohol oxidase (2VAO) the two-(α+β) domain (D), and flavocytochrome c3 (1QJD) the dinucleotide-binding 
multidomain (E). 
In conclusion, flavoenzymes are outstanding exceptions to the paradigms “similar 
sequence – similar structure – similar function” and “similar cofactor / ligand – similar 
structure – similar function” (Fraaije and Mattevi, 2000). Consequently, this protein group 
has been recently indicated as an exciting research area for the investigation of structural-
functional relationships (De Colibus and Mattevi, 2006). 
1.2.  Three-dimensional crystallography and X-ray diffraction 
Currently, three techniques are most suitable for obtaining high-resolution structures of 
macromolecules
3, namely X-ray diffraction (XRD) (54,018)
4, nuclear magnetic resonance 
spectroscopy (NMR) in solution (8,175) or in solid state (35) and electron microscopy (EM) 
(290). Other experimental models available on the PDB were additionally obtained by fiber 
diffraction (35), neutron diffraction (37), solution scattering (35), powder diffraction (18), 
infrared spectroscopy (4) and fluorescence transfer (1). 
The statistics show that XRD has been by far the most successful method used to solve 
macromolecular structures. This is due to a number of reasons. XRD studies can be performed 
(i) with the majority of biomolecules, (ii) with macromolecules of a broad molecular mass 
range
5, (iii) to high resolution limits
6 and (iv) with advanced high-throughput technologies and 
                                                 
3 The methodologies considered hereafter are all those used to create models of macromolecular structures 
accepted as entries in the PDB. 
4  The numbers in parentheses refer to the number of all PDB depositions obtained with the respective 
technique as of Jan, 15
th 2010. On the same day, the total number of PDB entries was 62,634. The sum of 
the values in parentheses exceeds this number because some entries were obtained by a combination of 
methodologies. 
5 One of the largest available structures is the Thermus thermophilus 70 S ribosome bound to EF-Tu and 
tRNA, whose coordinates are split among PDB entries 2WRN, 2WRO, 2WRQ and 2WRR. The biological 
unit of this complex has a molecular weight of 2.3 MDa. 
6 As of Jan, 15
th 2010 the highest resolution X-ray structure deposited in the PDB was 1EJG (Jelsch et al., 
2000), corresponding to the 46-residue-long amphipathic crambin, a membrane-toxic-like protein from the 
plant Crambe abyssinica. It was solved at a resolution of 0.54 Å. 
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dedicated facilities. 
However, XRD studies present disadvantages, too. They require (i) target crystallizability, (ii) 
sophisticated experimental stations, (iii) acquisition of complete and high quality diffraction 
data, (iv) experimental phase determination and most often (v) complementary information for 
interpreting the electron density map and for establishing structural-functional relationships. 
1.2.1.  Three-dimensional crystallography 
The prerequisite for successful 3-D crystallization experiments is a sample of high purity 
and homogeneity in milligram amounts
7. Such a sample is then subjected to sparse matrix 
or customised screening to search for the optimal crystallization condition. Most 
commonly, macromolecular crystals are grown by vapour diffusion, by evaporation, by 
free interface diffusion, by dialysis or in 
batch under oil (McPherson, 1999; 2009). 
 
Figure 1.4: Phase diagram for vapour diffusion
crystallization. At t0 the protein solution is mixed with
buffer containing a precipitating agent (0) and
equilibrated against the same buffer. During
equilibration the concentration increases. If the protein
solubility barrier is not crossed (1), the protein remains
in solution. If the solution becomes saturated (2), the
protein precipitates. In favourable cases, the solubility
barrier is crossed slowly and a supersaturated solution is
formed (3, 4 and 5) In the supersaturated labile region
nuclei form spontaneously (3 and 4). In the metastable 
region, nucleation can be induced by seeding,
mechanical stimulation or other techniques (5). Ideally, 
few nucleation points form and few but large crystals
grow in the drop (4). The representation of the structure
and of the crystals are taken from this work (see Results
section). 
Vapour diffusion is the most widely used 
technique. A typical vapour diffusion setup 
consists of a sealed chamber. In one region 
of the chamber, there is a reservoir solution 
generally composed of a precipitating agent, 
salts, a pH-buffering system and optional 
additives in water. In a separate region of 
the chamber, a drop of reservoir solution is 
mixed with the purified sample. According 
to whether the drop sits on or is hanging 
from a support, these are referred to as 
sitting- or hanging-drop vapour diffusion 
experiments. Figure 1.4 shows the time 
course of the phase diagram in such a 
crystallization setup. At initial time t0, the 
reservoir solution has a lower water activity 
(aw)
8 than the sample-reservoir drop. Water 
evaporates from the drop until an 
equilibrium is established (generally within 
                                                 
7 2 mg of sample (that is e.g. 200 µL at 10 mg/mL) was recently suggested as a starting point for initial 
sparse-matrix screening (Newby et al., 2009). 
8 Water activity is the vapour pressure of water in a given medium over the vapour pressure of pure water at 
the same temperature. 
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hours or days). The aw at equilibrium tends to correspond to the aw of the reservoir solution, 
because the volume of the reservoir solution is much greater than that of the drop (typically 
by a factor of 100 or 1000). Over time (weeks – months), water escapes the whole chamber 
despite it being tightly closed, so that the equilibrium shifts towards even lower aw values. 
During the process, the protein and precipitant concentrations increase and may cross the 
solubility barrier, so that the protein precipitates to a solid state. If the process occurs in an 
appropriate buffer environment and with appropriate kinetics, a metastable supersaturation 
condition forms temporarily. In such state, nuclei can form and induce precipitation of the 
sample in a regular array, a three-dimensional crystal. 
The formation of crystal contacts is a delicate and unpredictable process. Sample instability 
and flexible regions can hamper crystallization. A number of physical and chemical 
parameters also affect the crystallization process and need to be controlled, i.e. temperature, 
pressure, mechanical stimulation, the geometry of the setup, the chemical structure and 
concentration of the components in the crystallization drop and the pH and ionic strength 
of the solution.  
Crystals should be optimized to a size of approximately 0.1 – 1 mm in the three dimensions 
to be suitable for X-ray exposure, although it is nowadays already possible to obtain useful 
diffraction data with microcrystals of 5 – 20 µm in thickness. For X-ray crystallographic 
analysis, the crystals need to be extracted from the mother liquor with appropriate nylon 
loops or with glass capillaries. Exposure to the X-ray beams can be performed at room 
temperature or in a frozen state. Measurements at low temperatures reduce the damaging 
effect that radiation has on the crystal. However, freezing may distort crystal packing and 
lower diffraction quality, so appropriate cryo-protection is necessary. For initial tests, new 
robotic setups also offer the possibility to test diffraction by direct exposure of the 
crystallization plate to the X-ray beam. 
1.2.2.  Crystallization of membrane proteins 
Crystallization of membrane proteins is particularly challenging because of the intrinsic 
properties of these proteins (Michel, 1991; McPherson, 1999; Iwata, 2003). In the first 
place, the production of correctly folded, stable and abundant membrane proteins is 
difficult (Ostermeier and Michel, 1997; Michel, 2006). Additionally, membrane proteins 
which are composed of two hydrophilic surfaces on the two sides of the membrane, 
separated by a hydrophobic core, need to be solubilized using mild detergents. The choice 
of the optimal detergent is crucial for the stability of the protein and is a determining factor 
of its “crystallizability”. The presence of the detergent might hamper the formation of 
crystal contacts, it might distort the crystal lattices or it might induce phase separation in 
 
71.  INTRODUCTION 
the crystallization drops. Moreover, the detergent itself may crystallize in place of the 
protein (Michel, 2006). 
In order to facilitate and improve the crystallization of membrane proteins, a number of 
dedicated strategies were developed. (i) Small amphiphiles, compounds like heptane-1,2,3-
triol or benzamidine which form mixed micelles with the detergents, can be used to 
modulate the shape and the size of the micelles in a favourable way (Michel, 1983). (ii) 
The hydrophilic surfaces of membrane proteins, which form the crystal contacts, may be 
extended by co-crystallization with antibody fragments (Ostermeier et al., 1995; Hunte et 
al., 2000) or by insertion of large soluble domains into intra- or extra-cellular loops 
(Cherezov et al., 2007). (iii) Addition of lipids may facilitate the crystallization process, 
because lipids bind membrane proteins, contribute to their functional and structural 
integrity and occasionally provide lattice contacts, too (Palsdottir and Hunte, 2004; Hunte 
and Richers, 2008). (iv) Two crystallization techniques were specifically established to 
obtain crystals of membrane proteins, namely the bicontinous lipidic cubic phase (Landau 
and Rosenbusch, 1996) and the sponge phase (Wadsten et al., 2006) methods. 
1.2.3.  Experimental setup for X-ray diffraction 
A typical experimental setup for XRD is composed of an X-ray source, a crystal holder and 
an X-ray detector. 
The spectrum of X-ray radiation used to measure macromolecular crystals is the 
wavelength range 0.5 – 1.9 Å, corresponding to the size and length of atoms and molecular 
bonds. Such X-ray beams are sufficiently strong to penetrate the samples, but soft enough 
to interact with matter and to be scattered (Blow, 2002)
9. Two sources of this X-ray 
waverange are widely used. In a rotating anode generator, an electron beam is emitted from 
a heated wire (cathode) at -30 / -40 kV towards a copper anode
10. Excitation of copper 
leads to emission of an X-ray spectrum characterized by two particularly intensive bands. 
Through mirrors, the Kα band is selectively filtered and used for measurement. The X-ray 
beam produced by rotating anode generators
11 has a diameter of approximately 200 µm at 
the sample, a fixed wavelength (1.54178 Å for copper) and a brightness of 3·10
9 – 8·10
9 
                                                 
9 Instead, X-rays used for medical radiography are more penetrating and more weakly interacting with matter 
(λ < 0.2 Å).  
10 Anodes made of chromium, molybdenum, copper/chromium or copper/cobalt are also available but less 
common. 
11  The following specifications refer to the rotating anode generators used in this work, namely the 
MicroMax-007 HF source equipped with the RaxisIV
++ image plate detector and the FR-E+ SuperBright 
source equipped with the Saturn 944+ CCD detector, all produced by Rigaku. Full specifications can be 
found at http://www.rigaku.com. 
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photon/s/(0.1 % BW)/mm
2/mrad
2. In a synchrotron
12, the electrons are produced in bunches 
by a tungsten cathode at 90 – 100 keV, accelerated in a linear accelerator (LINAC), further 
accelerated in a circular booster and finally stored in a ring of approximately 30 – 2000 m 
in diameter at an energy of 2 – 6 GeV. The storage ring is composed of linear segments 
where the electrons are accelerated and of turns where the electron beam is bent by 
magnets. When their trajectory deviates, electrons lose energy by emitting X-rays 
tangentially. Sophisticated optical elements modulate the emitted X-ray beam to optimize 
its focus, monochromaticity and intensity. In third generation synchrotrons, particularly 
bright beams are not produced with bending magnets, but with undulators, so called 
insertion devices consisting of permanent magnets arranged in a periodic array and inserted 
into the straight sections of the storage ring. The X-ray beam produced in such a 
synchrotron beamline has a diameter of 5 – 50 µm, an often tunable wavelength in the 
range of 0.6 – 2 Å (20 – 6 keV) and a brightness of 10
18 – 10
21 photon/s/(0.1 % 
BW)/mm
2/mrad
2. 
Another essential component of an X-ray generator setup is the goniometer head, which 
holds and rotates the crystal during exposure. With the help of a digital camera, the crystal 
can be centred and aligned in the X-ray beam. A few millimetres before contacting the 
crystal, the X-ray beam is additionally focused by a collimator. Behind the crystal, a beam 
stop absorbs the unscattered beam, 99 % of the total incident beam intensity, thereby 
improving the signal-to-noise ratio of the diffraction image. 
The third essential component of an X-ray diffractometer is the detector that collects the 
scattered beam. Three kinds of detectors are currently used in macromolecular 
crystallography and have replaced the photographic films used in earlier times (Blow, 
2002). They differ in sensitivity, in recording speed and in dynamic range. Image plates (IP) 
contain phosphorus that absorbs X-ray photons and relaxes by fluorescence. Image plates 
are relatively slow (read-out time of 100 s) and have a limited dynamic range, up to 
1:50,000. Charge-coupled devices (CCDs) are more rapid (read-out time of 1 s) and 
sensitive, with a dynamic range up to 1:150,000. They capture X-rays through a 
photoactive region, a layer of silicon acting as a series of capacitors, that accumulate an 
electric charge proportional to the X-ray intensity. The capacitors are all integrated in a 
controlling circuit, which digitizes the electrical signal and “reads” the image. Finally, 
pixel detectors, like the Pilatus 6M detector developed at the Swiss Light Source, are also 
silicon detectors. However, differently than in CCDs, each pixel (170 x 170 µm
2) is 
                                                 
12 The following specifications refer to the synchrotron sources used in this work, namely the third generation 
synchrotrons Swiss Light Source (SLS), Villigen, Switzwerland (http://sls.web.psi.ch)  and European 
Synchrotron Radiation Facility (ESRF), Grenoble, France (http://www.esrf.eu). 
 
91.  INTRODUCTION 
Figure 1.5: X-ray diffractometer set-up. X-rays produced by a source (in this representation, a synchrotron) 
pass through a crystal hold by a loop or a capillary and hanging at a goniometer. The scattered beams interfere 
constructively if the Bragg’s law is satisfied and produce diffraction spots on a detector. The spatial scale of the
experiment is not respected, therefore approximate distances and sizes of the components are indicated. 
associated to its own amplifier, discriminator and counter circuit, thus conferring on the 
hardware much higher sensitivity and a dynamic range of 1:1,000,000. Pixel detectors are 
also faster in data acquisition (read-out time of 5 ms), because they are associated to a 
number of read-out channels 10 – 100 times higher than CCDs. 
Finally, additional equipment of an X-ray diffraction setup are an optional flux of nitrogen 
vapour at approximately 100 K for measurements in the frozen state and an X-ray 
fluorescence detector to measure the fluorescence emission properties of the crystal. Figure 
1.5 summarizes the components of an X-ray diffractometer. 
1.2.4.  X-ray diffraction theory 
Atoms are surrounded by electronic orbitals that are distributions of the probability of 
finding an electron in a given region around the nucleus and that therefore reflect the shape 
of the atomic electron density (ED). When more atoms are bound to each other to form a 
molecule, the ED distribution takes a complicated three-dimensional (3D) shape, but its 
intensity can still be described as a function of the molecular volume. In a regular 3D array 
of molecules, the ED function is periodic. 
A macromolecular crystal is a regular 3D array. Its minimal unit is called the unit cell. By 
simple translation of the unit cell along the crystal axis, the whole crystal volume can be 
filled. A unit cell may contain multiple asymmetric units related to each other by 
crystallographic symmetry elements (rotation or screw rotation axis) that define the space 
group of the crystal. The asymmetric units may themselves contain multiple copies of the 
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target molecule, related to each other by non-crystallographic symmetry (NCS), which 
refers to symmetry operations not compatible with the periodicity of the crystal. 
A crystal can be represented as a lattice, with each lattice point corresponding to a unit cell 
and separated from the neighbouring ones by distances corresponding to the unit cell 
dimensions (indicated by a, b and c). A plane drawn through the lattice points is defined as 
lattice plane. Moreover, a lattice plane set is a series of lattice planes parallel and 
equidistant from each other, such that all lattice points are intersected by one plane in the 
set and that each unit cell axis is divided by the set into equal parts. The dividers are called 
Miller indices and are indicated with h, k and l for the dimensions a, b and c, respectively. 
In a lattice plane set hkl, the distance between the planes is indicated with the symbol dhkl 
and it is measured in angstroms (Å). Given a crystal (its unit cell dimensions) and a 
minimal spacing dhkl min, it is possible to draw a fixed number of lattice plane sets, 
independent of the structure of the crystallized macromolecule and given by: 
Nsets = 4πVuc/3(dhkl min)
3     (eq.  1) 
where Vuc indicates the volume of the unit cell. 
When an X-ray beam interacts with an atom, a small percentage of photons excites its 
electrons and it is re-emitted in all directions as a beam of the same energy and frequency 
of the incident beam (elastic or Thomson scattering). The intensity of the scattered beam is 
proportional to the atomic ED. The scattered beam in one direction is composed of all 
photons scattered by the different atom positions. While all incident photons are in phase, 
the scattered photons are out of phase, since they have run a different light path, so they 
interfere with each other. The phase difference determines whether the interference event is 
constructive or destructive. Therefore, it also contributes to defining the intensity of the 
scattered beam. The function describing the beam scattered by an atom is called the atomic 
structure factor, fA: 
fA = r∫ρ(r)exp(2πir·S)dr     (eq.  2) 
where ρ(r) is the ED function and 2πir·S is an expression for the phase of the beams 
scattered by each position (r) around the atom. 
The beam scattered by a unit cell is the sum of the structure factors of each atom 
composing it, corrected by their phase difference relative to the origin of the unit cell. Its 
function is called the structure factor, F(S): 
F(S) = R∫fAexp(2πiR·S)dR    (eq.  3) 
where fA is the atomic structure factor defined above and R indicates the distance from the 
origin of the unit cell. 
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Analogously, the beam scattered by a crystal is the sum of all beams scattered by each unit 
cell and corrected by their phase difference. As a reference, it can be considered that 
macromolecular crystals have unit cell dimensions in the range of 100 Å and that the 
diameter of the incident beams produced i.e. by synchrotron sources is approximately 10 
µm. Therefore, approximately 1000 unit cells in one direction are contemporarily exposed. 
Because each position of a crystal scatters the X-ray beam in all directions and because all 
scattered beams have different phases, their interference is in most orientations a 
destructive event and the signal is cancelled out. Interference of the scattered beams is 
constructive only in precise directions, defined by Bragg’s law: 
nλ = 2dhklsinθ      (eq.  4) 
where n is an integer, λ the wavelength of the incident beam, dhkl the spacing of a lattice 
plane set and θ the angle between the lattice planes and the incident beam. During exposure, 
rotation of the crystal brings successively each set of lattice planes to form an angle θ with 
the incident beam satisfying Bragg’s law. 
The scattered beam in each of the directions that satisfy Bragg’s law is recorded on the X-
ray detector as a spot, called a reflection. Ideally, in each direction, the scattered beam 
should have the same diameter of the incident beam (5 – 200 µm) and therefore its signal 
should be recorded as a sharp peak on one single pixel on the detector (100 x 100 µm
2). 
However, due to imperfections in the crystal, broadening occurs and the intensity of each 
reflection spreads as a Gaussian distribution over few detector pixels. 
Each reflection is indicated with the same indices h, k and l as the lattice plane set from 
which it is produced and it corresponds to a precise dhkl. Reflections originating from sets 
of lattice planes very close to each other (small dhkl) carry high resolution information, 
while reflections originating from sets of lattice planes far from each other (large dhkl) carry 
low resolution information. Geometrically, sets of lattice planes close to each other form 
large θ angles with the incident beam and, vice versa, sets of lattice planes far apart from 
each other form smaller θ angles. Consequently, high resolution reflections are formed by 
the beams scattered further from the direction of the incident radiation whereas the low 
resolution reflections are found in the centre of the detector (Figure 1.6). The intensity of 
each reflection hkl is proportional to the second power of the structure factor and 
consequently to the ED across the set of lattice planes hkl: 
Ihkl = k|Fhkl|
2      (eq.  5) 
k = [λ
3/(ωVuc
2)][e
2/(mec
2)]VcI0LPA 
where k is a parameter that depends on the wavelength of the incident beam (λ), on the 
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angular speed of rotation (ω), on the 
volume of the unit cell (Vuc), on the 
charge of the electron (e), on the 
mass of the electron (me), on the 
speed of light (c), on the volume of 
the crystal (Vc), on the intensity of 
the incident beam (I0), on the 
Lorentz factor (L), on a polarization 
factor (P) and on an absorption 
factor (A). 
As can be seen from Bragg’s law 
(eq. 4), each reflection originates 
from one lattice plane set. Therefore, 
each contains partial information 
about the whole unit cell. 
Combining all pieces of information 
from all (at least  90 %) possible reflections that can be generated by a crystal (see eq. 1) is 
necessary to reconstruct the full structure of the target. This process consists of indexing 
the diffraction images to determine the space group which the crystal belong to, integrating 
the intensities of each reflection and finally scaling them to compensate for small beam 
fluctuations during data collection. The result is a collection of intensities and hkl indices 
of all reflections produced by the target crystal. Such a data set is characterized by its 
completeness and its redundancy, defined by the following equations: 
 
Figure 1.6:  X-ray diffraction from a crystal lattice.
For clarity, the representation has been drawn in two 
dimensions only. The set of lattice planes (1,1), 
separated by d1,1 < d1,0 carries information at higher 
resolution than the set (1,0). It corresponds to an 
incident angle θ1,1 > θ1,0 and therefore it generates a 
diffraction spot further from the beam centre. The insets 
show the geometrical construction of the Bragg’s law 
for the two lattice plane sets, respectively.  
completeness = Nur/Nup     (eq.  6) 
redundancy = Ntr/Nur     (eq.  7) 
where Nur is the number of unique recorded reflections, Nup the number of unique possible 
reflections and Ntr the number of total recorded reflections. 
1.2.5.  The phase problem 
In a classical light microscope, the beams scattered by the sample are converged by lenses 
and the original image is recomposed. Instead, it is not possible to produce appropriate 
lenses for X-rays because (i) it is impossible to shape materials, that are formed by atoms, 
so accurately to recompose sharp images at atomic size, and (ii) the X-ray refractive index 
of all material is very close to that of a vacuum (Blow, 2002). Consequently, an X-ray 
detector cannot record a picture of the electron density of the exposed crystal, but only the 
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scattered beams. In other words, in a diffraction experiment the periodic ED function, 
characterized by amplitudes and phases, is “transformed” into a list of reflections, 
indicating the intensities and positions of the scattered beams. This operation corresponds 
in mathematics to the Fourier Transform (FT) operation. Therefore, it can be said that the 
diffraction pattern of a crystal is the FT of its electron density distribution. The FT is a 
reversible operation, so that applying a reverse FT to the diffraction data set enables the 
recalculation of the ED function. However, the phase information of the interfering 
scattered beams is lost during the diffraction experiment and has to be independently 
determined. This is called the phase problem in X-ray crystallography. 
Three major strategies have been developed to solve the phase problem. These are 
molecular replacement, isomorphous replacement and anomalous dispersion.  
Molecular replacement is an indirect method that can be used if a structure of a template 
similar
13 to the target is available. The method consists of finding the best superposition of 
the template over the target molecule. This is a six-dimensional problem. Three rotational 
and three translational parameters (or, in other words, a rotation and a translation function) 
have to be defined to fit the template optimally into the target unit cell. The calculation is 
possible by comparing the Patterson functions
14  of target and template, respectively, 
because the Patterson function can be calculated without additional phase information. 
Once the best template orientation is found, the phases of the template are used to calculate 
an initial ED of the target. 
Isomorphous replacement and anomalous dispersion are two ab initio methods used to 
solve the phase problem. They exploit two different properties of heavy atoms
15 naturally 
present or artificially introduced into the target crystal. 
Isomorphous
16  replacement exploits the high scattering intensity of heavy atoms. It 
combines information from the data set of the untreated target and one or more data sets of 
the target derivatized with heavy atoms. The presence of additional atoms in the crystal 
changes its structure factor, and so the recorded intensities of the reflections. The 
                                                 
13 “Similar” means here similar in 3D structure. A cut-off of sequence similarity between target and template 
cannot be confidently defined because the paradigm “similar sequence – similar structure” does not 
thoroughly hold (see Chapter 1.1). However, it can be said that molecular replacement has good probability 
of success if template and target share above 25 % sequence identity and if the RMSD between their Cα 
traces is lower than 2.0 Å (Taylor, 2003). 
14 The Patterson function is the Fourier Transform of the diffraction intensities and not of the structure factors. 
15 Atoms are considered significantly “heavy” in macromolecular crystallography if their atomic number Z is 
26 (Fe) or higher (Blow, 2002). 
16 Structurally isomorphous means that there should not be significant conformational changes between the 
different forms of the target, that the space group should be conserved and that the crystallographic 
parameters, such as the unit cell dimensions, should not vary significantly (indicatively less than 1 %). 
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difference between the structure factor measured for the protein only (FP) and the structure 
factor of the protein plus derivative (FPH) corresponds to the contribution of the derivative 
alone (FH). Therefore, the difference Patterson function FPH – FP corresponds to the 
Patterson function of the derivative, FH. In the presence of a limited number of atoms (in 
the range of 10 per unit cell), the Patterson function of FH can be interpreted, the position 
of the derivative atoms localized in the unit cell and their ED assigned an amplitude and a 
phase. Once FH is defined, it can be used to calculate FP from: 
FH = FPH – FP      (eq.  8) 
However, the same vector FH can be derived both by the difference of +|FPH| and +|FP| or of 
–|FPH| and –|FP|. In other words, defining FH for one single derivative leaves an uncertainty 
on the phases of FP. The Harker construction (Harker, 1956; Turkenburg van Diepen, 1996) 
(Figure 1.7) helps to describe the relationship between FPH, FP and FH better. In order to 
solve this phase bias, either the calculation of the phase probability or the calculation of FH 
from at least a second derivative are necessary. Then, FP is defined in both its amplitude 
and phase and an initial ED can be calculated. The methods that make use of isomorphous 
Figure 1.7: Harker’s construction. The structure factor (F) functions, which are imaginary sinusoidal 
functions (see eq. 3), can be represented as circles in a real vs imaginary coordinate plane. The amplitudes of F
(|F|) corresponds to the radius of the circle, while the phase (φ) is given by the angle that |F| form with the real 
axis. The blue circle represents the scattering of the target protein (|FP|, φP). The red and orange circle represent 
the scattering of isomorphous crystals of the same protein derivatized with different heavy metals (|FPH|). The 
difference FH = (FPH – FP) is represented as a black vector, with amplitude |FH|. The scheme on the left shows 
the phase bias (φP1, φP2) when using a single derivative (SIR). The scheme on the right shows that adding a 
second derivative (MIR) aids in selecting between the two ambiguous phases. The figure is adapted from
Turkenburg van Diepen, 1996 (available on line at: http://www.ysbl.york.ac.uk/~mgwt/thesis-tth/index.html). 
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replacement for phase determination are the single and the multiple isomorphous 
replacement methods (SIR and MIR, respectively). 
Anomalous dispersion requires a beam of tunable wavelength to exploit the anomalous 
scattering of (heavy) atoms around their absorption edges, which are specific for each 
element. In fact, X-rays at an appropriate energy can induce a transition of an electron of 
certain atoms to an excited state. An electron of an outer shell falls back and emits a photon 
observed as fluorescence, while the incident beam is scattered with lower intensity and a 
different phase. To include the anomalous scattering component, the expression of the 
atomic scattering factor, fA (eq. 2), has to be corrected as a function of the wavelength λ to: 
fA(λ) = fA – δf′(λ) + if″(λ) = f′(λ) + if″(λ) (eq.  9) 
where δf′(λ) and f″(λ) define the intensity change and the phase change of the scattered 
beam at λ, respectively. A fluorescence detector near the goniometer can record the X-ray 
absorption spectrum of the derivatized crystal, from which f′ and f″ can be calculated. Four 
characteristic wavelengths can be defined. First, the peak point is the wavelength at which 
f″ is maximal. Second, the inflection point is the wavelength at which f′ is minimal. Finally, 
the high and low remote points are two wavelengths far from the absorption edge and at 
higher and lower energies than the peak point, respectively. Anomalous absorption by 
heavy atoms in the crystal has an influence on its diffraction pattern. When only normal 
scattering occurs, the X-ray diffraction pattern is centrosymmetric. Consequently, the 
structure factor from the plane h,k,l (Fh,k,l), and that from the plane -h,-k,-l (F-h,-k,-l) are 
identical and have the same intensities (Ih,k,l = I-h,-k,-l), despite having opposite phases (φh,k,l 
= -φ-h,-k,-l). The reflections h,k,l and -h,-k,-l are called Friedel’s pairs. Instead, when 
anomalous scattering occurs, the intensities of the two reflections of a Friedel’s pair are 
different. In particular, at the peak point the intensities are different because the scattered 
beams in the two directions have maximal phase difference, while at the inflection point 
the maximal difference is in the amplitudes of the two beams. Data can be collected on the 
same crystal at one or more of the four different wavelengths described above. From each 
resulting data set, the difference between the structure factors Fh,k,l and F-h,-k,-l can be 
computed. The resulting value is the anomalous component of the structure factor, FHA, 
contributed only by the heavy atoms. The heavy atom position in the unit cell can then be 
calculated from FHA and thus initial phases can be obtained to compute a first ED map for 
the crystal. The methods that most typically make use of anomalous dispersion are the 
single-wavelength or the multiple-wavelength anomalous dispersion methods (SAD and 
MAD, respectively). 
Anomalous dispersion and isomorphous replacement can also be combined to increase the 
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phasing power. The single and the multiple isomorphous replacement using anomalous 
scattering methods (SIRAS and MIRAS, respectively) combine the information of data sets 
from crystals derivatized with different metals and collected at their respective absorption 
edges. 
1.2.6.  Model building, refinement and validation 
The initial phases obtained with one of the described methods can be used to trace the 
peptide chain and to build an initial model of the target. This procedure can be done 
manually or automatically and in general it requires that the amino acid sequence of the 
target is known. 
Successively, the phases need to be iteratively improved by a refinement process. 
Refinement consists of (i) modifications of the model to improve the fitting to the observed 
structure factors
17, (ii) relaxation of the model by simulated annealing, (iii) inclusion of 
solvent molecules, ligands and cofactors, and also (iv) application of crystallographic 
restraints, such as translation-libration-screw rotation (TLS) and non-crystallographic 
symmetry (NCS) restraints. For TLS refinement, portions of the sample are defined as 
single rigid bodies and anisotropic refinement parameters are applied to each group. This 
procedure is advantageous for structures having domains with significantly different 
anisotropic motion. NCS restraints, instead, can be used if a molecule has identical copies 
within the asymmetric unit. NCS refinement takes into account these identities in the 
asymmetric unit and results in an improved signal-to-noise ratio. 
The iterative process of refinement can be followed up by statistical parameters, called R 
values, that quantify the level of agreement between the recorded data and the model being 
created. The Rfactor compares the observed amplitudes with the theoretical amplitudes of the 
model. It is defined by: 
Rfactor = Σhkl ||Fobs| - |Fcalc|| / Σhkl |Fobs|   (eq.  10) 
The Rfree value is an Rfactor calculated on a small percentage (5 %) of reflections that are 
excluded from refinement calculations. The Rfree value is a more independent evaluation of 
the quality of the model and not prone to model bias. When the refinement iterations 
cannot improve the R values further (convergence) and their values are in the range of 20 
% (Rfactor) and 25 % (Rfree) at a resolution of 2.0 – 2.5 Å, the model is ready and needs to be 
validated. To this purpose, a number of geometrical parameters are considered, i.e. the 
Ramachandran plot, the root mean square deviations (RMSD) of bonds and angles, the 
                                                 
17 i.e.: changing the orientation of amino acid side chains or – for structures solved by molecular replacement 
– changing the sequence of the template to the correct sequence of the target. 
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conformation of the rotamers and the polypeptide bond stereochemistry (trans or cis), the 
orientation of the side chains and the correctness of the non-covalent interactions between 
the functional groups. 
1.2.7.  Techniques complementary to X-ray diffraction studies 
For a successful and correct interpretation of the ED map, complementary characterization 
of the target is often useful or even necessary. 
First of all, as already mentioned, the knowledge of the protein sequence is important for 
model building, especially at medium-low resolutions (above 1.5 Å) and with initial ED 
maps of poor quality. Many genomic projects in the last decades have exponentially 
increased the number of available protein sequences and consequently they have also 
contributed to a faster development of macromolecular crystallography.  
Additionally, chemical knowledge on the structure of ligands or cofactors is necessary for 
modelling small molecules in the ED. If unknown ligands are present in the structure, 
techniques like mass spectrometry can be used to define their composition. 
Besides information that facilitates model building and structure refinement, a detailed 
biochemical characterization of the protein is also helpful for understanding which 
structural segments determine the functionality of the target. These results are obtained for 
instance through mutagenesis studies and / or functional assays. 
Finally, complementary techniques may be useful to compensate for two limitations of 
XRD studies. On one hand, XRD provides a model of a single conformation of the target. 
Obtaining structural data on multiple conformations or on intermediate states of reactions 
may be very difficult because of the instability, transience or flexibility of such species. 
This limitation can be overcome by spectrophotometric techniques, like Fourier transform 
infrared spectroscopy (FTIR), fluorescence resonance energy transfer (FRET), electron 
paramagnetic resonance (EPR), nuclear magnetic resonance (NMR) and Raman 
spectroscopy, and by computer calculations, like molecular dynamics simulations. On the 
other hand, certain structural features are difficult to obtain by X-ray crystallography. As 
an example, hydrogen bonds often play a crucial role in catalytic processes, but resolving 
hydrogen atoms by X-ray crystallography requires very high resolutions (< 1 Å). Neutron 
diffraction studies can instead reveal the positions of hydrogen atoms by making use of the 
neutron scattering properties of the hydrogen isotope deuterium (Blakeley et al., 2008). 
1.3.  Biological membranes 
Biological membranes are amphipathic barriers defining cellular compartments in living 
organisms. They mediate communication between the interior and exterior phases, they ensure 
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selective permeability, they provide shape to cells and organells through interaction with the 
cytoskeleton, they maintain the cell electrical potential, they are the location of cellular energy 
production and they metabolize hydrophobic substrates. 
Biological membranes are films of approximately 45 Å in thickness, with a central 20 – 30 Å 
broad hydrophobic core and two 10 – 15 Å broad interface regions on each side. Their actual 
size and morphology depend on the organism, on the subcellular compartment, on their 
composition and on the structure of the macromolecules embedded in them. 
Biological membranes are composed on average of a 1:1 weight ratio of lipids and proteins, 
with carbohydrates being present in minor amounts (1 – 5 %). This ratio corresponds to a 
molar ratio of about 50 lipid molecules per membrane protein (Guidotti, 1972). However, the 
precise membrane composition varies strongly with the cell type. For instance, the myelin 
sheath (Schwann cells) contains about 80 % w/w lipids, while the mitochondrial inner 
membrane and the membrane of Gram positive bacteria contain only 25 % w/w lipids (Guidotti, 
1972). 
Both the lipidic and the protein component determine the membrane properties. 
Lipids confer their amphipathic nature and their fluidity on the membranes. In addition, they 
interact directly with membrane proteins and contribute in an essential way to the stabilization 
of their structures and/or modulation of their functions (Palsdottir and Hunte, 2004; Hunte and 
Richers, 2008). Lipids are a class of biomolecules with heterogeneous structures, and include 
fatty acids, steroids, acylglycerols, phospholipids and sphingolipids as well as hydrophobic 
vitamins and quinones (Whitford, 2005). Phospholipids are the major components of biological 
membranes. They are amphipathic molecules with a glycerol-3-phosphate polar head group in 
general esterified with two C16 – C18 saturated or unsaturated fatty acid chains.  
Membrane proteins comprise 15 – 20 % of bacterial proteomes (Bendtsen et al., 2005) and up 
to 27 % of the human proteome (Almen et al., 2009). In absolute terms, their number in 
humans was recently predicted to be 6,718 (Almen et al., 2009). Besides representing a large 
percentage of the protein pool of all organisms, membrane proteins are attractive for 
biochemical and pharmaceutical research being targets of approximately 60 % of the drugs 
currently on the market (Arinaminpathy et al., 2009). Furthermore, among proteins, membrane 
proteins are outstanding because they occupy a complex biphasic cellular compartment. The 
peculiar physical and chemical nature of the lipidic bilayer limits the freedom of evolution of 
the membrane-embedded polypeptide portions. Consequently, it was said that the “folding 
space” of membrane proteins is “quasi-two-dimensional” and not three-dimensional like that of 
soluble proteins (Theobald and Miller, 2010). At least three different structural requirements 
specific for membrane proteins were identified. (i) Membrane proteins need to partition across 
five phases, namely two aqueous and one hydrophobic zones separated by two transition layers. 
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(ii) Transmembrane regions must be enriched in hydrophobic residues, while at the water-
membrane interface the polar heads of the phospholipids preferentially interact with 
tryptophans, lysines and arginines (von Heijne and Gavel, 1988). (iii) Transmembrane 
segments all need to have a comparable length, because the thickness of the membrane is 
approximately constant in all compartments and organisms. Additionally, also the functions 
possessed by membrane proteins may impose constraints on their transmembrane topology. 
This idea is suggested for example by the observation that a number of transporters (Yamashita 
et al., 2005; Faham et al., 2008; Weyand et al., 2008; Fang et al., 2009; Ressl et al., 2009) and 
one channel (Waight et al., 2010) all adopt a “5+5” inverted structural symmetry motif 
(Krishnamurthy et al., 2009) despite having no obvious sequence similarity and conducting 
different molecules across the bilayer. In summary, membrane proteins are subject to more 
structural constraints than soluble proteins and in particular they seem to be more prone to 
structural convergence. Consequently, exceptions in the paradigm “similar sequence – similar 
structure – similar function” are likely to be numerous for membrane proteins (Theobald and 
Miller, 2010), making structural-functional relationship studies on them particularly fascinating.  
Despite their exceptional interest, expression, extraction, solubilisation, purification and – for 
structure determination – crystallization remain difficult and expensive procedures for 
membrane proteins in comparison with soluble proteins. Because of these difficulties, studies 
on membrane proteins began later than those on soluble proteins and are still challenging. 
Initially, structural studies on membrane proteins were considered impossible, until the 
pioneering work by H. Michel and J. Deisenhofer in the early 1980s (Michel, 1982a; 1982b) 
led to solving the first three-dimensional membrane protein structure, Rhodopseudomonas 
viridis photosynthetic reaction centre, in 1985 (Deisenhofer et al., 1985). Now in 2010, the 
unique membrane protein structures available still represent only less than 1 % of the number 
of unique protein structures deposited in the Protein Data Bank (PDB)
18. 
1.3.1.  Peripheral  membrane proteins 
Membrane proteins can be classified into two groups according to their topology (Blobel, 
1980; Lomize et al., 2007). 
Polytopic membrane proteins (or transmembrane proteins, TMPs) are characterized by at 
least one transmembrane spanning segment. Therefore, they expose segments to each side 
                                                 
18   A statistics of membrane protein structures is available from the Membrane Protein Data Bank 
[www.mpdb.ul.ie, (Raman et al., 2006)], which covers integral, anchored and peripheral membrane proteins 
and peptides. According to this data bank, as of Jan, 15th 2010, the total number of membrane protein and 
peptide structures deposited on the PDB was 1,037 (corresponding to 267 unique structures), of which 843 
were determined by XRD, 167 by NMR, and 27 by EM. The membrane proteins with known structure 
belong to 146 unique protein families. 
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of the membrane. TMPs are either α-helix-bundle or β-barrel proteins (von Heijne, 1994). 
These two assemblies guarantee an energetically favourable distribution of polar and 
apolar residues in the hydrophobic membrane environment, while a combination of α-
helices and β-sheets has been observed more rarely
19. 
On the other hand, peripheral membrane proteins (PMPs) interact with one membrane 
leaflet only. Among PMPs, amphitropic proteins (APs) bind the membrane transiently. 
They are soluble proteins that undergo a conformational change upon activation, acquire 
affinity to the lipid bilayers and consequently bind the membrane to perform their 
membrane-related functions. Activation can be stimulated by external factors, such as 
fluctuations of pH or ligand concentration, but also by changes in the membrane 
composition itself. The recent structure of Escherichia coli pyruvate oxidase well 
exemplifies the membrane-binding/release cycle of APs.  Upon flavin reduction, the C-
terminal segment of that enzyme rearranges from a half-barrel to a helix, thereby acquiring 
affinity to the lipidic bilayer and opening the active site to the second substrate, the 
lipophilic ubiquinone 8 (Neumann et al., 2008). Another group of PMPs are monotopic 
membrane proteins (MMPs). They bind the membrane constitutively and cannot be 
isolated in a stable water-soluble form. Examples of MMPs with known structure are 
prostaglandin H2 synthases 1 and 2
20   (PDB id.: 1Q4G and 1CX2), microsomal 
prostaglandin E synthase (1Z9H), 11-β-hydrosteroid dehydrogenase (1XSE), 
apocarotenoid cleavage oxygenase (2BIX),   electron transfer flavoprotein 
(ETF):ubiquinone oxidoreductase (2GMH), lanosterol synthase
21  (1W6K),  squalene-
hopene cyclase (2SQC), carnitine acyltransferase (1T7Q), carnitine O-palmitoyltransferase 
2 (2H4T), cytochrome P450 (2BDM), monoamine oxidase B (1OJA), and fatty acid amide 
hydrolase (1MT5), [see http://blanco.biomol.uci.edu/Membrane_Proteins_xtal.html; 
http://opm.phar.umich.edu; (Lomize et al., 2007)]. 
PMPs perform various physiological functions (Johnson and Cornell, 1999). Some catalyse 
reactions that may require membrane attachment, either because the catalysis itself is 
influenced by membrane components (i.e. protein kinase C, PKC; cytidylyltransferase, CT) 
or because the substrates of the protein are hydrophobic (i.e. phospholipases, lipid kinases). 
Others interact with membrane components (i.e. with TMPs) thus ensuring an effective 
                                                 
19 For instance, it has been observed in some outer membrane proteins, such as porin OmpF (PDB id.: 
2OMF), the ferric citrate transporter FecA (1PO0) and the colicin I receptor (2HDF). However, in those 
structures the membrane-interacting domain consists of an all-β barrel, while a distinct all-α or mixed α/β 
domain folds inside the central pore generated by the barrel itself. 
20 Also known as cyclooxygenases (COX) 1 and 2. 
21 Also known as oxidosqualene cyclase (OSC). 
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assembly of e.g. signalling complexes (i.e. G proteins, lipid kinases). Finally, PMPs may 
constitute a connection between membrane and cytoskeleton (i.e. vinculin, hisactophilin) 
or mediate endocytosis and other processes of membrane remodelling (Johnson and 
Cornell, 1999; Bhatia et al., 2009). 
The strength of a PMP binding to the membrane depends on different forces (Johnson and 
Cornell, 1999; Lomize et al., 2007). (i) The electrostatic contribution is mainly due to the 
interactions of basic residues (arginine, lysine) with the polar head groups of anionic lipids. 
These interactions can be competed at high ionic strength and can vary depending on the 
protonation and phosphorylation state of surface amino acids. (ii) Hydrophobic interactions 
involve apolar residues and in particular tryptophans and tyrosines, which are often present 
at the water-lipid interface of all membrane proteins (Granseth et al., 2005; Lomize et al., 
2007). Through hydrophobic interactions some proteins specifically target to membranes 
having a particular composition. (iii) The distortion of the lipidic bilayers by PMPs 
increases or decreases the freedom of the lipidic acyl side chains and changes the layer 
curvature. Therefore, it also contributes positively or negatively to the free energy of 
protein-membrane binding. (iv) For APs, membrane binding is additionally influenced by 
the free energy required by the protein to undergo the conformational change upon 
activation and by an entropy factor, due to the reduced degree of freedom of the protein 
bound to the membrane with respect to the protein in solution. 
Depending on the interactions occurring between PMPs and lipid bilayers, the degree of 
penetration of PMPs into the membrane varies. Those proteins that only form electrostatic 
interactions with the lipids are buried approximately 3 Å under the membrane surface. If 
hydrophobic interactions are also formed, the protein can insert as much as 15 – 25 Å into 
the membrane. In some cases, the membrane-inserted form of some APs traverses both 
leaflets of the bilayer (i.e. SecA, colicins, diphtheria toxin). 
On the basis of the structures known to date, it can be observed that the structural motifs 
for peripheral membrane binding are rather 
heterogeneous. However, some common 
features can be described (Figure 1.8). 
 
Figure 1.8: Peripheral membrane proteins. Three
different strategies can be adopted by PMPs to bind the
membrane:  amphipathic in-plane helices (A), covalent
binding to aliphatic chains (B), and  lipid clamp
domains (C). The Figure is reproduced from Johnson
and Cornell, 1999. 
(i) Lipid clamps are structural motifs which 
direct protein binding to a specific lipid in 
the membrane. Examples are the cysteine-
rich domain (named CRD or C1) specific 
for diacylglycerol, the calcium-and-lipid-
binding domain (CaLB or C2) interacting 
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with anionic phospholipids and the Pleckstrin Homology (PH) domain specific for 
phosphatidylinositol. (ii) Covalent binding to membrane-embedded aliphatic chains is 
another strategy used by soluble proteins to attach tightly to bilayers. Soluble proteins with 
covalently-bound lipids are i.e. Raf or the Gα subunit of G-proteins. (iii) The Bin, 
Amphiphysin, Rvs (BAR) and the Epsin NH2-Terminal Homology (ENTH) domains are α-
helical membrane binding modules that sense and regulate the curvature of the bilayer and 
play therefore a major role in endocytosis, actin regulation and signalling (Itoh and De 
Camilli, 2006). Their structure was first revealed by crystallographic work on Drosophila 
amphiphysin [PDB id.: 1URU, (Peter et al., 2004)]. (iv) Amphipathic helices (AHs) also 
sense changes in the physical properties of the bilayer (electrostatic potential, lipid packing 
density, curvature strain). They occur in APs, like CT, DnaA, ADP-ribosylation factor 
(ARF), blood clotting factor VIII and vinculin, and in MMPs, like prostaglandin synthase 
or squalene hopene synthase. Each of these proteins displays a different helical length and 
a different tertiary structure arrangement in the amphipathic domain, but they also share 
some conserved features. In particular, the distinctive parameters of amphipathic helices 
are an overall positive net charge, a high hydrophobic moment and a relative 
hydrophobicity of ΔGH/Nresidues = 1 – 2 Kcal/mol
22 (Eisenberg et al., 1982; Engelman et al., 
1986; Johnson and Cornell, 1999). AHs typically intercalate in the polar head group region 
of the membrane within 15 Å of the water exposed surface. Finally, they are not specific 
for particular lipid classes, with the exception of the amphipathic domain of blood clotting 
factor VIII. 
1.3.2.  Enzymes in the membrane 
A number of reactions are catalyzed by membrane proteins. Enzymes in the membranes 
take part in the lipid and quinone biosynthesis pathways, in the metabolism of 
neurotransmitters and of mediators of inflammatory processes, in signalling cascades, in 
synaptic activities, in the synthesis of the bacterial cell wall, in proteolytic processes, in 
photosynthesis and cellular respiration, in other oxidoreductive processes and in reactions 
associated to ATP hydrolysis (Lenaz and Degli Esposti, 1994). 
A peculiarity of membrane-localized enzymes is that they typically catalyse the reaction 
between a soluble and a hydrophobic molecule. Consequently, their catalytic site must be 
accessible from the membrane as well as from the bulk solvent. Three strategies have been 
identified to satisfy this requirement (Forneris and Mattevi, 2008) (Figure 1.9). (i) In 
enzymes such as metalloproteases, the lipophilic molecule moves by lateral diffusion while 
                                                 
22 ΔGH is the energy of displacement from a membrane mimetic environment to water. 
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Figure 1.9: Membrane-bound enzymes. Three different strategies can be adopted by membrane enzymes for 
catalyzing reactions between lipophilic and water-soluble substrates: lateral diffusion (A), desorption (B) and 
catalysis at the water-membrane interface (C). The Figure is reproduced from Forneris and Mattevi, 2008. 
the hydrophilic substrate reaches the membrane-buried active site through a specific funnel. 
(ii) In hydrosteroid dehydrogenases (HSDs), bacterial fatty acyl-CoA synthetase (FACS) 
and fatty acid amide hydrolase (FAAH), the lipophilic reactant can be “desorbed” from the 
membrane through a hydrophobic cavity and reaches the active site localized in a water-
soluble domain of the protein. (iii) Enzymes like peptidoglycan transglycosylase and 
phospholipases perform their reactions at the water-membrane interface. Finally, an 
atypical role is played by i.e. saposins, non-enzymatic PMPs acting as “helpers” for water-
soluble enzymes that process lipophilic substrates. Saposins extract glycosphingolipids 
from the membrane via large flexible domains, undergo a significant conformational 
change and present their ligand to the enzymes in the surrounding solution. 
1.4.  Extremophiles 
It has been known for several decades that life is possible in very demanding environments 
such as geothermal sources, polar regions, acid and alkaline springs and the cold pressurized 
depths of the oceans. The discovery of life forms in harsh conditions has raised scientific 
curiosity as to the biochemical mechanisms of adaptation and the possibility of exploiting them 
for new chemical and biotechnological processes (Horikoshi and Grant, 1998). 
“Extreme” habitats are populated by species representing all three domains of life, but 
prokaryotes and in particular archaea are predominant (Rothschild and Mancinelli, 2001). 
These organisms that tolerate or require and, so to say, “love” (“philos” in ancient Greek), 
“extreme” conditions were named “extremophiles” first by MacElroy (Macelroy, 1974). 
However, the definition of “extreme” is controversial. For example, in an anthropocentric view 
extreme conditions are those incompatible with the life of human beings. Instead, Rottschild 
and Mancinelli (Rothschild and Mancinelli, 2001) more objectively defined as extreme those 
environments in which biomolecules are unstable. The physical and chemical factors that the 
authors considered are temperature, pressure, pH, ionic strength, hydration, abundance of 
nutrients and exposure to toxic agents, including gases (O2, CO2, H2S), heavy metals and 
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synthetic compounds. Consequently, a number of classes of extremophiles can be enumerated 
(Rothschild and Mancinelli, 2001; Gerday and Glansdorff, 2007). Thermophiles are resistant to 
temperatures above 60 °C, the highest temperature compatible with life being 113 °C at present 
knowledge. Psycrophiles survive cold temperatures between -2 °C and 20 °C. Alkalyphiles 
thrive at pH values above 9, while acidophiles at pH values below 4. Piezophiles live at high 
pressure, up to 70 – 80 MPa in the deepest oceanic trenches. Halophiles are organisms adapted 
to high ionic strengths, up to 5 M NaCl. Xerophiles tolerate desiccation and can live in 
environments with water activity well below 0.8
23 . Among xerophiles, endolithic and 
hypolithic organisms can grow into or under the surface of stony substances. Oligotrophic life 
forms can grow in nutritionally limited environments. Radioresistant organisms survive 
exposures of up to i.e. 20 kGy of γ radiation or 1000 J/m
2 of UV radiation. Toxicotolerant 
species are able to withstand high levels of damaging agents and among them metallotolerants 
specifically tolerate high concentrations of heavy metals. Finally, aerobic organisms may also 
be considered extremophiles since they tolerate exposure to oxygen, a particularly reactive 
species especially in its reduced peroxide and hydroxyl radical forms and consequently an 
unquestionable source of macromolecular damage (Rothschild and Mancinelli, 2001). 
1.4.1.  Thermophiles and proteins from thermophilic organisms 
Most thermophiles are found in early diverging branches of the 16 – 18 S rRNA universal 
phylogenetic tree (Hough and Danson, 1999) so that it is debated whether they constitute 
the ancestors of life forms on Earth (Gerday and Glansdorff, 2007). They occupy a variety 
of natural or artificial environmental niches, including hot natural or industrial waters, sun-
heated soils, geothermal areas and heated waste dumps. Depending on the optimal growth 
temperature, they can be subdivided into moderate thermophiles, that live between 60 °C 
and 80 °C, and hyperthermophiles, that live above 80 °C (Horikoshi and Grant, 1998). 
At high temperatures, the membrane fluidity increases to lethal levels and proteins and 
nucleic acids normally denature. Moreover, the solubility of gasses is altered, affecting O2- 
or CO2-dependent metabolic pathways. To our present knowledge, there is not a universal 
mechanism of thermal stabilization, but a number of different strategies used to cope with 
high temperature stresses can be described (Hough and Danson, 1999; Rothschild and 
Mancinelli, 2001; Jaenicke and Sterner, 2006; Gerday and Glansdorff, 2007). 
(i)  The membrane composition is adjusted to maintain optimal fluidity and decrease 
permeability. The polar head group of the phospholipids is not always glycerol, as 
for mesophilic organisms, but it may also be a longer chain polyol, i.e. nonitol 
                                                 
23 As reference, the aw of a saturated solution of NaCl is 0.75. 
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(Jaenicke and Sterner, 2006). Polyols form a denser hydrogen bonding network, 
thereby increasing membrane compactness. Furthermore, ether bonds between the 
polar head groups and the fatty acid chains widely substitute the ester connection 
typical of mesophilic membranes. Besides conferring higher resistance to 
hydrolysis (Gerday and Glansdorff, 2007), the replacement of ester with ether 
bonds provides a barrier to transmembrane proton flux (Jaenicke and Sterner, 
2006). Additionally, the acyl chains of thermophilic lipids are saturated so that 
stronger hydrophobic interactions can be formed. The mobility of the chains is 
decreased by the presence of methyl side groups at every fourth carbon atom in the 
backbone or by cyclization. Finally, the length of the acyl chains also differs with 
respect to those of lipids in mesophilic organisms. In the latter, the fatty acids have 
an even number of carbon atoms, C16 and C18 being the most common species. In 
thermophiles, instead, longer chains (i.e. C20-24) and chains with odd numbers of 
carbon atoms (i.e. C17 in Thermodesulfobacterium) are also observed (Jaenicke 
and Sterner, 2006). In some cases, the two membrane leaflets are covalently 
connected through dibiphytanyl-diglycerol-tetraether lipids, whose C30-40 acyl 
chains span the entire membranes. Such monolayers have a constant thickness of 
25 – 30 Å and are particularly rigid (Jaenicke and Sterner, 2006; Gerday and 
Glansdorff, 2007) (Figure 1.10). 
(ii)  DNA stability is enhanced by mono- or divalent salts that shield the negative 
charges of the phosphate groups and protect the DNA from depurination and 
hydrolysis. Formation of G-C pairs stabilizes ribosomal and transfer RNA, while 
an increase in G-C content is not observed in chromosomal DNA of thermophiles. 
The DNA is rather stabilized by a DNA reverse gyrase, a unique type-I DNA-
topoisomerase that causes supertwists, and by very basic histones (Horikoshi and 
Grant, 1998). 
(iii)  Proteins are stabilized by increasing ion-pair content and compactness. They also 
tend to form higher-order oligomers (Kumar et al., 2000; Yano and Poulos, 2003; 
Tanaka et al., 2004). The presence of additional inter-subunit interactions 
involving amino acid residues near the carboxyl terminus with respect to their 
mesophilic homologues has also been correlated to thermostability (Russell et al., 
1997). Additionally, the secondary structural elements are stabilized by shorter 
surface loop connections, by optimized electrostatic and hydrophobic interactions, 
by disulfide bridges, by a more pronounced hydrophobicity in the protein core and 
by a higher helical propensity of residues in α-helices (Rothschild and Mancinelli, 
2001; Jaenicke and Sterner, 2006; Gerday and Glansdorff, 2007).  
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Figure 1.10: Structures of glycerophospholipids. The central skeleton of the glycerol molecule (top) is 
derivatized with fatty acid hydrophobic chains (left) and with polar head groups (right) of various chemical 
nature. The lipidic polar heads in mesophilic and thermophilic organisms are the same. Instead, the typical 
aliphatic chains of mesophilic species (saturated or unsaturated esters) are often substituted by chains with
other structures in thermophilic species. Such differences consist of methyl branching, cyclization, ether bonds, 
and longer chains spanning through the entire membrane (tetraether lipids). In thermophiles, the glycerol
moiety may also be substituted by nonitol. 
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Of particular interest is the stabilization of the thermophilic enzymes, which need 
to be sufficiently rigid to prevent denaturation but flexible enough to undergo the 
conformational changes required by catalysis. An efficient compromise is achieved 
with the presence of large solvent filled cavities in the protein core, which provide 
the enzyme with “resilience”, that is, the propensity of accumulating elastic energy 
upon deformation (Hough and Danson, 1999). 
 
In conclusion, thermophilic macromolecules are particularly good candidates for structural 
studies, thanks to their pronounced stability. However, heterologous overproduction of 
membrane proteins from thermophiles can be problematic, in particular because of the 
strong differences in the lipid bilayer composition of the source and host organisms. For 
those membrane proteins naturally expressed in high abundance, ideal structural studies are 
performed after extracting the proteins from the native cells. 
1.4.2.  Aquifex aeolicus 
Aquifex aeolicus (VF5) is an extremophilic organism because it requires high temperatures 
and exposure to hydrogen, oxygen and carbon dioxide for growth. It is a hyperthermophilic 
bacterium belonging to the order Aquificales. It grows optimally at 85 – 95 °C and was 
isolated from shallow hydrothermal volcanic areas in the Aeolian Islands, Italy (Huber and 
Eder, 2006)
24. It can be artificially grown in liquid medium SME supplemented with 
thiosulfate (Huber and Eder, 2006). Its cells are rod-shaped, with a length of 2 – 6 µm and 
a diameter of approximately 0.5 µm (Huber and Eder, 2006). 
A. aeolicus is a chemolithoautotroph. It uses inorganic carbon sources for biosynthesis
25 
and inorganic chemical energy sources
26. It is an obligate aerobic bacterium that cannot 
tolerate high oxygen concentrations but can survive in levels of oxygen as low as 7.5 ppm. 
It preferentially gains energy through the “Knallgas” reaction
27  that produces water
28. 
Instead of hydrogen, it can also use thiosulfate as an energy source, producing sulfuric acid 
(H2SO4) and hydrogen sulfide (H2S) (Huber and Eder, 2006). Its cellular membrane is 
predominantly composed of ester-linked fatty acids (C18:0, C20:1, Ccy-21)
29, alkyl glycerol 
                                                 
24 Therefore the species name “aeolicus”. “VF5” indicates the strain that was isolated and whose genome has 
been sequenced (Deckert et al., 1998). 
25 A. aeolicus fixes CO2 through the reductive tricarboxylic acid cycle (Deckert et al., 1998; Guiral et al., 
2005). 
26 i.e.: elemental sulfur, hydrogen, nitrate (Guiral et al., 2005). 
27 2H2 + O2 Æ 2H2O 
28 This explains the genus name “Aquifex”, which means “water maker” (Huber et al., 1992). 
29 Cn indicates an alkyl chain with n carbon atoms; :0, saturated; :1, monounsaturated; cy, cyclopropyl ring.  
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monoethers (C18:0, C20:1) and glycerol diethers (C18:0/18:0, C18:0/21:1, C20:0/20:0) (Huber and Eder, 
2006).  
Its gene pool constists of the chromosomal genome and of an extrachromosomal element 
(ECE), both sequenced in 1998 with a calculated sequence redundancy of 4.83 (Deckert et 
al., 1998). The genome size (1.551.335 base pairs in length) is only one-third that of 
Escherichia coli (Deckert et al., 1998), indicating simpler metabolic pathways and a 
smaller proteome. Deckert and coworkers report that the genome is densely packed, that 
most genes are expressed in polycistronic operons and that many convergently transcribed 
genes overlap slightly. Interestingly, the genes that are functionally grouped within operons 
in other organisms or that encode subunits of the same enzyme are often separated in A. 
aeolicus. For example, it never recurs that two genes for amino acid biosynthesis are 
encoded in the same operon (Deckert et al., 1998). In contrast, genes required for electron 
transport, hydrogenase subunits, transport systems, ribosomal subunits and flagella are 
often in functionally related operons. No introns or inteins were originally detected in the 
genome (Deckert et al., 1998)
30. The authors suggest that this might be related to 
autotrophy and a consequent lifestyle that decreases the need for selective regulation. A 
high G+C content in stable RNA, two genes for reverse gyrase and an overall abundance of 
charged amino acids with respect to mesophilic organisms are the genomic features that 
can be related to A. aeolicus thermal stability (Deckert et al., 1998). 
From the genome sequence some information can be obtained on the organisation of the A. 
aeolicus respiratory chain. The enzymes for oxygen-dependent energy production are 
similar to those of other bacteria. NADH:ubiquinone oxidoreductase (respiratory complex 
I), succinate:quinone oxidoreductase (respiratory complex II), ubiquinol:cytochrome c 
oxidoreductase (bc1 complex, respiratory complex III), cytochrome c, cytochrome c 
oxidase (respiratory complex IV) and F1-Fo ATPase (respiratory complex V) are present. 
Additionally, the presence of a Rieske-like protein adjacent to a sulfide dehydrogenase 
subunit opens up the possibility that A. aeolicus respiration could be sulfur-dependent 
(Deckert et al., 1998). Moreover, a number of other oxidoreductases have been identified 
in the genome and metabolize alternative electron donors and acceptors, also contributing 
to electron transfer in the membranes. These proteins are cytochrome bd ubiquinol oxidase, 
sulfide:quinone oxidoreductase (SQR), nitrate reductase, DMSO reductase
31, cytochrome 
c552, hydrogenase I, hydrogenase II, formate dehydrogenase, flavocytochrome c:sulfide 
dehydrogenase (FCSD), ferredoxin, sulfur oxygenase reductase (SOR) and sulfur oxidation 
                                                 
30 One intein was annotated recently (Huber and Eder, 2006). 
31 DMSO reductase was recently renamed sulfur reductase (Guiral et al., 2005). 
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Figure 1.11: A. aeolicus respiratory pathways. Depending on the energy source, A. aeolicus has been 
proposed to use different pathways for cellular energy production. Panel A: in the presence of hydrogen (H2) 
and elemental sulfur (S
0), it couples hydrogen oxidation by hydrogenase II (H-II, possessing a cytochrome bII
transmembrane subunit, Cyt b
II) with sulfur reduction by sulfur reductase (SR, previously annotated as DMSO
reductase). Panel B: in the presence of sulfide (H2S) and oxygen (O2), it oxidizes sulfide to elemental sulfur by 
sulfide:quinone oxidoreductase (Sqr) and transfers electrons to the membrane quinone pool (Q) for oxygen-
dependent respiration either via a quinol oxidase (Qox) or via the cytochrome bc1 complex (bc), cytochrome c
(c) and cytochrome c oxidase (cox). Panel C: in the presence of hydrogen and oxygen, it oxidizes hydrogen and
reduces quinones through hydrogenase I (H-I, possessing a cytochrome bI transmembrane subunit, Cyt b
I), 
thereby allowing oxygen-dependent respiration via the cytochrome bc1 complex (bc), cytochrome c (c) and 
cytochrome c oxidase (cox). The Figure is adapted from Guiral et al., 2009. 
proteins (Sox). A number of schemes for possible A. aeolicus respiratory pathways in 
different growing conditions have been proposed (Nübel et al., 2000; Guiral et al., 2005; 
Guiral et al., 2009) (Figure 1.11). 
Finally, it must be considered that approximately 23 % of the A. aeolicus genome coding 
regions could not be assigned a known function by comparison to homologous sequences 
and were thus annotated as hypothetical proteins. Therefore, it will be impossible to have a 
comprehensive view of A. aeolicus metabolic pathways until functional and structural data 
becomes available for this large number of as yet uncharacterized proteins. 
Currently, 160 unique structures
32 of proteins from A. aeolicus are deposited on the PDB, 
including 3 proteins associated with the membrane
33. 
1.5.  The sulfur cycle and sulfur metabolism 
Sulfur (16S) is a compound of versatile chemistry. It is present in nature as 25 different isotopes, 
four of which are stable (
32S, 
33S, 
34S and 
36S) and one of which is widely used as a marker for 
its radioactivity (
35S). The electron configuration of sulfur, [Ne]3s
23p
4, allows it to acquire a 
broad range of valence states from -2 to +6 and thus be the most versatile source of oxidant and 
                                                 
32 The numbers refer to a PDB database search performed on Jan, 15
th 2010. On that day, the total number of 
proteins from A. aeolicus on the PDB was 309. 
33 Sulfide:quinone oxidoreductase (SQR), PDB id.: 3HYV, (Marcia et al., 2009); a hybrid complex of A. 
aeolicus SecYEG and Bacillus subtilis SecA, PDB id.: 3DL8, (Zimmer et al., 2008); and leucine transporter 
(LeuT), PDB id.: 2A65, (Yamashita et al., 2005). 
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reductant species. Biologically relevant 
sulfur compounds are sulfide [S
2-], 
polysulfides [Sn
2-, in the most stable 
chains n = 4 – 5], elemental sulfur [in 
different allotropic forms of which 
orthorhombic cyclooctasulfur (S8) is the 
most stable], organic sulfoxides [R-SO-
R’, i.e. dimethyl sulfoxide, DMSO, 
(CH3)2SO], dithionite [S2O4
2-], 
thiosulfate [
-O3S-S
-], sulfite [SO3
2-], 
polythionates [
-O3S-Sn-SO3
-, i.e. 
dithionate, n = 0, trithionate, n = 1, 
tetrathionate, n = 2, pentathionate, n = 3] 
and sulfate [SO4
2-]. The multiplicity of sulfur species, along with their pronounced reactivity, 
makes sulfur chemistry and biochemistry very rich. 
 
Figure 1.12: The sulfur cycle. It is calculated that 10
8
tonnes per year of sulfur are exchanged between the 
atmosphere and the soil and waters as sulfide (Kelly, 
1980). The Figure is adapted from the Encyclopaedia 
Britannica online (http://www.britannica.com). 
Biological sulfur metabolism is part of the natural sulfur cycle (Kelly, 1980; Ehrlich and 
Newman, 2009) (Figure 1.12). Two metabolic lines include reactions involving sulfur 
compounds. Assimilatory sulfur metabolism consists of reactions introducing sulfur into 
biologically active organic molecules
34, while dissimilatory reactions are used to produce 
cellular energy. Organisms using a dissimilatory sulfur metabolism are predominantly in the 
bacterial world and can be classified according to whether they use oxidised or reduced sulfur 
species as electron donors/acceptors (Ehrlich and Newman, 2009). 
Sulfur reducing bacteria (SRB) use sulfate, sulfite, thiosulfate or elemental sulfur as terminal 
electron acceptors. They are anaerobic species belonging to the group of Gram negative δ-
proteobacteria, i.e. the genera Desulfovibrio,  Desulfomonas and Desulfobacter and some 
species of Clostridia. Sulfate reduction to sulfide involves the enzymes ATP sulfurylase, 
inorganic pyrophosphatase (ppaC), APS reductase
35, sulfite reductase (SIR, Dsr) and a number 
of membrane associated complexes such as quinone-interacting membrane-bound 
oxidoreductase (Qmo), heterodisulfide reductase (Hdr) and Tmc (Pereira, 2008). These 
organisms are ecologically important because they release reduced sulfur species into the 
environment, i.e. in marine sediments and in the human colon. 
In contrast, sulfur oxidising bacteria (SOB) use reduced sulfur compounds as electron donors. 
They are either phototrophic or chemotrophic bacteria. Phototrophic SOB include (i) green 
                                                 
34  Biologically relevant sulfur species are the amino acids cysteine and methionine, iron-sulfur clusters, 
coenzyme A, biotin, lipoic acid, molybdopterin, thionucleotides (Stacey, 1965) and thiamine. 
35 APS is adenosine 5’-phosphosulfate. 
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sulfur bacteria (GSB), i.e. of the genus Chlorobium, (ii) purple sulfur bacteria (PSB), i.e. γ-
proteobacteria of the genus Chromatium (e.g. Allochromatium vinosum), (iii) purple non-sulfur 
bacteria, i.e. the genus Rhodopseumonas, and (iv) cyanobacteria, i.e. the genera Oscillatoria, 
Aphanotece,  Synechococcus and Nostoc. Chemotrophic SOB belong to the class of 
proteobacteria, i.e. of the genera Pseudomonas, Beggiatoa and Thiobacillus. Many archaeal 
genera also oxidize sulfur compounds, i.e. Acidianus and Sulfolobus. Enzymes involved in 
sulfur oxidation are (i) sulfide:quinone oxidoreductase (SQR) and flavocytochrome c:sulfide 
dehydrogenase (FCSD) that oxidize sulfide to zero-valent sulfur, (ii) Dsr-like enzymes working 
in reverse that oxidize polysulfides to sulfite, (iii) enzymes of the rhodanese 
(thiosulfate:cyanide sulfur transferase) family that disproportionate thiosulfate to elemental 
sulfur and sulfite, (iv) the Sat/Apr/Qmo
36 system or the polysulfide reductase-like complex 3 
that oxidize sulfite to sulfate and (v) thiosulfate:quinone oxidoreductase (TQO) and the sulfur-
oxidizing enzyme (Sox) that oxidize thiosulfate to sulfate (Dahl and Friedrich, 2008). 
In conclusion, it is worth mentioning that also eukaryotes can thrive in sulfur rich habitats and 
make use of sulfur compounds in dissimilatory reactions (Theissen and Martin, 2008a).  
1.5.1.  Biological roles of sulfide 
Sulfide was first identified by the Swedish pharmacist Carl Wilhelm Scheele (1742 – 1786) 
(Dobbin, 1931). It is present in different physical states. The diprotonated form, H2S, is a 
gas at standard pressure and temperature. In solution, hydrogen sulfide dissociates into the 
ions HS
- and S
2- with respective pKA values of 6.89 and >14. At physiological pH in water, 
about one-fourth of free hydrogen sulfide exists as H2S and three-fourths as HS
- (Furne et 
al., 2008). Its reduction potential is -270 mV for oxidation to elemental sulfur and -200 mV 
for oxidation to disulfide (Brune, 1989). In this work, the term “sulfide” refers indistinctly 
to H2S, HS
- or S
2-, if not mentioned otherwise. 
The equilibrium between the gaseous and the water soluble phases confers on sulfide an 
important ecological role in the sulfur cycle. In fact, sulfur is predominantly exchanged 
between the atmospheric and the terrestrial or acquatic environments as sulfide (Kelly, 
1980). 
Sulfide is also a compound of notable biomedical interest.  
Its toxicity is long known (Nicholls, 1975). Sulfide binds to iron in heme groups of 
cytochromes and globins therefore inhibiting respiration. Its LD50 in rodents is comparable 
to that of cyanide and corresponds to 1.1 mg/kg for intravenous administration or 100 – 
200 mg/kg for skin or oral exposure (Wilson et al., 2008). 
                                                 
36 Sat stands for sulfate adenylyltransferase, Apr for APS reductase. 
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Nonetheless, life did originate in a highly sulfidic environment (Theissen et al., 2003) and 
several organisms including eukaryotes tolerate sulfidic surroundings, such as deep sea 
hydrothermal vents, marine sediments (Grieshaber and Volkel, 1998; Theissen and Martin, 
2008a) and the human colon (Levitt et al., 1999; Wilson et al., 2008). Additionally, sulfide 
is generated in vivo in the catabolism of the amino acids cysteine, methionine and 
homocysteine. Three enzymes release sulfide as a product, cystathionine β-synthase (CBS), 
cystathionine γ-lyase (CSE) and 3-mercaptopyruvate sulfurtransferase (3MST) (Stipanuk 
and Beck, 1982; Kuo et al., 1983; Swaroop et al., 1992). Other sources of sulfide are 
proteins containing FeS clusters, that release sulfide in acidic conditions or upon 
denaturation, and proteins containing bound sulfane sulfur, a divalent sulfur atom bound 
only to other sulfur (i.e. as persulfide or polysulfide) and released under reducing 
conditions (Kimura, 2010). 
Cells are therefore exposed to sulfide. It has been determined that free sulfide 
concentrations in i.e. the human brain are in the range of 10 nM – 10 µM, depending on the 
method used. The physiological exposure to sulfide has certainly required the development 
of sulfide detoxifying pathways. In addition, research efforts of the last decade have 
demonstrated that, interestingly, sulfide also takes part in a number of important cellular 
processes. The various metabolic roles of sulfide have been reviewed recently (Kimura, 
2010). 
Firstly, in bacteria and archaea, sulfide acts as an electron donor in aerobic and anaerobic 
respiration and in anoxygenic photosynthesis (Arieli et al., 1991; Nübel et al., 2000). 
Secondly, the homeostasis of sulfide levels in yeast is related to heavy metal tolerance 
processes since heavy metal sulfides precipitates at high sulfide levels and are cytotoxic 
(Shahak and Hauska, 2008). 
Finally, the physiological relevance of sulfide in higher organisms, including mammals and 
in particular humans, is being extensively studied. In the first place, it has been questioned 
whether the physiological effects attributed to sulfide are occurring at physiological 
concentrations (Olson, 2009) and whether sulfide is the direct mediator of such effects or 
rather a “cofactor” potentiating the activity of other compounds (i.e. nitric oxide) (Grossi, 
2009b; 2009a). However, it has been established that sulfide is indeed a substrate for 
human cells (Goubern et al., 2007). Much experimental evidence attributed to sulfide the 
roles of antioxidant (Kimura, 2010) and nociceptive messenger (Smith, 2009). More 
interestingly, sulfide was recently classified as a “gasotransmitter”, together with nitric 
oxide (NO) and carbon monoxide (CO). In fact, it possesses all the features of 
“gasotransmitters” (Wang, 2002; 2004), namely (i) it is a small compound gas at standard 
temperature and pressure (see above), (ii) it is freely permeable to membranes (Mathai et 
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al., 2009), (iii) it is endogenously generated (see above), (iv) it has specific functions at 
physiologically relevant concentrations
37, (v) it has specific cellular and molecular targets
38, 
and (vi) it has physiological functions that can be mimicked by exogenous counterparts, 
including potential pharmaceuticals already under clinical trials (Szabo, 2007). At a 
molecular level, sulfide may regulate the function of its targets by forming covalent S-
sulfydryl cysteine adducts, in a similar way like nitric oxide (NO) induces the formation of 
S-nytrosyl cysteines (Mustafa et al., 2009). 
Last but not least, sulfide is also associated with many pathological states, including 
Alzheimer’s disease (Kamoun, 2004), Down syndrome (Ichinohe et al., 2005), ulcerative 
colitis (Roediger et al., 1996; Moore et al., 1997), penile erection disfunctions 
(d'Emmanuele di Villa Bianca et al., 2009), inflammation (Pae et al., 2009; Bhatia, 2010) 
and atherosclerosis (Muellner et al., 2009; Schreier et al., 2010).  
1.6.  Sulfide:quinone oxidoreductase 
Sulfide:quinone oxidoreductases (SQRs) are membrane-associated enzymes of great 
evolutionary importance because they catalyze sulfide-dependent quinone reduction, an 
essential reaction used by early organisms to thrive in the sulfidic anoxic conditions of oceanic 
environments (Theissen et al., 2003). At present, SQRs still play a number of physiological 
roles. They contribute to sulfide detoxification, to sulfide-dependent respiration (Nübel et al., 
2000), to anoxigenic photosynthesis (Arieli et al., 1991), to heavy metal tolerance (HMT) in 
yeast (Vande Weghe and Ow, 1999) and possibly to sulfide homeostasis in mammals (Shahak 
and Hauska, 2008). Because of their importance, SQR genes have been conserved throughout 
evolution and the currently available annotated genome information reveals that they are 
present in a wide range of organisms, including all domains of life and also humans, though 
being absent in plants (Shahak and Hauska, 2008). 
Sequence homology studies reveal that SQRs belong to the superfamily of flavoprotein 
disulfide oxidoreductases (FDRs). 
1.6.1.  Flavoprotein disulfide oxidoreductases (FDRs) 
Flavoprotein disulfide oxidoreductases (FDRs) are flavoenzymes structurally characterized 
by the presence of two Rossmann-fold FAD- and NAD(P)H-binding domains and by a C-
                                                 
37 e.g.: it alters the induction of hippocampal long-term potentiation (LTP) (Eto et al., 2002), it induces 
smooth muscle relaxation (Zhao et al., 2001; Yang et al., 2008; Chang et al., 2010), it mediates sympathetic 
neurotransmission (Kulkarni et al., 2009), it induces intracellular acidification in glia cells (Lu et al., 2010), 
it inhibits insulin signalling (Yang et al., 2005) and it is vasoactive (Benavides et al., 2007; Olson and 
Whitfield, 2010). 
38 e.g.: NMDA receptors (Eto et al., 2002), Cl
−/HCO3
− exchanger and Na
+/H
+ exchanger (Lu et al., 2010), 
Ca
2+-channels and Ca
2+-dependent K
+ channels (Kombian et al., 1993). 
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terminal family-specific region, 
named “interface domain” (Figure 
1.13) (Argyrou and Blanchard, 
2004). They either catalyze the 
reduction of disulfide species to 
thiols or the opposite oxidative 
reaction. 
Three groups of FDRs have been 
described according to the non-
flavin redox active group that they 
possess (Argyrou and Blanchard, 
2004). 
Group I FDRs present a 
CysXXXXCys disulfide/thiol pair 
near the active site on the si-face of 
FAD (McNaught and Wilkinson, 
1997). They bind FAD non-covalently. Their active oligomeric unit is a dimer and a 
HisXXXXGlu pair in the “interface domain” of one monomer participates in the reaction 
catalysed by the partner monomer. Members of group I FDRs are soluble pyridine-
nucleotide:disulfide oxidoreductases, like glutathione reductase (E.C.: 1.8.1.7, PDB id.: 
3DK4), lipoamide dehydrogenase (1.8.1.4, 3LAD), trypanothione reductase (1.8.1.12, 
1FEB) and mycothione reductase (1.8.1.15) (Williams, 1992). Flavocytochrome c:sulfide 
dehydrogenase (FCSD) (1.8.2.-, 1FCD) can also be classified as a group I FDR (Shahak 
and Hauska, 2008). However, FCSD is exceptional because it oxidizes sulfide and transfers 
electrons to cytochrome c. Additionally, it binds FAD covalently through an 8-α-S-
cysteinyl bond (Heuts et al., 2009). 
 
Figure 1.13: The superfamily of flavoprotein 
disulfide reductases. FDRs are subdivided into three 
groups. They all possess two similar domains, one 
binding FAD (“FAD”), the other binding pyridine-
nucleotides (“NAD(P)H”). Instead, their C-terminal 
region (“Central” and “Interface”) is specific for each 
subfamily. Some proteins with significant sequence 
similarity to FDRs deviate from this common 
classification scheme (“Others”). The figure is 
reproduced from Argyrou and Blanchard, 2004. 
Group II FDRs use a second disulfide/thiol pair located in the “interface domain” on the 
protein surface, in addition to the one located on the si-face of FAD. The two cysteine 
couples are structurally close to each other, so that reducing equivalents are transferred 
from the protein core to the surface and become accessible by the substrates of these 
enzymes, which are much larger than the substrates of group I FDRs. Group II FDRs are 
high molecular weight thioredoxin reductase (1.8.1.9, 1ZKQ), mercuric ion reductase 
(1.16.1.1, 1ZK7) and alkylhydroperoxide (Ahp) reductase (1.8.1.-, 1N8J). Low molecular 
weight thioredoxin reductase (1.8.1.9, 1TRB) can also be classified in this group, but it 
shows atypical features. It does not possess the interface domain and it possesses only one 
cystine in a different position than that of group I FDRs. The two cysteines are separated 
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by two rather than four amino acids and they are located on the re-face of FAD. Low 
molecular weight thioredoxin reductase transfers reducing equivalents to the protein 
surface through a pronounced conformational change. 
Finally, group III FDRs use a cysteine sulfenic acid (Cys-S-OH) or cysteine coenzyme A 
(Cys-S-S-CoA) group as non-flavin redox centres. They are NADH peroxidase (1.11.1.1, 
1JOA), NADH oxidase (1.6.3.1) and coenzyme A disulfide reductase (1.8.1.14, 1YQZ). 
1.6.2.  Sulfide:quinone oxidoreductases (SQRs) 
SQRs (1.8.5.-) belong to group I FDRs. At the beginning of this work, no structural 
information about any SQR was available. The closest structural model was represented by 
Allochromatium vinosum FCSD (PDB id.: 1FCD). In fact, SQRs oxidize sulfide similarly 
to FCSDs, while they are not known to reduce disulfide groups, as other group I FDRs do. 
Besides the limited structural knowledge, only a few SQR-like proteins have been 
functionally characterized. As a consequence, in some cases it is unclear whether SQR-like 
gene sequences do encode for true SQRs (Pham et al., 2008; Chan et al., 2009). Finally, 
the level of sequence similarity among putative SQRs is poor.  
The scarce bioinformatic, functional and structural data make SQR classification 
complicated. Originally, three SQR groups were identified (Theissen et al., 2003). Type I 
SQRs, found in bacteria like Aquificales, α and β Proteobacteria and Firmicutes, were 
described to have micromolar affinity to their substrates and contribute to cellular 
respiration (Nübel et al., 2000) and anaerobic photosynthesis (Arieli et al., 1991; Arieli et 
al., 1994; Griesbeck et al., 2000; Griesbeck et al., 2002). Instead, type II SQRs, found in 
other bacteria and in mitochondria, were described to have a much lower affinity to sulfide 
and to require additional reaction partners in order to catalyse a still not well-understood 
biochemical reaction (Hildebrandt and Grieshaber, 2008; Theissen and Martin, 2008b). 
Finally, no type III SQR has been characterized yet. More recently, the classification has 
been extended to five SQR groups plus one uncharacterized group, based on improved 
sequence alignment calculations that made use of the increased number of available 
sequences (Pham et al., 2008). 
The bioinformatic and enzymatic studies that have been performed on SQRs identified 
sequence features involved in sulfide oxidation. Most importantly, type I SQRs present 
three conserved and essential cysteine residues in regions expected to be near the FAD 
(Griesbeck et al., 2000; Griesbeck et al., 2002), but none corresponds to the cysteine that 
covalently binds the flavin in FCSD. Therefore, it was believed that type I SQRs bound 
FAD non-covalently and that, in contrast to group I FDRs, their reaction cycle involved 
three and not two cysteines. In type II SQRs, one cysteine is substituted by a tyrosine, 
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which led to the hypothesis that a reaction partner might be needed by this SQR subfamily 
in order to compensate for the missing cysteine. Moreover, mutagenesis studies indicated 
that Val 294 (A. aeolicus SQR numbering) imparts high sulfide affinity to type I SQRs, 
because when it is mutated to or replaced by an aspartate, as in the type II SQRs, the KM 
for sulfide increases by two orders of magnitude. Finally, Tyr 161, Glu 162 and Lys 312 
were proposed to be involved in protonation / deprotonation events (Griesbeck et al., 2002; 
Shahak and Hauska, 2008). 
Upon sulfide oxidation, SQRs transfer two electrons to hydrophobic quinone acceptors. 
Therefore, SQRs need to interact with the membrane unlike all other FDRs, which are 
soluble enzymes. Both the membrane interaction and the mechanism of quinone reduction 
have also been difficult to describe in the absence of structural and functional data. For 
example, different SQR topology predictions have been proposed. SQRs were depicted 
either as transmembrane proteins (Guiral et al., 2009) or as peripheral membrane proteins 
(Arieli et al., 1991). Additionally, some SQR homologues have been reported to bind the 
membrane tightly and to require detergent treatment for solubilization, while others seem 
to bind the bilayer superficially and to be detachable by chaotropic agents (Schütz et al., 
1997). In addition, several residues were predicted to be involved in quinone reduction on 
the basis of mutagenesis and sequence conservation studies (Griesbeck et al., 2002; Grüber, 
2002). In particular, the hydrophobic amino acids Phe 39, Pro 46 and Leu 136 were 
proposed to bind quinone, while His 128 and His 193 (A. aeolicus SQR numbering) were 
thought to mediate proton transfer (Griesbeck et al., 2002; Shahak and Hauska, 2008). 
Besides the description of putative sites involved in sulfide oxidation and quinone 
reduction, the predictions about the SQR catalytic mechanism included hypotheses on the 
product of the reaction. On the basis of extensive but not conclusive biochemical 
experiments, it was proposed that type I SQRs polymerize sulfide to soluble polysulfide 
species. For Rhodobacter caspulatus SQR, it was suggested that the product of the reaction 
could be S10
2- species, rapidly non-enzymatically hydrolyzed to the more stable S4-5
2- 
(Griesbeck et al., 2002). For type II SQRs, it has been observed that the reaction produces 
protein-bound persulfides to be converted to sulfite and eventually to thiosulfate by two 
mitochondrial-matrix protein partners. The latter are a sulfur dioxygenase (ETHE-1), 
structurally characterized in Arabidopsis thaliana (PDB id.: 2GCU) and pharmacologically 
relevant because its misfunction leads to ethylmalonic encephalopathy, a fatal autosomal 
recessive disorder, and a sulfurtransferase of the rhodanese family (McCoy et al., 2006; 
Hildebrandt and Grieshaber, 2008; Tiranti et al., 2009; Lagoutte et al., 2010). 
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1.7.  Aim of the work 
The aim of this work is to determine the 3-D structure of the sulfide:quinone oxidoreductase 
from Aquifex aeolicus and to understand its reaction mechanism. 
The work consists of (i) the identification and the isolation of the protein from the native 
membranes of A. aeolicus by conventional chromatography, electrophoresis and peptide mass 
fingerprinting, (ii) the biochemical characterization of the target by spectrophotometric 
techniques, analytical ultracentrifugation and electron microscopy, (iii) functional studies of 
the enzyme by means of a spectrophotometric activity assay and (iv) the structure 
determination of the purified protein complex by 3-D crystallization and X-ray diffraction 
experiments. 
The high resolution 3-D structure will contribute to the clarification of a number of properties 
of the protein, particularly its oligomeric state, its membrane topology, its thermal stability, the 
mode of binding of its cofactor FAD and the geometry of its active sites. Ultimately, structure 
determination aims at defining an experimental basis for the understanding of the intriguing but 
complicated SQR catalytic mechanism.  
The potential cellular roles of SQR and the physiological importance of both its substrates, 
sulfide and quinone, confer to the study a significant toxicological, microbiological, 
bioenergetical and biomedical relevance. 
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2. Results 
Genome sequencing (Deckert et al., 1998) indicated that Aquifex aeolicus possesses at least one 
gene with similarity to sulfide:quinone oxidoreductases, namely protein Aq_2186 (accession codes 
NP_214500,  gi|15607118). Aq_2186 (hereafter referred to as SQR) is a protein composed of 430 
amino acids, with a predicted molecular weight (MW) of 47.5 kDa, a theoretical isoelectric point 
(pI) of 6.5 and a GRAVY score of -0.032, indicating moderate hydrophobicity. Different programs 
predict a different number of transmembrane helices (0 to 3) from the primary structure (Marcia, 
2005). 
2.1.  Identification 
2.1.1.  Sulfide:quinone reductase activity in A. aeolicus native membranes 
A. aeolicus membranes were prepared as described in the Material and Methods section 
and thawed on ice before use. The membranes possess SQR activity, as detected using a 
spectrophotometric activity test (see Table 2.2 in Chapter 2.2.1). This result confirmed a 
previous characterization of A. aeolicus membranes (Nübel et al., 2000) and provided 
evidence for the presence of SQR in the membrane preparation.  
2.1.2.  Denaturing gel electrophoresis (SDS-PAGE) 
The membranes solubilised in 3 % dodecyl-β-D-maltoside (DDM) were first fractionated 
on an anion exchanger shown in Figure 2.1. 
The fractions containing SQR activity were analysed on SDS-PAGE gels. Two fluorescent 
gel bands could be identified by 
illumination with ultraviolet light 
before staining, indicating the 
presence of flavoproteins. One band 
migrates at an apparent molecular 
weight of approximately 35 kDa and 
the other at 47 kDa, this latter value 
being in agreement with the 
expected molecular weight of the 
SQR monomer. The lower band is 
significantly more fluorescent than 
the upper one. Interestingly, the 
sample becomes homogeneous for 
the electrophoretic run after 
 
Figure 2.1: Fractionation of total solubilized 
membranes. The Figure shows the elution profile of 
total solubilized A. aeolicus membrane proteins loaded 
on the anion exchanger MonoQ. The black line 
represents the absorption at 280 nm and the red line the 
absorption at 415 nm. The grey line represents the 
elution gradient applied. The percentage of buffer B, 
containing 1 M NaCl (buffer A contains 50 mM NaCl), 
is indicated on the right axis. The position of the 
fractions possessing SQR activity and used for further 
purification is indicated by the black bars. 
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extensive boiling (1 h) or addition of urea 
before gel loading. Upon such treatment, 
only the band at 47 kDa is visible, but it has 
lost its fluorescence completely (Figure 2.2). 
2.1.3.  Peptide mass fingerprint 
(PMF) 
After staining with Coomassie Brilliant Blue, 
both fluorescent bands were excised and 
subjected to trypsin digestion. Their peptide 
mass fingerprint (PMF) was characterized 
with MALDI-TOF mass spectrometry (T. 
Beckhaus, Goethe University, Frankfurt am 
Main, Germany) and easy-nLC-ESI-q-TOF 
mass spectrometry (Dr. J. Langer, Max 
Planck Institute of Biophysics, Frankfurt am Main, Germany). Both bands were identified 
to be protein Aq_2186 and show an identical sequence coverage of 70 % (Table 2.1). It is 
noteworthy that Met 1 has never been identified by PMF analysis and is also absent in the 
3D structure. Therefore, it is likely that this residue is removed after protein synthesis and 
it is not present in the active form of SQR. Nonetheless, the numbering of the SQR 
sequence was not changed in order to maintain continuity with the previous literature. 
 
Figure 2.2: SDS-PAGE. Lane A is a Coomassie-
brilliant-blue-stained gel. SQR can be identified in two
bands migrating at approximately 35 and 47 kDa. Lane
B is the same gel lane observed in a UV transilluminator
before Coomassie staining. The SQR band at 35 kDa is
significantly more fluorescent than the band at 47 kDa,
indicating that it contains a flavin. Lane C is a silver
stained SDS-PAGE of the same sample boiled for 1 h 
before the electrophoretic run. Under such conditions,
SQR probably denatures completely, loses its
fluorescence (not shown), and migrates as a single band
at 47 kDa. 
2.2.  Purification 
2.2.1.  Purification from the membrane fraction 
SQR was purified in three chromatographic steps subsequent to the first anion exchange 
run. First, the protein mixture was fractionated through a size-exclusion chromatography 
(SEC) column (TSK1). Second, impurities were removed by detergent exchange. Finally, a 
second SEC column (TSK2) was used for a polishing run. The highest monodispersity in 
the final run is obtained at extreme ionic strength values, either in the absence of salt or 
with > 1 M NaCl (Marcia, 2005). As low ionic strength is advantageous for crystallization, 
in this work the pure protein was always kept in the absence of salt, unless otherwise 
indicated. The purification enrichment was approximately 20 fold with a yield of 32 % 
(Figure 2.3 and Table 2.2). 
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Table 2.1: SQR peptide mass fingerprinting (PMF)
a. 
Start – End  Observed MW (exp)  MW (cal) Delta Miss Sequence  Modification Ion 
score
2 – 22  1,026.5814 2,051.1483  2,051.164 -0,0157 1  M.AKHVVVIGGGVGGIATAYNLR.N    131
4 – 22  618.3462 1,852.0168  1,852.0319 -0,0151 0  K.HVVVIGGGVGGIATAYNLR.N    84
23 – 29  415.7227 829.4309  829.4368 -0,0059 0  R.NLMPDLK.I    48
23 – 29  846.4303 845.4230  845.4317 -0,0087 0  R.NLMPDLK.I  Oxidation (M)  33
30 – 53  937.1394 2,808.3964  2,808.4210 -0,0246 0  K.ITLISDRPYFGFTPAFPHLAMGWR.K  Oxidation (M)  17
54 – 68  833.9892 1,665.9638  1,665.9705 -0,0067 1  R.KFEDISVPLAPLLPK.F    93
55 – 68  513.6284 1,537.8634  1,537.8756 -0,0122 0  K.FEDISVPLAPLLPK.F    16
69 – 77  577.2939 1,152.5733  1,152.5815 -0,0082 0  K.FNIEFINEK.A    65
69 – 94  717.8476 2,867.3613  2,867.3825 -0,0212 1  K.FNIEFINEKAESIDPDANTVTTQSGK.K    40
78 – 94  867.4067 1,732.7988  1,732.8115 -0,0128 0  K.AESIDPDANTVTTQSGK.K    124
78 – 95  621.3044 1,860.8913  1,860.9065 -0,0152 1  K.AESIDPDANTVTTQSGKK.I    90
95 – 108  805.4394 1,608.8643  1,608.8763 -0,0119 1  K.KIEYDYLVIATGPK.L    110
96 – 108  741.3915 1,480.7684  1,480.7813 -0,0129 0  K.IEYDYLVIATGPK.L    93
178 – 203  919.4702 2,755.3888  2,755.4044 -0,0155 1  R.YKVPMTFITSEPYLGHFGVGGIGASK.R    68
180 – 203  822.4154 2,464.2245  2,464.2461 -0,0216 0  K.VPMTFITSEPYLGHFGVGGIGASK.R    73
180 – 204  656.0885 2,620.3249  2,620.3472 -0,0223 1  K.VPMTFITSEPYLGHFGVGGIGASKR.L    53
204 – 213  624.3362 1,246.6578  1,246.6670 -0,0092 1  K.RLVEDLFAER.N    84
205 – 213  546.2872 1,090.5598  1,090.5659 -0,0061 0  R.LVEDLFAER.N    61
205 – 224  772.4112 2,314.2117  2,314.2321 -0,0204 1  R.LVEDLFAERNIDWIANVAVK.A    66
214 – 224  414.8966 1,241.6679  1,241.6768 -0,0089 0  R.NIDWIANVAVK.A    59
225 – 246  818.0785 2,451.2136  2,451.2281 -0,0146 1  K.AIEPDKVIYEDLNGNTHEVPAK.F    80
247 – 266  1,073.4939 2,144.9732  2,144.9911 -0,0179 0  K.FTMFMPSFQGPEVVASAGDK.V    95
247 – 273  947.4540 2,839.3403  2,839.3673 -0,0271 1  K.FTMFMPSFQGPEVVASAGDKVANPANK.M    30
247 – 273  714.8409 2,855.3343  2,855.3622 -0,0279 1  K.FTMFMPSFQGPEVVASAGDKVANPANK.M  Oxidation (M)  3
247 – 273  958.1184 2,871.3333  2,871.3572 -0,0239 1  K.FTMFMPSFQGPEVVASAGDKVANPANK.M  2 Oxidation (M)  31
274 – 279  731.4171 730.4098  730.4160 -0,0061 0  K.MVIVNR.C    37
274 – 279  747.4102 746.4029  746.4109 -0,008 0  K.MVIVNR.C  Oxidation (M)  26
288 – 303  827.4771 1,652.9396  1,652.9501 -0,0105 0  K.NIFGVGVVTAIPPIEK.T    114
288 – 312  848.8234 2,543.4483  2,543.4727 -0,0244 1  K.NIFGVGVVTAIPPIEKTPIPTGVPK.T    64
304 – 312  455.2701 908.5256  908.5331 -0,0075 0  K.TPIPTGVPK.T    52
313 – 333  782.3728 2,344.0966  2,344.1160 -0,0194 0  K.TGMMIEQMAMAVAHNIVNDIR.N    99
313 – 333  787.7030 2,360.0873  2,360.1109 -0,0236 0  K.TGMMIEQMAMAVAHNIVNDIR.N  Oxidation (M)  83
313 – 333  793.0350 2,376.0833  2,376.1058 -0,0225 0  K.TGMMIEQMAMAVAHNIVNDIR.N  2 Oxidation (M)  24
334 – 342  537.7663 1,073.5180  1,073.5254 -0,0074 1  R.NNPDKYAPR.L    60
374 – 382  584.2863 1,166.5580  1,166.5695 -0,0115 1  K.MGKWAHYFK.T    60
383 – 392  666.8484 1,331.6823  1,331.6914 -0,0091 1  K.TAFEKYFLWK.V    68
393 – 405  730.8728 1,459.7310  1,459.7419 -0,0109 1  K.VRNGNIAPSFEEK.V    76
395 – 405  603.2895 1,204.5645  1,204.5724 -0,0079 0  R.NGNIAPSFEEK.V    78
395 – 412  1,024.5490 2,047.0834  2,047.0990 -0,0155 1  R.NGNIAPSFEEKVLEIFLK.V    19
406 – 412  431.2731 860.5316  860.5371 -0,0055 0  K.VLEIFLK.V    67
a: all of the peptides indicated in this table were identified in both of the SDS-PAGE gel bands, no additional 
peptides were detected. 
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Figure 2.3: Purification steps. Panels A – D show the chromatograms of all purification steps that follow the 
anion exchange run depicted in Figure 2.1. All chromatograms show the profile of elution monitored at 280 nm
(blue), 415 nm (red) and 456 nm (yellow). The gradients used for elution from the anion exchangers are 
indicated by the brown lines. % B indicates the percentage of buffer B, containing 1 M NaCl (buffer A contains
no salt). The fractions containing SQR pooled at each step are indicated by the black bars. Panel A is the 
elution profile of the first SEC column (TSK1). Panel B is the elution profile after the detergent shift to 
Zwittergent 3-10. Panel C is the elution profile after the detergent shift back to DDM. Panel D is the elution 
profile of the second SEC column (TSK2). Panels E and F show the same SDS-PAGE gel illuminated under 
UV light before staining (F) and stained with Coomassie blue (E). “M” is the SeeBlue® Plus2 Prestained 
Standard and “fM” the BenchMark™ Fluorescence Standard. The MW of the standard proteins are indicated on
the side in kDa. Lane 1 contains the solubilized membranes of A. aeolicus, lane 2 the fractions pooled from the
anion exchanger column depicted in Figure 2.1, lane 3 the fractions pooled from TSK1 (panel A) and lane 4 
those pooled from TSK2 (panel D). 
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Table 2.2: Purification enhancement
a. 
Preparation Protein  amount  Specific  activity  Total enzymatic units  Yield 
membranes  92 mg  8.83 U/mg  812.4 U  100 % 
solubilized membranes  140 mg  5.53 U/mg  774.2 U  95 % 
MonoQ  22 mg  24.1 U/mg  530.2 U  65 % 
TSK1  10 mg  46.9 U/mg  496.0 U  58 % 
detergent exchange  4 mg  82.0 U/mg  328.0 U  40 % 
TSK2  3 mg  87.6 U/mg  262.8 U  32 % 
a  the amount of protein was determined using the BCA assay. We find that this assay yields unrealistically 
low values when unsolubilized membranes are used (Peng et al., 2003). 
The purification protocol described in this work improves a previously assessed protocol 
(Marcia, 2005) to a significant extent, which proved crucial for the structural work. The 
protein purity was very high as judged by SDS-PAGE, clear native PAGE, analytical 
ultracentrifugation, in solution fingerprint mass spectrometry and single-particle electron 
microscopy (see following Chapters). 
2.2.2.  Necessity of detergent solubilisation 
SQR extraction from the membranes, as well as all purification, kinetic and crystallization 
studies required the use of detergent. Dodecyl-β-D-maltoside (DDM) and Zwittergent 3-10 
were used most extensively. In the absence of detergent micelles SQR is not stable. A 
time-course stability test was performed by storing the sample at 4 °C and testing its 
homogeneity by analytical gel 
filtration. The chromatograms show 
that the protein is extremely stable 
(for months) if solubilized in DDM, 
but quickly aggregates within 24 h 
in the absence of detergents (Figure 
2.4). 
 
Figure 2.4: Analytical SEC profile in the presence 
and absence of detergent. SQR is homogeneous in the 
presence of DDM after 1 month at 4 °C (red line), while 
it forms larger aggregates in the absence of detergent 
after 1 day at 4 °C (blue line). The x-axis reports the 
elution volume (V) in mL. The y-axis reports the 
absorption monitored at 280 nm. 
Similarly, single-particle electron 
microscopy shows that the pure 
protein without detergent forms 
large aggregates, while the same 
sample in DDM is monodisperse 
(Figure 2.5) (Dr. J. Vonck, Max 
Planck Institute of Biophysics, 
Frankfurt am Main, Germany). 
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Figure 2.5: Single-particle EM in the presence and absence of detergent. SQR purified in DDM is 
monodisperse and stable for months at 4 °C (A), while it forms aggregates within one day when the detergent is
removed (B). The image was kindly recorded by Dr. J. Vonck, Max Planck Institute of Biophysics, Frankfurt
am Main, Germany. 
2.2.3.  Isoelectric focusing (IEF) 
The pI of SQR was experimentally determined to be 4.2 – 4.5 on analytical isoelectric 
focusing gels incubated with detergent and ampholytes before the run (Figure 2.6). This 
value deviates significantly from that of 6.5 
predicted from the protein sequence. This 
difference is likely to be related to the 
topology of SQR (see Chapter 3.2) and in 
particular to the masking effect that the 
detergent micelle exerts on its membrane-
binding basic face (see Chapter 2.10.1 and 
Figure 2.34). 
 
Figure 2.6: IEF. On an analytical isoelectric focusing 
gel SQR migrates as a smeary band at an approximate
pI of 4.2 – 4.5. The gel was incubated with DDM and 
ampholytes in the pI range 3 – 7 before the run. 
2.3.  Determination of the oligomeric state 
2.3.1.  Size-exclusion chromatography (SEC) 
A calibrated SEC system (TSK column, Tosoh Bioscience, Japan) was used to determine 
the apparent MW of SQR based on its retention time. Because of the significant shift 
observed in the retention time of SQR in buffers of different salt concentrations (Marcia, 
2005), two calibration curves were calculated using buffers without salt and with 1 M NaCl. 
The apparent MW of SQR determined by SEC is about 120 kDa both in absence of salt and 
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Figure 2.7: SEC calibration curves at low and high ionic strength. The gel permeation column TSK was 
calibrated in buffer A (TrisHCl pH 7.4 20 mM, DDM 0.05 %, left panel) and in buffer B (buffer A with 1 M 
NaCl, right panel). The standards used are ribonuclease A (R, MW = 13.7 kDa), apoferritin (AF, 18.3 kDa),
chymotrypsinogen A (CT, 25.0 kDa), ovalbumin (O, 43.0 kDa), conalbumin (C, 75.0 kDa), aldolase (A, 158
kDa) and ferritin (F, 440 kDa). The x-axis reports the logarithm of the protein’s MW (log10MW). The y-axis 
reports a function (KAV) of the retention volume (V). KAV = (V – V0)/(Vtot – V0), Vtot corresponding to the total 
volume and V0 to the void volume of the column.  SQR (grey, dotted lines) results to have an apparent MW of 
about 120 kDa in both conditions. 
in presence of 1 M NaCl (Figure 2.7). The detergent contribution to the total size of the 
complex is limited to about 15 kDa. This value can be estimated from the experiment 
described in Figure 2.4, which shows that the retention volume of the non-aggregated SQR 
population in the absence of detergent is only moderately smaller (1 % of the total column 
volume) than that of the protein-detergent complex. 
2.3.2.  Non-denaturing gel electrophoresis (native PAGE) 
Four different protocols were used to determine the apparent molecular weight of SQR 
based on its electrophoretic mobility in a non-denatured state. Each experiment yielded a 
significantly different result. SQR runs homogeneously as a sharp band in gel systems run 
Figure 2.8: Native PAGE. A) BN-PAGE. B) CN-PAGE in DDM. C) CN-PAGE in DDM and DOC. D) CN-
PAGE without detergents. M indicates the Native Marker
TM Protein Standard, whose MW are indicated on both 
the left and the right side of the figure. BSA is bovine serum albumin run as an additional reference standard on
every gel (shown only for D). BSA is a monomer of 66 kDa but tends to oligomerize to dimeric (132 kDa) and
tetrameric (264 kDa) forms. While the migration profiles of the marker proteins and of BSA were not affected 
by the different experimental conditions, SQR electrophoretic behaviour changes significantly as described in
the text. 
 
452.  RESULTS 
in the absence of detergents (clear native PAGE), in the presence of DDM (clear native 
PAGE with detergent) or in the presence of the combination of DDM and DOC (high 
resolution clear native PAGE, (Wittig et al., 2007)). However, it shows polydispersity on 
Blue-Native PAGE gels (Schägger and von Jagow, 1991). Additionally, the SQR mobility 
varies substantially depending on the running system. In the absence of detergent, SQR 
migrates at an apparent MW of about 150 kDa, with DDM at about 250 kDa, with DDM 
and DOC at 70 – 80 kDa and in BN-PAGE gels four bands can be detected at about 50 kDa, 
90 kDa, 150 kDa and 280 kDa, respectively (Figure 2.8). 
2.3.3.  Laser-induced liquid-bead ion desorption (LILBID) mass spectrometry 
Laser-induced liquid-bead ion desorption mass spectrometry is a technique that analyses 
full-length protein solutions in their native form at low energy ionization, which not only 
preserves the full polypeptide sequence but also non-covalent interactions between protein 
subunits in a complex (Morgner et al., 2006). The largest SQR species observed as single-
charged oligomers have a size of 332.5 kDa, corresponding to seven SQR monomers. The 
series of double-charged species shows that a form with a theoretical mass of 522.5 kDa is 
also present, corresponding to the assembly of eleven SQR monomers (Figure 2.9). 
Measurements performed in ultrasoft mode could not determine confidently the size of the 
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Figure 2.9: LILBID anion mass spectrum. Red bars indicate oligomers carrying a single charge, blue bars
those with a double charge. 
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full SQR complex. Its complete charge distribution was not measurable, presumably 
because SQR aggregates and is heterogeneous under the experimental conditions (see 
Chapter 3.2) (L. Sokolova, Goethe University, Frankfurt am Main, Germany). 
2.3.4.  Crosslinking 
SQR was crosslinked with glutaraldehyde and subsequently analysed by SDS-PAGE. 
Figure 2.10 shows that the highest oligomer that can be formed is the trimeric species. 
2.3.5.  Analytical ultracentrifugation (AUC) 
Sedimentation velocity analytical ultracentrifugation (AUC) runs show that the SQR 
sample is homogeneous. The main component (89 % of the sample) sediments at s20 = 5.52 
S. Calculation of the apparent MW from this value requires an approximate knowledge of 
the protein shape (in terms of hydrodynamic radius, also known as the Stokes radius) and is 
strongly dependent on the protein elliptical shape. Assuming the protein to be globular, the 
apparent MW is calculated to be about 90 kDa. However, using the dimensions of the 
protein complex from the crystal structure (55 x 130 Å, see Paragraph 2.10.1), the value 
shifts to an apparent MW of about 140 kDa, similar to that expected for the trimeric SQR 
complex (Figure 2.11) (Dr. V. Vogel, Goethe University, Frankfurt am Main, Germany). 
 
 
Figure 2.10: Crosslinking. SDS-
PAGE gel of SQR treated (+) and
untreated (-) with the crosslinker
glutaraldehyde and boiled
extensively before gel loading. The
highest detectable oligomeric
species for SQR is the trimer. 
  Figure 2.11: Sedimentation velocity AUC. The rough results of the 
experiment (not shown) were interpreted using different frictional 
ratio parameters (f/f0), indicative of the protein shape. The light grey 
line was calculated using a floating value for f/f0 eventually 
converging to 1.22 and corresponds to an apparent MW of 90 kDa. 
This fitting procedure is optimal for globular samples. The orange,
blue and dark grey lines were calculated using fixed f/f0 values of 
1.5, 1.6 and 1.7, respectively, and correspond to MW of 117 kDa,
135 kDa and 142 kDa, respectively. Increasing f/f0 values best 
approximate the behaviour of oblong samples, like SQR. 
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This result was additionally confirmed by sedimentation equilibrium runs in three different 
density-matching conditions, corresponding to a DDM/sucrose/D2O mixture, a 
C12E9/sucrose mixture and a C12E9/D2O mixture, respectively. The size of the protein 
complex determined by sedimentation equilibrium AUC is 160 kDa (± 10 %). 
2.3.6.  Single-particle electron microscopy 
Negative staining single-particle electron microscopy shows that SQR is monodisperse 
both in the presence and in the absence of salt. The particles were identified, filtered, 
averaged and aligned in self-organising maps from a neural network analysis. The result 
shows a similar protein shape in buffers without salt and with 1 M NaCl, respectively. The 
protein in the presence of salt is more compact than in the absence of salt, which correlates 
with the different retention factor from the SEC column (see Chapter 2.3.1). The majority 
of the particles are composed of three strong electron density regions. Dimeric and 
tetrameric particles are also observed, probably due to the different orientations of SQR on 
the carbon grid (Figure 2.12) (Dr. D. Parcej, Max Planck Institute of Biophysics, Frankfurt 
am Main, Germany). 
Figure 2.12: Single-particle EM. Self-organising maps from a neural network analysis of SQR single particles
recorded by electron microscopy. The map on the left is produced from the sample purified in the absence of 
salt, while the map on the right from the sample purified in the presence of 1 M NaCl. The numbers indicate 
the number of particles corresponding to each node. 
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2.4.  Characterization of the cofactor FAD 
2.4.1.  Full-length Matrix-Assisted Laser-Desorption Ionization Time-of-Flight 
mass spectrometry (MALDI-TOF MS) 
Full length MALDI-TOF MS shows 
two m/Z signals for the purified 
SQR at values of 47,517 Da and 
48,292 Da, respectively. The 
difference in mass approximately 
corresponds to the mass of FAD 
confirming that this is the flavin 
cofactor of SQR, as expected by 
homology with other FDRs (Shahak 
and Hauska, 2008) (Figure 2.13) (Dr. 
J. Langer, Max Planck Institute of 
Biophysics, Frankfurt am Main, 
Germany and Dr. U. Bahr, Goethe 
University, Frankfurt am Main, 
Germany). 
 
Figure 2.13: Full-length MALDI-TOF mass 
spectrum. SQR gives two signals at 47,517 Da and 
48,292 Da. The difference between the two peaks (775 
Da ± 50 Da) is in the range of the MW of the cofactor 
FAD. 
2.4.2.  VIS-UV absorption and fluorescence spectra 
The SQR VIS-UV spectrum shows the typical flavin absorption bands at 356 nm and 456 
nm in the air-oxidised sample, in addition to the absorption peak at 280 nm, typical of FAD 
and of the tryptophan residues in the protein (Figure 2.14). From the oxidised-minus-
 
 
Figure 2.14: VIS-UV spectra. Air-oxidized SQR 
(blue) shows two characteristic absorption peaks at
365 and 456 nm respectively, which disappear in the 
dithionite-reduced (red) form. 
  Figure 2.15: Fluorescence emission spectra.
SQR was excited at 365 nm and its fluorescence 
recorded before (blue) and after (red) addition of 
Na2S. 
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Figure 2.16: High resolution full-length easy-nLC-ESI-q-TOF mass spectrum. A) Chromatogram of the 
separation of full-length SQR on the reverse-phase nano-LC column. Two peaks can be separated, likely 
corresponding to two species with different oxidation states, as explained in the text. B) Deconvolution of the 
spectrum of the first eluting peak. Four species are detectable with a difference of 32 Da in MW, which 
corresponds to the atomic mass of sulfur. 
reduced difference spectrum it can be calculated that there is one FAD molecule per 
protein monomer, as expected by homology with other FDRs (Shahak and Hauska, 2008). 
The protein also shows the typical FAD fluorescence emission band at 550 nm upon 
excitation at 365 nm. The intensity of the signal decreases upon addition of sulfide, as had 
been shown comprehensively in a previous work on the R. capsulatus SQR (Griesbeck et 
al., 2002) (Figure 2.15). 
2.5.  Characterization of additionally bound ligands 
2.5.1.  Total X-ray fluorescence (TXRF) spectroscopy 
TXRF spectroscopy was used to investigate the presence of possible additional metal 
cofactors in the sample. The results show that SQR does not contain any metal centres and 
that FAD is therefore the only cofactor. Unexpectedly, however, a careful analysis of the 
TXRF data showed that the protein contains a higher number of sulfur atoms than expected 
from the primary structure. Seven cysteines and thirteen methionines, that is 20 sulfur 
atoms, are expected from the sequence, but a calibrated TXRF experiment showed the 
presence of 30.8 sulfur atoms for every 2 phosphate atoms (one FAD molecule contains a 
diphosphate group). Although preliminary, this result suggests the presence of 10 – 11 
sulfur atoms copurified with SQR (C. Rittmeyer and Dr. S. Metz, Goethe University, 
Frankfurt am Main, Germany). 
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2.5.2.  Full-length Liquid Chromatography Electrospray Ionization quadrupole 
Time-of-Flight mass spectrometry (easy-nLC-ESI-q-TOF MS) 
The sulfur content in the protein was investigated by high resolution full-length ESI-q-TOF 
mass spectrometry. The purified protein solution was separated by analytical HPLC into 
two fractions corresponding to two SQR species. Deconvolution of the spectra showed that 
each species displays peak series with 32 Da increments, corresponding to the atomic 
weight of sulfur. At least 4 peaks were detected for each series (Figure 2.16). The two 
species differed by 16 Da in size, indicating a single oxidation for the species with the 
biggest retention volume (Dr. J. Langer, Max Planck Institute of Biophysics, Frankfurt am 
Main, Germany). 
2.5.3.  Other techniques 
The sulfur content of SQR was also investigated, unsuccessfully, by other techniques, such 
as peptide mass fingerprint mass spectrometry (PMF-MS), full length MALDI-TOF MS, 
high energy LILBID MS and X-ray diffraction after treating the crystals with reducing 
agents. In addition, other methodologies, such as sulfur K-edge XANES, radioactive 
labelling with Na2
35S and 
33S NMR have not been attempted yet because, although 
promising, they are either too costly or inaccessible. Table 2.3 summarizes all attempts 
performed to characterize the sulfur species in SQR. 
Table 2.3: Characterization of the sulfur species bound to SQR. 
Technique Comment 
TXRF  10 – 11 extra sulfur atoms every 2 phosphate atoms 
ESI-QTOF MS  chain of minimum 4 sulfur atoms 
Crystallization  
  reduction before 
crystallization 
protein denatured or could not be crystallized 
when crystallized, the structure showed an unmodified 
putative polysulfur chain (see Chapter 2.10.4) 
  reduction in crystal crystals  dissolved 
when stable, the structure showed an unmodified putative 
polysulfur chain (see Chapter 2.10.4) 
PMF  MS  fragments containing putative sulfur modification not 
identified 
MALDI-TOF MS  below experimental resolution 
LILBID MS  below experimental resolution 
S K-edge XANES  no beam time allocated at ID 26, ESRF, Grenoble, France  
Na2
35S too  costly 
33S  NMR  isotope not available as sulfide; too high protein amount 
required 
 
512.  RESULTS 
2.6.  Characterization of the enzymatic activity 
The enzymatic activity of purified SQR was determined via a spectrophotometric assay (Nübel 
et al., 2000). The reaction buffer (50 mM Bis-TrisHCl, pH 7.0) was chosen due to the 
observation that the range of possible pH tests is limited by the chemical properties of the 
substrates used. Quinones are unstable at 
basic pH (Morton, 1965), whereas Na2S 
develops H2S(g) if the pH is acidic. 
 
Figure 2.17: Salt dependency of the SQR enzymatic
activity. The SQR activity was tested in buffers
containing different salts at a concentration of 250 mM.
The grey bars correspond to the activity measured in the
membranes of A. aeolicus, while the red bars to the 
activity measured on the purified protein. The specific
activity is indicated in percentage, with 100 % as the
activity of the sample in the absence of salts. 
The results confirm and extend a previous 
characterization of A. aeolicus SQR (Marcia, 
2005). The Michaelis-Menten constants (KM) 
for the substrates are in line with those 
determined for the non-solubilized enzyme 
in the membranes of A. aeolicus (Nübel et 
al., 2000) and for the purified A. aeolicus 
SQR heterologously expressed in 
Escherichia coli (Schödl, 2003). Both 
sulfide and the quinones have micromolar 
affinity to the enzyme. 
As expected for a hyperthermophilic enzyme, the activity is temperature-dependent and it is 
highest at 80 °C (the highest temperature tested), close to the optimal bacterial growth 
conditions. The activation energy of SQR is about 14 kJ/(K·mol). Particularly remarkable is the 
stability of the purified complex over time at high temperature. The protein incubated at 80 °C 
for longer than one day retains 50 % activity. Furthermore, SQR treatment with quinone 
Table 2.4: Kinetic parameters. 
KM-decylUQ  2.16 ± 0.19 µM 
KM-UQ1  5.40 ± 0.22 µM
KM-UQ4  1.6 ± 0.28 µM
KM-UQ9  6.43 ± 0.20 µM
KM-Na2S  5.94 ± 0.52 µM 
specific activity at 40 °C  71.17 ± 4.28 U/mg
activation energy  14.08 ± 0.36 kJ/(K•mol)
t1/2 at 80 °C  32 h 
IC50 antimycin (in 10 µM decylUQ)  15 ± 2.5 µM 
IC50 NaCl  250 mM
pH optimum  6.5 
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analogues (e.g. antimycin) shows a concentration-dependent, competitive mechanism of 
inhibition. The presence or absence of detergent in the reaction buffer does not affect the 
specific activity significantly. Under aerobic conditions 80 % of the activity is retained. Finally, 
the ionic strength – which influences the shape of the protein significantly (see Chapter 2.3.6) – 
affects its activity as well. Increasing salt concentrations were observed to reduce the activity 
of SQR, with 250 mM NaCl reducing it to 50 % with respect to an assay performed in absence 
of salt. Additionally, different salts show a different degree of inhibition (Figure 2.17). The 
calculated activity parameters are summarized in Table 2.4. 
2.7.  Three-dimensional crystallization 
2.7.1.  Crystallization by vapour diffusion 
SQR could be crystallized in dodecyl-ß-D-maltoside (DDM) by hanging- and sitting-drop 
vapour diffusion using two different precipitating agents, MPD and ammonium sulfate.  
In the MPD condition (Figure 2.18)
37, crystals were grown with 35 – 45 % (v/v) MPD in 
the absence of any additional salts or buffering agents. However, addition of 50 – 200 mM 
sodium phosphate makes the crystallization process faster and improves the crystal quality. 
The crystals grown in the MPD condition diffract X-rays and their resolution was 
improved from 10 Å (initial hit) to 3.5 Å. 
In the ammonium sulfate condition (Figure 2.19)
38, crystals could only be grown at a 
concentration of 2.0 ± 0.1 M ammonium sulfate and exclusively in the presence of PEG as 
additional precipitating agent 
(ideally 2 – 5 % PEG 400). The pH 
compatible with crystal formation 
ranges from 4.0 to 7.0 units and can 
be buffered with sodium citrate, 
sodium acetate or sodium 2-(N-
morpholino)-ethanesulfonate (MES). 
In such conditions, the reservoir 
solution is already very close to 
saturation. If the crystallization drop 
is left open under the microscope, 
 
Figure 2.18: Crystallization in MPD. Left panels: two 
crystals grown by vapour diffusion in the MPD 
condition. Right panel: one of their representative 
diffraction patterns. The resolution at the edge is 3 Å. 
                                                 
37 Initial hits were obtained from condition D1, Jena Bioscience Classic screen 7 (JB7_D1, 35 % MPD) and 
from condition 39, Quiagen MPD Suite screen (40 % MPD, 0.2 M sodium phosphate). 
38 Initial hits were obtained from condition C3, Jena Bioscience Classic screen 6 (JB6_C3, 0.1 M Na-MES 
pH 6.5, 2.0 M ammonium sulfate, 5 % PEG 400). 
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Figure 2.19: Crystallization in ammonium sulfate and PEG. Hexagonal and needle crystals grown in the 
same crystallization drop. The scale bar is indicated in the top right corner in micrometer. 
phase separation occurs within 30 s and salt precipitation after about 120 s, making crystal 
handling particularly difficult. Two crystal forms can be grown in the ammonium sulfate 
condition and they often appear in the same crystallization drops. They have a hexagonal, 
prism shape and a thin, elongated shape. They will be hereafter referred to as the 
“hexagonal” and the “needle” crystals, respectively. The hexagonal crystals are thick and 
single, they are approximately 100 – 300 µm big in all dimensions and grow in about 1 – 3 
weeks. They diffract X-rays to a resolution of 1.5 – 2.0 Å. The needle crystals are thin and 
fragile, are often branched or broken along their longer axis, reach a size of approximately 
10 x 50 x (200 – 1000) µm
3 and take longer to grow than the hexagonal crystals (up to 6 
weeks). Their resolution could be improved from 4 Å to 1.8 Å. Both crystal forms tend to 
redissolve 2 weeks – 2 months after their formation. Further details about their biochemical 
and diffraction properties are reported in Chapters 2.7.3 and 2.8.1. 
 
2.7.2.  Effect of physical and chemical factors on the crystallization by vapour 
diffusion 
Extensive screening of all physical and chemical parameters that affect the crystallization 
process was performed in the attempt to improve the crystal size, resolution and stability 
and the speed of crystal growth. These experiments included screening of temperature, pH, 
precipitating agents, the presence or absence of oxygen, detergents used to keep the protein 
in solution, detergents used as crystallization additives, other small molecules used as 
crystallization additives, crystallization plate types and the scale of the crystallization 
experiment. Table 2.5 presents a summary of the crystallization screening experiments. 
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Table 2.5: Crystallization screening. 
Screening parameter  Crystals  Diffraction 
Temperature    
10 °C  spherulites  – 
16 °C  spherulites 
hexagonal, 4 weeks 
– 
high mosaicity 
18 °C  hexagonal, 1 – 3 weeks 
needle, 2 – 6 weeks 
high mosaicity 
used for structure solution 
25 °C  hexagonal, 1 – 3 days  high mosaicity 
    
buffer, pH    
Na-citrate, 4.5 – 5.5  microcrystals  – 
Na-acetate, 4.5 – 6.5  hexagonal, 1 – 3 weeks 
needle, 2 – 6 weeks 
high mosaicity 
used for structure solution 
Na-ADA, 6.0 – 7.0  microcrystals  – 
Na-MES, 6.0 – 7.0  hexagonal, 1 – 3 weeks 
needle, 2 – 6 weeks 
high mosaicity 
used for structure solution 
TrisHCl, 7.5 – 8.5  hexagonal, 1 – 3 weeks  high mosaicity 
Na-HEPES, 7.0 – 8.5  hexagonal, 1 – 3 weeks  high mosaicity 
CAPSO, 9.5  –  – 
    
Oxygen    
aerobic condition  hexagonal, 1 – 3 weeks 
needle, 2 – 6 weeks 
high mosaicity 
used for structure solution 
anaerobic condition  hexagonal, 1 – 3 weeks  high mosaicity 
    
Precipitating agent (PEG)     
PEG 200 (< 5 % v/v)  hexagonal, 8 weeks  high mosaicity 
PEG 400 (2 – 5 % v/v)  hexagonal, 1 – 3 weeks 
needle, 2 – 6 weeks 
high mosaicity 
used for structure solution 
PEG 350 MME (3 – 7 %)  –  – 
PEG 550 MME (< 5 %)  hexagonal, 1 – 5 weeks  high mosaicity 
PEG longer chain  phase separation  – 
    
Detergents (after extensive detergent shift) 
UM hexagonal  high  mosaicity 
α-DDM hexagonal  high  mosaicity 
NG hexagonal  high  mosaicity 
LDAO phase  separation  – 
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Zwittergent 3-10  phase separation  – 
    
Small molecules additives (to the ammonium sulfate condition) 
  Small inorganic salts 
FeSO4  microcrystals, > 8 weeks  – 
(NH4)Fe(SO4)2  microcrystals, > 8 weeks  – 
NaCl –  – 
NaBr  needles  3 – 4 Å 
    
  Organic salts 
Na,K-tartrate  needles  3 – 4 Å 
citrate trisodium salt  needles  3 – 4 Å 
ATP disodium salt  needles  3 – 4 Å 
    
  Organic amines 
taurine  plates  4 – 6 Å 
sarcosine  plates  4 – 6 Å 
spermidine  plates  4 – 6 Å 
D-pipecolic acid  plates  4 – 6 Å 
glycyl-glycyl-glycine microcrystals  – 
urea microcrystals  – 
betaine microcrystals  – 
spermidine tetrachloride  microcrystals  – 
proline clear  drop  – 
    
  Antioxidants 
glutathione microcrystals  – 
nicotinic acid  needles  too fragile 
DTNB microcrystals  – 
ascorbate microcrystals  – 
    
  Others    
DMSO hexagonal  high  mosaicity 
    
Detergents (as additives to the ammonium sulfate condition) 
  Maltosides 
NM phase  separation  – 
DM microcrystals  – 
UM microcrystals  – 
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DDM  hexagonal, 1 – 3 weeks 
needle, 2 – 6 weeks 
high mosaicity 
used for structure solution 
13M  plates  3.5 – 4 Å 
14M  plates  3.5 – 4 Å 
16M microcrystals  – 
    
  Thiomaltosides 
OTM  plates  3.5 – 4 Å 
NTM microcrystals  – 
DTM  plates  3.5 – 4 Å 
    
  Cyclohexylmaltosides 
CYMAL-1 microcrystals  – 
CYMAL-2 clear  drop  – 
CYMAL-3 plates  high  mosaicity 
CYMAL-4 microcrystals  – 
CYMAL-5 plates  4  Å 
CYMAL-6  plates, too fragile  – 
    
  Glucosides 
6G clear  drop  – 
OG microcrystals  – 
NG hexagonal 
plates 
high mosaicity 
3 Å 
    
  Thioglucosides 
7TG precipitate  – 
OTG microcrystals  – 
NTG microcrystals  – 
    
  Alkylphoscholines 
FOS8 plates  10  Å 
FOS9 plates  2.5  Å 
FOS10 microcrystals  – 
FOS12 microcrystals  – 
    
  Hydroxyethylglucamides (HEGA) 
HEGA8 hexagonal  high  mosaicity 
HEGA9  needles, too fragile  – 
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  Cyclo-hydroxyethylglucamides (c-HEGA) 
c-HEGA8 clear  drop  – 
c-HEGA9  needles, too fragile  – 
c-HEGA10  plates, < 2 weeks  3.5 Å 
c-HEGA11 plates  – 
     
  Methylglucamides 
MEGA8 plates  – 
MEGA9 plate  3  Å 
     
  Sucrose monoalkylesthers 
OS hexagonal  high  mosaicity 
DS hexagonal  – 
LS hexagonal  7  Å 
     
  Dimethylamine-N-oxide 
DDAO microcrystals  – 
LDAO phase  separation  – 
     
  Ammoniopropansulfonate 
Zwittergent 3-8  hexagonal  mosaicity 
Zwittergent 3-10  prism 
plates 
mosaicity 
2.8 Å, space group P21 
Zwittergent 3-12  plates  mosaicity 
Zwittergent 3-14  microcrystals  – 
     
  Polyoxyethylenalkylethers 
C12E8 plates  3  Å 
C12E9 microcrystals  – 
Thesit microcrystals  – 
     
  Tetramethylbutylphenylpolyoxyethylene 
Triton X-100  microcrystals  – 
     
  Others 
CTAB microcrystals  – 
DeoxyBigChap plates  5  Å 
HECAMEG  plates   3.5 - 4 Å 
BAM small  plates  – 
DDMAB phase  separation  – 
CHAPSO precipitate – 
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2.7.3.  Biochemical characterization of the crystals obtained by vapour diffusion 
Both the hexagonal and the needle crystal forms obtained with ammonium sulfate and PEG 
by vapour diffusion were characterized biochemically. Their electrophoretic properties on 
SDS-PAGE are similar and they reproduce the behaviour of the pure protein in solution 
(Figure 2.20). 
Their absorption spectrum was 
recorded in the visible range using a 
microspectrophotometer and differs 
slightly between the two forms, 
possibly due to the different 
polarization effect caused by the 
regular arrangement of the 
molecules in the two crystal lattices. 
Both FAD absorption bands are 
visible (Figure 2.21). Thirdly, both 
crystal forms were analysed by full-
length MALDI-TOF mass 
spectrometry and show a similar profile, analogous to that of the pure protein in solution. 
Finally, an activity assay performed using dissolved crystals shows that both crystal forms 
retain similar enzymatic rates (± 20 %) as the purified protein solution. 
 
Figure 2.20: SDS-PAGE of the crystals. Silver-stained 
SDS-PAGE of the SQR solution and of the hexagonal 
and needle crystals. The samples were boiled for 0, 3 or 
60 min before loading onto the gels as indicated in the 
third row. Due to lack of sample, the needle crystals 
were only boiled for 0 or 60 min. The lane marked with 
“M” is the Prestained Protein Marker, Broad Range. 
The MW of the two marker proteins visible in this 
Figure is indicated in kDa on the left. 
Figure 2.21: VIS spectra of the crystals. The absorption spectra of the needle crystals are shown in the left 
panel, those of the hexagonal crystals in the right panel. The spectra of the air-oxidised forms are shown in dark 
blue, those of the dithionite-reduced forms in light blue. The insets show the crystals used for the measurement, 
in the crystallization drop (oxidised state, upper inset) and in the quartz capillary (reduced state, lower inset), 
respectively. 
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2.7.4.  Crystallization with substrates and inhibitors 
Three strategies were followed in order to crystallize SQR with substrates, substrate 
analogues or inhibitors. (i) Copurification was performed by mixing SQR with a 10-fold 
excess of the compounds before the last chromatographic step (TSK2). (ii) 
Cocrystallization was performed by mixing 
SQR with a 10-fold excess of the 
compounds immediately prior to 
crystallization (t0). (iii) Soaking was 
performed by adding a concentrated solution 
of the compound either to the crystallization 
drop after the crystals had formed or directly 
to the cryo-protecting solution. The soaking 
experiments were carried out for 1 – 24 h. 
Table 2.6 summarizes the crystallization 
screening trials in the presence of substrates 
and inhibitors. The chemical structures of 
the most important quinone analogues used 
are shown in Figure 2.22. 
 
Figure 2.22: Quinones analogues used for
crystallization screening. A – E) Quinone derivatives
kindly provided by Prof. Bolognesi, Bologna
University, Italy. F) 2,3-dibromo-1,4-naphtoquinone
(Sigma-Aldrich). G) 2,3-dibromo-5,6-dimethyl-1,4-
benzoquinone (Sigma-Aldrich). H) Aurachin C, kind
gift of the Helmholtz Institut für Infektionsforschung,
Braunschweig, Germany. 
2.7.5.  Crystallization by other techniques 
Three other crystallization techniques were also tested. In lipidic cubic phase setups 
(Landau and Rosenbusch, 1996) crystals could not be grown. By sponge phase (Wadsten et 
al., 2006) crystals could be grown in a condition similar to the MPD condition already 
obtained by vapour diffusion. They were small and diffracted X-rays to about 8 Å 
resolution (Figure 2.23). Finally, in microbatch under paraffin oil, crystals were obtained in 
 
 
Figure 2.23: Crystals grown in sponge phase.    Figure 2.24: Crystals grown in microbatch under 
paraffin oil. A) Crystals grown in condition 
JBM1_A1. B) Crystals grown in condition JB6_C3.
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condition A1 of the Jena Bioscience Membrane screen 1 (JBM1_A1)
39 and in condition C3 
of the Jena Bioscience Classic screen 6 (JB6)
40. The crystals grown in JBM1_A1 were too 
small for diffraction studies, while those grown in JB6 had the same characteristics as the 
hexagonal crystals grown by vapour diffusion (Figure 2.24). Table 2.7 summarizes the 
crystallization attempts using techniques different from the vapour diffusion method. 
 
Table 2.6: Crystallization screening in the presence of substrates and inhibitors. 
Additive Crystals  Diffraction  Electron  density 
Copurification (addition of additive before TSK2) 
Decylubiquinone hexagonal  high  mosaicity  – 
Antimycin  needle, too fragile  –  – 
Na2S hexagonal  high  mosaicity  – 
      
Cocrystallization (addition of additive to the drop, at t0) 
Na2S (anaerobic)  hexagonal  high mosaicity  – 
Stigmatellin needles  –  – 
Antimycin  needle, too fragile  –  – 
Decylubiquinone hexagonal 
needle 
high mosaicity 
2.5 Å 
– 
NP
a 
UQ1 hexagonal  high  mosaicity  – 
UQ2 hexagonal  high  mosaicity  – 
UQ4 hexagonal  high  mosaicity  – 
UQ9 not  grown  –  – 
DMN not  grown  –  – 
      
Soaking (addition of additive to the drop after crystal growth or to the cryo-protecting solution) 
Na2S (anaerobic)  needle  2 – 3 Å  NP 
Decylubiquinone  needle  2 – 3 Å  structure solved 
Aurachin C  needle  2 – 3 Å  structure solved 
Antimycin  needle  2 – 3 Å  NP 
Stigmatellin  needle  2 – 3 Å  NP 
Other quinones (Figure 2.22)  needle  2 – 3 Å  NP 
a NP indicates a condition for which the structure was solved by rigid body refinement, but the ligand could 
not be identified in the electron density map. 
 
                                                 
39 15 % w/v PEG 400, 15 % w/v Glycerol, 100 mM Hepes sodium salt pH 7.5, 200 mM CaCl2. 
40 2 M ammonium sulfate, 5 % w/v PEG 400, 100 mM MES sodium salt pH 6.5. 
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Table 2.7: Crystallization screening using techniques different from vapour diffusion. 
Technique Condition  Resolution  Remarks 
Lipidic cubic phase 
  no crystal growth  – –
   
Sponge phase 
  MPD / AmPO4  8 Å  small crystals
  
Microbatch 
 JBM1_A1  – microcrystals
  JB6_C3  3 Å high mosaicity 
 
2.8.  X-ray diffraction 
2.8.1.  X-ray diffraction patterns of the hexagonal and needle crystals 
The two most promising crystal forms were the hexagonal and the needle crystals. Despite 
their biochemical properties being relatively similar (see Chapter 2.7.3), the diffraction of 
these two crystal forms is tremendously different. 
The hexagonal crystals diffract X-rays to a higher resolution (on average 2.0 Å, at best 1.5 
Å) but their diffraction pattern shows such high mosaicity – in terms of reflection size – 
that processing of the data is impossible. In most cases the diffraction does not show single 
 
 
 
Figure 2.25: Diffraction of the hexagonal crystals.
The diffraction pattern of the hexagonal crystals is
characterized by high mosaicity and it is not possible
to index it. The resolution at the edge is 1.5 Å. 
  Figure 2.26: Diffraction of the needle crystals. The
diffraction pattern of the needle crystals shows single
spots and is suitable for structure determination. The
resolution at the edge is 2.0 Å. 
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Table 2.8: Crystallographic data for the hexagonal and needle crystals. 
Parameter Hexagonal  crystals  Needle  crystals 
best resolution  1.5 Å 1.8 Å
space group  – P212121
unit cell dimensions  – 112 x 154 x 178 Å
3
Nmolecules in AU  – 6
Matthews coefficient  – 2.67 Å
3/Da
Solvent content  – 53 %
spots, but rather smeared lines. Interestingly, the intensity of diffraction of the hexagonal 
crystals changes dramatically depending on the temperature at which data are collected. 
The same crystal showed a very weak diffraction pattern at room temperature (cooled with 
a jet of cold air), but the intensity became much stronger after freezing (with a jet of liquid 
nitrogen vapour). Nonetheless, at both temperatures, the diffraction is characterized by 
high mosaicity (Figure 2.25). 
The needle crystals are instead characterized by a more regular lattice, resulting in a 
diffraction pattern of good quality, but they diffract X-rays to a lower resolution (on 
average 3 – 4 Å, at best 1.8 Å, Figure 2.26). Therefore, they are suitable for data collection. 
They belong to the space group P212121 with unit cell dimensions of about 112 x 154 x 178 
Å
3 and they are generally isomorphous. The asymmetric unit contains six SQR molecules, 
which corresponds to a Matthews coefficient of 2.67 Å
3/Da and to a solvent content of 53 
%. Table 2.8 summarizes the crystallographic data of the hexagonal and needle crystals. 
2.8.2.  Attempts to improve X-ray diffraction of the hexagonal and needle crystals 
Both the hexagonal and the needle crystal forms required optimization for data collection 
and data processing. 
The greatest difficulty with the hexagonal crystal form was the high mosaicity. Besides the 
screening of a number of parameters to improve crystallization (see Chapter 2.7) other 
attempts aimed at improving the diffraction quality on the crystals themselves. These 
included treatment of the crystals in a humidity chamber setup
41 (Dr. Christian Benda, Max 
Planck Institute of Biochemistry, Martinsried, Germany), extensive screening of 
                                                 
41 The humidity chamber set-up consists of a jacket to surround the loop on the goniometer. The jacket is 
connected to a humidifier and guarantees a constant vapour jet parallel to the loop pin and directed towards 
the crystal. The humidity of the vapour jet can be controlled, thereby inducing swelling or shrinking of the 
crystal in the loop. Such alterations of the crystal packing have been in some cases useful for improving the 
diffraction quality (Sanchez-Weatherby et al., 2009). The measurement on site has to be carried out at room 
temperature. Alternatively, the set-up can be used to treat and optimize the crystal, which is then 
immediately flash frozen and measured separately. 
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cryoprotecting solutions (Table 2.9), seeding, recrystallization (Figure 2.27), annealing and 
optimization of the data collection parameters (detector distance, oscillation angle). None 
of these attempts improved the mosaicity of the hexagonal crystals. 
The problems with the needle crystal form were the high fragility and the high sensitivity 
to radiation damage. The latter problem was 
tackled using antioxidants as crystallization 
additives (see Table 2.5), performing data 
collection with a highly filtered X-ray beam 
and merging multiple data sets. Improving 
the purification protocol was however the 
crucial determinant for obtaining complete 
and redundant data sets. The detergent 
exchange between the purification steps 
TSK1 and TSK2 improves the quality of the 
preparation, most likely because Zwittergent 
3-10 separates SQR from traces of a NiFe 
hydrogenase B-type cytochrome subunit, a 
heme- and Fe-S cluster-containing protein 
(Brugna-Guiral et al., 2003) responsible for 
a dominant spectral band in the heme 
absorption region detected in an early stage 
of the project (Marcia, 2005). 
Table 2.9: Screening of cryoprotecting solution. 
Cryoprotectant Effect 
mother liquor  crystals unstable
ammonium sulfate > 2 M  salt spots, ice rings
glycerol in the mother liquor  loss of diffraction
glycerol in buffer  loss of diffraction
PEG 400 in the mother liquor  immediate phase separation, crystals unstable
PEG 400 in buffer < 30 %  crystals dissolve
PEG 400 in buffer 40 – 50 % v/v  used for structure solution and soaking 
experiments, crystals stable for > 24 h
PEG 1000 or longer chains  loss of diffraction
perfluoropolyether (Hampton, 100 %)  salt spots, ice rings
 
Figure 2.27: Recrystallized SQR. The crystals shown 
in this Figure were obtained by recrystallization of the
hexagonal crystals. 50 hexagonal crystals were fished
and washed in the cryo-protecting solution, dissolved in
2 µL water, mixed with an equal volume of the original
mother liquor and equilibrated against the same solution
in sitting drop vapour diffusion set-ups. The diffraction
pattern of recrystallized SQR is still characterized by
high mosaicity (not shown). 
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2.9.  Determination of the structure 
2.9.1.  Heavy metal soaking 
The SQR structure had to be solved by experimental phase determination because attempts 
to solve the phase problem by molecular replacement using A. vinosum FCSD coordinates 
(PDB id.: 1FCD) were unsuccessful. In the absence of a heterologous expression system to 
incorporate seleno-methionines into the protein sequence recombinantly, SQR was 
derivatized with heavy metal compounds in order to exploit multiple isomorphous 
replacement and anomalous scattering. A number of compounds were tested following 
three strategies. (i) Cocrystallization with the derivatives typically did not permit crystal 
growth. (ii) Soaking in the crystallization drop was also unsuccessful due to the instability 
of the drop (see Chapter 2.7.1) and probably because of the high concentration (2 M) of 
ammonium ions, which tend to form complexes with the heavy metals, preventing their 
binding to the protein (Sigler and Blow, 1965). (iii) Soaking in the cryoprotectant solution 
was successful. Table 2.10 summarises the results of the heavy metal screening 
experiments. 
The presence of the metal in the crystals was detected by fluorescence X-ray scans at the 
synchrotron beam line. The fluorescence absorption spectrum of the crystals also 
determines the wavelengths with maximal f’ and f’’ to use for anomalous scattering data 
collection. Figure 2.28 shows the fluorescence absorption spectrum of a needle crystal 
derivatized with K2OsCl6. For certain compounds, metal soaking into the crystals could be 
conveniently monitored visually, as a change in the crystal colour (Figure 2.29). 
Table 2.10: Screening of heavy atom derivatives. 
Additive  Resolution  Absorption edge (peak  energy in eV)  Sites 
K2OsCl6  3 Å Os L-III  (10,879.4)  12 
AuCl3  3 Å Au L-III  (11,925.7)  33 
Hg(CH3COO)  3 Å Hg L-III  (12,322.9)  not found 
Na3IrCl6  3 Å Ir L-III  (11,221.1)  not found 
Lu(CH3COO)  3 Å Lu L-III  (9,283.4)  not found 
K2PtBr4  3 Å Br K  (13,509.8)  not found 
K2PtBr4  3 Å Pt L-III  (11,570.5)  not found 
Sm(CH3COO)  3 Å Sm L-II  (7,313.6)  not found 
K2OsO4 6  Å –  –  –
KAu(CN)2 10  Å  –  –  –
Ethyl mercury 
phosphate 
no diffraction –  –  –
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Figure 2.28: X-ray fluorescence
spectrum. A needle crystal derivatized with 
K2OsCl6 was exposed to filtered X-ray 
radiation in the energy (in keV) range 
around the Os L-III absorption edge. The 
left Y-axis shows the fluorescence emission 
counts in the region of interest (ROI, blac
 
k 
line). The right Y-axis shows the values of f′ 
(blue) and f″ (red) derived from the 
fluorescence spectrum. 
  Figure 2.29: Crystals derivatized with heavy metals.
Hexagonal (A) and needle (B) crystals soaked with K2OsCl6. 
After a few hours the crystals change colour from the original 
yellow to brown, indicating accumulation of the heavy metal
in the crystal lattice. 
 
 
2.9.2.  Phase determination by Multiple Isomorphous Replacement with 
Anomalous Scattering (MIRAS method) 
The phases were determined by the MIRAS method using crystals derivatized with 
K2OsCl6 and AuCl3. The metal binding sites were determined with SHELX (Sheldrick et 
al., 2001) and refined with SHARP (Fortelle and Bricogne, 1997). 12 Os binding sites are 
particularly clear and give the predominant 
contribution to the phasing process. They 
are also beautifully symmetric, revealing the 
arrangement of the SQR molecules in the 
asymmetric unit (Figure 2.30). Automatic 
interpretation of the initial electron density 
map was poor, therefore the protein 
sequence was modelled manually starting 
from a 15-amino-acid peptide correctly 
positioned by ARP/wARP (Lamzin et al., 
2001). The initial model was refined to a 
final Rfree of 23.5 % (Rwork is 19.2 %) in the 
resolution range 20.0 – 2.30 Å, using TLS 
refinement and NCS averaging of the six 
 
Figure 2.30: Heavy metal binding sites. These 12 Os
binding sites in the asymmetric unit of the needle
crystals were used together with 33 Au binding sites
(not shown) to calculate the initial phases of the SQR
structure. 
 
66 2.  RESULTS 
monomers in the asymmetric unit. Final rounds of refinements were done without NCS. 
Table 2.11 summarizes the data collection statistics for the derivatized crystals. 
 
 
Table 2.11: Crystallographic statistics for the derivative data sets used for MIRAS 
phasing
a. 
Parameter  Derivative (Os)  Derivative (Au) 
Space group  P212121  P212121 
Unit cell dimensions (Å)  a = 112.30 
b = 155.86 
c = 178.26 
a = 112.10 
b = 154.30 
c = 176.70 
  Peak Inflection  Remote  Peak 
Wavelength (Å)  1.14000 1.14050 1.13010  1.03864 
Resolution (Å)  50.0 – 3.5 
(3.6 – 3.5)
50.0 – 3.5 
(3.6 – 3.5)
50.0 – 4.0 
(4.1 – 4.0) 
50.0 – 2.3 
(2.4 – 2.3) 
Rmerge (%)  12.3 (38.2) 12.8 (42.4) 8.2 (19.2)  6.2 (8.9) 
I/σ(I)  12.69 (4.30) 12.26 (3.96) 15.77 (8.41)  15.38 (12.38)
Completeness (%)  98.9 (98.9) 98.9 (99.1) 98.7 (99.2)  99.7 (99.9) 
Redundancy  3.36 (3.34) 3.37 (3.42) 3.33 (3.42)  3.83 (3.42) 
a the numbers in parenthesis refer to the highest resolution shell. 
 
 
2.9.3.  Structure determination by rigid body refinement of quinone- and aurachin 
C-bound SQR and at high X-ray energy 
The crystals of decylubiquinone-bound and aurachin C-bound SQR were isomorphous with 
the ones of the protein “as-purified”. One data set of the protein bound to decylubiquinone 
was collected at high energy wavelength (near the Fe absorption edge, 6.5 keV) in order to 
study the residual anomalous scattering of sulfur. Also this data set was isomorphous to the 
data set used for structure solution. The corresponding structures were determined by rigid 
body refinement introducing the appropriate ligands modeled with the program Sketcher of 
the CCP4 suite (Collaborative computational project number 4, 1994). They have an 
RMSD of about 0.4 – 0.5 Å with respect to the “as-purified” structure. Table 2.12 
summarizes the corresponding crystallographic data. 
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Table 2.12: Data collection and refinement statistics for the SQR structures solved
a. 
Parameter  “As purified”  Decylubiquinone  Aurachin C  6.5 keV 
Data collection 
Space group  P212121 P212121 P212121  P212121 
Unit cell dimensions (Å)  a = 112.85 
b = 154.92 
c = 178.04
a = 110.78 
b = 154.01 
c = 175.55
a = 111.18 
b = 154.23 
c = 176.53 
a = 110.78 
b = 154.01 
c = 175.55 
Wavelength (Å)  0.91984 1.00150 1.00148  1.90744 
Resolution (Å)  50.0 – 2.30 
(2.40 – 2.30)
50.0 – 2.00 
(2.10 – 2.00)
50.0 – 2.90 
(3.00 – 2.90) 
50.0 – 2.30 
(2.40 – 2.30)
Rmerge (%)  8.3 (34.4) 10.5 (76.5) 8.3 (39.6)  12.4 (58.6) 
I/σ(I)  14.87 (3.44) 13.17 (1.86) 16.74 (4.05)  9.97 (2.40) 
Completeness (%)  97.9 (87.9) 96.2 (76.7) 98.8 (95.7)  91.1 (75.9) 
Redundancy  3.47 (2.47) 4.74 (1.86) 3.72 (3.41)  2.54 (1.63) 
        
Refinement 
Resolution (Å)  2.30 2.00 2.90  2.30 
Total reflections  471,639 921,962 249,689  596,959 
Rwork / Rfree (%)  19.2 / 23.5 20.0 / 23.7 19.4 / 24.1  20.3 / 24.7 
RMSD  
  bond length (Å)  0.010 0.008 0.006  0.009 
  bond angles (°)  1.420 1.179 0.989  1.308 
Number of atoms   
  protein 20,136 20,029 20,094  20,029 
  cofactor (FAD)  318 318 318  318 
  detergent (DDM)  210 210 210  210 
  water 571 1,142 194  546 
  ions (SO4
2-) 120 120 120  120 
  ligand – 138 168  138 
  sulfur 54 50 59  50 
  buffer (MES)  72 – –  –
a the numbers in parenthesis refer to the highest resolution shell, Rwork and Rfree were calculated according to 
eq. 1.2.6.1 (see Chapter 1.2.6). 
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2.10.  Description of the structure 
2.10.1. Overall structure 
The six monomers in the 
asymmetric unit of A. aeolicus SQR 
are associated in two homotrimeric 
units. Each trimer is elliptical in 
shape, with dimensions of 130 Å in 
diameter and 50 – 60 Å in thickness 
(Figure 2.31). Additionally, the 
surface of the trimer is characterized 
by a pronounced polarity, as 
visualized on the basis of 
electrostatic potential calculations 
performed using GRASP (Nicholls 
et al., 1993). One side of the trimer, 
formed by the two Rossmann-fold 
domains, shows an overall negative surface potential, while the other side is characterized 
by an excess of positive charges and a pronounced hydrophobic patch in each monomer 
(Figure 2.32). Oligomerization contacts are mediated by two protein regions. In helices 202 
– 213, near the central three-fold axis, Arg 204 of each monomer forms salt bridges with 
Figure 2.31: Biological unit. SQR forms a trimer with
a thickness of approximately 55 Å (left). When seen 
from its soluble face (right), the complex can be 
inscribed in a circle with a radius of about 65 Å. Each 
monomer is shown in a cartoon representation and 
coloured in a different tone of blue.  All Figures 
showing the structure were generated with PyMOL 
(www.pymol.org). 
 
Figure 2.32: Electrostatic surface potential. Left panel: the SQR trimer has one overall negative (red) surface 
corresponding to the Rossmann domains facing the solvent. Right panel: rotation of the trimer by 180° shows
the domain that mediates the interaction with the membrane. It has an overall intense positive charge (blue)
with hydrophobic (white) patches corresponding to helices 376 – 395 and 400 – 412. Sulfate ions and MES 
molecules are shown in yellow. The electrostatic surface potential was calculated using the software GRASP
excluding solvent molecules. The scale bar is indicated in the inset at the bottom of the Figure. 
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Glu 207 and Asp 208 of the neighboring 
monomers. On the outer side, the C-terminal 
18-amino-acid loops and residues 364 – 371 
form contacts with residues 174 – 181 and 
211 – 215 of their neighbouring monomers. 
Figure 2.33: Amphipathic helices. Helical wheels of 
the amphipathic helices 376 – 395 (right) and 400 – 412 
(left). The hydrophobic amino acids are in grey boxes,
the polar residues are in blue/red boxes. “N” and “C”
indicate the N and C termini of the helices, respectively.
 
Figure 2.34: Disulfide bonds. Snapshot of the disulfide 
bridges between Cys 419 – Cys 430 and Cys 422 – Cys 
280 in the C-terminal domain of one SQR monomer. 
The protein chain is represented as semitransparent
cartoon in light green, the Cα trace of the C-terminal 18 
amino acids is highlighted in dark green and the side
chains of the cysteines forming the disulfide bonds are 
represented as yellow sticks. 
The six monomers are structurally nearly 
identical. They are composed of two FAD-
binding Rossmann domains typical of FDRs 
and of a C-terminal domain distinctive of 
each FDR subfamily. In A. aeolicus SQR, 
the C-terminal domain consists of two parts. 
First, residues 376 – 412 form an 
amphipathic helix-turn-helix motif. The two 
helices (Lys 376 – Asn 395 and Pro 400 – 
Lys 412) are graphically illustrated in Figure 
2.33. Their positive net charge (+4) and 
their relative hydrophobicity (1.21 kcal/mol) 
are comparable with values of other 
amphipathic helical domains of monotopic 
membrane proteins (Johnson and Cornell, 
1999). Second, residues 413 – 430 form an 
18-amino-acid long loop characterized by 
the presence of two disulfide bridges (Figure 
2.34).  
2.10.2. Interaction with the membrane 
The structure suggests that the SQR trimer interacts with the membrane through its 
hydrophobic patches and its positively charged face and the membrane interaction domain 
can be subdivided into four structural motifs (Figure 2.35). 
First, the N-terminal surface residues (Ala 2, Lys 3, Arg 22, Lys 29) and the spatially 
adjacent Arg 333 and Asn 334 of each subunit are distributed on a layer perpendicular to 
the central trimeric three-fold axis. 
Second, within the same layer, but on the inner central region of the trimer, the subunits 
form a positively charged ring with a diameter of about 25 Å circling the three-fold axis. 
Its positive potential is due to three lysines (Lys 172, Lys 173, Lys 412) and three arginines 
(Arg 177, Arg 213, Arg 369) and a few main chain N atoms. Two putative sulfate groups 
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form ion pairs with protein atoms compensating the excess of acidic residues that would 
weaken the interactions between the monomers. Both are present as strong electron density 
peaks in all six monomers of the asymmetric unit and appear to originate from one sulfate 
ion and one MES molecule (Figure 2.36). 
Third, four lysine residues (Lys 54, Lys 68, Lys 387 and Lys 405), conserved in type I 
SQRs, are oriented towards the bulk solvent. 
Finally, the base of the trimer body is the part of the protein most deeply inserted into the 
membrane, approximately 12 Å below the layer of the N-terminus and of the sulfate groups. 
It consists of the helix-turn-helix amphipathic motif (residues 376 – 412). At the positive 
N-terminal end of helix 376 – 395, the indole group of conserved Trp 377 “snorkels up” 
(Lomize et al., 2007) in a characteristic manner and, at the C-terminal end, Trp 391, Arg 
394 and Asn 395 bind a putative sulfate ion (Figure 2.37). A dodecyl-β-D-maltoside (DDM) 
molecule can be identified in the electron density lying in between the helices. The 
detergent mimics both the physiological lipids as well as the substrate quinone that 
presumably enters SQR at this site (see Chapter 2.10.5). The maltose polar head group of 
DDM presents its oxygen atoms at hydrogen bond distances (3 – 3.5 Å) from residues Lys 
Figure 2.35: Membrane-binding motifs. The SQR trimer interacts with the membrane through four 
distinctive motifs, here represented in different colours. The N-terminal domain is dark green, the inner domain 
binding one sulfate ion and one MES molecule is light green, the four conserved lysines are dark blue and the
base of the trimer body is yellow. The membrane is indicated in grey. The overall trimer is in a semi-
transparent cartoon representation. The side chains of Arg 204 of all three monomers are represented in cyan 
sticks to highlight the central trimerization contacts. Other residues and molecules are shown only for the two 
subunits in the foreground for a clearer visualization. The FAD is in cyan mesh. The side chains of the residues
and the molecules belonging to the different membrane interacting motifs are shown as sticks. For sulfate 
groups a semi-transparent surface representation is also shown. The distances reported in angstrom on the right 
were calculated from the plane of the sulfur atoms of the MES molecules respectively to the Cα atom of Arg 
204 (7 Å) and the C3B atom of the maltose head of DDM (12 Å) in chain A. An approximate value (40 Å) 
indicates the membrane thickness according to White and Wimley, 1994. 
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373 and Trp 377 and from one putative sulfate ion, whereas its acyl chain makes 
hydrophobic contacts (3.5 – 4.2 Å) with residues Phe 357, Phe 381, Leu 407, Phe 410 and 
Leu 411. Other unexplained electron density peaks can also be identified in the 
amphipathic domain and more precisely between the two helices near the DDM molecule, 
in the quinone binding cavity (see Chapter 2.10.5) and in contact with loop 396 – 399. 
2.10.3. Binding site of the cofactor FAD 
SQR binds FAD in the same position as other FDRs do. The isoalloxazine ring binds the 
central Rossmann domain and it is planar, in contrast with the more bent conformation 
found in the related FCSD structure. The ribitol-adenosine moiety extends into the N-
terminal Rossmann domain. The electron density of FAD is connected from its C8M group 
(the methyl group in position C8 of the FAD isoalloxazine ring) to the side chain of Cys 
124. Most interestingly, their distance is too long for a direct covalent linkage and therefore 
this flavin-protein linkage is of a type that has not been observed before (Heuts et al., 
 
Figure 2.36: Monomer-monomer contacts 
mediated by sulfate groups. In the inner membrane-
facing side of the trimer, one sulfate ion (SO4
2-) and 
one MES molecule bind at the monomer-monomer 
interface. The sulfate ion is forming ion pairs between 
Arg 369 of one monomer (light blue) and Lys 172 of a 
neighbouring chain (light green). The protein is in a 
semi-transparent cartoon representation, relevant 
amino acids and protein-bound molecules are shown 
in sticks. A semitransparent surface representation of 
the sulfate ion and the MES molecule is shown in 
orange. Interatomic distances are indicated in
angstrom and depicted as black dotted lines. 
 
 
Figure 2.37: Putative lipid clamps. Sulfate ions (SO4
2-) bind to the SQR amphipathic domain in two 
positions, possibly mimicking sites of specific binding of zwitterionic lipids. Left panel: the environment of 
conserved Trp 377, whose side chain interacts with the maltose head group of DDM and with a sulfate ion. 
Right panel: the environment of Trp 391, whose indole group interacts with a sulfate ion together with Arg 
394 and Asn 395. 
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Figure 2.38: Cys 124-FAD linkage. Left panel: anomalous difference map around the catalytic site calculated 
from a data set collected at 6.5 keV and shown at 3.0 σ contour level in blue mesh. Anomalous peaks are
visible for S atoms of cysteines and methionines and for the phosphate groups of the FAD. One additional peak
is present between the sulfhydryl group of Cys 124 and the C8M group of FAD, indicating that a relatively
heavy atom with residual anomalous scattering at 6.5 keV, possibly S, is present in the structure. Right panel: 
2Fo-Fc electron density map at 1 σ contour level in blue mesh of the protein-FAD linkage. The Sγ atom of Cys 
124 and the putative S atom providing the linkage are indicated. The protein monomer is shown in the same 
orientation in the two panels. Its Cα trace is shown in a semitransparent cartoon representation in green. The 
FAD and the side chains of the relevant residues are in sticks, colour-coded according to the atom type (C 
green, N blue, O red, S orange and P magenta). 
2009). The connection is provided by a relatively heavy atom as identified in an anomalous 
difference map calculated on the basis of a 2.30 Å resolution data set collected at a 
wavelength of 1.907 Å (Figure 2.38). We interpreted it as a sulfur atom possibly 
contributed by the substrate, sulfide (see Chapter 3.4). Thus, according to our interpretation 
of the electron density, SQR binds FAD through a labile persulfide bond (Cys-Sγ-S-CH2-
FAD) and not through a stable thioether bond (Cys-Sγ-CH2-FAD). 
2.10.4. Sulfide oxidation site 
The sulfide oxidation site is located on the re-face of FAD. The aromatic FAD rings and 
the protein segment Ser 155 – Pro 159 delimit a cavity that extends approximately 15 Å 
parallel and 4 Å perpendicular to the isoalloxazine plane. The cavity is accessible from the 
bulk solvent through a channel characterized by a positive electrostatic surface potential. 
Four solvent molecules occupy the channel at consecutive sites from the periplasm to Ser 
155, conserved only in type I SQRs, and might mimic the trace of the substrate, H2S. At 
the end of the channel sits Val 294, also conserved only in type I SQRs and essential for 
activity (Griesbeck et al., 2002) (Figure 2.39). Interestingly, the loop Val 294 – Lys 312 
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Figure 2.39: Putative sulfide access channel.
Sulfide (here indicated as H2S in a yellow circle) 
reaches the SQR active site through a positively
charged channel (black arrow). The side chain of Val 
294, represented in black sticks, resides at the inner
end of such channel. The surface of the protein is
colored according to its electrostatic surface 
potential (see Figure 2.32). 
  Figure 2.41: Distances between key atoms in the 
active site. The distances between the essential 
SQR cysteine residues (Cys 124, Cys 156, and Cys 
347) and FAD positions C8M and C4A are 
represented as red dotted lines and indicated in 
angstrom. The side chains of Cys 124, Cys 156 and 
Cys 347 are in a double conformation (-SHa/-SHb)
as modelled in the structure. 
 
 
  
 Figure  2.40:  Superposition of SQR on FCSD. 
SQR (blue semitransparent cartoon representation) 
has an overall fold similar to FCSD (red 
semitransparent cartoon representation). However, 
two loops around the sulfide oxidation site have 
different conformations. SQR loop 294 – 312 
(bright blue) is longer than FCSD loop 294 – 303 
(bright red) and extends towards the left side of the 
Figure. SQR loop 152 – 159  (dark purple) and 
FCSD loop 154 – 163 (dark pink) also show a 
different orientation, such that FCSD Cys 161 is 
closer to FAD than SQR Cys 156. The FAD 
molecules are in cyan and yellow for the SQR and 
FCSD respectively. The side chains of the Cys 
residues are shown in sticks. 
delimiting the channel on one side and the segment Pro 152 – Pro 159 opposite to the 
isoalloxazine ring are linked by hydrogen bonds and exhibit a conformation different from 
that of the FCSD structure (Chen et al., 1994) (Figure 2.40). Three cysteines essential for 
activity (Griesbeck et al., 2002) face the cavity as schematically depicted in Figure 2.41. 
Cys 124 binds the FAD dimethylbenzyl ring as described in the previous Chapter 2.10.3. 
Cys 347 is part of a rigid β-sheet on the pyrimidine-2,4-dione side. Cys 156 is localized in 
the loop Pro 152 – Pro 159 and, among the three cysteines, it is the residue with the highest 
potential degree of mobility. 
The sulfide oxidation pocket is unexpectedly not empty in the structure. The density of the 
Sγ atom of Cys 156 in one conformation extends to form a long chain on one side. The 
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chain is oriented towards Cys 347, it is surrounded by conserved hydrophobic amino acids 
(Phe 194, Val 196, Ile 199, Ala 349 and Phe 358) and it is near the couple Tyr 161 – Glu 
162 implicated in proton exchange during the reaction (Nübel et al., 2000; Shahak and 
Hauska, 2008). In some monomers (i.e. monomer A and F in the structure of the “as 
purified” protein), the density closes to form a circle (Figure 2.42). In some other 
monomers (i.e. monomer D) the density connected to Cys 156 is shorter but a chain is also 
observable connected to Cys 347 (Figure 2.43). 
We currently have no evidence for the crystallographic and possibly functional reasons for 
such differences between the densities of the active site of the single monomers. Since 
polysulfur is known to be the product of the reaction (Griesbeck et al., 2002) and because 
sulfur has the property of forming chains, we have interpreted 2Fo-Fc density regions 
higher than 1 σ with chains of S atoms adjusting the occupancy (30 %) to have Fo-Fc 
difference maps with positive and negative signals lower than 3 σ and B factors close to the 
average values of the whole protein chain (Boverall = 38 Å
2). The geometry of the S chains 
modelled into the electron density is compatible with that of sulfur species known from 
 
 
Figure 2.42: Putative polysulfur chain
attached to Cys 156. In chain A of the “as-
purified” structure, the electron density map of 
the sulfhydryl group of Cys 156 extends to form 
a circle and was thus interpreted as a covalently
bound cyclooctasulfur ring (S8). The density is
visible also in the simulated annealing 2Fo-Fc
omit map represented here in blue mesh at 1.0 σ 
contour level. The second sulfur atom of the
chain (S*) would be trivalent, as explained in the
text. The colour code is the same as in Figure
2.38. 
  Figure 2.43: Putative polysulfur chain attached to 
Cys 347. The sulfide oxidation site of monomer D in 
the “as-purified” structure shows an elongated 
electron density peak extending from the sulfhydryl 
group of Cys 347, and a weaker density prolonging 
the side chain of Cys 156. Here the simulated 
annealing 2Fo-Fc omit map around Cys 156 and Cys 
347 is represented in blue mesh at 1.0 σ contour level. 
The colour code is the same as in Figure 2.38. 
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inorganic chemistry
42. A few additional electron density peaks still remain unexplained in 
the sulfide oxidation cavity. 
2.10.5. Quinone reduction site 
The quinone binding site is on the FAD si-face and it is accessible through a channel 
formed between the amphipathic helices described above. The quinone was localised in the 
2Fo-Fc simulated annealing omit map at 0.8 σ (Figure 2.44). In the same region, the 
structure of the protein “as-purified” shows a density peak of different shape, possibly 
corresponding to a co-purified hydrophobic molecule. In the quinone-bound structure, the 
binding site is not fully occupied, which correlates to the low affinity (in the micromolar 
range) measured in kinetic experiments. However, it is possible to locate the aromatic ring 
and the hydrophobic side chain unequivocally. The aromatic ring is bound between the 
benzene ring of Phe 385 and the side chain of Ile 346 (both are conserved residues among 
SQRs but not in FCSDs). There is a network of solvent molecules and charged amino acids 
including Glu 318 and Lys 382 (conserved among SQRs) and Gln 319, Lys 392 and Glu 
403 around the benzoquinone ring. The aliphatic side chain extends towards the membrane 
attachment domain and interacts with the 
hydrophobic side chains of amino acids Met 
315, Ile 348, Phe 381, Tyr 388, Phe 402, Val 
406, Leu 407. The position of the quinone 
binding site is confirmed also by the 
structure of SQR in an inhibitor-bound state. 
Aurachin C, a quinone-analogue reported to 
be a potent competitive inhibitor of A. 
aeolicus SQR (Nübel et al., 2000), was 
soaked into the crystals and the structure 
was solved at 2.9 Å resolution. It also does 
not differ significantly from the structure of 
the protein “as-purified”. The structure 
shows an electron density peak for the 
inhibitor in the same pocket that was 
identified to bind decylubiquinone. 
 
Figure 2.44: The quinone binding site.
Decylubiquinone (UQ, light blue stick representation)
was localised in the electron density map between the
side chains of Ile 346 and Phe 385 on FAD si-face. 
Here, the simulated annealing 2Fo-Fc omit map is shown
in blue mesh at 0.8 σ contour level. The colour code is 
the same as in Figure 2.38. 
                                                 
42 see for instance the description of the structure of the S8 ring in Rettig et al. (Rettig and Trotter, 1973), of 
the allotropic forms of elemental sulfur in Meyer (Meyer, 1964) and of trivalent S atoms in Wong et al. 
(Wong et al., 2002). 
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3. Discussion 
3.1.  The structural membrane proteomics approach 
This work was undertaken as part of a structural membrane proteomic project on A. aeolicus 
described previously (Wedemeyer, 2007). It is worth here presenting and discussing the 
working strategy because it is both an uncommon approach and has had important 
consequences on the choice of the experiments, on the protocols established and on the results 
achieved. 
Most importantly, it has to be considered that the project consists of the isolation of membrane 
proteins from native cells. Such an approach, directed to structural studies, has advantages and 
disadvantages. First of all, since A. aeolicus cells require extreme and costly growing media, 
the same batches of membranes need to be used in our laboratories by a whole research group. 
Consequently, it is not possible to improve the production yield of a single protein specifically 
by optimizing i.e. the cell growing conditions or the membrane solubilisation protocol or the 
first chromatographic fractionation of the solubilized material. Therefore, this approach is only 
applicable to proteins that are already highly expressed in the source organism. Secondly, the 
work on a native system excludes the possibility of exploiting protein tagging for purification. 
Homologous recombination to enhance expression, introduce tags or mutate the target are also 
discouraged by the difficult growing conditions of the organism. Nonetheless, SQR is one of 
the most abundant enzymes in A. aeolicus membranes and an efficient protocol could be 
established to prepare a very pure sample in sufficient amounts for crystallization studies by 
means of conventional chromatographic techniques. 
Despite some limitations, isolating SQR from native A. aeolicus cells had numerous 
advantages. In general, as a hyperthermophilic organism, A. aeolicus is a source of stable, 
compact protein complexes, ideal for structural studies. At the same time, membrane protein 
production in a native lipidic environment is advantageous in comparison to heterologous 
expression in another bacterial system like E. coli, given the substantial differences in 
membrane composition between thermophilic and mesophilic organisms. Furthermore, 
previous attempts to purify A. aeolicus SQR from the heterologous expression host E. coli were 
hampered by unsatisfactory levels of FAD incorporation (Schödl, 2003), while spectral 
characterization suggests that in our preparation the presence of apoprotein is negligible. 
Finally, certain features of the SQR structure, namely the unusual FAD-to-protein linkage and 
the putative polysulfur chain in the active site, are presumably a consequence of the activity of 
SQR  in vivo before cell harvesting and might have not been present if the enzyme were 
produced heterologously. 
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Figure 3.1: The structural membrane proteomics approach. 
Figure 3.1 summarizes the working strategy in a flowchart and highlights the iterative nature of 
the process. In contrast to a genomic approach, which focuses on a single (set of) specific 
gene(s), a proteomic project concerns itself with the analysis of the full proteome of the target 
organism. Each experiment aims in first place to the identification and to the choice of the 
target, even before contributing to its direct biochemical characterization. In other words, 
parallel studies on the target need to be carried out to determine its sequence, its abundance, its 
purity and its interactions with other partners, besides its biochemical and its structural 
properties. It is therefore important that each result is used to improve and interpret all the 
others at every stage of the project. The iterative nature of such a working flowchart is well-
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exemplified by two experiences from this work, the first related to the establishment of the 
purification protocol, the second to the interpretation of the electron density map. The 
purification protocol was optimized in two successive steps. An initial protocol was useful for 
obtaining the first crystals. Then, during crystallization trials, one additive, the detergent 
Zwittergent 3-10, was identified as modifying the crystal properties. The biochemical 
investigation on the effect that Zwittergent 3-10 has on the protein preparation led to a crucial 
improvement in the original purification protocol, by including a detergent exchange step. Only 
the crystals grown from this second, more pure protein preparation were suitable for structure 
determination. The second example is related to the unexpected structural features that, as 
mentioned above, were observed in the SQR active site and that could have hardly been 
predicted before the determination of the structure. As a consequence, after structure solution, 
the biochemical characterization of the protein had to be extended in order to support the 
crystallographic observations and to suggest an experiment-based interpretation of the electron 
density maps. 
3.2.  Biochemical and crystallographic studies on a monotopic 
membrane protein 
As observed in the crystal structure and in agreement with the expectation from previous 
biochemical and bioinformatic investigation (Shahak and Hauska, 2008), SQR belongs to the 
class of integral monotopic membrane proteins (MMPs). Here it is commented on what 
consequences the SQR topology has had on the biochemical and crystallographic studies, while 
its structural and functional implications are discussed in Chapter 3.3.2. 
Integral MMPs are, like transmembrane proteins (TMPs), amphipathic. However, the 
electrostatic surface potential distribution in MMPs and TMPs strongly differs. TMPs consist 
of two polar regions on opposite sides separated by a hydrophobic belt. Instead, in MMPs one 
face has hydrophilic character and is exposed to the bulk solvent, while the opposite face is 
enriched in basic residues (positively charged) and in hydrophobic patches. The latter face 
binds the membrane in vivo, while in vitro it requires the presence of detergent for correct 
folding and to prevent aggregation. The surface dipolarity typical of MMPs is particularly 
pronounced in SQR. 
In addition, the dimensions of the SQR complex reveal that the protein is rather flat, 
resembling the shape of an elliptical disc rather than that of a globular sphere. The SQR shape 
is a consequence of its necessity to bind the membrane as a trimer, as discussed later. 
Because of its dipolar surface, its binding to detergent molecules and its ellipticity, all features 
inherent to its membrane topology, SQR behaves in a way that strongly deviates from standard 
soluble proteins. In particular, all biochemical techniques that are affected by surface charge 
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distribution and shape are biased by the membrane-bound nature of SQR. This is specifically 
true for techniques used to estimate the molecular weight of the protein, such as size-exclusion 
chromatography and native electrophoresis, and possibly also for the LILBID MS setup, where 
SQR aggregation may result from non-specific electrostatic or hydrophobic interactions in the 
small energised droplets generated by the ion source. 
The crystallographic behaviour of SQR is also significantly affected by the asymmetry of its 
surface, and it could not be otherwise, since crystal contacts form through surface residues. The 
disordered detergent molecules, the steric impediment of the detergent micelle and the non-
Figure 3.2: The crystal lattice of SQR. Panel A shows the asymmetric unit of the crystals in the three 
orientations, indicated by the x-, y- and z-axis, almost parallel to the crystallographic unit cell axis. It is 
composed by a dimer of trimers, here represented as ribbons, with each protein chain coloured differently. 
Panel B shows the disposition of the SQR hexamers along the y-axis. The protein complexes form a row 
confining the hydrophobic portion (H) of the structure in between two layers of trimers and exposing the polar
regions (P) on the two sides. The dotted black box indicates one asymmetric unit (see panel A, left). The
molecules obtained by symmetry operations are depicted in grey. Panel C shows the disposition of the SQR
complexes in the x- and y- dimensions. The protein complexes form a bidimensional plane. One asymmetric 
unit is coloured as in panel A, the symmetry-related units are coloured grey. The dotted black box indicates one
row of SQRs in the y-dimension (see panel B, rotated by 90° over the y-axis). Panel D shows the full SQR 
lattice. The xy-planes described in panel B (one is indicated here by the dotted black box) are repeated in the z-
dimension. Although the detergent-filled region is not exactly continuous along the x-axis, it is possible to 
identify successive layers of polar (P) and hydrophobic (H) regions, as it is defined in the text for “type I” 
monotopic membrane protein crystals. 
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specific hydrophobic contacts formed by the membrane-inserted regions make it difficult for 
membrane proteins to form regular three-dimensional arrays. TMPs overcome these problems 
in two ways (Michel, 1983; 2006). One possibility is that two-dimensional crystals form in the 
plane of the membrane and stack over each other in an ordered manner (type I membrane 
protein crystals). Another possibility is that crystal contacts are formed exclusively among the 
polar regions of the protein and that the hydrophobic cores of the proteins are solvated by the 
detergent micelle (type II membrane protein crystals). Considering the structures available to 
date, MMPs also seem to adopt two alternative crystalline patterns which closely recall those 
described for TMPs. In the “type I” MMP crystals, the molecules also form a two-dimensional 
array mimicking the disposition over the membrane. However, TMPs in the type I crystals can 
form crystal contacts with both their polar regions on the two sides of the membrane, while 
MMPs cannot, because they possess only one polar face. Consequently, each two-dimensional 
plane of MMPs needs to come in contact with an identical one oriented “upside-down”, so that 
the hydrophobic faces are facing each other and are excluded from the bulk solvent. This 
pattern can then be translated up- and downwards in the third dimension. It is noteworthy to 
remark that, in this type I crystalline arrangement, the two dimensional layers of the protein are 
alternatively in contact through polar and non-polar faces. The hydrophobic contacts, which are 
generally less specific, confer fragility and irregularity to the crystals. Possibly, this is the 
reason why it has been so difficult and so rare to obtain SQR crystals not characterized by high 
mosaicity. On the other hand, in the “type II” MMP crystals, the membrane binding domain 
surrounded by the detergent is segregated in cavities of the crystal lattice and the contacts 
between the protein units are mediated only by the polar faces. Oxidosqualene cyclase (PDB 
id.: 1W6K) and prostaglandin H2 synthase 1 (1Q4G) crystallize in the “type I” form, while 
fatty acid amide hydrolase (1MT5), 11-β-hydroxysteroid dehydrogenase (1XSE), cytochrome 
P450 (2BDM), prostaglandin H2 synthase 2 (1CVU), apocarotenoid cleavage oxygenase 
(2BIX), carnitine acyltransferase (1T7Q), electron transfer flavoprotein:quinone 
oxidoreductase (2GMH) and squalene hopene cyclase (2SQC) form “type II” crystals. 
The lattice of SQR needle crystals (Figure 3.2) shows that in one dimension (along the 
crystallographic y-axis) the molecules are arranged on two sides of a layer filled by detergent 
molecules and corresponding to a hypothetical membrane plane. These rows of SQR 
complexes visible along the y-axis extend to form planes along the x-axis. Although the 
detergent-filled region is not continuous along the x-axis, it is confined to the core of the planes. 
Instead, the surface of the planes is composed on both sides by the hydrophilic portions of the 
protein complexes. Finally, the xy planes are repeated in the z dimension exclusively through 
polar crystal contacts. This distribution of the molecules in the SQR lattice is similar to that 
defined above for “type I” MMP crystals. It would be curious to study the tendency of SQR to 
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form two-dimensional crystals by detergent-lipid exchange and, because of the pronounced 
polarity of the SQR surface potential, to test whether crystallization in a stationary magnetic 
field (Moreno et al., 2007) would improve the speed of crystal growth or the resolution of 
diffraction. 
3.3.  Overall three-dimensional structure 
SQR is composed of three structural regions, like other type I FDRs. The N-terminal and the 
central domains are two Rossmann-fold domains, similar to other nucleotide-binding proteins, 
as inferred from a structural alignment performed with DALI (Table 3.1). Instead, the C-
terminal or “interface domain” (Argyrou and Blanchard, 2004) is a structural region specific 
for each FDR subfamily. In SQRs, it is composed of two amphipathic helices (residues 376 – 
412) and a C-terminal 18-amino-acid loop (residues 413 – 430). Its function is to form 
oligomeric contacts, to interact with the membrane and to interact with the quinone, as 
discussed in Chapters 3.3.1, 3.3.2 and 3.6, respectively. 
Although not possessing a completely new structural fold, A. aeolicus SQR shows a number of 
interesting and in some cases unexpected features. In particular, it shows surprising differences 
Table 3.1: Structural alignment of SQR against known protein structures
a. 
Target
b (PDB code / chain id)  RMSD
c  N° aligned residues
d Identity
e 
1FCD / A  2.4  362  21 
3H8L / A  2.8 356 24 
2YVF / A  2.8  321  18 
2GMH / A  3.1  143 17 
1DX1 / C  3.1 329 14 
1NDA / B  3.2 325 16 
2QCU /B  3.2 148 15 
4GR1 3.2 328 15 
1ZK7 / A  3.3 322 14 
2CFY / F  3.4 327 15 
1QLA / A  4.5 190 13 
a The alignment was performed with the software DALI (www.ebi.ac.uk/dali) against the PDB database.
 
b PDB codes correspond to the following proteins: 1FCD, flavocytochrome c:sulfide dehydrogenase; 3H8L, 
sulfide:quinone oxidoreductase (from Acidianus ambivalens); 2YVF, ferredoxin reductase; 2GMH, electron 
transfer flavoprotein (ETF):ubiquinone reductase; 1DXl, dihydrolipoamide dehydrogenase; 1NDA, 
trypanothione oxidoreductase; 2QCU, glycerol-3-phosphate dehydrogenase; 4GR1, glutathione reductase; 
1ZK7, mercuric reductase; 2CFY, thioredoxin reductase; 1QLA (2BS2), quinol:fumarate reductase. 
c Average root-mean-square deviations (RMSD) for all atoms indicated in angstrom. 
d Total number of structurally aligned residues. 
e Percentage of structurally aligned residues that are identical in SQR and in the respective aligned partner.  
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from the structure of Allochromatium vinosum flavocytochrome c:sulfide dehydrogenase (PDB 
id.: 1FCD), which had been for almost two decades the only structural reference for SQRs, and 
to another structure of an SQR solved recently, that of Acidianus ambivalens SQR (3H8L) 
(Brito et al., 2009). The differences pertain to the oligomeric state, to the structural basis of 
membrane attachment, to the details of the substrate binding sites and to the hypothesis on the 
reaction mechanism. 
3.3.1.  Oligomeric state 
All structures of MMPs, and in particular of monotopic membrane enzymes, reported to 
date are either monomeric, like ETF:UQ oxidoreductase (PDB id.: 2GMH), oxidosqualene 
cyclase (1W6K), apocarotenoid cleavage oxygenase (2BIX), cytochrome P450 (2BDM), 
11-β-hydroxysteroid dehydrogenase (1XSE) and carnitine acyltransferase (1T7Q), or 
dimeric, like fatty acid amide hydrolase (1MT5), prostaglandin H2 synthase 1 (1Q4G) and 
2 (1CVU), monoamine oxidase B (1OJA) and squalene hopene cyclase (2SQC) (Balali-
Mood et al., 2009). 
Also all FDRs characterized to date were shown to be functional in a dimeric state 
(Argyrou and Blanchard, 2004). Only the oligomeric state of SQRs was difficult to 
characterize unequivocally because of the uncertainties related to the fact that SQRs are the 
only FDRs bound to the membrane. Solubilized Oscillatoria limnetica SQR was proposed  
to be either a monomer surrounded by a detergent belt or a dimer with less detergent 
associated to it (Arieli et al., 1994), while Rhodobacter capsulatus SQR was later shown to 
be functional in a multimeric form (Schütz et al., 1997). 
The  A. aeolicus SQR structure shows that the protein forms a trimeric complex. 
Crosslinking and density-matched sedimentation equilibrium analytical ultracentrifugation, 
techniques which are least sensitive to protein shape and electrostatic effects and which 
allow masking the contribution from the detergent micelle, suggest that SQR is trimeric 
also in solution. Also the reconstruction by single-particle electron microscopy reveals that 
SQR exists as a trimer, probably with a tendency to form hexamers, as observed in the 
asymmetric unit of the crystal structure.  
Comparison of SQR sequences shows poor conservation of the residues that mediate 
oligomerization, so that trimerization might not be a common feature of SQRs. For 
example, the A. ambivalens SQR (Brito et al., 2009) is dimeric, even though it must be said 
that the structural disorder of the 50-amino-acid C-terminal domain absent in the structure 
may be responsible for a non-physiological oligomerization in that protein. It would not be 
exceptional that SQRs adopt different oligomerization states in different organisms. For 
example, another monotopic membrane enzyme, lanosterol cyclase, is dimeric in bacteria 
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(squalene hopene cyclase), but monomeric in eukaryotes (oxidosqualene cyclase) (Ruf et 
al., 2004). However, it is certain that, in A. aeolicus SQR, the trimeric state guarantees 
thermal stability and an optimal membrane attachment surface and therefore has a 
physiological relevance. 
3.3.2.  Membrane-binding mode 
MMP structures often do not reveal the details of their protein-to-lipid interactions (Balali-
Mood et al., 2009). The SQR structure presented in this work is exceptional in this respect 
because it provides information on the degree of penetration into the bilayer and on 
specific binding sites for phospholipids. 
Membrane insertion of SQR follows two of the common strategies described for peripheral 
membrane proteins (see Chapter 1.3.1), namely the presence of in-plane amphipathic 
helices and of lipid clamps. The amphipathic helix-loop-helix C-terminal domain (Figure 
2.33) presumably induces SQR to insert into the lipid bilayer to a depth of about 12 Å, 
which implicates complete penetration through the lipidic polar head group region (White 
and Wimley, 1994; Johnson and Cornell, 1999) and contacts between the exposed 
hydrophobic side chains and the membrane hydrocarbon core. In the same domain, two 
tryptophan residues (Trp 377 and Trp 391, Figure 2.37) are involved in specific binding to 
sulfate groups in the crystal structure. Sulfate groups are an important determinant for 
assessing protein-lipid interactions because sulfate chemically mimics the phosphate heads 
of cellular lipids. Therefore, position 377 and 391 in A. aeolicus SQR represent two 
putative lipid clamps and may possess affinity for zwitterionic phospholipids, preferred by 
tryptophan (Cho, 2001). 
Furthermore, the observed binding sites of some sulfates between the subunits (i.e. one 
sulfate ion bridges Lys 172 of one monomer and Arg 369 of a neighbouring monomer, 
Figure 2.36) suggest that membrane insertion stabilizes oligomerization and, vice versa, the 
trimer creates an appropriate surface for binding lipid phosphate groups. The presence of 
oligomeric interactions mediated by salt ions also explains the fact that SQR is more 
compact in buffers with high salinity, as observed by size exclusion chromatography 
(Chapter 2.3.1) and electron microscopy (Chapter 2.3.6). The reduction in the rate of 
enzymatic activity measured at high salt concentrations might instead result from a 
competition of salt anions with sulfide and is unlikely to be physiological. In addition, it 
must be mentioned that, conversely, an increase of activity at high salt concentrations was 
observed for A. aeolicus SQR overexpressed in E. coli (Schödl, 2003). Therefore further 
investigation is needed to characterize the SQR reaction at high values of ionic strength. 
Certainly, the coupling between membrane insertion, trimerization and enzymatic activity 
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might ensure that SQR exclusively reduces hydrophobic quinones and, perhaps, might also 
facilitate the release of the water-labile polysulfur product into the membrane via a non-
polar environment (see following Chapter 3.7). 
SQR shares common features of membrane association, such as characteristic tryptophans, 
exposed hydrophobic residues, amphipathic segments and positively charged surface areas, 
with some other monotopic membrane proteins, i.e. the prostaglandin H2 synthase 1  (PDB 
id.: 1Q4G) and the squalene hopene cyclase  (2SQC). However, the fold of the inserted 
segments differs substantially. Even more divergent are the membrane insertion motifs of 
the structurally and functionally related flavoproteins ETF-UQ oxidoreductase (PDB id. 
2GMH) and glycerol-3-phosphate dehydrogenase (PDB id. 2QCU). Interestingly, the 
comparison with A. ambivalens SQR, which might have one single amphipathic membrane 
anchor, seems to suggest that the membrane binding motifs are different even within the 
SQR family itself. Membrane attachment of monotopic membrane proteins has been 
probably developed at a later stage of protein evolution than enzyme differentiation for a 
specific catalytic activity. Within 
SQRs, the differences may correlate 
with the different sensitivity to 
quinone analogues (Griesbeck et al., 
2000). 
A final consideration needs to be 
made for the description of how 
SQR insertion perturbs the lipidic 
bilayer. The effect of amphitropic 
and monotopic membrane proteins 
on the membrane has been 
extensively studied by coarse-
grained molecular dynamics 
simulations (Fowler et al., 2007; 
Balali-Mood et al., 2009) (Figure 
3.3). It was found that some protein 
complexes insert into the membrane 
in a “shallow” manner, perturb only 
one membrane leaflet and interact 
with the membrane “symmetrically”, 
meaning that each monomer 
Figure 3.3: Lipid bilayer perturbation by monotopic 
membrane proteins. Final snapshots (t = 700 ns) 
generated by coarse-grained molecular dynamics
simulations are shown for nine monotopic membrane 
proteins (the corresponding PDB codes are indicated in 
the insets). Phosphate atoms of the lipids are coloured 
purple, basic protein residues blue, hydrophobic 
residues green, and others gray. The Figure is 
reproduced from Balali-Mood et al., 2009. 
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penetrates it to an identical extent. Other proteins, in contrast, insert “asymmetrically” and 
more deeply, so that some residues may even come in contact with the polar heads of the 
lipids belonging to the opposite membrane leaflet. The latter proteins induce a pronounced 
distortion of the entire bilayer. Based on those computational studies and considering the 
symmetry and the electrostatic properties of the SQR trimer, it seems more likely that SQR 
interacts with only one membrane leaflet through a shallow insertion. 
3.3.3.  Thermal stability 
Functional assays show that A. aeolicus SQR has an exceptionally high thermal stability 
(Table 2.4). The three-dimensional structure shows that the protein adopts at least five 
different strategies to adapt to high temperatures. (i) As discussed above, SQR is trimeric 
and not monomeric or dimeric like other monotopic membrane proteins and other FDRs. 
“Increased oligomerization” (Yano and Poulos, 2003) was proposed to be a way of 
enhancing protein complex stability (Tanaka et al., 2004), although this issue is debated 
(Kumar et al., 2000). (ii) The six direct hydrogen bonds plus the two mediated by solvent 
molecules that constitute the monomer to monomer interactions and the involvement of an 
arginine (Arg 204) in the central contact region of the trimer are typical features of 
thermostable proteins (Kumar et al., 2000; Yano and Poulos, 2003; Tanaka et al., 2004). 
(iii) It is interesting to notice that seven cysteines are present in the A. aeolicus SQR. This 
is unusual because highly reactive cysteines are normally less frequent in 
hyperthermophilic proteins (Vieille and Zeikus, 2001). However, in SQR, four of these 
cysteines are reciprocally bound to form two disulfide bridges (Figure 2.34). Such 
disulfides stabilize the C-terminal domain, a sensitive region of the structure that mediates 
trimer formation, contributes to cover the active site (see Chapter 3.5) and ensures a stable 
and site-specific membrane interaction. The C-terminal disulfide bonds also corroborate 
the idea that the protein is localized in a periplasmic oxidising environment (Schütz et al., 
1999). (iv) The cofactor FAD is bound tightly through a covalent bond, as discussed in 
Chapter 3.4, and (v) large solvent-filled cavities surround its isoalloxazine moiety and 
constitute the active sites of the enzyme. These features confer an advantageous resilience 
(Hough and Danson, 1999) to SQR and so also contribute to its structural stability. 
3.4.  FAD binding mode 
SQR binds FAD covalently, thus preventing dissociation and consequent protein 
destabilization (Heuts et al., 2009). An helix dipole at the N
1-C
2=O
2 locus, a glutamate near the 
N
5 FAD atom and a cysteine tethering the flavin, three recently identified structural features 
needed for covalent flavinylation (Heuts et al., 2009), are present in the structure. The 
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connection consists of an unusual 8-α-X-Sγ-cysteinyl bond with Cys 124, that might affect the 
reduction potential of FAD (Heuts et al., 2009) and that we interpreted as a persulfide bond on 
the basis of an experimental anomalous difference electron density map (Chapter 2.10.3). 
Should this interpretation be confirmed, it would represent the first case of an 8α-S-Sγ-cysteinyl 
bond to FAD (Heuts et al., 2009). Cysteine persulfides were however already found in the 
active site of other enzymes, i.e.: sulfurtransferase (PDB id: 1E0C), NifS/CsdB (1KMJ), 
rhodanese (1RHS) and sulfur oxygenase reductase (2CB2). Covalent FAD binding is unusual 
in group I FDRs. It is known to occur only in the other sulfide oxidising enzyme, FCSD, but 
the structural origin of the linking cysteine is different in this latter protein. In FCSD, Cys 42 
binds FAD from its si-face inducing a distortion in the planarity of the isoalloxazine ring, while 
in SQR Cys 124 is situated near the dimethylbenzyl side and the FAD ring is planar. 
Surprisingly, a difference is present also among SQRs. In fact, A. ambivalens SQR binds FAD 
through a direct thiol 8α-Sγ-cysteinyl bond with Cys 129, whose Sγ atom is only 1.53 Å away 
from the FAD position C8M. In other SQRs, then, the corresponding cysteine is replaced by a 
tyrosine, so that these enzymes probably form an 8-α-O-tyrosyl bond with FAD (Heuts et al., 
2009) (see Chapter 3.8). 
The location of the catalytically active residues around FAD also differs significantly between 
FDRs and SQRs and even among SQRs themselves. The redox active disulfide pair typical of 
group I FDRs normally forms a disulfide bridge in the oxidised state. The cysteines lie on the 
si-side of FAD, 2 – 4 Å apart from its C4A atom, and one forms a covalent bond with it during 
the reaction cycle. The cysteines are proximal in the protein sequences too, with a consensus 
motif C1XXXXC2. In both SQRs and FCSDs, instead, the two cysteines are located on the re-
face of FAD, a situation curiously recalling the case of low molecular weight thioredoxin 
reductase (PDB id: 1CL0), a group II and not a group I FDR (Argyrou and Blanchard, 2004). 
Additionally, they are far away from each other in the sequence (Cys 161 and Cys 337 in A. 
vinosum FCSD, Cys 156 and Cys 347 in A. aeolicus SQR and Cys 178 and Cys 350 in A. 
ambivalens SQR). Only in the FCSD structure do they form a disulfide bond and Cys 161 is 
sufficiently close (3.34 Å) to the C4A atom of FAD to form a covalent connection. In A. 
aeolicus SQRs and in A. ambivalens SQR, instead, the corresponding cysteines are far apart 
from each other (the Sγ – Sγ distance is 8.3 Å and 6.5 Å, respectively). Moreover, in the 
conformations observed in the structures, the distances between Cys 156 and the C4A atom of 
FAD in A. aeolicus SQR (6.24 Å) and between Cys 178 and the C4A atom in A. ambivalens 
SQR (4.90 Å) are too long for a covalent attachment (Table 3.2). 
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Table 3.2: Location of key atoms in the active site of FDRs. 
Protein  PDB code  Position
a  Distance
b  FDR group 
glutathione reductase  3DK4  si 3.37 I
lipoamide dehydrogenase  3LAD  si 3.24 I
trypanothione reductase  1FEB  si 3.44 I
A. vinosum FCSD  1FCD  re 3.34 I
A. aeolicus SQR  3HYV  re 6.24 (C156); 5.57 (C347)  I
A. ambivalens SQR  3H8L  re 4.90 (C178); 7.57 (C350)  I
low MW thioredoxin 
reductase 
1CL0  re 3.40 II
a Position of the redox active disulfide centre relative to FAD isoalloxazine ring (re- or si-face). 
b Distances of the Cys-Sγ atoms relative to FAD-C4A atom in angstrom. 
3.5.  Sulfide oxidation site 
In SQRs, sulfide oxidation occurs on the re-face of FAD. In FDRs, this region is in general 
accessible from the bulk solvent and binds the pyridine-nucleotide substrate NAD(P)H. In 
SQRs, however, NAD(P)H binding is hindered by the presence of specific polypeptide 
segments, hereafter referred to as “capping loops”, that guarantee exclusive access of sulfide to 
the active site. In A. aeolicus SQR, the “capping loops” are residues Val 294 – Lys 312, Pro 
189 – Arg 204 and part of the 18-amino-acid C-terminal segment. The latter two loops 
interestingly mediate the oligomerization contacts in the quaternary structure. Loop 294 – 312 
contains the crucial invariant residues Val 294, shown to be responsible for sulfide affinity 
(Griesbeck et al., 2002), and Lys 312, proposed to be involved in proton exchange during the 
reaction cycle (Brito et al., 2009). Residues Pro 311 (through the main chain oxygen atom) and 
Lys 312, together with Ser 155, coat a channel that connect the active site to the bulk solvent. 
Electron density peaks for several solvent molecules, suggest that this channel might be 
occupied by H2S (a chemical analogue of H2O) during the catalytic reaction. 
Surprisingly, the geometry of the “capping loops” is not conserved in the other two sulfide 
oxidising enzymes of known structure, namely A. vinosum FCSD and A. ambivalens SQR. As a 
consequence, sulfide reaches the active site through completely different pathways in those 
enzymes. In FCSD the “capping loops” are substituted by short segments so that the redox 
active disulfide bridge is exposed to the solvent. No additional residues have been described to 
be involved in attracting or guiding sulfide to its binding site. In A. ambivalens SQR, instead, 
the active site is shielded by the “capping loop” Gly 154 – Cys 178. This segment extends in 
the opposite direction as loop 294 – 312 of A. aeolicus SQR (Figure 3.4). Moreover, the sulfide 
access channel, defined by residues Ser 176, Ser 214, Asp 215 and Asp 353 in A. ambivalens 
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SQR, is located in a different structural 
position than the access channel of A. 
aeolicus SQR. As a reference, the 
distance between the carboxyl group of 
Asp 215 (A. ambivalens SQR) and the 
hydroxyl group of Ser 155 (A. aeolicus 
SQR) is 12.5 Å. 
Finally, both A. aeolicus SQR (this work) 
and  A. ambivalens SQR (Brito et al., 
2009) present an active site occupied by 
a chain covalently attached to the redox 
active cysteines. In both cases, the 
electron density has been interpreted 
with polysulfur species, assuming that 
the structures represent an intermediate 
of the reaction cycle, with the forming 
product still attached to the protein. The 
geometry of such polysulfur chains 
differs in the two structures. In A. aeolicus SQR, the chain never connects Cys 156 to Cys 347, 
it is 3 – 9 putative sulfur atoms long, it extends either the side chain of Cys 156 or the side 
chain of Cys 347 and it closes to form a putative S8 ring in some monomers. In A. ambivalens 
SQR, instead, it consists of a 3-sulfur-atom connection between Cys 178 and Cys 350. Such 
structural differences lead to different catalytic hypothesis for the two SQRs (see Chapter 3.7). 
 
Figure 3.4: SQR “capping loops”. A. aeolicus SQR 
(semitransparent cartoon representation in blue) was 
superposed on A. ambivalens SQR (in red) with the 
server DALI (see Table 3.1). Their “capping loops”, 
represented as ribbons, possess completely different 
orientations. Loops 294 – 312 and 412 – 430 in A. 
aeolicus SQR extend from right to left in the Figure, 
while loop 154 – 178 in A. ambivalens SQR from left to 
right. Consequently, in the two proteins the sulfide 
oxidation site varies and the whole reaction mechanism 
may be different, as described in the text. The FAD 
molecules are shown as sticks to facilitate the 
localization of the active sites of the enzymes. 
3.6.  Quinone reduction site 
Quinone reduction takes place on the si-face of FAD. Quinone reaches the active site through a 
channel in between the two amphipathic helices in the C-terminal membrane-attachment 
domain. Based on a classification of the different strategies by which membrane-bound 
enzymes interact with their lipophilic substrates (Forneris and Mattevi, 2008), it can be 
concluded that SQRs “desorb” the quinones from the lipid bilayer. 
Considering the disposition of the residues around quinone-binding pockets of other quinone 
reductases and quinol oxidases, it must be said that no general rule has yet been identified. In 
SQR, the pocket extends approximately 8.2 Å (distance between Ile 346 and Phe 385) x 11.7 Å 
(distance between Glu 318 and Lys 382). The benzoquinone ring is sandwiched between the 
two apolar residues Ile 346 and Phe 385 as in other membrane proteins (Murray et al., 1999). 
Histidines, which are often observed to form hydrogen bonds with the quinone oxygen atoms 
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(Fisher and Rich, 2000) and which were expected to bind the quinone also in SQR (Griesbeck 
et al., 2000; Griesbeck et al., 2002), are not found in the binding pocket. The closest histidines 
are His 47 and His 379, located 10 – 13 Å apart from the binding site. On the contrary, a 
number of other polar residues and of putative solvent molecules surround the quinone and 
form a hydrogen-bonding network. Glu 318 and / or Lys 382, conserved among SQRs, seem to 
be the most likely candidates mediating proton transfer. Finally, the quinone-bound SQR 
structure determines the shortest distance between quinone and FAD to be about 3.5 Å, which 
allows fast electron transfer. 
3.7.  Enzymatic activity 
Kinetic data are reported for SQRs from A. aeolicus [(Nübel et al., 2000; Schödl, 2003) and 
this work], R. capsulatus (Schütz et al., 1997; Griesbeck et al., 2002), O. limnetica (Arieli et al., 
1994),  Aphanothece halophytica (Bronstein et al., 2000), Acidithiobacillus ferrooxidans 
(Wakai et al., 2004), Paracoccus denitrificans (Schütz et al., 1998) and A. ambivalens (Brito et 
al., 2009) and also for the FCSD from A. vinosum (Fukumori and Yamanaka, 1979)
41. In 
general, SQRs and FCSDs exhibit similar substrate affinities in the micromolar range. 
Exceptionally, a number of bacterial SQRs [from Pseudomonas putida (Shibata and Kobayashi, 
2006) and Bacillus stearotheromophilus (Shibata et al., 2007)] and all reported mitochondrial 
homologues [from Saccharomyces pombe (Vande Weghe and Ow, 1999) and Arenicola 
marina (Hildebrandt and Grieshaber, 2008; Theissen and Martin, 2008b)] show millimolar 
affinity to sulfide and an increased catalytic efficiency only in the presence of reaction partners 
such as cyanide or thioredoxin and sulfite. 
Despite the observation of related kinetic values, it is an open question whether the complex 
polysulfur formation reaction proceeds by the same or a different enzymatic mechanism in 
different SQR types. In fact, the different structural features between A. aeolicus SQR, A. 
ambivalens SQR and A. vinosum FCSD described in the previous chapters argue for a different 
reaction cycle.  
The overall SQR reaction couples a reductive step (sulfide oxidation) and an oxidative step 
(quinone reduction) to provide reducing equivalents for redox processes in the membrane. 
Electron flow between the two half-reactions is accomplished via FAD by exploiting its 
capability to accept an electron pair from a transiently bound sulfide adduct and to donate these 
two electrons one by one to the neighboured quinone via the space. Both half-reactions are 
spatially separated. Quinone reduction can be described only from the structure of A. aeolicus 
SQR (see Chapter 3.6). On the other hand, sulfide oxidation can be addressed in more detail by 
                                                 
41  It was questioned whether the FCSD sulfide oxidising activity measured in vitro has physiological 
relevance (Reinartz et al., 1998). 
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comparing A. aeolicus SQR, A. ambivalens SQR and A. vinosum FCSD. SQRs, and possibly 
also FCSDs, catalyze a reaction of sulfur polymerisation whereby polysulfur intermediates are 
covalently attached to the enzyme. This enigmatic multi-step process, composed of initiation, 
elongation and termination steps, requires more complicated structural and mechanistic 
features than for the established reactions of the other FDRs. The chemistry of sulfur in the 
binding pocket of a protein and – in the physiological state – at the high temperatures at which 
A. aeolicus and A. ambivalens grow is complex and its description certainly requires deeper 
investigation. However, the available structural data suggest hypotheses for plausible reaction 
schemes.  
A typical reaction scenario (hereafter referred to as the C4A mechanism
42) is established for 
FDRs and it involves a redox-active cysteine/cystine couple that is oxidized/reduced by FAD 
via a Cys-Sγ-C4A-FAD charge-transfer intermediate. This mechanism requires a distance 
between the sulfur atom of one of the cysteines and the C4A atom in the range of 3 – 4 Å 
(Table 3.2). A reaction scheme in analogy with the mechanism known for FDRs was indeed 
proposed for A. ambivalens SQR (Brito et al., 2009). Surprisingly, though, in the presented 
structure of A. aeolicus SQR, the key atoms are with 5 – 8 Å  too far away for a direct reaction 
(Table 3.2), which would imply substantial conformational changes for such a mechanism to 
take place. From the structure (B factors, quality of the electron density), however, there is no 
hint of flexibility for any protein segment. Two other reaction mechanisms are therefore 
proposed for A. aeolicus SQR, which require shorter protein movements. 
The first proposal is a subtle variation of the FDR C4A mechanism. It implies the formation of 
a Cys-Sγ-S-C4A-FAD adduct, where the additional S atom would be contributed by the 
substrate of the reaction, sulfide. Therefore, it is hereafter referred to as the C4A-S mechanism 
(Figure 3.5). Forming a Sγ-S-C4A bond would require a movement of the protein chain 
approximately half as long as forming a direct Sγ-C4A bond. In this case, the thiol/disulfide 
pairs in the fully oxidised enzyme would be Cys 156 – Cys 347 (A. aeolicus SQR) or Cys 178 
– Cys 350 (A. ambivalens SQR) and SQRs would possibly adopt a structure similar to that of 
FCSD in the fully oxidised state. The C4A-S mechanism would also include a Cys156-Sγ-S-Sγ-
Cys347 trisulfide bridge proposed by Griesbeck et al. (Griesbeck et al., 2000) as a central 
intermediate. 
                                                 
42 “C4A” refers here to the general mechanism of FDRs and to the mechanism proposed for A. ambivalens 
SQR (Brito et al., 2009), while the “C4A mechanism” described in (Marcia et al., 2009) is referred to as 
“C4A-S”. 
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Figure 3.5: The C4A-S mechanism. The individual steps are numbered according to the following criteria.
The number in the grey insets indicates the number of external S atoms accumulated during polymerization. 
For example, the steps marked with number 1 relate to the addition of the first sulfide atom, and so on. The
letter indicates the oxidoreduction stage of the reaction. Letter A refers to the fully oxidized form, which
presents a disulfide bridge in the initial step of catalysis and a polysulfide state in the following cycles. This
state is open for sulfide binding (H2S, yellow circle). Letter B refers to the charge-transfer complex between 
protein and FAD. Letter C refers to the Cys156-Sγ-S-C4A-FAD covalent adduct described in the text. The FAD 
is in a reduced state and the protein is open for binding the substrate quinone (UQ, red box). A significant 
protein conformational change seems to be required to bring Cys 156 closer to FAD position C4A. This 
possibly involves a rotation of loops 294 – 312 and 152 – 159 towards a conformation closer to that of the 
corresponding loops of FCSD (see Figure 2.40). Letter D indicates the state in which FAD is reoxidised after
electrons are transferred to the quinone (the reduced quinol form is indicated as UQH2,  pink box). A 
polysulfide bridge connects Cys 156 and Cys 347. After quinol release the fully oxidised state (letter A) is
formed again. After elongation to a 9-S-atom chain, the polysulfur can close on itself to form a cyclooctasulfur 
still covalently bound to the protein through one S atom in a trivalent state, as described in the text and
observed in some monomers of the structure. This intermediate is indicated by the letter S. Protonation and 
deprotonation are mediated by charged residues present in the catalytic pocket of the enzyme but not depicted
in this scheme. These might include i.e. Glu 162 on the re-side (Griesbeck et al., 2002) and Glu 318 and/or 
water molecules on the si-side of FAD. 
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Figure 3.6: The C8M mechanism. The individual steps are numbered according to the criteria explained for
Figure 3.5. Letter A refers to the fully oxidized form, which presents a disulfide bridge in the initial step of
catalysis and a trisulfide bridge state in the following cycles. This state is open for sulfide binding (H2S, yellow 
circle). Letter B refers to the state after sulfide binding. Cys124-Sγ-S
- attacks FAD quinone-methide tautomer 
in position C8M. Letter C refers to the C8M adduct described in the text. The FAD is in a reduced state and the
protein is open for binding the substrate quinone (indicated as UQ in a box with a red background). This stage 
presents an equilibrium with the growing polysulfur chain exchanged between Cys 156 and Cys 347 after the
second cycle. Letter C1 refers to the conformation in which the chain is attached to Cys 347, letter C2 to the one 
in which the chain binds Cys 156. A significant protein conformational change seems to be required to favour
the S chain exchange between Cys 156 and Cys 347. This would possibly involve a rotation of loop 294 – 312 
and of the loop including Cys 156 towards a conformation closer to that of the corresponding loops of FCSD 
(see Figure 2.40). Letter D indicates the state in which FAD is reoxidised after electrons are transferred to the
quinone (the reduced quinol form is indicated as UQH2 in a box with pink background) and a transient Cys124-
S
+ state is formed. After quinol release the fully oxidised state (letter A) is formed again. The reaction
terminates as described for Figure 3.5. 
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The third crucial cysteine Cys 124 which covalently binds to FAD via a disulfide bridge would 
certainly influence the FAD position and its electronic properties, i.e. its redox potential, but 
would not directly participate in polymerisation. While the C4A mechanism would result in a 
stoichiometry of the reaction of n:(n-1) sulfide molecules oxidised over quinone molecules 
reduced (Brito et al., 2009), the stoichiometry would be 1:1 if a C4A-S mechanism would be 
followed. This stoichiometric difference is a fine but possibly measurable parameter that may 
help in discriminating between the two mechanisms in the future. 
The A. aeolicus SQR structures, though, also suggest an alternative mechanism for conveying 
electron pairs from sulfide to FAD which, of course, also implies a different elongation cycle. 
The connection between the Cys 124 Sγ and FAD C8M atoms via a labile persulfide bridge 
inspires a fairly speculative reaction scheme. The mechanism is hereafter referred to as the 
C8M mechanism and it is schematically illustrated in Figure 3.6. It recalls the description 
(Edmondson and Newton-Vinson, 2001) of FAD incorporation into flavoproteins that 
covalently bind their cofactor. In the proposed reaction scheme, one sulfur atom of the 
persulfide is the Sγ atom of Cys 124 and the other one originates from the substrate, S
2-, after 
reduction of a Cys124-S-S-Cys156 disulfide fully oxidised state. The hypothesis that SQR 
presents a Cys124-S-S-Cys156 disulfide in the oxidised state is compatible with the 
observation that the sulfide access pathway in A. aeolicus SQR (but not in A. ambivalens SQR) 
leads to the region of the active site between Cys 124 and Cys 156. Successively, the species 
Cys124-S-S
- attacks the FAD quinone-methide tautomer to form the “C8M adduct” observed in 
the structure. After electron transfer, a transient Cys124-S-S
+ state is generated and the 
trisulfide bridge (Griesbeck et al., 2000) is formed by a nucleophilic attack by Cys156-S
- at 
Cys124-S-S
+. Cys 347 is involved in taking over the growing sulfur chain and pulling it into a 
hydrophobic pocket, thereby setting Cys156-S
- free for the next reaction cycle. This alternative 
mechanism attributes a central role to Cys 124 but the hypothesis is weakened by the fact that 
Cys 124 is not conserved in mitochondrial SQR sequences, where it is replaced by a tyrosine, 
and by the fact that in A. ambivalens SQR the corresponding cysteine binds FAD directly. 
However, the active site and the mechanism of sulfide oxidation appear to be substantially 
different in A. aeolicus, A. ambivalens and in the mitochondrial SQRs. This conclusion is based 
(i) on the effect of site specific exchanges (V294D and C124Y) on the enzyme kinetics 
(Griesbeck et al., 2002), (ii) on the different modes of FAD binding (Chapter 3.4), (iii) on the 
strong differences between entire segments (“capping loops”, see Chapter 3.5 and 3.8) and (iv) 
on the necessity proven for type II SQRs to have reaction partners such as cyanide or 
thioredoxin and sulfite to oxidize sulfide efficiently (Hildebrandt and Grieshaber, 2008; 
Theissen and Martin, 2008b). 
In all postulated mechanisms, the reaction is spontaneously initiated by sulfide, an oxidized 
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FAD, quinone and a disulfide bond. The 
specific conformational changes at the 
basis of the polymerization are difficult 
to postulate because in the structure the 
distances between Cys 124, Cys 156 and 
Cys 347 are too long for direct sulfur-
sulfur coupling. It appears attractive to 
conclude that the distances between the 
cysteines increase stepwise during the 
elongation process. This conclusion is 
supported by the polysulfur chains 
visible in both SQR crystal structures, 
suggesting that the reaction is trapped in 
an advanced stage of the cycle. In A. 
aeolicus SQR, a concerted rotation of 
loops 294 – 312 and 152 – 157 towards 
a conformation closer to that observed 
for the equivalent FCSD segments could 
occur during elongation. 
Independent of the mechanism, the 
termination of elongation is presumably triggered by the limited space of the active site. The 
true product of the SQR reaction is unknown. Nonetheless, the A. aeolicus SQR structure 
shows that the active site can only provide a catalytically productive environment for up to a 9-
S-atom chain which is finally most likely cleaved to an S8 ring, as found in the electron density 
of some monomers. The release of the stable S8 ring might proceed via the sulfide channel. 
However, cyclooctasulfur is water labile and insoluble. Consequently, it becomes attractive to 
consider an alternative channel, very hydrophobic, conducting directly towards the inner 
membrane-facing side of the trimer and only closed by the contacting side chains of surface 
residues Leu 209 and Met 374 (Figure 3.7). Using this exit, S8 would move directly towards the 
membrane interior and it could finally be incorporated into sulfur globules. In A. aeolicus these 
are accumulated in the cytoplasm (Guiral et al., 2005) so that, despite being a monotopic and 
not a polytopic membrane protein, SQR would participate in cellular uptake of sulfur in an 
efficient manner (Figure 3.8). In other organisms, sulfur is stored in the periplasm (Reinartz et 
al., 1998). In this case, either membrane-bound SQRs transfer S8 to the membrane for 
periplasmic reuptake or they release hydrophilic polysulfides, as soluble FCSDs most likely do. 
More structural data on the C-terminal region of other SQRs would help in discriminating 
 
Figure 3.7: Putative product release channel. The 
sulfide oxidation site can be identified by the position of 
the FAD molecule, of Cys 156 and of the polysulfur 
chain, in the form of cyclooctasulfur S8. The latter 
extends into a hydrophobic cavity towards surface 
residues Leu 209 and Met 374 (the surface of these 
residues is shown in dark blue). The cavity could 
potentially open into the inner membrane-facing region 
of the trimer near the MES molecule bound to one of 
the membrane-interacting domains in the crystal 
structure (see Result section and Figure 2.35 and 2.36). 
The protein surface is in light cyan. The colour code for 
the residues and molecules shown is the same as in 
Figure 2.38. 
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Figure 3.8: Proposal for the complete SQR reaction in the cell. SQR (here in a semi-transparent cartoon 
representation) may participate to cellular sulfur uptake despite being a monotopic membrane protein. Sulfide 
(H2S) accesses the oxidation site (re-face of FAD) from a channel controlled by “capping loop” 294 – 312 
(blue ribbon). FAD (grey sticks) gets reduced through either a charge-transfer complex in position C4A or 
through an unusual alternative covalent adduct at position C8M, suggested by the described Cys 124-S-FAD 
linkage. Polymerization occurs over Cys 156 and 347. The mature product (a putative cyclooctasulfur ring,
orange sticks) is possibly released below the trimeric central contact (Arg 204, side chains in ochre sticks)
directly into the lipid bilayer, through a channel controlled by the side chains of Leu 209 and Met 374 (blue
sticks). In A. aeolicus, S8 would then be uptaken from the cytoplasmic side to be incorporated into sulfur
globules. At every cycle of sulfide oxidation a quinone molecule (UQ in a red box indicates the oxidized form, 
UQH2 in a pink box the reduced form) is reduced in the quinone binding pocket (si-face of FAD). The
membrane is here schematically represented as a light grey rectangular box. The DDM molecules bound to 
SQR are shown in yellow sticks in the membrane-embedded region. Details are highlighted only for the two 
monomers in the foreground for clearer visualization. Labels for the represented residues and compounds are 
shown only for the left monomer. 
between these two possibilities. 
3.8.  New structure-based sequence fingerprints for the classification 
of SQRs 
After about twenty years of research on SQRs, the first 3-D structures were solved in 2009 [this 
work and (Brito et al., 2009)]. At the same time, new SQR sequences became available and the 
functional characterization has also been extended (Hildebrandt and Grieshaber, 2008; 
Theissen and Martin, 2008b; Brito et al., 2009; Chan et al., 2009). These data show a 
surprising and previously unexpected variability among SQRs, until now all considered 
homologous. Based on these new findings, it is now possible to revisit and improve the 
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Table 3.3: Structure-based SQR classification
a. 
Type Organisms  H2S-
affinity 
Physiological 
role
b 
Model References 
I  Bacteria (α/β 
Proteobacteria, 
Cyanobacteria, 
Aquificales) 
µM respiration 
photosynthesis 
3HYV  (Arieli et al., 1994; Schütz et al., 1997; 
Schütz et al., 1998; Bronstein et al., 
2000; Griesbeck et al., 2000; Nübel et 
al., 2000; Griesbeck et al., 2002; 
Schödl, 2003; Wakai et al., 2004; 
Marcia et al., 2009) 
II  Bacteria (Firmicutes, 
Proteobacteria) 
Eukayotes (Homo 
sapiens) 
mM, µM 
with 
partners 
ND 1FCD  (Vande Weghe and Ow, 1999; Shibata 
and Kobayashi, 2006; Shibata et al., 
2007; Hildebrandt and Grieshaber, 
2008; Theissen and Martin, 2008b) 
III  Archaea 
(Sulfulobales) 
Bacteria 
(Chlorobiaceae) 
ND ND  1FCD  – 
IV  Bacteria 
(Chlorobiaceae, 
Chromatiaceae) 
yes (KM 
ND) 
respiration 3HYV  (Reinartz et al., 1998; Chan et al., 
2009) 
V  Archaea 
(Sulfulobales, 
Acidianus 
ambivalens) 
µM respiration 3H8L  (Brito et al., 2009) 
  Bacteria 
(Chlorobiaceae and 
others) 
not found  not found  3H8L  (Chan et al., 2009) 
VI  Bacteria 
(Chlorobiaceae, 
Aquificales, and 
others) 
yes (KM 
ND) 
respiration ND  (Chan et al., 2009) 
a: ND = not determined. 
b: besides sulfide detoxification. 
classification of this protein family. The structure-based sequence fingerprints are hereafter 
listed for each newly defined SQR class (Table 3.3, Figure 3.9 – 10, Appendix tables 35 – 37). 
Type I SQRs are proteins of Aquificaceae,  α- and β-Proteobacteria and Cyanobacteria 
(Theissen et al., 2003). Their activity was studied for the SQRs of O. limnetica (Arieli et al., 
1994),  R. capsulatus (Schütz et al., 1997; Griesbeck et al., 2002), A. aeolicus (Aq_2186) 
[(Nübel et al., 2000; Schödl, 2003)], A. halophytica (Bronstein et al., 2000), A. ferrooxidans 
(Wakai et al., 2004) and P. denitrificans (Schütz et al., 1998). They have affinity to their 
substrates in the micromolar range. In the cell, they are probably expressed in a constitutive 
manner in order to maintain efficient sulfide detoxification. For A. aeolicus, sulfide exposure 
primarily derives from the volcanic vents in its natural environment or from the catabolism of 
thiosulfate used as energy source (Chapter 1.4.2) and of cysteines, methionines and Fe-S 
clusters (Chapter 1.5.1) in the artificial growing medium. In addition, it was assessed that type I 
SQRs play a role in sulfide-dependent respiratory and photosynthetic processes (Arieli et al., 
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1994; Nübel et al., 2000). From the structure of A. aeolicus SQR, the following fingerprints 
can be defined for type I SQRs. Distinctive regions are a “capping loop” in position 294 – 312 
(A. aeolicus SQR numbering) and a C-terminus composed of a two-helix amphipathic motif 
and of an elongated loop. Necessary key residues are (i) Cys 124, involved in FAD binding and 
possibly in electron transfer, (ii) Cys 156 and Cys 347, a redox active couple, (iii) Ser 155, Val 
294 and Pro 311, mediating sulfide access to the active site, (iv) Glu 162 and Lys 312, probable 
proton donors/acceptors during the reductive semireaction, (v) Ile 346 and Phe 385, involved in 
quinone binding, and (vi) Glu 318 and Lys 382, involved in proton exchange during quinone 
reduction. Finally, the hydrophobicity of the residues shaping the cavity of polysulfur 
elongation is also a conserved feature in type I SQRs. 
Type II SQRs are proteins of Bacteria (Firmicutes and Proteobacteria), including a few 
pathogens (i.e. Staphylococcus aureus and Pseudomonas aeruginosa) and of Eukarya, 
including yeast (i.e. S. pombe), worms (i.e. A. marina), insects (i.e. Drosophila melanogaster) 
and mammals (i.e. Homo sapiens), but not plants (Shahak and Hauska, 2008). SQR activity 
was proven for bacterial (P. putida and B. stearotheromophilus) and mitochondrial homologues 
(S. pombe and A. marina SQRs) but only low (millimolar) affinity to sulfide was detected in 
the absence of reaction partners (Vande Weghe and Ow, 1999; Shibata and Kobayashi, 2006; 
Shibata et al., 2007; Hildebrandt and Grieshaber, 2008; Theissen and Martin, 2008b). It has 
been proposed that the physiological partners of type II SQRs are a sulfur dioxygenase (ETHE-
1) and a sulfurtransferase (rhodanese) localized in the mitochondrial matrix (Hildebrandt and 
Grieshaber, 2008; Tiranti et al., 2009; Lagoutte et al., 2010), but the nature of the interactions 
occurring between the three proteins is unknown to date. It certainly acquires a special interest 
given the increased importance attributed to sulfide, a newly characterised neurotransmitter in 
mammals. We believe that the best structural model currently available for type II SQRs is the 
A. vinosum FCSD. In fact, type II SQRs and bacterial FCSDs cluster in the same branch when 
phylogenetic trees are calculated including both sets of protein sequences [(Chan et al., 2009) 
and Figure 3.10]. The hallmark of type II SQRs is the absence of any conserved elongated loop, 
except for the elongated N-terminal signal peptide characteristic of the eukaryotic enzymes. In 
addition, a conserved tyrosine replaces the Cys 124 of type I SQRs and probably binds FAD 
through an 8-α-O-tyrosyl bond (Heuts et al., 2009). The other two essential cysteine residues 
are instead conserved and are likely to be exposed to the bulk solvent, as in FCSD, where they 
would be accessible by the SQR reaction partners sulfur dioxygenase and sulfurtransferase. Val 
294 is here substituted by an aspartate, while Glu 162 is replaced by a lysine. The residues 
involved in quinone reduction are not well conserved with respect to type I SQRs, and FCSD is 
obviously not a good model for that protein region. Further data are necessary to describe the 
quinone binding site and membrane attachment of type II SQRs. 
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Type III SQRs are the least characterized SQRs to date. They are proteins belonging to green 
sulfur bacteria (Chlorobiaceae, i.e. C. tepidum CT1025) and to Archaea (Sulfulobales). Neither 
their enzymatic activity nor their physiological role have been studied yet. From sequence 
comparison studies, it can be said that they are also missing the “capping loops”, like type II 
SQRs, but that they constitute an independent group because the similarity is higher within 
type III SQRs than to type II SQR members. Currently, the best model for type III SQRs is also 
FCSD. 
Type IV SQRs are predominantly found in green sulfur bacteria (Chlorobiaceae, i.e. C. 
tepidum CT0117), but not exclusively (one homologue is encoded in the purple sulfur γ-
proteobacterium A. vinosum). Their SQR activity had been detected in A. vinosum (Reinartz et 
al., 1998) and it was recently proven also for CT0117, a constitutively expressed protein, 
necessary but not sufficient for growth of C. tepidum on medium containing sulfide as the sole 
electron donor (Chan et al., 2009). The type IV SQRs are characterized by a series of five 
elongated loops. Three of them extend surface regions of A. aeolicus SQR. Precisely, they are 
inserted at Thr 90 near the adenosine moiety of FAD, at His 193 near the Val 294 – Lys 312 
“capping loop”, and at Asn 278 near the C-terminal end. The other two loops correspond to the 
Val 294 – Lys 312 “capping loop” of A. aeolicus SQR, although this protein segment is longer 
in type IV SQRs than in type I SQRs, and to the C-terminal loop of A. aeolicus SQR (type I 
and IV SQRs approximately share the same length). Additionally, all three cysteine residues 
characteristic of type I SQRs are conserved. Interestingly, the chemical properties of the 
residues that define sulfide access in type I SQRs are also conserved in type IV SQRs (Val 294 
is replaced by an isoleucine, Ser 155 by a threonine and Pro 311 is strictly conserved), 
indicating a similarity in the sulfide entry channel. Based on these observations and on the fact 
that type I and IV SQRs cluster in the same branch of the SQR phylogenetic tree [(Pham et al., 
2008), and Figure 3.10], the A. aeolicus SQR structure may be the best model for future studies 
on type IV SQRs. 
Type V SQRs are a group of archaeal proteins, predominantly belonging to Sulfulobales. A. 
ambivalens SQR also belongs to this group (Pham et al., 2008), unlike previously reported 
(Brito et al., 2009). Type V SQRs possess SQR activity and show micromolar affinity to their 
substrates, and play a role in sulfide dependent respiration (Brito et al., 2009). However, their 
structure differs significantly from that of type I SQRs (see Chapters 3.3 – 3.7). Important 
sequence fingerprints of type V SQRs are an elongated “capping loop” in position 154 – 178 (A. 
ambivalens SQR numbering) and a shorter C-terminus than in type I SQRs. Conserved key 
residues are Cys 129, which binds FAD covalently, Cys 178 and Cys 350, which constitute a 
thiol/disulfide pair, and Ser 214, Asp 215 and Asp 353, involved in sulfide binding and in 
proton exchange during sulfide oxidation along with Asp 307 and Lys 315. 
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Figure 3.9: Structure-based sequence alignment. 50 representative SQR and FCSD sequences were aligned 
with the program T-COFFEE in the mode Expresso, using the available structural information for the A. 
aeolicus and the A. ambivalens SQRs and for the A. vinosum FCSD. The sequences are indicated with 
increasing numbers (1 to 50, corresponding to the numbering used in Figure 3.10), with their gi identifier and 
with the abbreviated name of the organism which they belong to. The abbreviations correspond to: Aquifex 
aeolicus (Aaeolicus), Thiobacillus denitrificans (Tdenitrificans), Rhodobacter capsulatus (Rcapsulatus), 
Oscillatoria limnetica (Olimnetica), Acidithiobacillus ferrooxidans (Aferrooxidans), Nostoc species strain PCC 
7120 (NostocPCC7120), Synechocystis species strain PCC 6803 (SynechocystisPCC6803), Aphanothece 
halophytica (Ahalophytica), Saccharomyces pombe (Spombe), Drosophila melanogaster (Dmelanogaster), 
Homo sapiens (Hsapiens), Mus musculus (Mmusculus), Arenicola marina (Amarina), Staphylochoccus aureus
(Saureus),  Pseudomonas aeruginosa (Paeruginosa), Ralstonia solanacearum (Rsolanacearum), Sulfolobus 
tokodaii (Stokodaii), Chlorobium tepidum (Ctepidum),                                                                   (see next page)
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Figure 3.9 (continued). Archaeoglobus fulgidus (Afulgidus), Magnetospirillum magnetotacticum
(Mmagnetotacticum),  Sulfolobus solfataricus (Ssolfataricus), Pyrobaculum aerophilum (Paerophilum), 
Chlorobaculum parvum (Cparvum), Allochromatium vinosum (Avinosum), Prosthecochloris vibrioformis
(Pvibrioformis),  Pelodictyon luteolum (Pluteolum), Sulfurimonas denitrificans (Sdenitrificans), Acidianus 
ambivalens (Aambivalens), Sulfolobus islandicus (Sislandicus), Thermoplasma volcanium (Tvolcanium), 
Thermoplasma acidophilum (Tacidophilum), Acidithiobacillus caldus (Acaldus), Thiomonas intermedia
(Tintermedia), Persephonella marina (Pmarina), Thiomicrospira crunogena (Tcrunogena), Rhodopseumonas 
palustris (Rpalustris), Beggiatoa species PS (Beggiatoa), Chlorobium limicola (Climicola), Paracoccus 
denitrificans (Pdenitrificans). Sequences 35 to 38 correspond to the subbranch of type V SQR sequences,
whose SQR activity has not been proven (see text). The fingerprint regions are highlighted in red and indicated
at the top of the alignment. The alignment of the N- and C-terminal regions was manually adjusted with the 
software Jalview. The complete unmodified alignment is reported in Appendix table 37. 
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Figure 3.9 (continued). 
 
102 3.  DISCUSSION 
Figure 3.9 (continued). 
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Figure 3.10: Structure-based phylogenetic tree. The 
phylogenetic tree was calculated from the alignment 
reported in Figure 3.9 and drawn with the software 
Geneious. 
Additionally, Val 349 and Ala 401 may correspond to residues that bind quinones in type I 
SQRs while Lys 397 may mediate proton transfer, but the architecture of the quinone binding 
site in type V SQRs still has to be determined experimentally. The structural model for type V 
SQRs is A. ambivalens SQR.. 
Furthermore, a set of bacterial sequences clusters together with the archaeal type V SQRs. 
Their “capping loop” is present but shorter. Cys 129 is replaced by a serine or a threonine, 
residues that are not known to covalently bind FAD in position C8M (Hayashi et al., 2001; 
Halada et al., 2003). Finally, an alanine substitutes Ser 214, so that one putative hydrogen 
bonding group for sulfide in its access channel is missing. One member of this subgroup is C. 
tepidum CT0876, for which SQR activity was tested unsuccessfully (Chan et al., 2009). In the 
absence of functional evidence, this cluster cannot be assigned to an independent SQR group. 
Type VI SQRs are a group of bacterial proteins previously proposed as an “unclassified group” 
(Pham et al., 2008), including CT1087 from C. tepidum and Aq_788 from A. aeolicus (which 
we have identified in our A. aeolicus membrane preparations, data not shown). The SQR 
activity of CT1087 was recently demonstrated (Chan et al., 2009), so that these proteins can 
now be confidently classified as SQRs. Besides the absence of any obvious “capping loop”, 
these proteins possess cysteine residues in the positions of A. aeolicus SQR Cys 124 and Cys 
347 and an aspartate in place of Val 294. Strikingly, they also lack A. aeolicus SQR Cys 156, 
which is replaced by a valine or a methionine, according to our alignment. Interestingly, 
another cysteine (Cys 275 in CT1087) is conserved in type VI SQRs and corresponds to A. 
aeolicus SQR Phe 281, very far from the catalytic site. More experimental data are necessary in 
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order to understand whether type VI SQRs follow a completely different reaction mechanism 
not involving Cys 156 or whether they assume a different 3-D fold such that Cys 275 comes 
closer to the active site. 
3.9.  Conclusions and future perspectives 
In summary, this work has achieved (i) the identification and isolation of sulfide:quinone 
oxidoreductase (SQR) from the native membranes of the hyperthermophilic bacterium Aquifex 
aeolicus, (ii) the characterization of its biochemical properties, (iii) the characterization of its 
enzymatic activity and (iv) the determination of its three-dimensional X-ray structure in an “as-
purified” form and in substrate- and inhibitor-bound forms. The structures reveal that SQR is a 
monotopic membrane protein, specifically interacting with the lipidic bilayer as a trimer and 
that the protein adopts various strategies to resist to high temperatures. Additionally, the 
architecture of both the sulfide oxidation and the quinone reduction active sites could be 
described. Most surprisingly, the cofactor flavin adenine dinucleotide (FAD) is bound to the 
protein through an unprecedented putative persulfide linkage in position C8M and SQR was 
isolated in an intermediate state of the reaction cycle, with the partially formed polysulfide 
product covalently bound to the active site. Based on the structural and biochemical 
characterization of A. aeolicus SQR and on the comparison with the structure of A. ambivalens 
SQR, also solved recently, the structural-functional relationships of SQR could be established, 
identifying the specific residues and the structural domains which are essential for catalysis. 
Consequently, a new structure-based classification of SQRs was proposed. On the basis of this 
structural, functional and bioinformatic characterization, the complicated sulfur polymerization 
SQR reaction can now be described in more detail. Two different mechanistic hypotheses are 
proposed in this work and it is suggested that not all SQRs share the same reaction scheme. 
Finally, the overall reaction of A. aeolicus SQR was described to a more speculative extent also 
in its cellular context. Interestingly, it seems plausible that despite being a monotopic 
membrane enzyme, SQR may play a role in facilitating sulfur transport across the cellular 
membrane. 
Moreover, the project also opened new directions for future research on A. aeolicus SQR 
specifically and on SQRs in general. 
First, the characterization of the A. aeolicus SQR active site needs to be extended in order to 
demonstrate conclusively the presence of a polysulfide bound to Cys 156 and to Cys 347 and 
the presence of a persulfide bridge between Cys 124 and FAD. Second, the protein structure 
must be solved in alternative conformations and intermediate stages for comparison with those 
predicted by the hypothesised reaction mechanisms. Attempts towards the characterization of 
other structural intermediates of the reaction cycle are particularly challenging, because of the 
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nature of the reaction itself. The polysulfide species are highly reactive and unstable under 
many working conditions, investigations on the protein-FAD connection is hampered by the 
fact that loss of the cofactor results in enzyme denaturation and, finally, reducing agents to 
remove the putative sulfur derivatizations from the active site have been so far unsuccessful, 
probably because they compromise the integrity of the two C-terminal disulfide bridges so 
crucial for the protein’s stability. Nonetheless, further spectrophotometric and mass 
spectrometric experiments are already in progress. Reconstitution in artificial lipid vesicles is 
also a feasible biochemical experiment that would prove the overall SQR reaction. On one 
hand, this approach would allow studying the membrane-binding mode of SQR and 
determining i.e. whether the protein has or not the same affinity to bilayers of different 
composition. On the other hand, it would help in defining the nature of the reaction product and 
in particular whether the latter partitions in a hydrophilic or a hydrophobic environment. 
Finally, the establishment of an overexpression system is also planned as a tool to study SQR 
by molecular biological techniques. 
To a wider extent then, the variety in the SQR family also requires further investigation. It 
cannot be excluded that SQRs with novel sequences will be found that define additional SQR 
types. In addition, the described heterogeneity among the SQR sequences and the still very 
limited structural information available raise intriguing questions about the mechanisms of 
catalysis and the functional roles of SQRs in different organisms. Of particular interest is the 
concomitant presence of SQRs of different types in some species. Their cellular roles and the 
regulation of their expression and activity must be in some way related to their structural and 
mechanistic differences. It is possible that new structural and functional data will become 
available soon, especially about Acidithiobacillus ferrooxidans SQR, whose structure has 
already been solved (Zhang et al., 2009), but is not yet available. 
Last but not least, the study of the eukaryotic SQRs has a high priority, as they are potentially 
important in humans for the homeostasis of sulfide, a mediator of sympathetic 
neurotransmission and a key metabolite in neurodegenerative diseases. Three parallel strategies 
are conceivable for the production of the human mitochondrial sulfide:quinone oxidoreductase 
dehydrogenase-like protein (SQRDL). First, heterologous expression in E. coli might yield 
high amounts of protein, considering the high production levels detected in previous attempts 
(Ackermann, 2007; Maier, 2007). Nonetheless the efficiency of FAD reincorporation might be 
a bottleneck for this approach. Second, cell-free expression either in the presence or in the 
absence of detergent might be advantageous in producing a soluble enzyme. In fact, SQR is a 
monotopic membrane protein and not a transmembrane protein and this work shows that for 
short periods of time (hours) A. aeolicus SQR is stable in the absence of detergents. In addition, 
the incorporation of the cofactor FAD need not be a limitation for the cell-free system. 
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Thioredoxin reductase and glutathione reductase, two members of the FDR superfamily to 
which SQR belongs, have been successfully produced in a cell-free system in an active form 
(Knapp and Swartz, 2004) by supplementing the reaction mixture with commercial FAD. 
Actually, the presence of FAD might be useful for evaluating the correct folding of the cell-
free produced enzyme by simply recording its VIS-UV absorption spectrum. Third, production 
of SQRDL should be attempted in yeast, as a eukaryotic expression system might be 
advantageous for production of a mitochondrial target. Yeast expression has already been 
reported for Arenicola marina SQRDL in Saccharomyces cerevisiae (Theissen and Martin, 
2008b). Once a convenient expression system is found, the study should attempt to clarify how 
SQRDL interacts with sulfur dioxygenase (ETHE-1) and sulfurtransferase functionally and 
structurally. 
In conclusion, the data presented in this work allow drawing a first picture of the fascinating 
sulfide:quinone oxidoreductase reaction and they stimulate further genetic, biochemical and 
structural investigations. 
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4. Material and Methods 
4.1.  Materials 
4.1.1.  Suppliers 
The suppliers of all devices, materials and chemicals used in this work are listed in Table 
4.1. 
 
Table 4.1: List of suppliers. 
Company Location Web  address 
Adobe  San Jose, California, USA  http://www.adobe.com 
Anatrace  Maumee, Ohio, USA http://www.anatrace.com 
Agilent Böblingen,  D  http://www.agilent.com 
Applied Biosystems  Framingham, Massachusetts, 
USA 
http://www.appliedbiosystems.com 
Archaeenzentrum Regensburg,  D  http://www.biologie.uni-
regensburg.de/ 
Mikrobio/Thomm/Arbeitsgebiete/ 
fermentation.htm 
ATOMIKA Instruments  Tempe, Arizona, USA  http://www.cameca.com 
Avanti Polar Lipids  Birmingham, Alabama, USA  http://avantilipids.com 
Axygen Biosciences  Union City, California, USA  http://www.axygenbio.com 
Bandelin Sonorex  Mörfelden-Walldorf, D  http://www.sonorex.com 
Beckman Coulter  Krefeld, D  http://www.beckman.com 
Biometra Göttingen,  D  http://www.biometra.de 
Biomol Hamburg,  D  http://www.biomol.de 
Bio-Rad Laboratories GmbH  Munich, D  http://www.bio-rad.com 
Bio-Tek Instruments  Winooski, Vermont, USA  http://www.biotek.com 
Bruker-Nonius Rheinstetten,  D  http://www.bruker.com 
Calbiochem Darmstadt,  D  http://www.calbiochem.com 
Cartesian Technologies  Huntingdon, UK  http://www.cartesiantech.com 
Corning Life Sciences  Amsterdam, NL  http://www.corning.com 
Coy Laboratories  Grass Lake, Michigan, USA  http://www.coylab.com 
DigiLab Huntingdon,  UK  http://www.digilabglobal.com 
Eppendorf Hamburg,  D  http://www.eppendorf.com 
FEI-Philips Hillsboro,  Oregon, USA  http://www.fei.com 
Fluka Seelze,  D  http://www.sigmaaldrich.com 
GE Bayer Silicones  Bergen op Zoom, NL  http://www.gesilicones.com 
GE Healthcare  Munich, D  http://www.gehealthcare.com 
GERBU Biochemical Mart  Gaiberg, D  http://www.gerbu.de 
Genomics Solutions  Huntingdon, UK  http://www.genomicsolutions.com 
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Genzyme Haverhill,  UK  http://www.genzyme.co.uk 
Gilson Bad  Camberg,  D  http://www.gilson.com 
Glycon Luckenwalde,  D  http://www.glycon.de 
Greiner Bio-one GmbH  Frickenhausen, D  http://www.gbo.com/bioscience 
Hamilton Robotics  Bonaduz, CH  http://www.hamiltonrobotics.com 
Hampton Research  Aliso Vejo, California, USA  http://www.hamptonresearch.com 
Hansatech Instruments Ltd  Norfolk, UK  http://www.hansatech-
instruments.com 
Hartenstein A. Laborbedarf GmbH  Würzburg, D  http://www.laborversand.de 
Hellma Müllheim,  D  http://www.hellma-worldwide.com 
Helmholtz Institut für 
Infektionsforschung 
Braunschweig, D  http://www.helmholtz-hzi.de 
Heraeus Hanau,  D  http://www.wc-heraeus.com 
Hitachi High-Technologies  Tokyo, J  http://www.hitachi-hitech.com 
HKL Research  Charlottesville, Virginia, USA  http://www.hkl-xray.com 
Hoffmann Dental Manufaktur 
GmbH 
Berlin, D  http://www.hoffmann-dental.com 
IKA Werke  Staufen, D  http://www.ika.de 
Infors AG  Bottmingen-Basel, CH http://www.infors-ht.com 
Invitrogen Karlsruhe,  D http://www.invitrogen.com 
Jena Bioscience GmbH  Jena, D  http://www.jenabioscience.com 
Kipp & Zonen  Delft, NL  http://www.kippzonen.com 
Kindler O. GmbH  Freiburg, D  http://www.o-kindler.de 
Knick Egelsbach,  D  http://www.knick.de 
Kodak Köln,  D  http://www.kodak.com 
Leica Microsystems  Wetzlar, D  http://www.leica-microsystems.com 
MAGV Rabenau,  D  http://magv-gmbh.de 
Matrix Science  Boston, Massachusetts, USA  http://www.matrixscience.com 
Memmert Schwalbach,  D  http://www.memmert.com 
Merck – VWR International  Darmstadt, D  http://de.vwr.com 
Messer Sulzbach,  D  http://www.messergroup.com 
Mettler Toledo GmbH  Gieβen, D  http://www.mt.com 
Microfluidics Corporation  Newton, Massachusetts, USA  http://www.microfluidicscorp.com 
Microsoft Corporation  Redmond, Washington, USA  http://www.microsoft.com 
Millipore Schwalbach,  D  http://www.millipore.com 
Molecular Dimensions Ltd  Soham, UK  http://www.moleculardimensions.com 
Mozilla  Mountain View, California, 
USA 
http://www.mozilla.org 
Müller W.  Berlin, D   
NanoSeparations   Nieuwkoop, NL http://www.nanoseparations.com 
New England Biolabs  Ipswich, Massachusetts, USA  http://www.neb.com 
Nu-Chek Prep, Inc.  Elysian, Minnesota, USA  http://www.nu-chekprep.com 
NUNC GmbH  Wiesbaden, D  http://www.nunc.de 
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Olympus Hamburg,  D  http://www.olympus.de 
OXYL Bobingen,  D   
Pall GmbH  Dreieich, D  http://www.pall.com 
Perkin Elmer  Waltham, Massachusetts, 
USA 
http://www.perkinelmer.com 
Pierce Biotechnology  Rockford, Illinois, USA  http://www.piercenet.com 
Promega Madison,  Wisconsin,  USA  http://www.promega.com 
Proteros Martinsried,  D http://www.proteros.com 
Qiagen Hilden,  D  http://www1.qiagen.com 
RealVNC Ltd  Cambridge, UK  http://www.realvnc.com 
Riedel De Haen AG  Seelze, D  http://www.riedeldehaen.com 
Rigaku Tokyo,  J  http://www.rigaku.com 
Roche Diagnostics GmbH  Mannheim, D  http://www.roche.de 
Roth, Carl Roth GmbH + Co KG  Karlsruhe, D  http://www.carl-roth.de 
Sartorius AG  Göttingen, D  http://www.sartorius.de 
Scientific Industries  Bohemia, New York, USA  http://www.scientificindustries.com 
SERVA Electrophoresis GmbH  Heidelberg, D  http://www.serva.de 
Sharp Electronics GmbH  Hamburg, D  http://www.sharp.de 
Sigma-Aldrich Laborchemikalien 
GmbH 
Seelze, D  http://www.sigmaaldrich.com 
Sophos Abingdon,  UK  http://www.sophos.com 
Ted Pella  Redding, California, USA  http://www.tedpella.com 
Thomson Reuters  Philadelphia, Pennsylvania, 
USA 
http://thomsonreuters.com 
TOSOH Bioscience  Montgomeryville, 
Pennsylvania, USA 
http://www.tosohbioscience.com 
TTP LabTech  Melbourn, UK  http://www.ttplabtech.com 
Vivascience Hannover,  D  http://www.vivascience.com 
VWR Darmstadt,  D  http://de.vwr.com 
Zeiss, Carl Zeiss AG  Oberkochen, D  http://www.zeiss.de 
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4.1.2.  Chemicals 
The chemicals used in this work are listed in Table 4.2. 
 
 
Table 4.2: List of chemicals. 
Chemical name  Formula  Abbreviation  Supplier 
acetic acid  CH3COOH –  Roth 
N-(2-acetamido)iminodiacetic acid  C6H10N2O5 ADA  Sigma-
Aldrich 
acetonitrile CH3CN ACN  Roth 
acrylamide CH2CHC(O)NH2 –  Roth 
Al’s oil  Paraffin oil:Silicon oil = 
1:1 
– Hampton 
adenosine diphosphate disodium salt  C10H13N5O10P2Na2 –  Sigma-
Aldrich 
ammonium carbonate  (NH4)2CO3 –  Sigma-
Aldrich 
ammonium chloride  NH4Cl –  Merck 
ammonium hydrogen carbonate  NH4HCO3 AHC  Sigma-
Aldrich 
ammonium persulfate  (NH4)2S2O8 APS  Genzyme 
ammonium phosphate  (NH4)3PO4 –  Sigma-
Aldrich 
ammonium sulfate  (NH4)2SO4 –  Sigma-
Aldrich 
antimycin C13H14O5 –  Sigma-
Aldrich 
BCA
TM Protein Assay Reagent A + B  –  –  Pierce 
benzyldimethyldodecylammonium bromide  C21H38BrN BAM  Hampton 
1,3-
bis(tris(hydroxymethyl)methylamino)propane 
C8H19NO5 BisTris  Sigma-
Aldrich 
boric acid  H3BO3 –  Merck 
bromophenol blue  –  –  Roth 
cetrimonium (or 
hexadecyltrimethylammonium) bromide 
C19H42BrN CTAB  Hampton 
chloroform CHCl3 –  Roth 
3-[(3-Cholamidopropyl)dimethylammonio]-
1-propanesulfonate 
C32H58N2O7S CHAPS  Sigma-
Aldrich 
3-[(3-Cholamidopropyl)dimethylammonio]-
2-hydroxy-1-propanesulfonate 
C32H58N2O5S CHAPSO  Sigma-
Aldrich 
Coomassie Brilliant Blue R250 and G250  –  –  Serva 
α-cyano-4-hydroxy-cinnamic acid  C10H6NO3 CHCA  Bruker 
N-cyclohexyl-3-aminopropanesulfonic acid  C9H19NO3S CAPSO  Gerbu 
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cyclohexylethanoyl-N-
hydroxyethylglucamide 
C16H31NO7 C-HEGA-8  Anatrace 
cyclohexylpropanoyl-N-
hydroxyethylglucamide 
C17H33NO7 C-HEGA-9  Anatrace 
cyclohexylbutanoyl-N-
hydroxyethylglucamide 
C18H35NO7 C-HEGA-10  Anatrace 
cyclohexylpentanoyl-N-
hydroxyethylglucamide 
C19H37NO7 C-HEGA-11  Anatrace 
3-cyclohexylmethyl-4-O-(a-D-
glucopyranosyl)-b-D-glucopyranoside 
C19H34O11 CYMAL-1  Anatrace 
3-cyclohexylethyl-4-O-(a-D-
glucopyranosyl)-b-D-glucopyranoside 
C20H36O11 CYMAL-2  Anatrace 
3-cyclohexylpropyl-4-O-(a-D-
glucopyranosyl)-b-D-glucopyranoside 
C21H38O11 CYMAL-3  Anatrace 
3-cyclohexylbutyl-4-O-(a-D-
glucopyranosyl)-b-D-glucopyranoside 
C22H40O11 CYMAL-4  Anatrace 
3-cyclohexylpentyl-4-O-(a-D-
glucopyranosyl)-b-D-glucopyranoside 
C23H42O11 CYMAL-5  Anatrace 
3-cyclohexylhexyl-4-O-(a-D-
glucopyranosyl)-b-D-glucopyranoside 
C24H44O11 CYMAL-6  Anatrace 
n-decyl-β-D-maltoside C22H42O11 DM  Glycon 
1-S-n-decyl-β-D-thiomaltoside C22H42O10S DTM  Anatrace 
n-decyl-N,N-dimethylamine-N-oxide C12H27NO DDAO  Sigma-
Aldrich 
n-decyl-N,N-dimethyl-3-ammonio-1-
propanesulfonate 
C15H33NO3S  Zwittergent 3-
10 
Sigma-
Aldrich 
n-decyl-sucrose C22H42O11 DS  Calbiochem 
decylubiquinone C19H30O4 decyl-UQ  Sigma-
Aldrich 
deuterium oxide  D2O –  Sigma-
Aldrich 
2,3-dibromo-1,4-naphthoquinone C10H4Br2O2 –  Sigma-
Aldrich 
2,3-dibromo-5,6-dimethyl-1,4-benzoquinone C8H6Br2O2 –  Sigma-
Aldrich 
2,5-dihydroxybenzoic acid and 5-
methoxysalicylic acid, 1:9 mixture 
C7H6O4 and C8H8O4 sDHB  Bruker 
di-chloro-di-methyl-silane (CH3)2SiCl2 –  Sigma-
Aldrich 
2,3-dimethyl-1,4-naphthoquinone C12H10O2 DMN  Prof. 
Teixeira, 
Instituto de 
Tecnologia 
Química e 
Biológica, 
Lisboa, 
Portugal 
dimethylsulfoxide C2H6OS DMSO  Sigma-
Aldrich 
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n-dodecyl-N,N-dimethylamine-N-oxide C14H31NO LDAO  Sigma-
Aldrich 
n-dodecyl-β-D-maltoside C24H46O11  DDM (or LM)  Glycon 
N-dodecyl-N,N-(dimethylammonio)butyrate C18H37NO2 DDMAB  Hampton 
n-dodecyl-N,N-dimethyl-3-ammonio-1-
propanesulfonate 
C17H39NO3S  Zwittergent 3-
12 
Sigma-
Aldrich 
n-dodecyl-sucrose C24H46O11 LS  Calbiochem 
ethylene diamine tetra-acetic acid, di sodium 
salt 
C10H16N2O8 EDTA  Gerbu 
ethanol (p.a.)  CH3CH2OH –  Roth 
flavin adenine dinucleotide, di-sodium salt  C27H31N9O15P2Na2 FAD  Sigma-
Aldrich 
formaldehyde H2CO –  Sigma-
Aldrich 
N,N-bis[3-(D-
gluconamido)propyl]deoxycholamide 
C42H75N3O15 DeoxyBigChap  Calbiochem 
glutaraldehyde CH2(CH2CHO)2 –  Sigma-
Aldrich 
glycerol CH2(OH)CH(OH)CH2(OH) –  Gerbu 
glycine NH2CH2COOH –  Gerbu 
4-(2-hydroxyethyl)-piperazine-1-
ethanesulfonic acid 
C8H18N2O4S HEPES  Gerbu 
heptane-1,2,3-triol C7H16O3 –  Sigma-
Aldrich 
1-S-n-heptyl-β-D-thioglucopyranoside C13H26O5S 7TG  Glycon 
n-hexadecyl-β-D-maltoside C28H54O11 16M  Glycon 
n-hexane C6H14 –  Roth 
n-hexyl-β-D-glucopyranoside C12H24O6 6G  Glycon 
hydrochloric acid  HCl  –  Roth 
isopropanol (p.a.)  CH3CH(OH)CH3 –  Roth 
2-mercapto-ethanol CH2(OH)CH2(SH)  β-ME  Sigma-
Aldrich 
methanol (p.a.)  CH3OH –  Roth 
2-methyl-2,4-pentanediol C6H14O2 MPD  Fluka and 
Hampton 
methyl 6-O-(N-heptylcarbamoyl)-a-D-
glucopyranoside 
C15H29NO7 HECAMEG  Biomol 
monoolein C21H40O4 –  Nu-Chek 
Prep Inc. 
2-(N-morpholine)-ethane sulphonic acid  C6H13NO4S MES  Gerbu 
nitrogen (liquid)  N2 –  Messer 
nonaethylene glycol monododecyl ether  C30H62O10 C 12E9 Fluka 
nonanoyl-N-hydroxyethylglucamide C17H35NO7 HEGA-9  Biomol 
n-nonyl-β-D-glucopyranoside C15H30O6 NG  Biomol 
n-nonyl-β-D-maltoside C21H40O11 NM  Glycon 
N-nonyl-N-methyl-D-glucamide C20H39NO7 MEGA-9  Glycon 
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1-S-n-nonyl-β-D-thioglucopyranoside C15H30O5S NTG  Glycon 
1-S-n-nonyl-β-D-thiomaltoside C21H40O10S NTM  Hampton 
O,O’-bis(2-aminopropyl)-polyethylene glycol 
500 
–  Jeffamine 
ED600 
Sigma-
Aldrich 
octaethylene glycol monododecyl ether  C29H60O10 C 12E8 Fluka 
octanoyl-N-hydroxyethylglucamide C16H33NO7 HEGA-8  Biomol 
n-octyl-β-D-glucopyranoside C14H28O6 OG  Glycon 
n-octyl-N,N-dimethyl-3-ammonio-1-
propanesulfonate 
C13H27NO3S Zwittergent  3-8  Sigma-
Aldrich 
N-octyl-N-methyl-D-glucamide C19H37NO7 MEGA-8  OXYL 
n-octyl-sucrose C20H38O11 OS  Hampton 
1-S-n-octyl-β-D-thioglucopyranoside C14H28O5S OTG  Glycon 
1-S-n-octyl-β-D-thiomaltoside C20H38O10S OTM  Hampton 
paraffin oil  –  –  Hampton 
perfluoropolyether C50F102O16 PFO-X175/08  Hampton 
L-pipecolinic acid  C6H11NO2 –  Sigma-
Aldrich 
N-octyl-phoscholine C13H30NO3P FOS-8  Anatrace 
N-nonyl-phoscholine C14H32NO3P FOS-9  Anatrace 
N-decyl-phoscholine C15H34NO3P FOS-10  Anatrace 
N-dodecyl-phoscholine C17H38NO3P FOS-12  Anatrace 
polyethylene glycol 200 – 20000  CH2OH(OCH2CH2)nOH  PEG 200 – 
20000 
Fluka 
polyethylene glycol monomethylether  CH3(OCH2CH2)nOH  PEG MME 
550, 2000, 
5000 
Fluka 
polyethylene glycol 400 dodecyl ether  C12H23O2.(C2H4O)n.H Thesit  Fluka 
polyethylene glycol p-(1,1,3,3-
tetramethylbutyl)-phenyl ether 
C14H22O(C2H4O)n Triton  X-100  Gerbu 
potassium chloride  KCl  –  Merck 
potassium di-hydrogen phosphate  KH2PO4 –  Roth 
di-potassium hydrogen phosphate  K2HPO4 –  Roth 
potassium hydroxide  KOH  –  Roth 
potassium sulfate  K2SO4 –  Sigma-
Aldrich 
propanol (p.a.)  CH3CH2CH2OH –  Roth 
quinone derivatives  –  UQ1, UQ4, 
UQ9 
Sigma-
Aldrich 
quinone derivatives  –  –  Prof. 
Bolognesi, 
Bologna 
University, 
Italy 
silicon oil  C8H24O2Si3 –  Hampton 
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silicon paste  –  Baysilone-
Paste 
mittelviskös 
GE Bayer 
Silicones 
silver nitrate  AgNO3 –  Sigma-
Aldrich 
sodium acetate  CH3COONa –  Merck and 
Roth 
sodium azide  NaN3 –  Sigma-
Aldrich 
sodium carbonate  Na2CO3 –  Sigma-
Aldrich 
sodium chloride  NaCl  –  VWR 
tri-sodium citrate  Na3C6H5O7 –  Sigma-
Aldrich 
sodium deoxycholate  C24H39O4Na DOC  Sigma-
Aldrich 
sodium dithionite  Na2S2O4 –  Sigma-
Aldrich 
sodium dodecyl sulfate  C12H25SO4Na SDS  Gerbu 
sodium hydroxide  NaOH  –  Gerbu 
sodium potassium tartrate  C4H12KNaO10 –  Fluka 
sodium sulfate  Na2SO4 –  Sigma-
Aldrich 
sodium sulfide  Na2S –  Sigma-
Aldrich 
sodium thiosulfate  Na2S2O3 –  Sigma-
Aldrich and 
Roth 
stigmatellin C30H42O7 –  Sigma-
Aldrich 
sulfuric acid  H2SO4 –  Roth 
n-tetradecyl-β-D-maltoside C26H50O11 14M  Glycon 
n-tetradecyl-N,N-dimethyl-3-ammonio-1-
propanesulfonate 
C19H45NO3S  Zwittergent 3-
14 
Sigma-
Aldrich 
N,N,N,N-tetramethyl-p-ethylendiamide (CH3)2NCH2CH2N(CH3)2 TEMED  Roth 
n-tridecyl-β-D-maltoside C25H48O11 13M  Glycon 
N-(Tri(hydroxymethyl)methyl)glycine C6H13NO5 Tricine  Gerbu 
trifluoroacetic acid  CF3COOH TFA  Merck 
tris-hydroxymethyl-9-aminomethane C4H11NO3 Tris  Roth 
n-undecyl-β-D-maltoside C23H44O11 UM  Glycon 
uranyl acetate  UO2(CH3COO)2 –  Ted  Pella 
urea (NH2)2CO –  Merck 
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4.1.3.  Sparse-matrix crystallization screens 
The sparse-matrix screens used in this work are listed in Table 4.3. 
 
Table 4.3: List of sparse-matrix crystallization screens. 
Name of the screen  Number of conditions  Supplier 
Basic Kit for Membrane Proteins  48  Sigma-Aldrich 
JBScreen Classic 1 – 10  24 each  Jena Bioscience 
JBScreen Membrane 1 – 3  24 each  Jena Bioscience 
JBScreen PACT++  96  Jena Bioscience 
The MPDs  96  Qiagen 
The MbClass  96  Qiagen 
The MbClass II  96  Qiagen 
The pHClear  96  Qiagen 
The pHClear II  96  Qiagen 
The PEGs  96  Qiagen 
The Cations  96  Qiagen 
The Anions  96  Qiagen 
Structure Screen 1 (MD1-01)  48  Molecular Dimensions Ltd 
Structure Screen 2 (MD1-02)  48  Molecular Dimensions Ltd 
MemStart (MD1-21)  48  Molecular Dimensions Ltd 
Crystal Screen (HR2-110)  48  Hampton Research 
Crystal Screen 2 (HR2-112)  48  Hampton Research 
MembFac screen (HR2-114)  48  Hampton Research 
PEG/Ion Screen  48  Hampton Research 
Additive Screen (HR2-428)  96  Hampton Research 
Detergent Additive Screens 1 – 3 (HR2-410, 
HR2-411, HR2-412) 
24 each  Hampton Research 
Heavy atom screen Pt (HR2-442)  12  Hampton Research 
Heavy atom screen Au (HR2-444) 6  Hampton  Research 
Heavy atom screen Hg (HR2-446) 19  Hampton  Research 
Heavy atom screen M1 (HR2-448) 20  Hampton  Research 
Heavy atom screen M2 (HR2-450) 18  Hampton  Research 
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4.1.4.  Equipment and devices 
Equipment and devices used in this work are listed in Table 4.4. 
 
Table 4.4: List of equipment and devices. 
Device Type  Supplier 
Gel imaging station  gel documentation system (UV) 
and PC (maxdata) 
Bio-Rad 
Ampholytes SERVALYT
TM 3-10  Serva 
Anaerobic tent    Coy Laboratories 
Analytical balance  R180D-*D1 Sartorius  AG 
Balance  PM 4600 Delta Range  Mettler Toledo 
Centrifuge Sigma  4K10  Sigma-Aldrich 
Centrifuge 5415  R  Eppendorf 
Centrifuge  Optima XLA  Beckman Coulter 
Chromatography system  Äkta Purifier 10  GE Healthcare 
Chromatography system  Äkta Purifier 100  GE Healthcare 
Chromatography system  SMART  GE Healthcare 
Chromatography system  easy nano LC  Bruker / Proxeon 
Chromatography system  1200 HPLC  Agilent 
Concentrators  Amicon Ultra-15, Ultra-4, Ultra-
500 
Millipore 
Concentrators Centriprep  Millipore 
Concentrators Vivaspin  500  µL  Vivascience 
Crystallography bridges  CrystalBridge
TM Greiner  Bio-one 
Crystallography capillaries  Mark-Röhrchen für 
röntgenographische Aufnahmen, 
0.5 – 1.0 mm 
Müller W. 
Crystallography glasses  Microscopic glasses  Kindler 
Crystallography humidity chamber  Free Mounting System
TM Proteros 
Crystallography liquid nitrogen dewar  Agil-2  Air Liquide 
Crystallography liquid nitrogen dewar  Spearlab Cryogenic Foam Dewar 
2L (HR4-675) 
Hampton Research 
Crystallography loops  CrystalCap
TM (HR4-913)  Hampton Research 
Crystallography loops  CrystalCap Magnetic
TM (HR4-
733) 
Hampton Research 
Crystallography loops  MicroTube
TM 18 mm (HR4-921)  Hampton Research 
Crystallography loops  MicroTube
TM 21 mm (HR4-923)  Hampton Research 
Crystallography loops  CryoLoop
TM 0.05 – 1.0 mm  Hampton Research 
Crystallography loops  Mounted CryoLoop
TM 0.025 – 1.0 
mm 
Hampton Research 
Crystallography loops  CrystalCap HT
TM 0.025 – 1.0 mm  Hampton Research 
Crystallography plate  AxyGem
TM Axygen  Bioscience 
Crystallography plate  Crystal Quick
TM Greiner  Bio-one 
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Crystallography plate  Crystal Quick
TM hydrophob  Greiner Bio-one 
Crystallography plate  IMP@CT
TM Greiner  Bio-one 
Crystallography plate  Terasaki  Greiner Bio-one 
Crystallography plate  View Seal  Greiner Bio-one 
Crystallography plate  XRL Plates  Molecular Dimensions Ltd 
Crystallography plate  Linbro  Hampton Research 
Crystallography plate  Assay Deep Well Block, 2 mL  Corning 
Crystallography plate  Square Well Storage Mat  Corning 
Crystallography robot  MicroSys SQ Series  Cartesian Technologies 
Crystallography robot  Mosquito  TTP LabTech 
Crystallography robot  HoneyBee 963  DigiLab 
Crystallography storage and imaging 
system 
CRYSTAL FARM
TM 400  Bruker 
Crystallography tools  Vial Clamp
TM curved (HR4-671)  Hampton Research 
Crystallography tools  Vial Clamp
TM straight (HR4-670)  Hampton Research 
Crystallography tools  Crystal Wand Magnetic
TM straight 
(HR4-729) 
Hampton Research 
Crystallography tools  Crystal Wand
TM long with tab 
(HR4-602) 
Hampton Research 
Crystallography tools  CryoTong
TM 18 mm (HR4-637)  Hampton Research 
Crystallography tools  CryoTong
TM 21 mm (HR4-639)  Hampton Research 
Crystallography tools  CryoCane 5 vial holder (HR4-
709) 
Hampton Research 
Crystallography tools  CryoCane Color Coder (HR4-
715) 
Hampton Research 
Crystallography tools  Cryo Sleeve (HR4-708)  Hampton Research 
Crystallography tools  Micro-Tools
TM Set (HR4-811)  Hampton Research 
Crystallography tools  ClearSeal Film
TM Applicator 
(HR4-525) 
Hampton Research 
Crystallography tools  VDX
TM Plate with Sealant (HR3-
170) 
Hampton Research 
Crystallography tools  Manco Crystal Clear Sealing 
Tape 
Jena Biosciences 
Crystallography tools  Magnetic CryoVials with 
CryoCaps and DataMatrix (MD7-
406) 
Molecular Dimensions Ltd 
Crystallography tools  EMBL/ESRF Sample Changer 
Kit 
Molecular Dimensions Ltd 
Crystallography tools  Hoffmann’s Glaswachs  Hoffmann 
Crystallography tools  Leather gloves  VWR 
Developer D19  Kodak 
Electron microscope  Tecnai 12  FEI-Philips 
Electron microscope  CM 120  FEI-Philips 
Electrophoresis chamber  XCell Sure Lock Mini-Cell  Invitrogen 
Electrophoresis chamber    home made 
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Electrophoresis power supplier  PowerPac Basic  Bio-Rad 
Electrophoresis power supplier  PowerPac HC  Bio-Rad 
Electrophoresis plates  Glass plates for Hoefer SE-250  GE Healthcare 
ELISA reader  PowerWave X  Bio-Tek Instruments 
Flat bed scanner  SCAI  Zeiss 
Gel drier  Mididry D62  Biometra 
Gels for isoelectric focusing  SERVALYT PRECOTES
TM Serva 
Heating block  TB1 Thermoblock  Biometra 
Heating block – Mixer  Thermomixer Compact  Eppendorf 
Heating block – Mixer  Thermomixer Comfort  Eppendorf 
Incubator BK-600  Heraeus 
Films SO-163  Kodak 
Filter for producing deionised water  MilliQ Plus  Millipore 
Filters Nylon  membranes  Pall 
Fluorescence spectrophotometer  F-4500 Hitachi  High-Technologies 
Liquid Handling System  StarLET  Hamilton Robotics 
Luminescence Spectrophotometer LS  50  B  Perkin-Elmer 
Magnetic stirrer  RET IKAMAG  IKA Werke 
Mass spectrometer  micrOTOF-QII Bruker 
Mass spectrometer  maXis  Bruker 
Mass spectrometer  MALDI-TOF Voyager STR  Applied Biosystems 
Mass spectrometer  MALDI-TOF OmniFlex®  Bruker 
Membrane vacuum pumps  MP40 / System III  Biometra 
Microfluidizer 110LA  Microfluidics  Corporation 
Microspectrophotometer  Universal-Mikroskop-Spektral-
Photometer, UMSP 30 / 50 
Carl Zeiss 
Microwave R-222 Sharp 
Multipipette edp3  Mettler  Toledo 
Oxygen electrode  Oxygraph  Hansatech 
Optical microscope  SZ40  Olympus 
Optical microscope  M165C  Leica Microsystems 
Peristaltic pump  Miniplus 2  Gilson 
pH-meter 765  Calimatic  Knick 
Photometer Ultrospec  2100 pro  GE Healthcare 
Photometer Lambda  35  Perkin-Elmer 
Photometer Lambda  40  Perkin-Elmer 
Photometer Agilent  8453  Agilent 
Pipettes  P2 – P5000  Gilson 
Precision syringes    Hamilton 
X-ray generator  R-Axis IV
++ Rigaku 
Rotors   Beckman  Coulter 
SDS-Gels  NuPAGE Novex® 4-12% Bis-
Tris  
Invitrogen 
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SDS-Gels  NativePAGE Novex® 4-16% Bis-
Tris  
Invitrogen 
Sonification bath  RK 255 S  Bandelin Sonorex 
Speedvacuum Concentrator  5301  Eppendorf 
Thermostatic room 4 °C and 18 °C     
TXRF spectrometer  EXTRA IIA  ATOMIKA Instruments 
Ultracentrifuge  Optima MAX UC  Beckman Coulter 
UV-Monitor  Single Path Monitor UV-1  GE Healthcare 
UV-Monitor Writer  BD 41  Kipp & Zonen 
Vortexer Vortex-Genie  2  Scientific  Industries 
 
 
 
 
 
4.1.5.  Databases and servers 
The databases and servers used in this work are listed in Table 4.5. 
 
Table 4.5: List of databases and servers. 
Database Website 
EBI http://www.ebi.ac.uk 
Electron Microscopy Data Bank  http://www.ebi.ac.uk/pdbe/emdb 
Expasy http://www.expasy.org 
Google http://www.google.com 
NCBI http://www.ncbi.nlm.nih.gov 
OPM http://opm.phar.umich.edu 
PDB http://www.rcsb.org 
Membrane Protein Data Bank  http://www.mpdb.ul.ie 
Membrane Protein of Known 3D Structure  http://blanco.biomol.uci.edu/Membrane_Proteins_xtal.html 
Unix and Linux servers  in house computer facility 
Wikipedia http://en.wikipedia.org 
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4.1.6.  Software 
The software used in this work is listed in Table 4.6. 
 
Table 4.6: List of software. 
Software  Website or device  Reference or 
provider 
3D-PSSM http://www.sbg.bio.ic.ac.uk (Kelley et al., 2000) 
Amphipaseek http://npsa-pbil.ibcp.fr  (Sapay et al., 2006) 
Acrobat 7.0  http://www.adobe.com  Adobe 
ARP/wARP http://www.embl-hamburg.de/ARP  (Lamzin et al., 2001) 
BLAST http://blast.ncbi.nih.gov/Blast.cgi  (Altschul et al., 1997) 
CCP4 http://www.ccp4.ac.uk  (Collaborative 
computational project 
number 4, 1994) 
ChemSketch 
10.0 
http://www.acdlabs.com ACDLabs 
ClustalX2 and 
ClustalW2 
http://www.ebi.ac.uk/Tools/clustalW2  (Thompson et al., 1994; 
Thompson et al., 1997) 
CNS http://cns.csb.yale.edu/v1.1  (Brunger et al., 1998) 
Coot http://www.biop.ox.ac.uk/coot  (Emsley and Cowtan, 
2004) 
DALI http://www2.ebi.ac.uk/dali  (Holm et al., 2008) 
DataAnalysis 4.0  ESI-q-TOF MS  Bruker 
DM http://www.ccp4.ac.uk/html/dm.html  (Cowtan,  1994) 
D*Trek http://www.rigaku.com/software/dtrek.html  Rigaku, (Pflugrath, 
1999) 
EndNote X3  http://www.endnote.com  Thomson Reuters 
Firefox http://www.mozilla.com/firefox  Mozilla 
Flex Control  http://www.bdal.com/products/maldi-tof-toftof-ms.html  Bruker 
Geneious http://www.geneious.com  Drummond  et al. 
Ghostscript 8.53  http://www.ghostscript.com   
HKL Package  http://www.hkl-xray.com  HKL Research 
HMMTOP http://www.enzim.hu/hmmtop  (Tusnady and Simon, 
2001) 
IMP http://xray.bmc.uu.se/usf/imp_man.html  (Kleywegt and Jones, 
1994) 
Interner Explorer  http://www.microsoft.com/windows/Internet-explorer/ Microsoft  Corporation 
Jalview http://www.jalview.org  (Waterhouse et al., 
2009) 
Mascot http://www.matrixscience.com  Matrix  Science 
Matthew’s 
coefficient 
Calculator 
http://www.rigaku.co.jp/xrl/group1/tips/prg/vm.html Rigaku 
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O http://alpha2.bmc.uu.se/~alwyn  (Jones and Kjeldgaard, 
1997) 
Office 2003  http://office.microsoft.com  Microsoft Corporation 
Photoshop 6.0  http://www.adobe.com/products/photoshop  Adobe 
PyMOL http://www.pymol.org  (DeLano,  2002) 
ProtParam http://www.expasy.ch/tools/protparam.html  
RealVNC 4  http://www.realvnc.com  RealVNC Ltd 
Refmac 5  http://www.ccp4.ac.uk/dist/html/refmac5.html  (Murshudov et al., 
1997) 
SEDFIT http://www.analyticalultracentrifugation.com (Schuck,  2000) 
SEDNTERP http://www.jphilo.mailway.com/download.htm  courtesy of Dr. J. Philo 
SEDPHAT http://www.analyticalultracentrifugation.com  
SHARP http://www.globalphasing.com/sharp  (Fortelle and Bricogne, 
1997) 
SHELX http://shelx.uni-ac.gwdg.de/SHELX  (Sheldrick et al., 2001) 
SignalP http://www.cbs.dtu.dk/services/SignalP  (Emanuelsson et al., 
2007) 
Sophos Anti-
Virus 
http://antivir.gwdg.de Sophos 
SPIDER http://www.wadsworth.org/spider_doc/spider/docs/spider.html (Frank et al., 1996) 
T-COFFEE http://www.tcoffee.org  (Notredame et al., 
2000) 
TMHMM 2.0  http://www.cbs.dtu.dk/services/TMHMM-2.0  (Sonnhammer et al., 
1998) 
Unicorn v4.10 
and v5.01 
http://www5.gelifesciences.com/aptrix/upp01077.nsf/Content/ 
aktadesign_platform~system_software 
GE Healthcare 
WEB http://www.wadsworth.org/spider_doc/spider/docs/spider.html (Frank et al., 1996) 
XDS http://xds.mpimf-heidelberg.mpg.de  (Kabsch,  1993) 
Xmipp http://xmipp.cnb.csic.es  (Marabini et al., 1996) 
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4.1.7.  Columns and chromatographic matrices 
The columns and column materials used in this work are listed in Table 4.7. 
 
Table 4.7: List of columns and chromatographic matrices. 
Material Separation  type  Supplier 
CHT Ceramic Hydroxyapatite  affinity, ionic interaction, 
hydrophobic interaction 
Bio-Rad 
Cibacron Blue 3GA  affinity  Sigma-Aldrich 
Reactive dyes (blue 4, blue 72, brown 10, 
green 5, green 19, red 120, yellow 3, yellow 
86) 
affinity Sigma-Aldrich 
Mini Q 4.6/50 PE  ion exchange  GE Healthcare 
MiniQ PC 3.2/3  ion exchange  GE Healthcare 
MonoQ 10/100 GL  ion exchange  GE Healthcare 
HiTrap
TM Q-Sepharose
TM Fast Flow ion  exchange  GE  Healthcare 
HiTrap
TM DEAE-Sepharose
TM Fast Flow ion  exchange  GE  Healthcare 
HiTrap
TM CM-Sepharose
TM Fast Flow ion  exchange  GE  Healthcare 
HiTrap
TM SP-Sepharose
TM Fast Flow ion  exchange  GE  Healthcare 
HiTrap
TM Phenyl
TM Fast Flow hydrophobic  exchange  GE  Healthcare 
HiTrap
TM Butyl
TM Fast Flow hydrophobic  exchange  GE  Healthcare 
HiTrap
TM Octyl
TM Fast Flow hydrophobic  exchange  GE  Healthcare 
Disposable PD-10 desalting column  size-exclusion  GE Healthcare 
Superdex 200 10/300 GL  size-exclusion  GE Healthcare 
Superdex 200 PC 3.2/30  size-exclusion  GE Healthcare 
TSK-GEL G4000SW  size-exclusion TOSOH  Bioscience 
NS-MP-10 reverse  phase  NanoSeparations 
NS-AC-10 reverse  phase  NanoSeparations 
Sorbax SB-C8 high resolution cartridge  reverse phase  Agilent 
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4.1.8.  Enzymes, other proteins, kits and standards 
Enzymes, other proteins, kits and standards used in this work are listed in Table 4.8. 
 
Table 4.8: List of enzymes, other proteins, kits and standards. 
Standard Application  Supplier 
BenchMark
TM Fluorescence 
Standard 
Gel electrophoresis Invitrogen 
Bovine Serum Albumin  Protein concentration  Pierce 
Catalase, bovine liver  Activity assay  Sigma-Aldrich 
Gel filtration calibration kit (low 
and high molecular weight 
standards) 
Size-exclusion chromatography  GE Healthcare 
Glucose oxidase, Aspergillus niger Activity  assay  Sigma-Aldrich 
Lysozyme Crystallization  Sigma-Aldrich 
NativeMark
TM Protein Standard  Gel electrophoresis Invitrogen 
Peptide calibration standard Mass  spectrometry  Bruker 
Prestained Protein Marker, Broad 
Range (6 – 175 kDa) 
Gel electrophoresis  New England Biolabs 
Trypsin digestion kit  ProteoExtract® All-in-one  Calbiochem 
SeeBlue® Plus2 Prestained 
Standard 
Gel electrophoresis Invitrogen 
Sequence grade modified trypsin Mass  spectrometry  Promega 
Silver staining kit  SilverQuest
TM Invitrogen 
Tobacco mosaic virus  Electron microscopy   
Trypsin, sequence grade, modified Mass  spectrometry  Promega 
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4.2.  Methods 
4.2.1.  Protein biochemistry 
4.2.1.1.  DENATURING GEL ELECTROPHORESIS (SDS-PAGE) 
Denaturing gel electrophoresis was performed according to protocols modified from 
Laemmli (Laemmli, 1970). Protein samples mixed 1:5 with sample buffer (all solutions 
used are listed in Table 4.9) were typically incubated for 3 min at 90 °C. The samples 
were run in a purchased gel chamber (XCell SureLock Mini-Cell, Invitrogen) on 4 – 12 
% BisTris gels or 10 % BisTris gels (NuPAGE
TM Novex®, Invitrogen) using 
MES/SDS running buffer at 200 V constant for 45 min. Alternatively, self cast gels (5 
% stacking gel and 15 % separating gel) were run in a homemade gel chamber using 
Tris/glycine running buffer and a constant voltage of 200 V for 1 h. After 
electrophoresis, the gels were fixed with 7 % (v/v) acetic acid solution for 10 min if 
required or directly stained with colloidal Coomassie blue staining solution (detection 
range 5 – 10 µg protein). After 30 min at room temperature, the gels were destained 
using destaining solution. For higher detection sensitivity (0.05 – 0.1 µg protein), silver 
staining was performed according to a protocol optimized for subsequent fingerprint 
mass spectrometry in gel analysis (Shevchenko et al., 1996). In addition to the 
solutions listed in Table 4.9, the SilverQuest
TM Silver Staining Kit (Invitrogen) was 
also used. 
In gel detection of FAD was performed before staining by UV excitation (Unden et al., 
1980) in a gel-imaging station (Bio-Rad). 
 
Table 4.9: List of solutions for SDS-PAGE. 
Solution Component  Amount 
Stock solutions 
  Tris-HCl pH 8.8, 4x  Tris 36.34  g 
 SDS  0.4  g 
 H 2O  to 100 mL 
  Tris-HCl pH 6.8, 4x  Tris 6.06  g 
 SDS  0.4  g 
 H 2O  to 100 mL 
  APS 10 %  APS 1  g 
 H 2O  to 10 mL 
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Sample buffer 5x    
  glycerol 2.5  mL 
  βME 1.25  mL 
 SDS  0.75  g 
  Tris-HCl pH 8.0, 1M  2.5 mL 
  bromophenol blue  2.5 mL 
 H 2O  to 10 mL 
    
MES/SDS running buffer 20x    
  MES 97.6  g 
 Tris  60.6  g 
 SDS  10  g 
 EDTA  3  g 
 H 2O  to 500 mL 
    
Tris/glycine running buffer 10x    
  Tris 60.7  g 
 glycine 142.8  g 
 SDS  10  g 
 H 2O  to 1 L 
    
Molecular weight markers    
SeeBlue® Plus2 Prestained Standard 
Prestained Protein Marker, Broad Range (6 – 175 kDa) 
BenchMark
TM Fluorescence Standard 
    
Stacking gel 5 % (for 5 gels)    
  Acrylamide/bis (30 % T, 2.67 % C)  2.5 mL 
  Tris-HCl pH 6.8, 4x  3.75 mL 
 H 2O 8.75  mL 
 TEMED  5  µL 
  APS 10 %  36 µL 
    
Separating gel 15 % (for 5 gels)    
  Acrylamide/bis (30 % T, 2.67 % C)  12.375 mL 
  Tris-HCl pH 8.8, 4x  6.25 mL 
 H 2O 6.375  mL 
 TEMED  7.75  µL 
  APS 10 %  157.5 µL 
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Coomassie-blue staining solutions    
  Fixative solution  acetic acid  7 mL 
  H2O  to 100 mL 
  Staining solution  Coomassie Brilliant Blue R250  1 g 
 ethanol 150  mL 
  acetic acid  50 mL 
 H 2O  to 500 mL 
  Destaining solution  ethanol 150  mL 
  acetic acid  50 mL 
 H 2O  to 500 mL 
    
Silver staining solutions    
  Fixative solution  methanol 450  mL 
  acetic acid  100 mL 
  H2O  to 1 L 
  Sensitizing solution  Na2S2O3 0.02  g 
  H2O  to 100 mL 
  Staining solution  AgNO3 0.1  g 
  H2O  to 100 mL 
  Developing solution  formaline (37 % formaldehyde in water)  0.04 g 
  Na2CO3 2  g 
  H2O  to 100 mL 
  Quenching solution  acetic acid  1 mL 
  H2O  to 100 mL 
 
4.2.1.2.  NON-DENATURING GEL ELECTROPHORESIS (NATIVE PAGE) 
Non-denaturing electrophoresis was performed using self-cast Tris/glycine gels (3 % 
stacking gel and 8 % separating gel) in a homemade gel chamber using Tris/glycine 
native running buffer (all solutions are listed in the following Table 4.10). The gels and 
the running buffer were supplemented with no detergent (CN-PAGE), with DDM only 
(DDM-CN-PAGE or low resolution CN-PAGE) or with DDM and DOC (DOC-CN-
PAGE or high resolution CN-PAGE) (Wittig et al., 2007). Blue Native PAGE (BN-
PAGE) was performed by adding Coomassie blue to the running buffer only on the 
cathode side (Schägger and von Jagow, 1991; Schägger et al., 1994). Alternatively, the 
samples were run in commercial gel chambers (XCell SureLock Mini-Cell, Invitrogen) 
on 4 – 16 % BisTris gels (NativePAGE
TM Novex®, Invitrogen). In this case, the 
detergents were added, if appropriate, to the running buffer only. The runs were all 
performed at 125 V constant for the first 30 min, then the voltage was increased to 150 
V for 30 min and finally to 175 V for the last 30 min. 
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Table 4.10: List of solutions for native PAGE. 
Solution Component  Amount 
Stock solutions 
  Tris-HCl pH 8.8, 4x  Tris 36.34  g 
 HCl  to  pH  8.8 
 H 2O  to 100 mL 
  Tris-HCl pH 6.8, 4x  Tris 6.06  g 
 HCl  to  pH  6.8 
 H 2O  to 100 mL 
  APS 10 %  APS 1  g 
 H 2O  to 10 mL 
  Tris-HCl pH 8.6, 1 M  Tris 12.11  g 
 HCl  to  pH  8.6 
 H 2O  to 100 mL 
 
Tris/glycine running buffer 10x 
 Tris  29  g 
 glycine  144g 
  (DDM 20 %  2.5 mL) 
  (DOC 10 %  5 mL) 
 H 2O  to 1 L 
    
BisTris running buffer 20x 
 BisTris  209.2  g 
 Tricine  179.2  g 
 H 2O  to 1 L 
    
Sample buffer, Tris/glycine system, 2x 
  TrisHCl, pH 8.6, 1 M  1 mL 
 glycerol  1  g 
 bromophenol  blue  crystals 
 H 2O  to 10 mL 
    
Sample buffer, BisTris system, 4x 
 BisTris  0.418  g 
  HCl 6 N  0.107 mL 
 glycerol  4  g 
 NaCl  0.117  g 
 H 2O  to 10 mL 
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Cathode buffer additive, for BN-PAGE, 20x 
  Coomassie blue R250  1 g 
 H 2O  to 250 mL 
    
Stacking gel 3 % (for 5 gels) 
  Acrylamide/bis (30 % T, 2.67 % C)  1.5 mL 
  Tris-HCl pH 6.8, 4x  3.75 mL 
 H 2O 9.7  mL 
 TEMED  5  µL 
  APS 10 %  36 µL 
  (DDM 20 %  37.5 µL) 
  (DOC 10 %  75 µL) 
    
Separating gel 8 % (for 5 gels) 
  Acrylamide/bis (30 % T, 2.67 % C)  6.25 mL 
  Tris-HCl pH 8.8, 4x  6.25 mL 
 H 2O 12  mL 
 TEMED  7.75  µL 
  APS 10 %  157.5 µL 
  (DDM 20 %  62.5 µL) 
  (DOC 10 %  125 µL) 
    
Molecular weight markers 
 NativeMark
TM Protein Standard   
  Self-made marker (BSA, 20 mg / mL)  1 µL 
 
4.2.1.3.  ISOELECTRIC FOCUSING (IEF) 
Isoelectric focusing was performed using SERVALYT
TM PRECOTES
TM gels (150 µm 
thick) and a horizontal flat bed electrophoresis chamber (Servalyt). A broad range of 
ampholytes (Servalyt) was chosen to cover the pH range from 3 to 7. The gels were 
incubated for 30 min at room temperature with the ampholyte solution containing 0.05 
% DDM before the run. The run was performed according to the manufacturer’s 
guidelines. 
4.2.1.4.  MEMBRANE PREPARATION AND SOLUBILIZATION 
All experiments were performed using native cells of Aquifex aeolicus VF5 purchased 
from the Archaeenzentrum (Regensburg, Germany). The cells were grown at 95 °C in 
SME medium supplied with thiosulfate (Huber and Eder, 2006) under an atmosphere 
 
130 4.  MATERIAL AND METHODS 
composed of 97 – 99 % of the mixture N2 : H2 = 80 : 20 and by 3 – 1 % of O2
43. Cells 
were flash-cooled and stored at -20 °C. 40-gram batches of thawed cells were 
resuspended in 200 mL buffer containing 50 mM Tris-HCl pH 7.4 and disrupted using 
a microfluidizer (110LA, Microfluidics Corporation) at 1,000 MPa. Cell debris was 
removed by centrifugation at 10,000xg for 15 min and membranes were sedimented 
from the supernatant by centrifugation at 100,000xg for 1 h. The membranes were 
washed and re-suspended in the same buffer at an approximate protein concentration of 
12 mg/mL and stored in aliquots at -80 °C (Peng et al., 2003). Membranes were 
solubilized for 1 h at 50 ºC after dilution with an equal volume of 6 % DDM in water if 
not otherwise specified. The insoluble fraction was removed by ultracentrifugation at 
40,000 rpm at 4 °C for 1 h (Peng et al., 2003). 
4.2.1.5.  ION-EXCHANGE CHROMATOGRAPHY 
For preparative protein purification, the solubilized membrane proteins were loaded 
onto a MonoQ 10/100 GL column (GE Healthcare), preequilibrated with buffer A (20 
mM Tris-HCl pH 7.4) containing NaN3 0.05 %, NaCl 50 mM and DDM 0.05 %. The 
run was performed on an Äkta purifier 10. The proteins were eluted with a segmented 
gradient in the same buffer to 1 M NaCl. Fractions were analysed by SDS-PAGE and 
combined according to the protein content. The samples were concentrated in Amicon 
Ultra-15 concentrators (Millipore) with a membrane molecular weight cut-off of 10 
kDa. 
For analytical purposes, MiniQ or HiTrap-Sepharose anion exchange columns were 
used, either on an Äkta purifier 10, on an Äkta purifier 100 or on a SMART system 
according to the manufacturer’s guidelines. The columns were preequilibrated with the 
running buffer at the appropriate pH and eluted with linear gradient of NaCl up to 1 M. 
For detergent exchange from DDM to Zwittergent 3-10 and then back from 
Zwittergent 3-10 to DDM, a MonoQ 10/100 GL column was used. The protein in 
buffer A with 0.05 % DDM was desalted using PD-10 columns (if necessary) and 
loaded onto the MonoQ column preequilibrated with 5 column volumes in buffer A 
with 0.05 % DDM. The buffer was exchanged to buffer A with Zwittergent 3-10 (1.5x 
CMC) for at least 5 column volumes. The protein was then eluted with a linear 
gradient in the same buffer to 0.6 M NaCl in 3 column volumes. The fractions 
containing the protein in Zwittergent 3-10 were combined and desalted on the PD-10 
                                                 
43 0.01 % O2 is necessary and sufficient for cell growth and the maximal growth rate is observed at 1 % O2. 
Above 5 % O2 the gas mixture becomes explosive (Dr. H. Huber, Archaeenzentrum Regensburg, Germany, 
personal communication). 
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columns in the Zwittergent 3-10 buffer and then reloaded onto the MonoQ column 
preequilibrated with buffer A and Zwittergent 3-10. The detergent was exchanged back 
to 0.05 % DDM in 10 column volumes to ensure the most extensive removal of 
Zwittergent 3-10, which has a strong effect on the crystallization. The protein was 
eluted in buffer A with 0.05 % DDM and 1 M NaCl with a sharp linear gradient in 3 
column volumes. Finally the protein was desalted on PD-10 columns. 
4.2.1.6.  SIZE-EXCLUSION CHROMATOGRAPHY (SEC) 
For preparative purposes, a Superdex 200 10/300 GL column (GE Healthcare) or the 
TSK-GEL G4000SW column (TOSOH Bioscience) were used either on an Äkta 
purifier 10 or Äkta purifier 100. For analytical purposes, a Superdex 200 PC 3.2/30 
was used on a SMART system. After equilibration for 3 column volumes in the 
running buffer, the runs were performed according to the manufacturer’s guidelines. 
4.2.1.7.  OTHER CHROMATOGRAPHY 
For analytical purposes, other chromatographic resins (dye affinity resins, hydrophobic 
interaction resins, hydroxyapatite) were used according to the manufacturer’s 
guidelines. 
4.2.1.8.  DETERMINATION OF THE PROTEIN CONCENTRATION 
Protein concentration estimation was done by a colorimetric assay using the biuret 
method. The reagent was prepared as a 1:50 (v/v) mixture of BCA Assay reagents A 
and B (Pierce) respectively. BSA samples at concentration ranges from 0.01 to 0.1 
mg/mL or from 0.1 to 1 mg/mL were used as standards. 10 µL of standard or of a bi-
distilled water solution or of a convenient amount of protein sample were mixed with 
200 µL reagent in a 96-well reaction plate and incubated for 30 minutes at 37 °C or at 
60 °C, according to the standard used (the higher temperature was used to enhance the 
reaction of the less concentrated standards). The plate was then immediately analysed 
in an ELISA reader (Power Wave X, BioTek). The concentration of protein was 
calculated as an average of two measurements. 
4.2.2.  Protein characterization 
4.2.2.1.  BIOINFORMATICS 
Analysis of the SQR sequence in silico (theoretical pI, calculated molecular weight, 
amino acid and elemental composition) was performed with the program ProtParam 
(Gasteiger et al., 2003). Prediction of transmembrane helices was performed with the 
program TMHMM (Sonnhammer et al., 1998). 
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Tertiary structure comparison was performed with the program 3D-PSSM (Kelley et 
al., 2000). Comparison of the structural coordinates was performed using the server 
DALI [www.ebi.ac.uk/dali, (Holm et al., 2008)]. 
A structure-based sequence alignment was computed using the program T-COFFEE, 
version 8.13 (Notredame et al., 2000) on a set of 50 manually selected sequences in 
FASTA (Pearson) format (Pearson and Lipman, 1988). 44 sequences correspond to 
SQR members, equally distributed among the identified types (10 sequences for type V, 
8 sequences for each type I and II, and 6 sequences each for types III, IV and VI). 6 
sequences of bacterial FCSD homologues were also included. First, a fully automated 
run was performed online (http://tcoffee.vital-it.ch) using the Expresso/3DCoffee 
algorithm (Armougom et al., 2006) [method sap_pair (Taylor and Orengo, 1989)] and 
the full set of 50 sequences in FASTA format (see Appendix tables 35 – 37). Second, 
the sequences were separated into the seven groups (six SQR types plus the FCSD 
group) and a T-COFFEE sequence alignment (regular mode) was calculated 
independently. The alignments were successively combined as profiles in T-COFFEE, 
running the program locally, providing the structural coordinates 1FCD, 3HYV and 
3H8L and using the methods sap_pair (Taylor and Orengo, 1989) and TMalign_pair 
(Zhang and Skolnick, 2005). The two strategies yielded similar results. The final score 
of the alignment is 63, confidently above 40, the cutoff indicated by the developers of 
T-COFFEE as minimal for a reliable result. Manual adjustments in Jalview 
(Waterhouse et al., 2009) slightly improved the original score to 64. The phylogenetic 
tree was visualized with Geneious (Drummond, A.J. et al., available at 
www.geneious.com). 
4.2.2.2.  PEPTIDE MASS FINGERPRINT MASS SPECTROMETRY (PMF-MS) 
Protein identification was performed using a MALDI-TOF mass spectrometer 
(OmniFlex®, Bruker). Protein samples were prepared from Coomassie-stained SDS-
PAGE gels as described previously (Shevchenko et al., 1996). The target bands were 
excised from the gels, destained and dried. A trypsin solution was soaked into the gel 
pieces overnight at 37 °C. The peptides were extracted from the gels by sonication and 
the solution was acidified with TFA and dried in a rotary evaporator (SpeedVac). 
Finally the peptides were resuspended and mixed with a saturated solution of matrix 
(α-cyano-4-hydroxy-cinnamic acid, CHCA, Bruker) and loaded on a 7x7-well target 
(Bruker). Spectra were acquired operating in reflector delayed-extraction negative 
mode. Spectra from at least 1000 individual shots were averaged with the software 
provided by the manufacturer and then smoothed and analyzed using Mascot (Perkins 
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et al., 1999) and MoverZ (bioinformatics.genomicsolutions.com). 
PMF-MS experiments were also performed on a MALDI-TOF MS (Voyager STR, 
Bruker) in collaboration with Tobias Beckhaus (Goethe University, Frankfurt am Main, 
Germany). 
Finally, additional PMF-MS experiments primarily aimed at the detection of covalent 
protein modifications were performed by easy-nLC-ESI-q-TOF tandem MS in 
collaboration with Dr. Julian Langer (Max Planck Institute of Biophysics, Frankfurt am 
Main, Germany). For this latter purpose, the protein samples were prepared from SDS-
PAGE gels run in the presence or in the absence of reducing agent or directly on the 
protein solution. Excised gel bands containing the target proteins were proteolysed 
with the ProteoExtract All-in-one Trypsin Digestion kit (CalBiochem). The gel pieces 
were treated with reducing and blocking reagent or with a corresponding volume of 
water and digested with a protease (trypsin or chymotrypsin or a combination of the 
two) according to the manufacturer’s guidelines. In the last step, an extra 10 µl of 
buffer was added to harvest the proteolytic fragments. The supernatant containing these 
peptides was loaded onto reverse phase columns in a Bruker/Proxeon easy-nLC and 
eluted with a water/acetonitrile gradient. Peptides eluting from the column were 
ionised using a Bruker ESI-source with a nanoSprayer emitter and analysed by tandem-
MS in a q-TOF mass spectrometer (Bruker micrOTOF-Q-II and Bruker maXis). The 
data sets were processed using a standard proteomics script and the Bruker 
DataAnalysis 4.0 software. The resulting MS and MS/MS mass lists were used to 
search the NCBInr database using Mascot on a local server. 
The solutions used in the PMF-MS experiments as well as the details on data 
processing and the Mascot search parameters are listed in Table 4.11. 
4.2.2.3.  FULL-LENGTH  MATRIX-ASSISTED  LASER-DESORPTION  IONISATION  TIME-OF-FLIGHT 
MASS SPECTROMETRY (MALDI-TOF MS) 
Full-length MALDI-TOF mass spectrometry on protein from crystals was performed 
using a MALDI-TOF MS instrument (OmniFlex®, Bruker).  
Additionally, full-length MALDI-TOF MS (Voyager STR, Bruker) was performed on 
the protein solution in collaboration with Dr. Ute Bahr (Goethe University, Frankfurt 
am Main, Germany) and Dr. Julian Langer (Max Planck Institute of Biophysics, 
Frankfurt am Main, Germany). The experimental conditions were similar to those used 
for MALDI-TOF PMF-MS (see Chapter 4.2.2.2 and Table 4.11) but a 50 g/L in 0.05 % 
TFA solution of sDHB (1:9 mixture of 2,5-dihydroxybenzoic acid and 5-
methoxysalicylic acid) was used as a matrix. 
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Table 4.11: List of solutions and experimental conditions for PMF-MS. 
MALDI-TOF PMF-MS 
Solution Component  Amount 
  Destainer  AHC 100  mM 
 ACN  50  % 
 H 2O  
  Wash  ACN 100  % 
  Trypsin, stock 
solution (-70 
°C) 
sequence grade 
trypsin (Sigma-
Aldrich) 
1 mg / mL 
  acetic acid  50 mM 
 H 2O  
  Trypsin, 
working 
solution 
trypsin stock 
solution 
5 µL 
 AHC  40  mM 
 H 2O  to 250 µL 
  Cleavage  AHC 40  mM 
 H 2O  
  Acidification  TFA (10 % in water)  2 µL / sample 
  Resuspension  ACN 70  % 
 TFA  0.1  % 
 H 2O  
  Matrix  ACN 70  % 
 TFA  0.1  % 
 H 2O  
  matrix (CHCA)  to saturation 
    
easy-nLC-ESI-q-TOF PMF-MS 
  HPLC   Instruments  Bruker/Proxeon easy nano LC 
  Solvent A  Water 0.1% FA 
  Solvent B  ACN 0.1% FA 
 nano-LC  columns  NanoSeparations 
  −  pre-column  NS-MP-10 5 µm C18, 360 µm OD, 100 µm ID, L = 20 
mm 
  −  analytical 
column 
NS-AC-10 5um C18, 75µm OD, 75µm ID, L=10cm 
  Bruker ESI-Source  nanoSprayer for nanoLC 
  flow rate  300 nl / min 
 gradient  25 min total run time, 95 : 5 => 65 : 35 (15 mins) => 0 : 
100 (17 mins), for details, see chromatogram view of the 
individual runs 
  MS  mode  "auto" MS/MS, positive ion mode 
  mass range  50 - 2,200 m/z 
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  MS acquisition  2 Hz, cycle time 3 – 5.5 s 
  parental ion 
selection 
1 MS was followed by 3 MS / MS of the most intense 
ions; the precursor ions for MS/MS were chosen in the 
range from 400 to 1,400 m/Z; if an internal calibrant 
was used, its isotopes (1221.9-1225 m/Z) were excluded 
from fragmentation  
preferred charge states 2
+ - 4
+  
single-charged ions were not excluded  
active exclusion after 2 spectra for 0.5 min 
 collision  gas  nitrogen 
  MS / MS acquisition  threshold for MS / MS was set to an intensity of 1,000 
ions with intensity of 10,000 counts in MS were 
fragmented for 0.5 s 
ions with intensity of 1,000 counts were fragmented for 
1 s 
  Data analysis  autoMS(n) intensity  threshold:  1,000 
retention time window: 0 
 deconvolution  sum  peak 
S/N threshold:1 
relative intensity threshold: 0.1% 
mass range: 100 – 3,000 m/z 
  export  as .mgf file 
  Search  search engine  Mascot 2.2.2 
  type of search  MS/MS Ion Search 
  enzyme  trypsin, chymotrypsin or combination of both 
  variable 
modifications 
oxidation on methionines 
 fixed  modification  carbamidomethylation of cysteines (if reducing agent 
used) 
 mass  values  monoisotopic 
 protein  mass  unrestricted 
  peptide mass 
tolerance 
± 0.05 Da 
  fragment mass 
tolerance 
± 0.05 Da 
  max missed 
cleavages 
1 
  instrument type  ESI-QUAD-TOF (micrOTOF-Q-II and maXis) 
  database  NCBI nr (downloaded 19/08/2009) 
  minimum ion score  15 
  significance 
threshold 
p < 0.05 
  minimum peptide 
length 
5 
 scoring  standard 
individual ion scores > 31 indicate identity or extensive 
homology (p < 0.05) 
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4.2.2.4.  FULL-LENGTH LIQUID CHROMATOGRAPHY ELECTROSPRAY IONISATION QUADRUPOLE 
TIME-OF-FLIGHT MASS SPECTROMETRY (EASY-NLC-ESI-Q-TOF MS) 
Full-length mass spectrometry was additionally performed in collaboration with Dr. 
Julian Langer (Max Planck Institute of Biophysics, Frankfurt am Main, Germany). 
Proteins were loaded on a Sorbax SB-C8 high resolution cartridge (2.1 x 30 mm, 3.5 
µm) in an Agilent 1200 HPLC system. The samples were eluted using a 
water/acetonitrile gradient (see chromatogram views of individual chromatograms), 
ionised using a Bruker ESI-Sprayer emitter in an ESI-Source and analysed in a Bruker 
maXis q-TOF mass spectrometer. The ion optics were trimmed for detection of large 
proteins. Spectra in the eluting peaks were analysed using the Bruker DataAnalysis 4.0 
software. The spectra were binned and deconvoluted using the Bruker Maximum 
Entropy Algorithm. Table 4.12 summarizes the experimental conditions. 
Table 4.12: List of solutions and experimental conditions for full length easy-nLC-
ESI-q-TOF MS. 
Parameters Value 
HPLC conditions 
Instrument  Agilent 1200 HPLC 
Solvent A  Water 0.1% FA 
Solvent B  ACN 0.1% FA 
nano-LC columns (Agilent 
technologies) 
Sorbax SB-C8 high resolution cartridge (2.1 x 30 mm, 3.5 µm) 
Bruker ESI-Source  ESI-Sprayer for Agilent LC 
flow rate  500 µl / min 
gradient  100 : 0 => 10 : 90 (15 min) => 10 : 90 (19 min) => 100 : 0 (30 
min), for details, see chromatogram view of the individual runs 
   
Trimming of the ion optics for detection of large m/z values 
ISCID  90 eV 
funnel RF  400 Vpp 
fultipole RF  400 Vpp 
ion cooler RF  400 Vpp 
collision cell transfer time  199 µs 
collision cell RF  1,200 Vpp 
   
Full length charge deconvolution (Maximum Entropy Algorithm) 
selected mass range  1,100 – 2,500 m/z 
low mass  45,000 m/z 
high mass  55,000 m/z 
resolving power  15,000 m/z 
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4.2.2.5.  FULL-LENGTH LASER-INDUCED LIQUID BEAD ION DESORPTION MASS SPECTROMETRY 
(LILBID MS) 
Details of the experimental set-up for LILBID MS have been published elsewhere 
(Morgner et al., 2006). Briefly, micro-droplets of solution (diameter 50 μm) are 
produced on demand at 10 Hz by a piezo-driven droplet generator and introduced into 
vacuum via differential pumping stages. In vacuum the droplets are irradiated one by 
one by synchronized high-power mid-IR laser pulses of typically 5-ns pulse length. 
The pulses are generated in a home-made optical parametric oscillator (OPO) using 
LiNbO3 crystals and a Nd:YAG laser as pump. The wavelength of the OPO radiation is 
tuned to the absorption maximum of water at around 3 μm, corresponding to an 
excitation of its stretching vibrations. At a threshold intensity the droplet explodes, 
resulting in the emission of ions from the liquid into the gas phase. The ions are mass-
analysed in a time-of-flight (TOF) reflectron mass spectrometer. For detection of very 
large biomolecules, a Daly-type ion detector is used, working up to an m/Z range in the 
low MDa region. At low laser intensity, LILBID MS desorbs ions out of the liquid 
very gently (ultrasoft mode) enabling detection of non-covalently assembled protein 
complexes. At higher laser intensities the complex is thermolysed into its subunits 
(harsh mode). The signals from the detector are recorded by a transient recorder. For 
data acquisition and analysis a user-written labview program is used. The signal-to-
noise ratio is improved by subtracting an unstructured background, caused by 
metastable loss of water and buffer molecules, from the original ion spectra. These 
difference spectra are smoothed by averaging the signal over a pre-set number of 
channels of the transient recorder, with the smoothing interval always lying within the 
time resolution of the TOF mass spectrometer. LILBID MS experiments were 
performed in collaboration with Lucie Sokolova (Goethe University, Frankfurt am 
Main, Germany). 
4.2.2.6.  CROSSLINKING 
Purified SQR at a concentration of 0.1 mg/mL was incubated at room temperature for 1 
h with 5 mM glutaraldehyde in a buffer containing 10 mM HEPES, pH 8.2 and DDM 
0.05 %. After this time, the reaction was quenched with Tris-HCl 100 mM, pH 7.4 and 
the protein sample was analyzed by SDS-PAGE (Simanshu et al., 2006). 
4.2.2.7.  ANALYTICAL ULTRACENTRIFUGATION 
The apparent molecular weight of the SQR complex was estimated by sedimentation 
velocity and sedimentation equilibrium analytical ultracentrifugation in an Optima XL-
A centrifuge (Beckman Coulter). The data were collected at a wavelength of 280 nm. 
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Sedimentation velocity experiments were performed with 300 µL samples in Tris-HCl, 
pH 7.4, 20 mM, 0.05 % DDM at protein concentrations of 0.5 – 1 mg/mL (OD280 nm= 
0.2 – 0.4). Absorbance data were acquired at rotor speeds of 30,000 – 40,000 rpm and 
at a temperature of 20 ºC. The buffer density, buffer viscosity and the protein partial 
specific volumes were calculated using the software SEDNTERP, kindly provided by 
Dr. J. Philo (www.rasmb.org). Sedimentation velocity data were analyzed using the c(s) 
continuous distribution of Lamm equation solutions with the software SEDFIT 
(Schuck, 2000). Density-matched sedimentation equilibrium experiments were done at 
4 ºC at rotor speeds of 10,000, 15,000 and 20,000 rpm at a protein optical density 
(OD280 nm) of about 0.2 units in buffer 1 (Tris-HCl 20 mM, pH 7.4, DDM 0.05 % w/V, 
sucrose 27.6 % w/V, D2O 95 % V/V), buffer 2 (Tris-HCl 20 mM, pH 7.4, C12E9 0.01 
% w/V, sucrose 6.4 % w/V) and buffer 3 (Tris-HCl 20 mM, pH 7.4, C12E9 0.01 % w/V, 
D2O 46 % V/V), respectively. Global non-linear regression of the experimental 
absorbance profiles was performed using the software SEDPHAT 
(www.analyticalultracentrifugation.com). The partial specific volume of the protein 
was calculated from the protein sequence and corrected for each buffer condition 
according to previous reports (Mayer et al., 1999). 
4.2.2.8.  TOTAL X-RAY FLUORESCENCE (TXRF) SPECTROSCOPY 
Total X-ray Fluorescence was performed in collaboration with Dr. Steffen Metz and 
Claudia Rittmeyer (Goethe University, Frankfurt am Main, Germany). 
All measurements were performed on a TXRF spectrometer EXTRA IIA (ATOMIKA 
Instruments) equipped with molybdenum and tungsten excitation tubes (tungsten Lα 
and molybdenum Kα radiation), a Si(Li) solid state detector with an area of 80 mm
2, an 
automated sample changer and a computer-controlled multichannel analyser system. 
The tungsten tube was operated at 25 kV and 60 mA using a 30 µm Cu attenuation 
filter, whereas the molybdenum tube was operated at 50 kV and 40 mA using a 200 µm 
Mo, aluminium foil attenuation filter. The samples were measured for 1,000 s. Sulfur, 
phosphate and metal concentrations were determined on protein samples at a 
concentration of 20 µM, in Tris-acetate pH 7.4 20 mM with 0.05 % DDM. Cr (10 
mg/L) was added (1:10 ratio) as an internal standard. 4 µL of the final solution was air 
dried at room temperature onto an unsiliconized quartz glass carrier under clean bench 
conditions. Each sample was measured four times. A reference measurement was 
performed on the buffer without protein sample and taken as blank. 
4.2.2.9.  ENZYMATIC ACTIVITY ASSAY 
The enzymatic activity of the protein was performed according to Nübel and coworkers 
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(Nübel et al., 2000). The assay was performed using a diode array UV/Vis 
spectrophotometer (Agilent) measuring the time course of the 285 nm minus 300 nm 
absorption difference for 300 s. The reaction buffer (1 mL, degassed and nitrogen 
saturated) contained 50 mM Tris-HCl, pH 7.4, 20 mM glucose, 1 unit of glucose 
oxidase (type II from Aspergillus niger, Sigma-Aldrich) and 10 units of catalase (from 
bovine liver, Sigma-Aldrich). Semi-anaerobic cells (1 cm light path) made of Quarz-
Suprasil and sealed with a silicon lid (Hellma) were used. As a substrate, 
decylubiquinone was used at a final concentration of 10 µM. Commercial stocks of 25 
mg decylubiquinone were dissolved in 100 % ethanol and 2 mM aliquots were stored 
at -20 °C in light-protected Eppendorf cups. The reaction was started by the addition of 
Na2S to a final concentration of 100 µM. Stocks of Na2S were prepared fresh in 
degassed Tris-HCl 1 M pH 8.0. 
4.2.2.10. ABSORPTION AND FLUORESCENCE SPECTROSCOPY 
Quantification of the FAD cofactor in the pure protein preparation was done using an 
extinction coefficient of 10.8 cm
-1mM
-1 (Weyler and Salach, 1985) for the air-oxidised 
minus dithionite-reduced difference spectrum measured at 456 nm in a dual-
wavelength spectrophotometer (Perkin Elmer). 
Fluorescence emission spectra were measured in a fluorescence spectrophotometer (F-
4500, Hitachi) exciting the sample at a wavelength of 365 nm and recording the 
emission at 480 – 600 nm. The samples were measured in quartz cuvettes (Hellma) 
suitable for fluorescence data acquisition and adapted with a self-made holder to 
minimize sample volume to 200 µL. 
4.2.2.11. SINGLE-PARTICLE ELECTRON MICROSCOPY 
Single-particle electron microscopy was performed in the attempt to obtain a low 
resolution initial insight into the structure of the protein and information on its 
oligomeric state in solution. The experiments were performed in collaboration with Dr. 
D. Parcej (Max Planck Institute of Biophysics, Frankfurt am Main, Germany). 3 µL of 
pure sample at a concentration of approximately 0.04 mg/mL were applied to a glow-
discharged carbon-coated copper electron-microscope grid (400 mesh size). After 
adsorption for 1 minute, the specimen was stained by repetitive addition of 1 % (w/v) 
uranyl acetate followed by rapid drying (Stoops et al., 1992). Images were collected 
under low dose conditions onto Kodak SO-163 film using a Philips CM120 
microscope operating at 120 kV with a calibrated magnification of 58,000x. After 
development for 12 minutes in full-strength D19 developer, the films were digitized on 
a Zeiss SCAI flat bed scanner (Zeiss, Göttingen, Germany). Images were then 
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converted into SPIDER (Frank et al., 1996) format and binned to a final pixel size of 
0.36 nm on the sample scale. Well separated and stained single particles (462 particles) 
were manually selected in WEB (Frank et al., 1996) and windowed. To avoid reference 
bias, the single-particle images were first aligned using reference-free alignment 
(Marco et al., 1993) and then by three further rounds of translational and rotational 
alignment. Variability in the images was analysed using a Kehonen self-organising 
map within the package Xmipp (Marabini et al., 1996). Data were distributed on 7 x 7 
grid with hexagonal topology. 
Additional single-particle electron microscopy studies were performed in collaboration 
with Dr. J. Vonck (Max Planck Institute of Biophysics, Frankfurt am Main, Germany) 
in order to study the stability of the sample in the absence of detergent. 
4.2.3.  Protein crystallization and structure determination 
4.2.3.1.  PROTEIN CRYSTALLIZATION 
The homogeneous purified protein solution was concentrated and mixed with an 
equimolar amount of FAD (Sigma) dissolved in water to a final protein concentration 
of 8 – 10 mg/mL. The protein was crystallized by the hanging- or sitting-drop vapour 
diffusion method at 4, 10, 16, 18 or 25 °C. For random screening, 100 + 100 nL or 300 
+ 300 nL protein / reservoir drops were equilibrated against 100 µL reservoir solution 
using the crystallographic robots MicroSys SQ Series (Cartesian Technologies) or 
Mosquito (TTP LabTech) in Crystal Quick
TM (Greiner Bio-one) or AxyGem
TM 
(Axygen Bioscience) 96-well plates. The sparse matrix screens listed in Table 4.3 were 
used to obtain initial hits. For refinement, 1 + 1 µL protein / reservoir drops were 
equilibrated against 300 µL reservoir by hand in XRL 24-well plates (Molecular 
Dimensions Ltd) using silanized cover slides (silanization was performed using 2 % 
dichloro-dimethyl-silane in n-hexane and two successive washing steps in ethanol). All 
buffers were prepared with ddH2O (18 Ω) and filtered (0.2 µm membrane cut-off) to 
ensure the highest homogeneity of the particles in solution. When additives were used 
(i.e. the additive screen, the detergent additive screens or the heavy metal screens, 
Hampton, or the quinone analogues stock solutions, see later), 1 µL of protein solution 
was mixed with 0.8 µL of the self-made crystallization buffer and 0.2 µL of a 10-fold 
concentrated additive solution. Initial hits were obtained in the conditions JB6_C3 
(Jena Bioscience Classic screen 6, condition C3), JB7_D1 (Jena Bioscience Classic 
screen 7, condition D1) and MPD_39 (The MPDs, condition 39, Qiagen). The crystals 
used for structure determination were grown at 18 °C by hanging-drop vapour 
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diffusion in Na-acetate pH 5.6 0.1 M or Na-MES pH 6.5 0.1 M, ammonium sulfate 2.0 
M and PEG 400 2 – 5 % v/v. The crystals become visible after 3 – 6 weeks and reach 
their full size within 1 – 2 days.  
For phasing, the crystals were soaked with heavy metal solutions (prepared from the 
Hampton Research heavy atom screens). After crystal growth, a 10-fold concentrated 
water solution of the heavy metal was added to the crystallization drop to a final heavy 
atom concentration of 1 – 10 mM. After 1 – 24 h, the crystals were washed in cryo-
buffer and frozen. Alternatively, the heavy metal solution was added directly to the 
cryo-buffer. 
For substrate derivatization, the crystals were soaked with quinone analogues. Stock 
solutions in 100 % ethanol, methanol or DMSO were stored at -20 °C in light-protected 
cups (Eppendorf) and added to the crystallization drops as described for the heavy 
metal solutions. Alternatively, a minimal amount was mixed homogeneously with 100 
% PEG 400 and diluted with water and sodium acetate to a final concentration of 0.1 
M sodium acetate, pH 5.6, 40 % v/v PEG 400, 0.1 – 10 mM quinone. Then, the 
crystals were soaked for 24 h in this solution and directly frozen. 
Alternative crystallization methods tested were the batch method under oil, the lipidic 
cubic phase (Landau and Rosenbusch, 1996) and the sponge phase (Wadsten et al., 
2006). 
For crystallization in microbatch mode under oil, 1 µL protein solution was mixed with 
an equal volume of precipitant solutions from the commercial screens available in 
Terasaki plates (Greiner Bio-one). The drops were then covered with a thin layer of 
paraffin oil, Al’s oil or silicon oil. Crystals grew in the conditions JBM1_A1 (Jena 
Bioscience Membrane screen 1, condition A1) and JB6_C3 under paraffin oil. 
For crystallization in lipidic cubic phase, the phase was prepared according to the 
following protocol. Two gas-tight 250-µL syringes (here named A and B, Hampton 
Research) were connected through a home-made screw. Syringe A was filled with 
monoolein (solid, -80 °C stock, Nu-Chek Prep Inc.) and syringe B with the protein-
containing buffer such that the monoolein-to-buffer w/w ratio was precisely 60:40. The 
syringes were connected avoiding air gaps between the substances. The phase was 
prepared by gentle mixing of the solution in syringe B into the lipid in syringe A. The 
quality of the phase was inspected under a light microscope. The phase was directly 
dispensed by means of a home-made 200-nL dispenser into 96-well plates. They were 
then mixed with reservoir solutions between two glass slides separated by a thin paper 
foil and allowed to equilibrate. 
For crystallization in sponge phase, the lipidic cubic phase was first prepared using a 
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suitable detergent-containing buffer (Na-MES pH 6.5 20 mM, DDM 0.02 % w/v) 
instead of the protein solution. The phase was then aliquoted into small PCR tubes, 
centrifuged to the bottom of the tubes, covered with 4-fold volumes of a precipitating-
agent-containing buffer and equilibrated at 18 °C for 24 h. A screen of suitable 
precipitating-agent-containing buffers was developed in house together with Sabine 
Buschmann and Dr. Chitra Rajendran (Max Planck Institute of Biophysics, Frankfurt 
am Main, Germany, see Appendix table 34). The sponge phase was then mixed with 
the protein solution in standard hanging-drop vapour diffusion set-ups. Small crystals 
grew in the sponge phase condition generated using reservoir MPD_39 (The MPDs 
screen, condition 39, Quiagen). 
4.2.3.2.  BIOCHEMICAL CHARACTERIZATION OF THE CRYSTALS 
The VIS spectrum of the crystals was measured on a microspectrophotometer in house 
(Universal-Mikroskop-Spektral-Photometer, UMSP 30 / 50, Carl Zeiss). Single 
crystals were soaked from the cryo-protecting solution (see Chapter 4.2.3.3) into 
suitable quartz flat-faced capillaries (Müller W.) and the capillaries were sealed with 
wax. After measurement in the oxidized state, a few crystals of sodium dithionite were 
added to the solution and the capillary was sealed again for measurement of the same 
crystal in the reduced state. 
For SDS-PAGE electrophoresis and for full-length MALDI-TOF MS on an in house 
spectrometer (OmniFlex®, Bruker, see Chapter 4.2.2.3), 10 crystals of about 0.1 mm 
in all dimensions (hexagonal crystals) or of about 0.3 mm in at least one dimension 
(needle crystals) were extracted from the mother liquor, washed three times in cryo-
protecting solution and finally dissolved in water to be used directly. 
4.2.3.3.  X-RAY EXPOSURE AND DATA COLLECTION 
The crystals were either harvested at room temperature in glass capillaries of suitable 
dimensions (Müller W.) or stored in liquid nitrogen after extracting them from the 
crystallization drop with suitable nylon loops (Hampton Research), washing them in a 
cryo-protecting buffer and flash-cooling them under a cryo-jet. The cryo-protectant 
solution used for structure determination was composed of the crystallization buffer 
(0.1 M Na-MES or Na-acetate), supplemented with PEG 400, 40 – 50 % v/v. 
An attempt to improve diffraction by adjusting the humidity of the crystals was 
performed using the humidity chamber (Dr. Christian Benda, Max Planck Institute of 
Biochemistry, Martinsried, Germany). 
Crystals were screened at an in house rotating anode generator (Rigaku), at the 
European Synchrotron Radiation Facility (ESRF, Grenoble, France) and at the Swiss 
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Light Source (SLS, Villigen, Switzerland). All data sets used for structure 
determination were collected at the SLS beam lines X10SA and X06SA. 
4.2.3.4.  STRUCTURE DETERMINATION 
SQR formed needle crystals with a typical size of 0.02 x 0.05 x 0.2 mm
3  in the space 
group P212121 with unit cell dimensions of 112 x 154 x 178 Å
3, a solvent content of 53 
% and six molecules in the asymmetric unit. All data sets were reduced and scaled 
using the XDS suite (Kabsch, 1993). The phases were obtained by the MIRAS method 
using Os (K2OsCl6) and Au (AuCl3) derivatives. Heavy atom positions were 
determined with SHELX (Sheldrick et al., 2001) and refined with SHARP (Fortelle 
and Bricogne, 1997) to obtain initial phases. Solvent flattening was performed with the 
software DM (Cowtan, 1994) and non-crystallographic symmetry (NCS) averaging 
was performed in DM using the NSC matrix derived from LSQ in the program O 
(Jones and Kjeldgaard, 1997) and refined by IMP (Kleywegt and Jones, 1994). An 
initial model was obtained with the automated program ARP/wARP (Lamzin et al., 
2001) and subsequent model building was done manually in Coot (Emsley and Cowtan, 
2004). The initial model had an Rwork of 47 % and an Rfree of 50 %. Initial refinement 
was performed with CNS (Brunger et al., 1998) to an Rfree of 30 %. Further refinement 
was done with Refmac5, using TLS and imposing NCS restraints on the protein chains 
(Collaborative computational project number 4, 1994; Murshudov et al., 1997). Final 
rounds of refinement were done without NCS restraints. The datasets of the 
decylubiquinone and aurachin C soaked crystals were directly refined with Refmac5 
without the need of a molecular replacement run. Solvent, cofactor and substrate 
molecules were drawn with Sketcher and added to the coordinate files in Coot and 
Refmac5. Omit maps were calculated using CNS, excluding the atoms of interest and 
avoiding model bias by simulated annealing refinement. Details about the structure 
solution flowchart and the scripts used to run each program are reported in the 
Appendix tables 1 – 33. 
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Appendix 
Appendix table 1: Flowchart for structure solution
a 
Program Input  Output  Notes 
1.  Data collection 
at synchrotron  crystal  diffraction image 
files 
data collection strategy 
calculated with XDS 
       
2.  Indexing, integration 
XDS  XDS.INP  XDS_ASCII.HKL intensities 
       
3.  Scaling 
XDS  XSCALE.INP, XDS_ASCII.HKL  xscale.ahkl  intensities, scaled, merged from 
multiple data sets 
       
4.  Conversion to amplitudes 
XDS  XDSCONV.INP, xscale.ahkl  dataset.hkl amplitudes  (for  SHELX) 
   dataset.ccp4asc 
F2MTZ.INP 
amplitudes (for CCP4) 
F2MTZ (CCP4)  XDSMTZ.COM, F2MTZ.INP  dataset.mtz   
       
5.  Identification of heavy atom positions 
SHELX  SHELXC.INP, dataset.hkl files  ha.pdb  heavy atom sites in PDB format 
(integral coordinates) 
   ha.lst  heavy atom sites in .lst format 
(fractional coordinates) 
rename to HA.HATOM for 
SHARP 
       
6.  Refinement of heavy atom positions 
CAD (CCP4)  CAD_ANO_XDS.COM, dataset.mtz 
files 
miras.data.mtz  combined amplitudes of native 
and derivative data sets 
SHARP  SIN, ha.hatom, miras.data.mtz  eden-unique.mtz  structure factor file 
   HATOM.PDB  refined heavy atom file 
       
7.  Solvent flattening 
DM (in SHARP)  eden-unique.mtz  miras_50pc.mtz  structure factor file, solvent 
flattened 
       
8.  Density averaging using NCS operations derived from heavy atom positions 
  pdb file with symmetric heavy atom 
positions 
ha_1.pdb, 
ha_2.pdb, ha_3.pdb 
separated heavy atom groups, 
each belonging to a NCS region 
FFT (CCP4)  FFT.COM, miras_50pc.mtz  miras_50pc.map electron  density  map 
MAPMAN  manual input, miras_50pc.map miras_50pc.dsn6  electron density map in “O” 
format 
MAPMAN  manual input, miras_50pc.dsn6  miras_50pc.odb electron  density  bones 
O  O macros (M2, BN, BT), 
miras_50pc.dsn6, miras_50pc.odb 
bones_1.odb  electron density bones of region 
1 (to “copy” with NCS) 
MAMA  BONES_MASK.MAMAC, bones_1.odb  miras.mask  mask around bones of region 1 
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LSQ_EX (in O)  ha_1.pdb, ha_2.pdb, ha_3.pdb, 
miras.mask 
1to2.lsq, 1to3.lsq  NCS operation matrices 
IMP  IMP.COM, P212121.SYM, 
miras_50pc.map, miras.mask, 1to2.lsq, 
1to3.lsq 
miras_1to2.lsq, 
miras_1to3.lsq 
refined NCS operation matrices 
MAMA2CCP4 miras.mask  miras_ccp4.mask mask around bones of region 1 
(CCP4 format) 
DM  eden-unique.mtz, miras_ccp4.mask, 
DM_AVE.COM (with NCS operators 
from miras_1to2.lsq, miras_1to3.lsq) 
dm_miras.mtz  NCS-averaged structure factors 
       
9.  Model building 
ARP/wARP dm_miras.mtz,  SEQ.PIR first_model.pdb  partial model built 
automatically 
COOT first_model.pdb  first_model-
coot.pdb 
full initial model 
       
10. Refinement 
MTZ2VARIOUS  MTZ2CNS.COM, native.mtz  native.hkl  native amplitudes in CNS 
format 
CNS  CNS.COM    
  MAKE_CV.INP, native.hkl  native.cv  native amplitudes, with Rfree 
flag 
  GENERATE.INP, first_model-coot.pdb generate.pdb  coordinates of the full initial 
model in CNS format 
  GET_NCS_MATRICES.INP, 
generate.pdb 
NCS.DEF  NCS matrices from the model 
coordinates 
  RIGID.INP, generate.pdb, ncs.def, 
native.cv 
rigid.pdb  preliminary rigid body 
refinement 
  MINI.INP, rigid.pdb, ncs.def, native.cv  mini.pdb simulated  annealing refinement 
SKETCHER (in 
CCP4) 
  ligands.pdb, 
LIBRARY.CIF 
design ligands, write library 
files 
COOT mini.pdb,  ligands.pdb, library.cif  mini-coot.pdb  refined model with ligands, 
water molecules can be inserted 
with COOT, too 
UNIQUEIFY (in 
CCP4) 
native.mtz native_unique.mtz  native amplitude in CCP4 
format, with Rfree flag 
REFMAC5 (in 
CCP4) 
native_unique.mtz, mini-coot.pdb, 
TLSIN.TLS, library.cif 
TLSOUT.TLS, 
ref1.pdb 
definition of parameters for TLS 
refinement 
REFMAC5 (in 
CCP4) 
ref1.pdb, native_unique.mtz, library.cif final_model.pdb successive cycles to 
convergence 
       
11. Validation 
COOT final_model.pdb,  native_unique.mtz various statistics  Ramachandran plot, geometry 
analysis, peptide omega 
analysis, rotamer analysis, 
density fit analysis 
SFCHECK (in 
CCP4) 
final_model.pdb, native_unique.mtz various  statistics  Ramachandran plot, geometry 
analysis, peptide omega 
analysis, rotamer analysis, 
density fit analysis 
a in bold the files reported in the following Appendix tables. 
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Appendix table 2: XDS.INP script 
  
 JOB= ALL !XYCORR INIT COLSPOT IDXREF DEFPIX XPLAN INTEGRATE CORRECT 
 ORGX=1535    ORGY=1488    !Detector origin (pixels).  ORGX=NX/2; ORGY=NY/2 
 DETECTOR_DISTANCE= 280.   !(mm) 
 OSCILLATION_RANGE= 0.5            !degrees (>0) 
 X-RAY_WAVELENGTH= 0.91984        !Angstroem 
 MAXIMUM_NUMBER_OF_PROCESSORS=16!<25;ignored by single cpu version of xds 
!MINUTE=0   !Maximum number of minutes to wait until data image must appears 
!MAXIMUM_NUMBER_OF_JOBS=4 
 NAME_TEMPLATE_OF_DATA_FRAMES= image_???.img DIRECT  TIFF 
 DATA_RANGE=1 60     !Numbers of first and last data image collected 
 BACKGROUND_RANGE= 1 9  !Numbers of first and last data image for background 
 SPOT_RANGE= 1 9     !First and last data image number for finding spots 
 SPACE_GROUP_NUMBER=19  !0 for unknown crystals; cell constants are ignored. 
 UNIT_CELL_CONSTANTS=  112.85  154.92  178.04  90.0  90.0  90.0 
!REIDX=   0  0 -1  0  0 -1  0  0 -1  0  0  0 
 REFINE(IDXREF)=BEAM AXIS ORIENTATION CELL DISTANCE 
 REFINE(INTEGRATE)=DISTANCE BEAM ORIENTATION CELL !AXIS 
 REFINE(CORRECT)=DISTANCE BEAM ORIENTATION CELL AXIS 
!FRIEDEL'S_LAW=FALSE !Default is TRUE. 
!STARTING_ANGLE=  0.0      STARTING_FRAME=1 
 RESOLUTION_SHELLS=10 6 5 4 3 2 
!STARTING_ANGLES_OF_SPINDLE_ROTATION= 0 180 10 
!TOTAL_SPINDLE_ROTATION_RANGES=30.0 120 15 
!REFERENCE_DATA_SET= CK.HKL   !Name of a reference data set (optional) 
 NX=3072 NY=3072 QX=0.073242  QY=0.073242   !MARCCD 225mm version 
 ROTATION_AXIS= 1.0 0.0 0.0 
 INCIDENT_BEAM_DIRECTION=0.0 0.0 1.0 
 FRACTION_OF_POLARIZATION=0.99 ! SLS X06SA 
 POLARIZATION_PLANE_NORMAL= 0.0 1.0 0.0 
 AIR=0.001        !Air absorption coefficient of x-rays 
 DETECTOR=CCDCHESS        MINIMUM_VALID_PIXEL_VALUE=0     OVERLOAD=65000 
 DIRECTION_OF_DETECTOR_X-AXIS= 1.0 0.0 0.0 
 DIRECTION_OF_DETECTOR_Y-AXIS= 0.0 1.0 0.0 
 TRUSTED_REGION=0.0 1.35 !Relative radius limiting trusted region on detector 
!DARK_CURRENT_IMAGE=../images/blank.tif    !hardly ever used 
!TEST=1     !Test flag. 1,2 additional diagnostics and images 
!INDEX_ORIGIN= 0 0 0          ! used by "IDXREF" to add an index offset 
!INDEX_ERROR=0.05 INDEX_MAGNITUDE=8 INDEX_QUALITY=0.8 
!SEPMIN=6.0 CLUSTER_RADIUS=3 
!MAXIMUM_ERROR_OF_SPOT_POSITION=3.0 
 VALUE_RANGE_FOR_TRUSTED_DETECTOR_PIXELS= 6000 30000 !Used by DEFPIX 
 INCLUDE_RESOLUTION_RANGE=50.0 2.0 !Angstroem; used by DEFPIX,INTEGRATE,CORRECT 
!EXCLUDE_RESOLUTION_RANGE= 3.93 3.87 !ice-ring at 3.897 Angstrom 
!EXCLUDE_RESOLUTION_RANGE= 3.70 3.64 !ice-ring at 3.669 Angstrom 
!EXCLUDE_RESOLUTION_RANGE= 3.47 3.41 !ice-ring at 3.441 Angstrom 
!EXCLUDE_RESOLUTION_RANGE= 2.70 2.64 !ice-ring at 2.671 Angstrom 
!EXCLUDE_RESOLUTION_RANGE= 2.28 2.22 !ice-ring at 2.249 Angstrom 
!WFAC1=1.5  !This controls the number of rejected MISFITS in CORRECT; 
!BEAM_DIVERGENCE=   0.80         !arctan(spot diameter/DETECTOR_DISTANCE) 
!BEAM_DIVERGENCE_E.S.D.=   0.080 !half-width (Sigma) of BEAM_DIVERGENCE 
!REFLECTING_RANGE=  0.780 !for crossing the Ewald sphere on shortest route 
!REFLECTING_RANGE_E.S.D.=  0.113 !half-width (mosaicity) of REFLECTING_RANGE 
!NUMBER_OF_PROFILE_GRID_POINTS_ALONG_ALPHA/BETA=9 !used by: INTEGRATE 
!NUMBER_OF_PROFILE_GRID_POINTS_ALONG_GAMMA= 9     !used by: INTEGRATE 
!CUT=2.0    !defines the integration region for profile fitting 
!MINPK=75.0 !minimum required percentage of observed reflection intensity 
!DELPHI= 5.0!controls the number of reference profiles and scaling factors 
!PATCH_SHUTTER_PROBLEM=TRUE         !FALSE is default 
!STRICT_ABSORPTION_CORRECTION=FALSE !TRUE  is default 
! STRONG_PIXEL=5.0                              !used by: COLSPOT 
!MAXIMUM_NUMBER_OF_STRONG_PIXELS=1500000       !used by: COLSPOT 
!SPOT_MAXIMUM-CENTROID=3.0                     !used by: COLSPOT 
!MINIMUM_NUMBER_OF_PIXELS_IN_A_SPOT=6          !used by: COLSPOT 
!NBX=3  NBY=3  !Define a rectangle of size (2*NBX+1)*(2*NBY+1) 
!BACKGROUND_PIXEL=6.0                          !used by: COLSPOT,INTEGRATE 
!SIGNAL_PIXEL=3.0                              !used by: INTEGRATE 
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Appendix table 3: XSCALE.INP script 
  
 MAXIMUM_NUMBER_OF_PROCESSORS=16!<33;ignored by single cpu version of xscale 
 RESOLUTION_SHELLS= 10 4 3.2 3.1 3.0 2.9 2.8 2.7 2.6 2.5 2.4 2.3  
 SPACE_GROUP_NUMBER= 19 
 UNIT_CELL_CONSTANTS=   112.85   154.92   178.040  90.000  90.000  90.000  
!REIDX=-1 0 0 0    0 -1 0 0    0 0 -1 0 
!0-DOSE_SIGNIFICANCE_LEVEL=0.10 
 OUTPUT_FILE=xscale.ahkl  FRIEDEL'S_LAW= TRUE !FALSE !TRUE 
 INPUT_FILE= ../../run2/proc2A/XDS_ASCII.HKL  XDS_ASCII 50 2.3 
 INPUT_FILE= ../../run3/proc2A/XDS_ASCII.HKL  XDS_ASCII 50 2.3 
 INPUT_FILE= ../../run4/proc2A/XDS_ASCII.HKL  XDS_ASCII 50 2.3 
 
 
Appendix table 4: XDSCONV.INP script 
 
For SHELX: 
 
 SPACE_GROUP_NUMBER= 19 
 UNIT_CELL_CONSTANTS=  112.85   154.92   178.040  90.000  90.000  90.000  
 INPUT_FILE= xscale.ahkl  XDS_ASCII 50 2.3 
 OUTPUT_FILE= native.hkl  SHELX    FRIEDEL'S_LAW=TRUE  !FALSE !TRUE 
!GENERATE_FRACTION_OF_TEST_REFLECTIONS=0.05 
!INHERIT_TEST_REFLECTIONS_FROM_FILE=old.hkl SHELX 
!INHERIT_FRACTION_OF_TEST_REFLECTIONS=1.0 !Default is to keep them all (1.0) 
 WILSON_STATISTICS=TRUE !TRUE   !Default is TRUE 
 
For CCP4: 
 
 SPACE_GROUP_NUMBER=19 
 UNIT_CELL_CONSTANTS=  112.85   154.92   178.040  90.000  90.000  90.000  
 INPUT_FILE= xscale.ahkl  XDS_ASCII 50 2.3 
 OUTPUT_FILE= native.ccp4asc  CCP4    FRIEDEL'S_LAW=TRUE   !FALSE !TRUE 
!GENERATE_FRACTION_OF_TEST_REFLECTIONS=0.05 
!INHERIT_TEST_REFLECTIONS_FROM_FILE=old.hkl SHELX 
!INHERIT_FRACTION_OF_TEST_REFLECTIONS=1.0 !Default is to keep them all (1.0) 
 WILSON_STATISTICS=TRUE !TRUE   !Default is TRUE 
 
 
Appendix table 5: F2MTZ.INP script 
 
TITLE XDS to MTZ 
FILE native.ccp4asc 
SYMMETRY   19 
CELL    112.850   154.920   178.040    90.000    90.000    90.000 
LABOUT  H K L FP SIGFP 
CTYPOUT H H H  F   Q 
END 
 
 
Appendix table 6: XDSMTZ.COM command file 
 
f2mtz HKLOUT temp.mtz <F2MTZ.INP 
cad HKLIN1 temp.mtz HKLOUT native.mtz<<EOF 
LABIN FILE 1 ALL 
END 
EOF 
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Appendix table 7: SHELXC.INP script 
 
CELL   112.30   155.86   178.26  90.000  90.000  90.000 
SPAG P212121 
FIND 20 
NTRY 100 
SFAC Os 
PEAK ../run1/os_pk.hkl 
INFL ../run2/os_ip.hkl 
LREM ../run3/os_rm.hkl 
SHEL 50 4.5 
 
 
Appendix table 8: HA.HATOM file
a 
 
ATOM Os  0.45241 0.82864 0.22865  1.000  99.90 
ATOM Os  0.84344 0.67213 0.23048  1.000  98.56 
ATOM Os  0.82612 0.79963 0.17765  1.000  97.23 
ATOM Os  0.59807 0.57184 0.20250  1.000  90.72 
ATOM Os  0.46955 0.63644 0.28410  1.000  90.50 
ATOM Os  0.62160 0.89828 0.26573  1.000  83.35 
ATOM Os  0.72945 0.47730 0.26946  1.000  77.99 
ATOM Os  0.27950 0.65623 0.22902  1.000  69.39 
ATOM Os  0.70261 0.99218 0.17106  1.000  68.23 
ATOM Os  0.91979 0.90998 0.25200  1.000  63.77 
ATOM Os  0.87948 0.56358 0.14005  1.000  62.82 
ATOM Os  0.31103 0.81094 0.33240  1.000  56.40 
  
a Os sites in fractional coordinates obtained with SHELX and used as initial input in SHARP. 
 
Appendix table 9: CAD_ANO_XDS.COM command file 
 
cad    hklin1 native.mtz \ 
       hklin2 os_pk.mtz \ 
       hklin3 os_ip.mtz \ 
       hklin4 os_rm.mtz \ 
       hklin5 au_pk.mtz \ 
       hklout miras.data.mtz << eof-cad 
TITLE  sqr 
CELL    112.85   154.92   178.04  90.000  90.000  90.000  
RESOLUTION OVERALL 50 2.30 
SYMMETRY 19 
LABIN FILE 1 E1=FP E2=SIGFP 
CTYPE FILE 1 E1=F  E2=Q    
LABO  FILE 1 E1=F1 E2=SF1 
LABIN FILE 2 ALL 
CTYPE FILE 2 E1=F  E2=Q   E3=D  E4=Q E5=Y 
LABO  FILE 2 E1=F2 E2=SF2 E3=D2 E4=SD2 E5=IS2 
LABIN FILE 3 ALL 
CTYPE FILE 3 E1=F  E2=Q   E3=D  E4=Q E5=Y 
LABO  FILE 3 E1=F3 E2=SF3 E3=D3 E4=SD3 E5=IS3 
LABIN FILE 4 ALL 
CTYPE FILE 4 E1=F  E2=Q   E3=D  E4=Q E5=Y 
LABO  FILE 4 E1=F4 E2=SF4 E3=D4 E4=SD4 E5=IS4 
LABIN FILE 5 ALL 
CTYPE FILE 5 E1=F  E2=Q   E3=D  E4=Q E5=Y 
LABO  FILE 5 E1=F5 E2=SF5 E3=D5 E4=SD5 E5=IS5 
END 
eof-cad 
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Appendix table 10: SIN, input file for SHARP 
 
DATAFILES       /sharpfiles/datafiles 
TITLE           nat 3A0 os 3A6 au 4A0 
OBSFILE         miras.data.mtz 
LEVEL           ADVANCED 
MODE            REFINE RESIDUAL ELECTRON_DENSITY  
CYCLES          20 21 21 
REJECT          YES 5 
NUM_BINS        20 
STRATEGY        3 7 15 31 31 31 31 31 31 31 63 63 31 63 31 31 31 63 31 31 
BOX_CONSTR_XYZ  1 0.71 
BOX_CONSTR_F'   1 2.00 0.50 
WEED            1 0.50 3.00 
CELL            112.850 154.920 178.040 90.000 90.000 90.000 
SYMMETRY        P212121 
ATOMS { 
 C 12173 
 N 3378 
 O 3730 
 P 12 
 S 127 
} 
G-SITES { 
   G-SITE-01 X  0.528532   REFINE Y  0.638998   REFINE Z  0.783989   REFINE 
   G-SITE-02 X  0.548631   REFINE Y  0.830452   REFINE Z  0.727468   REFINE 
   G-SITE-03 X  0.155730   REFINE Y  0.670994   REFINE Z  0.731525   REFINE 
   G-SITE-04 X  0.378970   REFINE Y  0.897592   REFINE Z  0.765533   REFINE 
   G-SITE-05 X  0.400309   REFINE Y  0.572727   REFINE Z  0.703544   REFINE 
   G-SITE-06 X  0.174353   REFINE Y  0.799422   REFINE Z  0.676523   REFINE 
   G-SITE-07 X  0.270375   REFINE Y  0.476828   REFINE Z  0.768361   REFINE 
   G-SITE-08 X  0.723138   REFINE Y  0.655017   REFINE Z  0.728915   REFINE 
   G-SITE-09 X  0.118790   REFINE Y  0.562132   REFINE Z  0.639704   REFINE 
   G-SITE-10 X  0.688070   REFINE Y  0.817195   REFINE Z  0.831721   REFINE 
   G-SITE-11 X  0.301422   REFINE Y  0.995313   REFINE Z  0.672481   REFINE 
   G-SITE-12 X  0.078067   REFINE Y  0.910678   REFINE Z  0.751955   REFINE 
   G-SITE-13 X  0.779141   REFINE Y  0.053389   REFINE Z  0.217347   REFINE 
   G-SITE-14 X  0.418918   REFINE Y  0.442703   REFINE Z  0.122543   REFINE 
   G-SITE-15 X  0.182506   REFINE Y  0.976572   REFINE Z  0.162427   REFINE 
   G-SITE-16 X  0.091036   REFINE Y  0.667825   REFINE Z  0.188532   REFINE 
   G-SITE-17 X  0.536366   REFINE Y  0.581898   REFINE Z  0.239063   REFINE 
   G-SITE-18 X  1.358789   REFINE Y  0.537464   REFINE Z  0.778046   REFINE 
   G-SITE-19 X  1.181822   REFINE Y  0.602086   REFINE Z  0.837420   REFINE 
   G-SITE-20 X  0.300749   REFINE Y  0.720930   REFINE Z  0.486300   REFINE 
   G-SITE-21 X  0.542818   REFINE Y  0.710331   REFINE Z  0.887311   REFINE 
   G-SITE-22 X  1.237249   REFINE Y  0.889942   REFINE Z  0.848405   REFINE 
   G-SITE-23 X  1.336562   REFINE Y  0.632576   REFINE Z  0.968115   REFINE 
   G-SITE-24 X  0.687219   REFINE Y  0.825471   REFINE Z  0.619063   REFINE 
   G-SITE-25 X  0.503144   REFINE Y  0.336395   REFINE Z -0.010094   REFINE 
   G-SITE-26 X  0.627612   REFINE Y  0.759746   REFINE Z  0.639095   REFINE 
   G-SITE-27 X  0.322924   REFINE Y  0.581904   REFINE Z  0.593117   REFINE 
   G-SITE-28 X  0.602359   REFINE Y  0.631177   REFINE Z  0.711207   REFINE 
   G-SITE-29 X  0.175716   REFINE Y  0.864055   REFINE Z  0.549950   REFINE 
   G-SITE-30 X  1.115541   REFINE Y  0.824034   REFINE Z  0.752826   REFINE 
   G-SITE-31 X  0.270913   REFINE Y  0.868141   REFINE Z  0.590398   REFINE 
   G-SITE-32 X  1.288995   REFINE Y  0.953406   REFINE Z  0.880922   REFINE 
   G-SITE-33 X  0.579274   REFINE Y  0.644924   REFINE Z  0.918405   REFINE 
   G-SITE-34 X  0.039610   REFINE Y  0.846836   REFINE Z  0.488607   REFINE 
} 
COMPOUND { 
   COMPOUND-TEXT { 
   } 
   C-SITES { 
   } 
   CRYSTAL { 
      CRYSTAL-TEXT { 
      } 
      T-SITES { 
      } 
      WAVELENGTH { 
         WAVELENGTH-TEXT { 
         } 
         RESOLUTION    48.959     3.000 
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         BATCH { 
            BATCH-TEXT { 
            } 
            SCAL_K            0.61227 NOREFINE 
            SCAL_B           -0.00594 NOREFINE 
            SCAL_B6_ADD       6.015   0.000   6.906   0.000   0.000 -12.922 NOREFINE 
            NISO_BGLO         5.56207   REFINE 
            NISO_CLOC         0.00000 NOREFINE 
            NISO_BLOC         0.00000 NOREFINE 
            NANO_BGLO         0.00000 NOREFINE 
            NANO_CLOC         0.00000 NOREFINE 
            NANO_BLOC         0.00000 NOREFINE 
            COLUMNS H=H K=K L=L FMID=F1 SMID=SF1 
         } 
      } 
   } 
} 
COMPOUND { 
   COMPOUND-TEXT { 
   } 
   C-SITES { 
      C-SITE-01  G-SITE-01  Os 
      C-SITE-02  G-SITE-02  Os 
      C-SITE-03  G-SITE-03  Os 
      C-SITE-04  G-SITE-04  Os 
      C-SITE-05  G-SITE-05  Os 
      C-SITE-06  G-SITE-06  Os 
      C-SITE-07  G-SITE-07  Os 
      C-SITE-08  G-SITE-08  Os 
      C-SITE-09  G-SITE-09  Os 
      C-SITE-10  G-SITE-10  Os 
      C-SITE-11  G-SITE-11  Os 
      C-SITE-12  G-SITE-12  Os 
   } 
   CRYSTAL { 
      CRYSTAL-TEXT { 
      } 
      T-SITES { 
         T-SITE-01 { 
            C-SITE-01 
            HAT_OCC           1.23854   REFINE 
            HAT_B            38.06819   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-02 { 
            C-SITE-02 
            HAT_OCC           1.33834   REFINE 
            HAT_B            42.96159   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-03 { 
            C-SITE-03 
            HAT_OCC           1.24144   REFINE 
            HAT_B            40.09387   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-04 { 
            C-SITE-04 
            HAT_OCC           1.08752   REFINE 
            HAT_B            37.48332   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-05 { 
            C-SITE-05 
            HAT_OCC           1.39571   REFINE 
            HAT_B            70.70729   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-06 { 
            C-SITE-06 
            HAT_OCC           1.73159   REFINE 
            HAT_B            88.84402   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
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         T-SITE-07 { 
            C-SITE-07 
            HAT_OCC           1.01912   REFINE 
            HAT_B            43.04803   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-08 { 
            C-SITE-08 
            HAT_OCC           1.21206   REFINE 
            HAT_B            95.67684   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-09 { 
            C-SITE-09 
            HAT_OCC           1.00403   REFINE 
            HAT_B            58.90898   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-10 { 
            C-SITE-10 
            HAT_OCC           0.90715   REFINE 
            HAT_B            40.85367   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-11 { 
            C-SITE-11 
            HAT_OCC           1.02623   REFINE 
            HAT_B            48.74876   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-12 { 
            C-SITE-12 
            HAT_OCC           0.96901   REFINE 
            HAT_B            54.90962   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
      } 
      WAVELENGTH { 
         WAVELENGTH-TEXT { 
         } 
         RESOLUTION    48.959     3.600 
         BATCH { 
            BATCH-TEXT { 
            } 
            SCAL_K            0.83847   REFINE 
            SCAL_B           48.42561 NOREFINE 
            SCAL_B6_ADD       8.376   0.000  -3.334   0.000   0.000  -5.042   REFINE 
            NISO_BGLO         0.00000   REFINE 
            NISO_CLOC         0.00824   REFINE 
            NISO_BLOC         0.00000 NOREFINE 
            NANO_BGLO         0.00000   REFINE 
            NANO_CLOC         0.09352   REFINE 
            NANO_BLOC         0.00000 NOREFINE 
            HATOM_LABEL { 
               Os    ATOM_f' -15.87000 NOREFINE ATOM_f"  19.90000 NOREFINE  
            } 
            COLUMNS H=H K=K L=L FMID=F2 SMID=SF2 DANO=D2 SANO=SD2 ISYM=IS2 
         } 
      } 
      WAVELENGTH { 
         WAVELENGTH-TEXT { 
         } 
         RESOLUTION    48.959     3.700 
         BATCH { 
            BATCH-TEXT { 
            } 
            SCAL_K            0.83189   REFINE 
            SCAL_B           52.80913 NOREFINE 
            SCAL_B6_ADD       7.836   0.000  -6.864   0.000   0.000  -0.972   REFINE 
            NISO_BGLO         0.05022   REFINE 
            NISO_CLOC         0.05333   REFINE 
            NISO_BLOC         0.00000 NOREFINE 
            NANO_BGLO         0.00000   REFINE 
            NANO_CLOC         0.12022   REFINE 
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            NANO_BLOC         0.00000 NOREFINE 
            HATOM_LABEL { 
               Os    ATOM_f' -20.00000 NOREFINE ATOM_f"  13.00000 NOREFINE  
            } 
            COLUMNS H=H K=K L=L FMID=F3 SMID=SF3 DANO=D3 SANO=SD3 ISYM=IS3 
         } 
      } 
      WAVELENGTH { 
         WAVELENGTH-TEXT { 
         } 
         RESOLUTION    48.959     3.900 
         BATCH { 
            BATCH-TEXT { 
            } 
            SCAL_K            0.83411   REFINE 
            SCAL_B           51.79986 NOREFINE 
            SCAL_B6_ADD       8.794   0.000  -6.217   0.000   0.000  -2.577   REFINE 
            NISO_BGLO         0.00158   REFINE 
            NISO_CLOC         0.05253   REFINE 
            NISO_BLOC         0.00000 NOREFINE 
            NANO_BGLO         0.00000   REFINE 
            NANO_CLOC         0.14499   REFINE 
            NANO_BLOC         0.00000 NOREFINE 
            HATOM_LABEL { 
               Os    ATOM_f' -10.00000 NOREFINE ATOM_f"  10.00000 NOREFINE  
            } 
            COLUMNS H=H K=K L=L FMID=F4 SMID=SF4 DANO=D4 SANO=SD4 ISYM=IS4 
         } 
      } 
   } 
} 
COMPOUND { 
   COMPOUND-TEXT { 
   } 
   C-SITES { 
      C-SITE-01  G-SITE-01  Au 
      C-SITE-02  G-SITE-02  Au 
      C-SITE-03  G-SITE-03  Au 
      C-SITE-04  G-SITE-04  Au 
      C-SITE-05  G-SITE-05  Au 
      C-SITE-06  G-SITE-06  Au 
      C-SITE-07  G-SITE-07  Au 
      C-SITE-08  G-SITE-08  Au 
      C-SITE-09  G-SITE-10  Au 
      C-SITE-10  G-SITE-11  Au 
      C-SITE-11  G-SITE-12  Au 
      C-SITE-12  G-SITE-13  Au 
      C-SITE-13  G-SITE-14  Au 
      C-SITE-14  G-SITE-15  Au 
      C-SITE-15  G-SITE-16  Au 
      C-SITE-16  G-SITE-17  Au 
      C-SITE-17  G-SITE-18  Au 
      C-SITE-18  G-SITE-19  Au 
      C-SITE-19  G-SITE-20  Au 
      C-SITE-20  G-SITE-21  Au 
      C-SITE-21  G-SITE-22  Au 
      C-SITE-22  G-SITE-23  Au 
      C-SITE-23  G-SITE-24  Au 
      C-SITE-24  G-SITE-25  Au 
      C-SITE-25  G-SITE-26  Au 
      C-SITE-26  G-SITE-27  Au 
      C-SITE-27  G-SITE-28  Au 
      C-SITE-28  G-SITE-29  Au 
      C-SITE-29  G-SITE-30  Au 
      C-SITE-30  G-SITE-31  Au 
      C-SITE-31  G-SITE-32  Au 
      C-SITE-32  G-SITE-33  Au 
      C-SITE-33  G-SITE-34  Au 
   } 
   CRYSTAL { 
      CRYSTAL-TEXT { 
      } 
      T-SITES { 
         T-SITE-01 { 
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            C-SITE-01 
            HAT_OCC           0.65116   REFINE 
            HAT_B            40.35831 NOREFINE 
            HAT_B6_ADD        2.202   6.719   3.304   0.665  -5.318  -5.507   REFINE 
         } 
         T-SITE-02 { 
            C-SITE-02 
            HAT_OCC           0.84302   REFINE 
            HAT_B            45.46768 NOREFINE 
            HAT_B6_ADD        2.112  -1.454   2.721   2.529  -7.678  -4.833   REFINE 
         } 
         T-SITE-03 { 
            C-SITE-03 
            HAT_OCC           0.79082   REFINE 
            HAT_B            44.46211 NOREFINE 
            HAT_B6_ADD        7.824  -1.415   0.907  -1.104   0.686  -8.732   REFINE 
         } 
         T-SITE-04 { 
            C-SITE-04 
            HAT_OCC           0.69823   REFINE 
            HAT_B            55.23544 NOREFINE 
            HAT_B6_ADD        1.836  -2.622   1.899  11.104  -1.914  -3.734   REFINE 
         } 
         T-SITE-05 { 
            C-SITE-05 
            HAT_OCC           0.82216   REFINE 
            HAT_B            68.65910 NOREFINE 
            HAT_B6_ADD        9.522  -4.414   2.937  -6.250  -0.563 -12.459   REFINE 
         } 
         T-SITE-06 { 
            C-SITE-06 
            HAT_OCC           0.84218   REFINE 
            HAT_B            64.67327 NOREFINE 
            HAT_B6_ADD        8.196   3.753  -2.825   4.039   7.907  -5.372   REFINE 
         } 
         T-SITE-07 { 
            C-SITE-07 
            HAT_OCC           0.51035   REFINE 
            HAT_B            86.83897   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-08 { 
            C-SITE-08 
            HAT_OCC           0.37383   REFINE 
            HAT_B            80.43972   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-09 { 
            C-SITE-09 
            HAT_OCC           0.41543   REFINE 
            HAT_B            75.86452   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-10 { 
            C-SITE-10 
            HAT_OCC           0.40864   REFINE 
            HAT_B            63.16261   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-11 { 
            C-SITE-11 
            HAT_OCC           0.48451   REFINE 
            HAT_B            88.14870   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-12 { 
            C-SITE-12 
            HAT_OCC           0.63079   REFINE 
            HAT_B            37.99104   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-13 { 
            C-SITE-13 
            HAT_OCC           0.69017   REFINE 
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            HAT_B            59.56096   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-14 { 
            C-SITE-14 
            HAT_OCC           0.72704   REFINE 
            HAT_B            49.73992   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-15 { 
            C-SITE-15 
            HAT_OCC           0.08550   REFINE 
            HAT_B             1.00000 NOREFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000   REFINE 
         } 
         T-SITE-16 { 
            C-SITE-16 
            HAT_OCC           0.56739   REFINE 
            HAT_B            56.43816   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-17 { 
            C-SITE-17 
            HAT_OCC           0.11234   REFINE 
            HAT_B             1.00000   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-18 { 
            C-SITE-18 
            HAT_OCC           0.53362   REFINE 
            HAT_B            61.42216   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-19 { 
            C-SITE-19 
            HAT_OCC           0.38506   REFINE 
            HAT_B            41.58083   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-20 { 
            C-SITE-20 
            HAT_OCC           0.52782   REFINE 
            HAT_B            53.53659   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-21 { 
            C-SITE-21 
            HAT_OCC           0.52708   REFINE 
            HAT_B            62.48635   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-22 { 
            C-SITE-22 
            HAT_OCC           0.37368   REFINE 
            HAT_B            37.04106   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-23 { 
            C-SITE-23 
            HAT_OCC           0.33543   REFINE 
            HAT_B            26.10094   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-24 { 
            C-SITE-24 
            HAT_OCC           0.34827   REFINE 
            HAT_B            32.66870   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-25 { 
            C-SITE-25 
            HAT_OCC           0.51300   REFINE 
            HAT_B            59.52833   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
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         } 
         T-SITE-26 { 
            C-SITE-26 
            HAT_OCC           0.62263   REFINE 
            HAT_B            77.23315   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-27 { 
            C-SITE-27 
            HAT_OCC           0.43867   REFINE 
            HAT_B            43.64398   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-28 { 
            C-SITE-28 
            HAT_OCC           0.17985   REFINE 
            HAT_B             4.30505   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-29 { 
            C-SITE-29 
            HAT_OCC           0.31355   REFINE 
            HAT_B            19.09131   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-30 { 
            C-SITE-30 
            HAT_OCC           0.40023   REFINE 
            HAT_B            32.90198   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-31 { 
            C-SITE-31 
            HAT_OCC           0.35576   REFINE 
            HAT_B            29.47239   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-32 { 
            C-SITE-32 
            HAT_OCC           0.02042   REFINE 
            HAT_B             1.00000   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
         T-SITE-33 { 
            C-SITE-33 
            HAT_OCC           0.01762   REFINE 
            HAT_B             1.00000   REFINE 
            HAT_B6_ADD        0.000   0.000   0.000   0.000   0.000   0.000 NOREFINE 
         } 
      } 
      WAVELENGTH { 
         WAVELENGTH-TEXT { 
         } 
         RESOLUTION    50.000     4.000 
         BATCH { 
            BATCH-TEXT { 
            } 
            SCAL_K            0.82879   REFINE 
            SCAL_B           15.61462 NOREFINE 
            SCAL_B6_ADD       1.939   0.000  -0.151   0.000   0.000  -1.788   REFINE 
            NISO_BGLO         1.27865   REFINE 
            NISO_CLOC         0.50367   REFINE 
            NISO_BLOC         0.00000 NOREFINE 
            NANO_BGLO         0.00000   REFINE 
            NANO_CLOC         0.09530   REFINE 
            NANO_BLOC         0.00000 NOREFINE 
            HATOM_LABEL { 
               Au    ATOM_f' -22.50000   REFINE ATOM_f"   6.69440   REFINE  
            } 
            COLUMNS H=H K=K L=L FMID=F5 SMID=SF5 DANO=D5 SANO=SD5 ISYM=IS5 
         } 
END 
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Appendix table 11: HATOM.PDB
a 
 
CRYST1  112.850  154.920  178.040  90.00  90.00  90.00 P212121 
SCALE1      0.008861  0.000000  0.000000        0.00000 
SCALE2      0.000000  0.006455  0.000000        0.00000 
SCALE3      0.000000  0.000000  0.005617        0.00000 
ATOM      1 OS   HET 1   1      59.645  98.994 139.581  1.24 38.07 
ATOM      2 OS   HET 1   2      61.913 128.654 129.518  1.34 42.96 
ATOM      3 OS   HET 1   3      17.574 103.950 130.241  1.24 40.09 
ATOM      4 OS   HET 1   4      42.767 139.055 136.295  1.09 37.48 
ATOM      5 OS   HET 1   5      45.175  88.727 125.259  1.40 70.71 
ATOM      6 OS   HET 1   6      19.676 123.847 120.448  1.73 88.84 
ATOM      7 OS   HET 1   7      30.512  73.870 136.799  1.02 43.05 
ATOM      8 OS   HET 1   8      81.606 101.475 129.776  1.21 95.68 
ATOM      9 OS   HET 1   9      13.405  87.085 113.893  1.00 58.91 
ATOM     10 OS   HET 1  10      77.649 126.600 148.080  0.91 40.85 
ATOM     11 OS   HET 1  11      34.015 154.194 119.729  1.03 48.75 
ATOM     12 OS   HET 1  12       8.810 141.082 133.878  0.97 54.91 
ATOM     13 AU   HET 2   1      59.645  98.994 139.581  0.65 40.36 
ATOM     14 AU   HET 2   2      61.913 128.654 129.518  0.84 45.47 
ATOM     15 AU   HET 2   3      17.574 103.950 130.241  0.79 44.46 
ATOM     16 AU   HET 2   4      42.767 139.055 136.295  0.70 55.24 
ATOM     17 AU   HET 2   5      45.175  88.727 125.259  0.82 68.66 
ATOM     18 AU   HET 2   6      19.676 123.847 120.448  0.84 64.67 
ATOM     19 AU   HET 2   7      30.512  73.870 136.799  0.51 86.84 
ATOM     20 AU   HET 2   8      81.606 101.475 129.776  0.37 80.44 
ATOM     21 AU   HET 2  10      77.649 126.600 148.080  0.42 75.86 
ATOM     22 AU   HET 2  11      34.015 154.194 119.729  0.41 63.16 
ATOM     23 AU   HET 2  12       8.810 141.082 133.878  0.48 88.15 
ATOM     24 AU   HET 2  13      87.926   8.271  38.697  0.63 37.99 
ATOM     25 AU   HET 2  14      47.275  68.584  21.818  0.69 59.56 
ATOM     26 AU   HET 2  15      20.596 151.291  28.918  0.73 49.74 
ATOM     27 AU   HET 2  16      10.273 103.459  33.566  0.09  1.00 
ATOM     28 AU   HET 2  17      60.529  90.148  42.563  0.57 56.44 
ATOM     29 AU   HET 2  18     153.339  83.264 138.523  0.11  1.00 
ATOM     30 AU   HET 2  19     133.369  93.275 149.094  0.53 61.42 
ATOM     31 AU   HET 2  20      33.939 111.686  86.581  0.39 41.58 
ATOM     32 AU   HET 2  21      61.257 110.044 157.977  0.53 53.54 
ATOM     33 AU   HET 2  22     139.624 137.870 151.050  0.53 62.49 
ATOM     34 AU   HET 2  23     150.831  97.999 172.363  0.37 37.04 
ATOM     35 AU   HET 2  24      77.553 127.882 110.218  0.34 26.10 
ATOM     36 AU   HET 2  25      56.780  52.114  -1.797  0.35 32.67 
ATOM     37 AU   HET 2  26      70.826 117.700 113.785  0.51 59.53 
ATOM     38 AU   HET 2  27      36.442  90.149 105.599  0.62 77.23 
ATOM     39 AU   HET 2  28      67.976  97.782 126.623  0.44 43.64 
ATOM     40 AU   HET 2  29      19.830 133.859  97.913  0.18  4.31 
ATOM     41 AU   HET 2  30     125.889 127.659 134.033  0.31 19.09 
ATOM     42 AU   HET 2  31      30.573 134.492 105.115  0.40 32.90 
ATOM     43 AU   HET 2  32     145.463 147.702 156.839  0.36 29.47 
ATOM     44 AU   HET 2  33      65.371  99.912 163.513  0.02  1.00 
ATOM     45 AU   HET 2  34       4.470 131.192  86.992  0.02  1.00 
 
a refined heavy atom positions used for initial phasing by SHARP. 
 
Appendix table 12: input parameters for solvent flattening with DM in SHARP 
 
 Directory ............................... /sharpfiles/logfiles/miras.1 
 Date .................................... Thu Mar  6 09:53:09 CET 2008 
 Data .................................... eden-unique.mtz 
 FP, SIGFP ............................... FP, SIGFP ('native' amplitude and sigma) 
 FB, PHIB ................................ Fcent, PHIcent (for initial map) 
 HLA, HLB, HLC, HLD ...................... HLA, HLB, HLC, HLD (for phase combination) 
 FH, PHIH ................................ FH, PHIH (heavy atom contribution) 
 Spacegroup .............................. P212121 (19) 
 Cell .................................... 112.850 154.920 178.040 90.000 90.000 90.000 
 Resolution limits ....................... 50.000 - 2.65 &Aring; 
 Solvent fraction ........................ 0.50 
 Flipping factor ......................... -1.0000 
 Radius of solvent sphere ................ 5 - 2.65 &Aring; 
 Protein to solvent density ratio ........ 1.34375 
 Truncating min / max density in protein . 0.4 0.99 
 no. of cycles ........................... 5 + 90 + 5 
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Appendix table 13: FFT.COM command file 
 
fft hklin miras_50pc.mtz  mapout   miras_50pc.map << EOF 
TITLE  sqr 
GRID  112 156 180 
RESOLUTION 50. 2.65 
SYMMETRY 19 
FFTSYMMETRY 1 
XYZLIM 0 111 0 155 0 179 
RHOLIM 100. 
LABIN F1=FPsha PHI=PHIshasol W=FOMshasol 
EOF 
# 
extend   mapin   miras_50pc.map  mapout  miras_50pc.exmap     << eof-extend 
XYZLIM  5 68 20 109 25 95 
SYMMETRY 19 
eof-extend 
 
 
Appendix table 14: O macro files 
 
@M2 
 
!contour a map at the current active center 
 centre_id wait_id 
 paint_case atom_name 4 c* n* o* s*  yellow blue red magenta  
!mol sirm1 obj sph spher 40 end 
 map_file ../dm/ miras_50pc.dsn6 
 map_obj mp50 
 map_par 30. 30. 30. 1.2 slate_blue 0.5 0.1 0  !11. 
 map_act 
 map_draw 
 message ' ' 
 
############################################################## 
 
@BN 
 
bone_redefine 
wait_id wait_id 5 
5 
message ' ' 
 
############################################################## 
 
@BT 
 
bone_redefine 
wait_id wait_id 3 
message ' ' 
 
 
Appendix table 15: BONES_MASK.MAMAC command file 
 
new cell  112.8500  154.9200  178.0400   90.0000   90.0000   90.0000 
new grid 112 156 180 
new radius 5 
new bones bonesmask 
expand bonesmask 
fill bonesmask 
contract bonesmask 
island bonesmask 
WRite bonesmask miras.mask 
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Appendix table 16: NCS operations
a 
 
miras_1to2.lsq 
 
.LSQ_RT_12                R         12 (3(1x,f12.7))                            
   -0.5336170   -0.8399070    0.0990430 
   -0.8402240    0.5131610   -0.1751830 
    0.0963120   -0.1766990   -0.9795420 
  146.5375820  113.2809370  273.5504760 
 
####################################### 
 
miras_1to3.lsq 
 
.LSQ_RT_13                R         12 (3(1x,f12.7))                            
    0.9082180    0.0026710    0.4184890 
    0.0019220   -0.9999960    0.0022100 
    0.4184930   -0.0012030   -0.9082190 
  -50.7582440  227.9414830  231.1131440 
 
a determined with LSQ_EX (in O) and IMP from the heavy metal binding positions. 
 
 
Appendix table 17: IMP.COM command file 
 
virus_imp << EOF 
../maps/2402/miras_50pc.map 
miras.mask 
symm/p212121.sym 
miras_1to2.lsq      # miras_1to3.lsq 
A 
EOF 
 
 
 
Appendix table 18: P212121.SYM, symmetry operation file for space group P212121
a 
 
.space_group_operators     r    48  (3F10.5) 
   1.00000   0.00000   0.00000 
   0.00000   1.00000   0.00000 
   0.00000   0.00000   1.00000 
   0.00000   0.00000   0.00000 
  -1.00000   0.00000   0.00000 
   0.00000  -1.00000   0.00000 
   0.00000   0.00000   1.00000 
   0.50000   0.00000   0.50000 
   1.00000   0.00000   0.00000 
   0.00000  -1.00000   0.00000 
   0.00000   0.00000  -1.00000 
   0.50000   0.50000   0.00000 
  -1.00000   0.00000   0.00000 
   0.00000   1.00000   0.00000 
   0.00000   0.00000  -1.00000 
   0.00000   0.50000   0.50000 
 
a to be used in IMP. 
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Appendix table 19: DM_AVE.COM command file 
 
dm                                   \ 
        hklin eden-unique.mtz \ 
        hklout dm_miras.mtz  \ 
        ncsin1 miras_ccp4.mask \ 
        histlib /soft/dec/xtal/ccp4/v4.2.1/lib/data/hist.lib             \ 
        << 'my-data' 
SOLC 0.5 
MODE SOLV HIST AVER 
COMB PERT 
NCYC 70 
COMBINE PERT 
SCHEME RES FROM 5.0 
RESOLUTION 50. 2.5 
AVER DOMAIN 1 REFI 
OMAT 
   1.00000   0.00000   0.00000 
   0.00000   1.00000   0.00000 
   0.00000   0.00000   1.00000 
   0.00000   0.00000   0.00000 
AVER DOMAIN 1 REFI 
OMAT 
  -0.5336170   -0.8399070    0.0990430 
  -0.8402240    0.5131610   -0.1751830 
   0.0963120   -0.1766990   -0.9795420 
 146.5375820  113.2809370  273.5504760 
AVER DOMAIN 1 REFI 
OMAT 
   0.9082180    0.0026710    0.4184890 
   0.0019220   -0.9999960    0.0022100 
   0.4184930   -0.0012030   -0.9082190 
 -50.7582440  227.9414830  231.1131440 
LABI FP=FP SIGFP=SIGFP PHIO=PHIB FOMO=FOM - 
     HLA=HLA HLB=HLB HLC=HLC FDM=FB PHIDM=PHIB  
LABO PHIDM=PHIDM FOMDM=WDM - 
     HLADM=HLADM HLBDM=HLBDM HLCDM=HLCDM      
'my-data' 
 
 
Appendix table 20: SEQ.PIR file
a 
 
> sqr.pir 
 
MAKHVVVIGGGVGGIATAYNLRNLMPDLKITLISDRPYFGFTPAFPHLAMGWRKFEDISVPLAPLLPKFN 
IEFINEKAESIDPDANTVTTQSGKKIEYDYLVIATGPKLVFGAEGQEENSTSICTAEHALETQKKLQELY 
ANPGPVVIGAIPGVSCFGPAYEFALMLHYELKKRGIRYKVPMTFITSEPYLGHFGVGGIGASKRLVEDLF 
AERNIDWIANVAVKAIEPDKVIYEDLNGNTHEVPAKFTMFMPSFQGPEVVASAGDKVANPANKMVIVNRC 
FQNPTYKNIFGVGVVTAIPPIEKTPIPTGVPKTGMMIEQMAMAVAHNIVNDIRNNPDKYAPRLSAICIAD 
FGEDAGFFFADPVIPPRERVITKMGKWAHYFKTAFEKYFLWKVRNGNIAPSFEEKVLEIFLKVHPIELCK 
DCEGAPGSRC 
 
a sequence of A. aeolicus SQR in PIR format, for ARP/wARP. 
 
Appendix table 21: MTZ2CNS.COM command file 
 
mtz2various HKLIN native.mtz HKLOUT native.hkl << EOF 
RESOLUTION 10000 2.3 
OUTPUT CNS 
LABIN FP=FP SIGFP=SIGFP  
END 
EOF 
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Appendix table 22: CNS.COM command file 
 
 /soft/.../cns_solve-0208231106.exe  < mini.inp              > mini.log 
#/soft/.../cns_solve-0208231106.exe  < generate.inp          > generate.log 
#/soft/.../cns_solve-0208231106.exe  < rigid.inp             > rigid.log 
#/soft/.../cns_solve-0208231106.exe  < make_cv.inp           > make_cv.log 
#/soft/.../cns_solve-0208231106.exe  < get_ncs_matrices.inp  > get_ncs_matrices.log 
 
 
Appendix table 23: MAKE_CV.INP script 
 
{====================== crystallographic data ========================} 
{===>} sg="P2(1)2(1)2(1)"; 
{===>} a=112.85; 
{===>} b=154.92; 
{===>} c=178.04; 
{===>} alpha=90.0; 
{===>} beta=90.0; 
{===>} gamma=90.0; 
{===>} test_set="test"; 
{===>} test_flag=1; 
{===>} reflection_infile="native.hkl"; 
{===>} percentage=5.0; 
{===>} low_res=500.0; 
{===>} high_res=2.3; 
{===>} ref_sel=(all); 
{===>} reflection_outfile="native.cv"; 
{===========================================================================} 
{        things below this line do not normally need to be changed          } 
{===========================================================================} 
... 
 
 
Appendix table 24: GENERATE.INP script 
 
{============================== important =================================} 
{* Coordinates for molecules of the same type (eg. all protein, all  
   nucleic acid etc) can be input in the same coordinate file if the 
   different chains are separated by a TER card or each chain has 
   a different segid or chainid. *} 
{* A break in a chain can be detected automatically or should be delimited 
   by a BREAK card. In this case no patch (head, tail or link) will be 
   applied between the residues that bound the chain break. *} 
{* If a segid is present in the coordinate file it will be read unless 
   segid renaming is used below. If renaming is used then all chains in a  
   coordinate file will be given the same segid. *} 
{* If a PDB chain identifier is present in the coordinate file then this  
   can be used for the segid *} 
{* NB. All input PDB files must finish with an END statement *} 
{============================ protein files ================================} 
{===>} prot_coordinate_infile_1="initial_model.pdb"; 
{===>} prot_rename_1=false; 
{===>} prot_segid_1=""; 
{===>} prot_convert_1=false; 
{===>} prot_separate_1=true; 
{========================= nucleic acid files ==============================} 
{===>} nucl_coordinate_infile_1=""; 
{===>} nucl_rename_1=false; 
{===>} nucl_segid_1=""; 
{===>} nucl_convert_1=false; 
{===>} nucl_separate_1=true; 
{============================= water files =================================} 
{===>} water_coordinate_infile_1=""; 
{===>} water_rename_1=false; 
{===>} water_segid_1=""; 
{===>} water_convert_1=false; 
{========================= carbohydrate files ==============================} 
{===>} carbo_coordinate_infile_1=""; 
{===>} carbo_rename_1=false; 
{===>} carbo_segid_1=""; 
{===>} carbo_convert_1=false; 
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{======================== prosthetic group files ===========================} 
{===>} prost_coordinate_infile_1=""; 
{===>} prost_rename_1=false; 
{===>} prost_segid_1=""; 
{===>} prost_convert_1=false; 
{============================ ligand files =================================} 
{===>} lig_coordinate_infile_1=""; 
{===>} lig_rename_1=false; 
{===>} lig_segid_1=""; 
{===>} lig_convert_1=false; 
{============================== ions files =================================} 
{===>} ion_coordinate_infile_1=""; 
{===>} ion_rename_1=false; 
{===>} ion_segid_1=""; 
{===>} ion_convert_1=false; 
{============================ renaming atoms ===============================} 
{===>} ile_CD_becomes="CD1"; 
{===>} OT1_becomes="O"; 
{===>} OT2_becomes="OXT"; 
{======================= automatic mainchain breaks ========================} 
{===>} auto_break=true; 
{===>} break_cutoff=2.5; 
{===>} prot_break_infile="CNS_TOPPAR:protein_break.top"; 
{======================= automatic disulphide bonds ========================} 
{===>} auto_ss=true; 
{===>} disulphide_dist=3.0; 
{========================= manual disulphide bonds =========================} 
{===>} ss_use_1=false; 
{===>} ss_i_segid_1=""; ss_i_resid_1=0; 
{===>} ss_j_segid_1=""; ss_j_resid_1=0; 
{===>} ss_use_2=false; 
{===>} ss_i_segid_2=""; ss_i_resid_2=0; 
{===>} ss_j_segid_2=""; ss_j_resid_2=0; 
{========================= RNA to DNA conversion  ==========================} 
{===>} dna_sele=(none); 
{=========================== carbohydrate links  ===========================} 
{===>} carbo_use_1=false; 
{===>} carbo_patch_1="B1N"; 
{===>} carbo_i_segid_1="BBBB"; carbo_i_resid_1=401; 
{===>} carbo_j_segid_1="AAAA"; carbo_j_resid_1=56; 
{===>} carbo_use_2=false; 
{===>} carbo_patch_2="B1N"; 
{===>} carbo_i_segid_2="BBBB"; carbo_i_resid_2=402; 
{===>} carbo_j_segid_2="AAAA"; carbo_j_resid_2=182; 
{===>} carbo_use_3=false; 
{===>} carbo_patch_3=""; 
{===>} carbo_i_segid_3=""; carbo_i_resid_3=0; 
{===>} carbo_j_segid_3=""; carbo_j_resid_3=0; 
{===>} carbo_use_4=false; 
{===>} carbo_patch_4=""; 
{===>} carbo_i_segid_4=""; carbo_i_resid_4=0; 
{===>} carbo_j_segid_4=""; carbo_j_resid_4=0; 
{===>} carbo_use_5=false; 
{===>} carbo_patch_5=""; 
{===>} carbo_i_segid_5=""; carbo_i_resid_5=0; 
{===>} carbo_j_segid_5=""; carbo_j_resid_5=0; 
{===>} carbo_use_6=false; 
{===>} carbo_patch_6=""; 
{===>} carbo_i_segid_6=""; carbo_i_resid_6=0; 
{===>} carbo_j_segid_6=""; carbo_j_resid_6=0; 
{========================= generate parameters =============================} 
{===>} hydrogen_flag=false; 
{===>} hydrogen_build="all"; 
{===>} atom_build=(not(known)); 
{===>} atom_delete=(none); 
{===>} set_bfactor=false; 
{===>} bfactor=15.0; 
{===>} set_occupancy=false; 
{===>} occupancy=1.0; 
{============================= output files ================================} 
{===>} structure_outfile="generate.mtf"; 
{===>} coordinate_outfile="generate.pdb"; 
{===>} pdb_o_format=true; 
{================== protein topology and parameter files ===================} 
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{===>} prot_topology_infile="CNS_TOPPAR:protein.top"; 
{===>} prot_link_infile="CNS_TOPPAR:protein.link"; 
{===>} prot_parameter_infile="CNS_TOPPAR:protein_rep.param"; 
{================ nucleic acid topology and parameter files =================} 
{===>} nucl_topology_infile="CNS_TOPPAR:dna-rna.top"; 
{===>} nucl_link_infile="CNS_TOPPAR:dna-rna.link"; 
{===>} nucl_parameter_infile="CNS_TOPPAR:dna-rna_rep.param"; 
{=================== water topology and parameter files ====================} 
{===>} water_topology_infile="CNS_TOPPAR:water.top"; 
{===>} water_parameter_infile="CNS_TOPPAR:water_rep.param"; 
{================= carbohydrate topology and parameter files ===============} 
{===>} carbo_topology_infile="CNS_TOPPAR:carbohydrate.top"; 
{===>} carbo_parameter_infile="CNS_TOPPAR:carbohydrate.param"; 
{============= prosthetic group topology and parameter files ===============} 
{===>} prost_topology_infile=""; 
{===>} prost_parameter_infile=""; 
{=================== ligand topology and parameter files ===================} 
{===>} lig_topology_infile=""; 
{===>} lig_parameter_infile=""; 
{===================== ion topology and parameter files ====================} 
{===>} ion_topology_infile="CNS_TOPPAR:ion.top"; 
{===>} ion_parameter_infile="CNS_TOPPAR:ion.param"; 
{===========================================================================} 
{         things below this line do not need to be changed unless           } 
{         you need to apply patches - at the appropriate places marked      } 
{===========================================================================} 
... 
 
 
Appendix table 25: GET_NCS_MATRICES.INP script 
 
{======================= molecular structures =========================} 
{===>} structure_infile="generate.mtf"; 
{===>} coordinate_infile="generate.pdb"; 
{========================== atom selection ===========================} 
{===>} atom_ref=(resid 4:418 and name CA); 
{===>} atom_ncs_1=(resid 1004:1418 and name CA); 
{===>} atom_ncs_2=(resid 2004:2418 and name CA); 
{===>} atom_ncs_3=(resid 3004:3418 and name CA); 
{===>} atom_ncs_4=(resid 4004:4418 and name CA); 
{===>} atom_ncs_5=(resid 5004:5418 and name CA); 
{===>} ignore_name=false; 
{=========================== output files ============================} 
{===>} list_outfile="get_ncs_matrices.list"; 
{===========================================================================} 
{        things below this line do not normally need to be changed          } 
{===========================================================================} 
... 
 
 
Appendix table 26: NCS.DEF script 
 
{============================ NCS type ===============================} 
{===>} ncs_type="restrain"; 
{===================== strict NCS (Skew matrix) ======================} 
{===>} skew_use=false; 
{===>} skew_matrix=( 1 0 0 ) 
                   ( 0 1 0 ) 
                   ( 0 0 1 ); 
{===>} skew_vector=(0 0 0); 
{=============== strict NCS (X-ray and nonbonded terms) ==============} 
{===>} ncs_op_1=true; 
{===>} ncs_matrix_1=( 1 0 0 ) 
                    ( 0 1 0 ) 
                    ( 0 0 1 ); 
{===>} ncs_vector_1=(0 0 0); 
{===>} ncs_op_2=false; 
{===>} ncs_matrix_2=( -0.999932 -0.011239  0.003138 ) 
                    (  0.010826 -0.793178  0.608894 ) 
                    ( -0.004354  0.608886  0.793246 ); 
{===>} ncs_vector_2=(174.4428 -1.5140 0.7045); 
{===>} ncs_op_3=false; 
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{===>} ncs_matrix_3=( 1 0 0 ) 
                    ( 0 1 0 ) 
                    ( 0 0 1 ); 
{===>} ncs_vector_3=(0 0 0); 
{===>} ncs_op_4=false; 
{===>} ncs_matrix_4=( 1 0 0 ) 
                    ( 0 1 0 ) 
                    ( 0 0 1 ); 
{===>} ncs_vector_4=(0 0 0); 
{===>} ncs_op_5=false; 
{===>} ncs_matrix_5=( 1 0 0 ) 
                    ( 0 1 0 ) 
                    ( 0 0 1 ); 
{===>} ncs_vector_5=(0 0 0); 
{===>} ncs_op_6=false; 
{===>} ncs_matrix_6=( 1 0 0 ) 
                    ( 0 1 0 ) 
                    ( 0 0 1 ); 
{===>} ncs_vector_6=(0 0 0); 
{===>} ncs_op_7=false; 
{===>} ncs_matrix_7=( 1 0 0 ) 
                    ( 0 1 0 ) 
                    ( 0 0 1 ); 
{===>} ncs_vector_7=(0 0 0); 
{================= strict NCS (nonbonded term only) ==================} 
{===>} nb_ncs_op_1=false; 
{===>} nb_ncs_matrix_1=( 1 0 0 ) 
                       ( 0 1 0 ) 
                       ( 0 0 1 ); 
{===>} nb_ncs_vector_1=(0 0 0); 
{===>} nb_ncs_op_2=false; 
{===>} nb_ncs_matrix_2=( 1 0 0 ) 
                       ( 0 1 0 ) 
                       ( 0 0 1 ); 
{===>} nb_ncs_vector_2=(0 0 0); 
{===>} nb_ncs_op_3=false; 
{===>} nb_ncs_matrix_3=( 1 0 0 ) 
                       ( 0 1 0 ) 
                       ( 0 0 1 ); 
{===>} nb_ncs_vector_3=(0 0 0); 
{===>} nb_ncs_op_4=false; 
{===>} nb_ncs_matrix_4=( 1 0 0 ) 
                       ( 0 1 0 ) 
                       ( 0 0 1 ); 
{===>} nb_ncs_vector_4=(0 0 0); 
{===>} nb_ncs_op_5=false; 
{===>} nb_ncs_matrix_5=( 1 0 0 ) 
                       ( 0 1 0 ) 
                       ( 0 0 1 ); 
{===>} nb_ncs_vector_5=(0 0 0); 
{====================== NCS restraint group 1 ========================} 
{===>} group.1.weight=300; 
{===>} group.1.sigb=2; 
{===>} group.1.equiv.1=(resid 4:418 and name CA); 
{===>} group.1.equiv.2=(resid 1004:1418 and name CA); 
{===>} group.1.equiv.3=(resid 2004:2418 and name CA); 
{===>} group.1.equiv.4=(resid 3004:3418 and name CA); 
{===>} group.1.equiv.5=(resid 4004:4418 and name CA); 
{===>} group.1.equiv.6=(resid 5004:5418 and name CA); 
{====================== NCS restraint group 2 ========================} 
{===>} group.2.weight=300; 
{===>} group.2.sigb=2; 
{===>} group.2.equiv.1=(none); 
{===>} group.2.equiv.2=(none); 
{===>} group.2.equiv.3=(none); 
{===>} group.2.equiv.4=(none); 
{===>} group.2.equiv.5=(none); 
{===>} group.2.equiv.6=(none); 
{===========================================================================} 
{        things below this line do not normally need to be changed          } 
{===========================================================================} 
... 
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Appendix table 27: RIGID.INP script 
 
{======================= molecular structure =========================} 
{===>} structure_infile="generate.mtf"; 
{===>} parameter_infile_1="CNS_TOPPAR:protein_rep.param"; 
{===>} parameter_infile_2=""; 
{===>} parameter_infile_3=""; 
{===>} parameter_infile_4=""; 
{===>} parameter_infile_5=""; 
{===>} coordinate_infile="generate.pdb"; 
{====================== crystallographic data ========================} 
{===>} sg="P2(1)2(1)2(1)"; 
{===>} a=112.85; 
{===>} b=154.92; 
{===>} c=178.04; 
{===>} alpha=90; 
{===>} beta=90; 
{===>} gamma=90; 
{===>} anom_library=""; 
{===>} reflection_infile_1="native.cv"; 
{===>} reflection_infile_2=""; 
{===>} reflection_infile_3=""; 
{===>} obs_f="fobs"; 
{===>} obs_sigf="sigma"; 
{===>} test_set="test"; 
{===>} test_flag=1; 
{===>} obs_w=""; 
{===>} obs_i=""; 
{===>} obs_sigi=""; 
{===>} obs_pa=""; 
{===>} obs_pb="";  
{===>} obs_pc="";  
{===>} obs_pd=""; 
{===>} obs_phase=""; 
{===>} obs_fom=""; 
{===>} low_res=50.0; 
{===>} high_res=4.0; 
{===>} obs_type="amplitude"; 
{===>} sigma_cut=0.0; 
{===>} obs_rms=10000; 
{=================== non-crystallographic symmetry ===================} 
{===>} ncs_infile="ncs.def"; 
{============ initial B-factor and bulk solvent corrections ==========} 
{===>} bscale="anisotropic"; 
{===>} low_res_bscale=6.0; 
{===>} bulk_sol=true; 
{===>} bulk_mask_infile=""; 
{===>} sol_k=-1; 
{===>} sol_b=-1; 
{========================== atom selection ===========================} 
{===>} atom_select=(resid 4:5418); 
{===>} r_group_1=(resid 4:418); 
{===>} r_group_2=(resid 1004:1418); 
{===>} r_group_3=(resid 2004:2418); 
{===>} r_group_4=(resid 3004:3418); 
{===>} r_group_5=(resid 4004:4418); 
{===>} r_group_6=(resid 5004:5418); 
{=============== rigid body minimization parameters ==================} 
{===>} rigid_nstep=20; 
{===>} num_cycles=1; 
{===>} reftarget="mlf"; 
{===>} target_bins=-1; 
{===>} fft_memory=-1; 
{=========================== output files ============================} 
{===>} coordinate_outfile="rigid.pdb"; 
{===>} pdb_o_format=true; 
{===========================================================================} 
{         things below this line do not normally need to be changed         } 
{         unless more than one group is required                            } 
{===========================================================================} 
... 
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Appendix table 28: MINI.INP script 
 
{======================= molecular structure =========================} 
{===>} structure_infile="generate.mtf"; 
{===>} coordinate_infile="rigid.pdb"; 
{===>} topology_infile_1="CNS_TOPPAR:protein.top"; 
{===>} topology_infile_2=""; 
{===>} topology_infile_3="CNS_TOPPAR:water.top"; 
{===>} topology_infile_4="CNS_TOPPAR:ion.top"; 
{===>} topology_infile_5=""; 
{===>} prot_link_infile="CNS_TOPPAR:protein.link"; 
{===>} nucl_link_infile="CNS_TOPPAR:dna-rna.link"; 
{===>} parameter_infile_1="CNS_TOPPAR:protein_rep.param"; 
{===>} parameter_infile_2=""; 
{===>} parameter_infile_3="CNS_TOPPAR:water_rep.param"; 
{===>} parameter_infile_4="CNS_TOPPAR:ion.param"; 
{===>} parameter_infile_5=""; 
{===>} break_cutoff=2.5; 
{===>} prot_break_infile="CNS_TOPPAR:protein_break.top"; 
{===>} disulphide_dist=3.0; 
{===>} atom_delete=(none); 
{============================ renaming atoms ===============================} 
{===>} ile_CD_becomes="CD1"; 
{===>} OT1_becomes="O"; 
{===>} OT2_becomes="OXT"; 
{====================== crystallographic data ========================} 
{===>} sg="P2(1)2(1)2(1)"; 
{===>} a=112.85; 
{===>} b=154.92; 
{===>} c=178.04; 
{===>} alpha=90.; 
{===>} beta=90.; 
{===>} gamma=90.; 
{===>} reflection_infile_1="native.cv"; 
{===>} reflection_infile_2=""; 
{===>} reflection_infile_3=""; 
{===>} anom_library=""; 
{===>} obs_f="fobs"; 
{===>} obs_sigf="sigma"; 
{===>} test_set="test"; 
{===>} test_flag=1; 
{===>} obs_i=""; 
{===>} obs_sigi=""; 
{===>} obs_pa=""; 
{===>} obs_pb=""; 
{===>} obs_pc=""; 
{===>} obs_pd=""; 
{===>} obs_w=""; 
{===>} obs_phase=""; 
{===>} obs_fom=""; 
{===>} low_res=50; 
{===>} high_res=2.30; 
{===>} obs_type="amplitude"; 
{===>} sigma_cut=0.0; 
{===>} obs_rms=10000; 
{=================== non-crystallographic symmetry ===================} 
{===>} ncs_infile="ncs.def"; 
{============ initial B-factor and bulk solvent corrections ==========} 
{===>} bscale="anisotropic"; 
{===>} low_res_bscale=6.0; 
{===>} bulk_sol=true; 
{===>} bulk_mask_infile=""; 
{===>} sol_k=-1; 
{===>} sol_b=-1; 
{========================== atom selection ===========================} 
{===>} atom_select=(known and not hydrogen); 
{===>} atom_fixed=(none); 
{===>} atom_harm=(none); 
{===>} k_harmonic=10; 
{===>} atom_rigid=(none); 
{===>} atom_main=(name ca or name n or name c or name o or name ot+); 
{===>} conf_1=(none); 
{===>} conf_2=(none); 
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{===>} conf_3=(none); 
{===>} conf_4=(none); 
{===>} restraints_infile=""; 
{====================== annealing parameters =========================} 
{===>} anneal=true; 
{===>} md_type="cartesian"; 
{===>} geometry_min=20; 
{===>} md_scheme="slowcool"; 
{===>} temperature=3000; 
{===>} cool_rate=50; 
{===>} constant_steps=50; 
{===>} seed=82364; 
{===>} torsion_maxlength=50; 
{===>} torsion_maxtree=20; 
{===>} torsion_maxchain=2000; 
{===>} torsion_maxbond=6; 
{===================== minimization parameters =======================} 
{===>} minimize_nstep=30; 
{===>} bfactor_nstep=20; 
{===>} rweight=-1; 
{===>} bmin=1; 
{===>} bmax=200; 
{===>} bsig_main=1.5; 
{===>} asig_main=2.0; 
{===>} bsig_side=2.0; 
{===>} asig_side=2.5; 
{====================== refinement parameters ========================} 
{===>} num_cycles=3; 
{===>} reftarget="mlf"; 
{===>} wa=-1.4; 
{===>} target_bins=-1; 
{===>} fft_memory=-1; 
{==================== map generation parameters ======================} 
{===>} write_map=true; 
{===>} map_type="sigmaa"; 
{===>} map_coeff_1="fofc"; 
{===>} map_coeff_2="2fofc"; 
{===>} grid=0.35; 
{===>} fill_in=false; 
{===>} map_scale=true; 
{===>} map_format="cns"; 
{===>} map_mode="molecule"; 
{===>} xmin=0; 
{===>} xmax=0; 
{===>} ymin=0; 
{===>} ymax=0; 
{===>} zmin=0; 
{===>} zmax=0; 
{===>} atom_map=(known and not hydrogen); 
{===>} map_cushion=3.0; 
{=========================== output files ============================} 
{===>} output_root="mini"; 
{===>} pdb_o_format=true; 
{============================= defaults ==============================} 
{===>} defaults_file=""; 
{===========================================================================} 
{        things below this line do not normally need to be changed          } 
{===========================================================================} 
... 
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Appendix table 29: UNIQUEIFY.INP script (in CCP4i) 
 
NREF 0 
SYMMETRY 
END 
CELL 112.8500 154.9200 178.0400 90.0000 90.0000 90.0000 
SYMMETRY 'P 21 21 21' 
LABOUT F=FUNI SIGF=SIGFUNI 
RESOLUTION 2.300 
################################################ 
FREERFRAC 0.05 
END 
################################################ 
LABI FILE 2  E1=FreeR_flag 
LABI FILE 1  ALLIN 
END 
################################################ 
COMPLETE FREE=FreeR_flag 
END 
 
 
Appendix table 30: REFMAC5.INP script (in CCP4i) 
 
refi resolution 2.300 20.041 
make check NONE 
make - 
    hydrogen YES - 
    hout NO - 
    peptide NO - 
    cispeptide YES - 
    ssbridge YES - 
    symmetry YES - 
    sugar YES - 
    connectivity NO - 
    link NO 
ncsr nchains 6 chains A B C D E F - 
    nspans 1 - 
    2 430 4 
refi - 
    type REST - 
    resi MLKF - 
    meth CGMAT - 
    bref ISOT 
ncyc 10 
scal - 
    type SIMP - 
    reso 2.3 20.041 - 
    LSSC - 
    ANISO - 
    EXPE 
solvent YES - 
    VDWProb 1.2 - 
    IONProb 0.8 - 
    RSHRink 0.8 
weight - 
    MATRIX 0.05 
monitor MEDIUM - 
    torsion 10.0 - 
    distance 10.0 - 
    angle 10.0 - 
    plane 10.0 - 
    chiral 10.0 - 
    bfactor 10.0 - 
    bsphere 10.0 - 
    rbond 10.0 - 
    ncsr 10.0 
labin  FP=FP SIGFP=SIGFP - 
   FREE=FreeR_flag 
labout  FC=FC FWT=FWT PHIC=PHIC PHWT=PHWT DELFWT=DELFWT PHDELWT=PHDELWT FOM=FOM 
PNAME unknown 
DNAME unknown220408 
RSIZE 80 
END 
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Appendix table 31: TLSIN.TLS script 
 
TLS    Chain A 
RANGE  'A   1' 'A 430' ALL 
TLS    Chain B 
RANGE  'B   1' 'B 430' ALL 
TLS    Chain C 
RANGE  'C   1' 'C 430' ALL 
TLS    Chain D 
RANGE  'D   1' 'D 430' ALL 
TLS    Chain E 
RANGE  'E   1' 'E 430' ALL 
TLS    Chain F 
RANGE  'F   1' 'F 430' ALL 
 
 
Appendix table 32: LIBRARY.CIF for the SQR “as-purified” structure (PDB id.: 3HYV) to 
be used in REFMAC5 
 
global_ 
_lib_name         ? 
_lib_version      ? 
_lib_update       ? 
# ------------------------------------------------ 
# 
# ---   LIST OF MONOMERS --- 
# 
data_comp_list 
loop_ 
_chem_comp.id 
_chem_comp.three_letter_code 
_chem_comp.name 
_chem_comp.group 
_chem_comp.number_atoms_all 
_chem_comp.number_atoms_nh 
_chem_comp.desc_level 
H2S      .   'HYDROSULFURIC ACID                  ' non-polymer         3   1 . 
MES      .   'N-(EHTYLSULFITE)MORPHOLINE          ' non-polymer        24  12 . 
PS9      PS9 'OCTATHIOCANE                        ' non-polymer         8   8 . 
LMT      LMT 'DODECYL-BETA-D-MALTOSIDE            ' non-polymer        81  35 . 
FAD      FAD 'FLAVIN-ADENINE-DINUCLEOTIDE         ' non-polymer        83  53 . 
CSS      CSS 'S-MERCAPTOCYSTEINE                  ' non-polymer        14   8 . 
# 
# ---   LIST OF LINKS --- 
# 
data_link_list 
loop_ 
_chem_link.id 
_chem_link.comp_id_1 
_chem_link.mod_id_1 
_chem_link.group_comp_1 
_chem_link.comp_id_2 
_chem_link.mod_id_2 
_chem_link.group_comp_2 
_chem_link.name 
  1.61   FAD      .        .        H2S      .        . 
 bond_FAD-C8M_=_H2S-S 
  1.62   FAD      .        .        H2S      .        . 
 bond_FAD-C8M_=_H2S-S 
  2.04   CYS      .        .        H2S      .        . 
 bond_CYS-SG_=_H2S-S 
  1.94   CSS      .        .        PS9      .        . 
 bond_CSS-SD_=_PS9-S2 
  1.93   CSS      .        .        PS9      .        . 
 bond_CSS-SD_=_PS9-S2 
  1.33   SER      .        .        CSS      .        . 
 bond_SER-C_=_CSS-N 
  1.34   CSS      .        .        PHE      .        . 
 bond_CSS-C_=_PHE-N 
# 
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# --- DESCRIPTION OF MONOMERS --- 
# 
data_comp_H2S 
# 
loop_ 
_chem_comp_atom.comp_id 
_chem_comp_atom.atom_id 
_chem_comp_atom.type_symbol 
_chem_comp_atom.type_energy 
_chem_comp_atom.partial_charge 
 H2S           HS1    H    H         0.000 
 H2S           S      S    S         0.000 
 H2S           HS2    H    H         0.000 
loop_ 
_chem_comp_tree.comp_id 
_chem_comp_tree.atom_id 
_chem_comp_tree.atom_back 
_chem_comp_tree.atom_forward 
_chem_comp_tree.connect_type 
 H2S      HS1    S      .      END 
 H2S      S      n/a    HS1    START 
 H2S      HS2    S      .      . 
loop_ 
_chem_comp_bond.comp_id 
_chem_comp_bond.atom_id_1 
_chem_comp_bond.atom_id_2 
_chem_comp_bond.type 
_chem_comp_bond.value_dist 
_chem_comp_bond.value_dist_esd 
 H2S      S      HS1       coval       0.960    0.020 
 H2S      HS2    S         coval       0.960    0.020 
loop_ 
_chem_comp_angle.comp_id 
_chem_comp_angle.atom_id_1 
_chem_comp_angle.atom_id_2 
_chem_comp_angle.atom_id_3 
_chem_comp_angle.value_angle 
_chem_comp_angle.value_angle_esd 
 H2S      HS1    S      HS2     109.470    3.000 
# 
data_comp_MES 
# 
loop_ 
_chem_comp_atom.comp_id 
_chem_comp_atom.atom_id 
_chem_comp_atom.type_symbol 
_chem_comp_atom.type_energy 
_chem_comp_atom.partial_charge 
_chem_comp_atom.x 
_chem_comp_atom.y 
_chem_comp_atom.z 
 MES           O3S    O    OS       -0.330      0.069    0.043   -0.007 
 MES           S      S    ST        0.000      1.156    1.058   -0.016 
 MES           O1S    O    OS       -0.330      1.953    0.844   -1.240 
 MES           O2S    O    OS       -0.330      1.947    0.851    1.217 
 MES           C8     C    CH2       0.000      0.337    2.494   -0.011 
 MES           H81    H    H         0.000     -0.282    2.557    0.886 
 MES           H82    H    H         0.000     -0.300    2.553   -0.896 
 MES           C7     C    CH2       0.000      1.314    3.621   -0.024 
 MES           H71    H    H         0.000      1.957    3.567   -0.904 
 MES           H72    H    H         0.000      1.931    3.610    0.877 
 MES           N4     N    N         0.000      0.548    4.826   -0.064 
 MES           C5     C    CH2       0.000      1.340    6.058   -0.043 
 MES           H51    H    H         0.000      1.935    6.143   -0.955 
 MES           H52    H    H         0.000      2.004    6.069    0.824 
 MES           C6     C    CH2       0.000      0.368    7.231    0.043 
 MES           H62    H    H         0.000     -0.181    7.269   -0.900 
 MES           H61    H    H         0.000      0.962    8.140    0.155 
 MES           O1     O    O2        0.000     -0.546    7.129    1.119 
 MES           C2     C    CH2       0.000     -1.067    5.834    1.210 
 MES           H22    H    H         0.000     -2.129    5.927    1.446 
 MES           H21    H    H         0.000     -0.555    5.335    2.036 
 MES           C3     C    CH2       0.000     -0.898    5.013   -0.067 
 MES           H32    H    H         0.000     -1.196    5.541   -0.975 
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 MES           H31    H    H         0.000     -1.392    4.039   -0.035 
loop_ 
_chem_comp_tree.comp_id 
_chem_comp_tree.atom_id 
_chem_comp_tree.atom_back 
_chem_comp_tree.atom_forward 
_chem_comp_tree.connect_type 
 MES      O3S    S      .      . 
 MES      S      O2S    C8     . 
 MES      O1S    S      .      . 
 MES      O2S    n/a    S      START 
 MES      C8     S      C7     . 
 MES      H81    C8     .      . 
 MES      H82    C8     .      . 
 MES      C7     C8     N4     . 
 MES      H71    C7     .      . 
 MES      H72    C7     .      . 
 MES      N4     C7     C3     . 
 MES      C5     C6     H51    . 
 MES      H51    C5     .      END 
 MES      H52    C5     .      . 
 MES      C6     O1     C5     . 
 MES      H62    C6     .      . 
 MES      H61    C6     .      . 
 MES      O1     C2     C6     . 
 MES      C2     C3     O1     . 
 MES      H22    C2     .      . 
 MES      H21    C2     .      . 
 MES      C3     N4     C2     . 
 MES      H32    C3     .      . 
 MES      H31    C3     .      . 
 MES      N4     C5     .    ADD 
loop_ 
_chem_comp_bond.comp_id 
_chem_comp_bond.atom_id_1 
_chem_comp_bond.atom_id_2 
_chem_comp_bond.type 
_chem_comp_bond.value_dist 
_chem_comp_bond.value_dist_esd 
 MES      O1S    S         deloc       1.480    0.020 
 MES      O2S    S         deloc       1.480    0.020 
 MES      S      O3S       deloc       1.480    0.020 
 MES      C8     S         single      1.662    0.020 
 MES      H81    C8        single      1.092    0.020 
 MES      H82    C8        single      1.092    0.020 
 MES      C7     C8        single      1.524    0.020 
 MES      H71    C7        single      1.092    0.020 
 MES      H72    C7        single      1.092    0.020 
 MES      N4     C7        single      1.455    0.020 
 MES      C5     N4        single      1.455    0.020 
 MES      H51    C5        single      1.092    0.020 
 MES      H52    C5        single      1.092    0.020 
 MES      C6     C5        single      1.524    0.020 
 MES      H62    C6        single      1.092    0.020 
 MES      H61    C6        single      1.092    0.020 
 MES      N4     C3        single      1.455    0.020 
 MES      H31    C3        single      1.092    0.020 
 MES      H32    C3        single      1.092    0.020 
 MES      C3     C2        single      1.524    0.020 
 MES      H22    C2        single      1.092    0.020 
 MES      H21    C2        single      1.092    0.020 
 MES      C2     O1        single      1.426    0.020 
 MES      O1     C6        single      1.426    0.020 
loop_ 
_chem_comp_angle.comp_id 
_chem_comp_angle.atom_id_1 
_chem_comp_angle.atom_id_2 
_chem_comp_angle.atom_id_3 
_chem_comp_angle.value_angle 
_chem_comp_angle.value_angle_esd 
 MES      O3S    S      O1S     109.500    3.000 
 MES      O3S    S      O2S     109.500    3.000 
 MES      O3S    S      C8      109.500    3.000 
 MES      O1S    S      O2S     109.500    3.000 
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 MES      O1S    S      C8      109.500    3.000 
 MES      O2S    S      C8      109.500    3.000 
 MES      S      C8     H81     109.500    3.000 
 MES      S      C8     H82     109.500    3.000 
 MES      S      C8     C7      109.500    3.000 
 MES      H81    C8     H82     107.900    3.000 
 MES      H81    C8     C7      109.470    3.000 
 MES      H82    C8     C7      109.470    3.000 
 MES      C8     C7     H71     109.470    3.000 
 MES      C8     C7     H72     109.470    3.000 
 MES      C8     C7     N4      105.000    3.000 
 MES      H71    C7     H72     107.900    3.000 
 MES      H71    C7     N4      109.470    3.000 
 MES      H72    C7     N4      109.470    3.000 
 MES      C7     N4     C5      120.000    3.000 
 MES      C7     N4     C3      120.000    3.000 
 MES      C5     N4     C3      120.000    3.000 
 MES      N4     C5     H51     109.470    3.000 
 MES      N4     C5     H52     109.470    3.000 
 MES      N4     C5     C6      105.000    3.000 
 MES      H51    C5     H52     107.900    3.000 
 MES      H51    C5     C6      109.470    3.000 
 MES      H52    C5     C6      109.470    3.000 
 MES      C5     C6     H62     109.470    3.000 
 MES      C5     C6     H61     109.470    3.000 
 MES      C5     C6     O1      109.470    3.000 
 MES      H62    C6     H61     107.900    3.000 
 MES      H62    C6     O1      109.470    3.000 
 MES      H61    C6     O1      109.470    3.000 
 MES      C6     O1     C2      111.800    3.000 
 MES      O1     C2     H22     109.470    3.000 
 MES      O1     C2     H21     109.470    3.000 
 MES      O1     C2     C3      109.470    3.000 
 MES      H22    C2     H21     107.900    3.000 
 MES      H22    C2     C3      109.470    3.000 
 MES      H21    C2     C3      109.470    3.000 
 MES      C2     C3     H32     109.470    3.000 
 MES      C2     C3     H31     109.470    3.000 
 MES      C2     C3     N4      105.000    3.000 
 MES      H32    C3     H31     107.900    3.000 
 MES      H32    C3     N4      109.470    3.000 
 MES      H31    C3     N4      109.470    3.000 
loop_ 
_chem_comp_tor.comp_id 
_chem_comp_tor.id 
_chem_comp_tor.atom_id_1 
_chem_comp_tor.atom_id_2 
_chem_comp_tor.atom_id_3 
_chem_comp_tor.atom_id_4 
_chem_comp_tor.value_angle 
_chem_comp_tor.value_angle_esd 
_chem_comp_tor.period 
 MES      var_1    O3S    S      C8     C7       180.000   20.000   1 
 MES      var_2    S      C8     C7     N4       180.000   20.000   3 
 MES      var_3    C8     C7     N4     C5       180.000   20.000   1 
 MES      var_4    C7     N4     C3     C2       120.000   20.000   1 
 MES      var_5    C7     N4     C5     C6       180.000   20.000   1 
 MES      var_6    N4     C5     C6     O1        60.000   20.000   3 
 MES      var_7    C5     C6     O1     C2       -60.000   20.000   1 
 MES      var_8    C6     O1     C2     C3         0.000   20.000   1 
 MES      var_9    O1     C2     C3     N4        60.000   20.000   3 
loop_ 
_chem_comp_chir.comp_id 
_chem_comp_chir.id 
_chem_comp_chir.atom_id_centre 
_chem_comp_chir.atom_id_1 
_chem_comp_chir.atom_id_2 
_chem_comp_chir.atom_id_3 
_chem_comp_chir.volume_sign 
 MES      chir_01  S      O1S    O2S    O3S       positiv 
loop_ 
_chem_comp_plane_atom.comp_id 
_chem_comp_plane_atom.plane_id 
_chem_comp_plane_atom.atom_id 
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_chem_comp_plane_atom.dist_esd 
 MES      plan-1    N4        0.020 
 MES      plan-1    C7        0.020 
 MES      plan-1    C5        0.020 
 MES      plan-1    C3        0.020 
# 
data_comp_PS9 
# 
loop_ 
_chem_comp_atom.comp_id 
_chem_comp_atom.atom_id 
_chem_comp_atom.type_symbol 
_chem_comp_atom.type_energy 
_chem_comp_atom.partial_charge 
_chem_comp_atom.x 
_chem_comp_atom.y 
_chem_comp_atom.z 
 PS9           S3     S    S2        0.000      0.000    0.000    0.000 
 PS9           S4     S    S2        0.000      1.414    1.414    0.000 
 PS9           S5     S    S2        0.000      0.552    3.219   -0.001 
 PS9           S6     S    S2        0.000      1.960    4.630    0.164 
 PS9           S7     S    S2        0.000      1.116    6.436   -0.001 
 PS9           S8     S    S2        0.000      2.494    7.848    0.325 
 PS9           S9     S    S2        0.000      1.691    9.651    0.001 
 PS9           S2     S    S2        0.000      3.018   11.068    0.483 
loop_ 
_chem_comp_tree.comp_id 
_chem_comp_tree.atom_id 
_chem_comp_tree.atom_back 
_chem_comp_tree.atom_forward 
_chem_comp_tree.connect_type 
 PS9      S3     S2     .      END 
 PS9      S4     n/a    S5     START 
 PS9      S5     S4     S6     . 
 PS9      S6     S5     S7     . 
 PS9      S7     S6     S8     . 
 PS9      S8     S7     S9     . 
 PS9      S9     S8     S2     . 
 PS9      S2     S9     S3     . 
 PS9      S3     S4     .    ADD 
loop_ 
_chem_comp_bond.comp_id 
_chem_comp_bond.atom_id_1 
_chem_comp_bond.atom_id_2 
_chem_comp_bond.type 
_chem_comp_bond.value_dist 
_chem_comp_bond.value_dist_esd 
 PS9      S2     S3        single      2.000    0.020 
 PS9      S2     S9        single      2.000    0.020 
 PS9      S4     S3        single      2.000    0.020 
 PS9      S5     S4        single      2.000    0.020 
 PS9      S6     S5        single      2.000    0.020 
 PS9      S7     S6        single      2.000    0.020 
 PS9      S8     S7        single      2.000    0.020 
 PS9      S9     S8        single      2.000    0.020 
loop_ 
_chem_comp_angle.comp_id 
_chem_comp_angle.atom_id_1 
_chem_comp_angle.atom_id_2 
_chem_comp_angle.atom_id_3 
_chem_comp_angle.value_angle 
_chem_comp_angle.value_angle_esd 
 PS9      S4     S3     S2      109.470    3.000 
 PS9      S3     S4     S5      109.470    3.000 
 PS9      S4     S5     S6      109.470    3.000 
 PS9      S5     S6     S7      109.470    3.000 
 PS9      S6     S7     S8      109.470    3.000 
 PS9      S7     S8     S9      109.470    3.000 
 PS9      S8     S9     S2      109.470    3.000 
 PS9      S9     S2     S3      109.470    3.000 
loop_ 
_chem_comp_tor.comp_id 
_chem_comp_tor.id 
_chem_comp_tor.atom_id_1 
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_chem_comp_tor.atom_id_2 
_chem_comp_tor.atom_id_3 
_chem_comp_tor.atom_id_4 
_chem_comp_tor.value_angle 
_chem_comp_tor.value_angle_esd 
_chem_comp_tor.period 
 PS9      var_1    S3     S4     S5     S6       175.000   20.000   1 
 PS9      var_2    S4     S5     S6     S7       175.000   20.000   1 
 PS9      var_3    S5     S6     S7     S8       175.000   20.000   1 
 PS9      var_4    S6     S7     S8     S9       175.000   20.000   1 
 PS9      var_5    S7     S8     S9     S2       175.000   20.000   1 
 PS9      var_6    S8     S9     S2     S3       175.000   20.000   1 
 PS9      var_7    S9     S2     S3     S4       175.000   20.000   1 
 PS9      var_1    S5     S4     S3     S2       175.000   20.000   1 
# 
data_comp_LMT 
# 
loop_ 
_chem_comp_atom.comp_id 
_chem_comp_atom.atom_id 
_chem_comp_atom.type_symbol 
_chem_comp_atom.type_energy 
_chem_comp_atom.partial_charge 
_chem_comp_atom.x 
_chem_comp_atom.y 
_chem_comp_atom.z 
 LMT           'O6''  O    OH1       0.000      0.000    0.000    0.000 
 LMT           'HO6'' H    H         0.000      0.414   -0.870   -0.079 
 LMT           'C6''  C    CH2       0.000      1.013    1.013    0.000 
 LMT           'H6'1' H    H         0.000      1.634    0.905   -0.891 
 LMT           'H6'2' H    H         0.000      1.634    0.905    0.891 
 LMT           'C5''  C    CH1       0.000      0.356    2.388    0.000 
 LMT           'H5''  H    H         0.000     -0.189    2.528   -0.944 
 LMT           'C4''  C    CH1       0.000     -0.616    2.529    1.165 
 LMT           'H4''  H    H         0.000     -1.386    1.748    1.091 
 LMT           'C3''  C    CH1       0.000     -1.286    3.897    1.155 
 LMT           'H3''  H    H         0.000     -2.370    3.768    1.026 
 LMT           'O3''  O    OH1       0.000     -1.036    4.561    2.399 
 LMT           'HO3'' H    H         0.000     -1.394    5.459    2.363 
 LMT           'C2''  C    CH1       0.000     -0.746    4.762    0.022 
 LMT           'H2''  H    H         0.000     -1.123    4.376   -0.935 
 LMT           'O2''  O    OH1       0.000     -1.198    6.110    0.193 
 LMT           'HO2'' H    H         0.000     -0.792    6.674   -0.480 
 LMT           O1B    O    O2        0.000      0.090    2.375    2.395 
 LMT           C1B    C    CH1       0.000     -0.750    2.612    3.522 
 LMT           H1B    H    H         0.000     -1.026    3.675    3.527 
 LMT           O5B    O    O2        0.000     -0.029    2.333    4.720 
 LMT           C5B    C    CH1       0.000     -0.586    1.227    5.428 
 LMT           H5B    H    H         0.000     -0.583    0.339    4.781 
 LMT           C6B    C    CH2       0.000      0.247    0.951    6.674 
 LMT           H6B1   H    H         0.000      0.319    1.861    7.273 
 LMT           H6B2   H    H         0.000      1.248    0.631    6.378 
 LMT           O6B    O    OH1       0.000     -0.377   -0.082    7.446 
 LMT           HO6B   H    H         0.000      0.190   -0.312    8.194 
 LMT           C4B    C    CH1       0.000     -2.017    1.554    5.836 
 LMT           H4B    H    H         0.000     -2.439    0.703    6.389 
 LMT           'O4''  O    OH1       0.000     -2.021    2.712    6.678 
 LMT           'HO4'' H    H         0.000     -2.933    2.966    6.873 
 LMT           C3B    C    CH1       0.000     -2.883    1.836    4.613 
 LMT           H3B    H    H         0.000     -3.691    1.093    4.563 
 LMT           O3B    O    OH1       0.000     -3.452    3.146    4.724 
 LMT           HO3B   H    H         0.000     -3.936    3.356    3.914 
 LMT           C2B    C    CH1       0.000     -2.058    1.768    3.333 
 LMT           H2B    H    H         0.000     -1.788    0.722    3.133 
 LMT           O2B    O    OH1       0.000     -2.833    2.273    2.240 
 LMT           HO2B   H    H         0.000     -2.285    2.303    1.444 
 LMT           'O5''  O    O2        0.000      1.359    3.394    0.117 
 LMT           'C1''  C    CH1       0.000      0.809    4.705    0.015 
 LMT           'H1''  H    H         0.000      1.182    5.305    0.857 
 LMT           'O1''  O    O2        0.000      1.247    5.312   -1.199 
 LMT           C1     C    CH2       0.000      0.634    6.582   -1.407 
 LMT           H11    H    H         0.000      0.813    7.219   -0.538 
 LMT           H12    H    H         0.000     -0.441    6.449   -1.544 
 LMT           C2     C    CH2       0.000      1.229    7.236   -2.649 
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 LMT           H21    H    H         0.000      1.130    6.545   -3.489 
 LMT           H22    H    H         0.000      2.287    7.435   -2.466 
 LMT           C3     C    CH2       0.000      0.513    8.541   -2.975 
 LMT           H31    H    H         0.000      0.536    9.183   -2.092 
 LMT           H32    H    H         0.000     -0.523    8.316   -3.233 
 LMT           C4     C    CH2       0.000      1.186    9.256   -4.141 
 LMT           H41    H    H         0.000      1.243    8.567   -4.987 
 LMT           H42    H    H         0.000      2.195    9.545   -3.839 
 LMT           C5     C    CH2       0.000      0.400   10.497   -4.547 
 LMT           H51    H    H         0.000      0.266   11.129   -3.667 
 LMT           H52    H    H         0.000     -0.577   10.185   -4.922 
 LMT           C6     C    CH2       0.000      1.135   11.278   -5.630 
 LMT           H61    H    H         0.000      1.348   10.606   -6.463 
 LMT           H62    H    H         0.000      2.074   11.651   -5.215 
 LMT           C7     C    CH2       0.000      0.294   12.450   -6.123 
 LMT           H71    H    H         0.000      0.007   13.060   -5.264 
 LMT           H72    H    H         0.000     -0.603   12.058   -6.606 
 LMT           C8     C    CH2       0.000      1.076   13.303   -7.115 
 LMT           H81    H    H         0.000      1.440   12.659   -7.919 
 LMT           H82    H    H         0.000      1.925   13.752   -6.597 
 LMT           C9     C    CH2       0.000      0.197   14.402   -7.702 
 LMT           H91    H    H         0.000     -0.238   14.976   -6.881 
 LMT           H92    H    H         0.000     -0.602   13.937   -8.283 
 LMT           C10    C    CH2       0.000      1.008   15.329   -8.599 
 LMT           H101   H    H         0.000      1.516   14.727   -9.355 
 LMT           H102   H    H         0.000      1.751   15.846   -7.987 
 LMT           C11    C    CH2       0.000      0.109   16.353   -9.282 
 LMT           H111   H    H         0.000     -0.465   16.879   -8.516 
 LMT           H112   H    H         0.000     -0.575   15.826   -9.950 
 LMT           C12    C    CH3       0.000      0.926   17.348  -10.076 
 LMT           H123   H    H         0.000      1.526   17.918   -9.415 
 LMT           H122   H    H         0.000      1.547   16.830  -10.759 
 LMT           H121   H    H         0.000      0.276   17.993  -10.608 
loop_ 
_chem_comp_tree.comp_id 
_chem_comp_tree.atom_id 
_chem_comp_tree.atom_back 
_chem_comp_tree.atom_forward 
_chem_comp_tree.connect_type 
 LMT      'O6''  'C6''  'HO6'' . 
 LMT      'HO6'' 'O6''  .      . 
 LMT      'C6''  'C5''  'O6''  . 
 LMT      'H6'1' 'C6''  .      . 
 LMT      'H6'2' 'C6''  .      . 
 LMT      'C5''  'O5''  'C6''  . 
 LMT      'H5''  'C5''  .      . 
 LMT      'C4''  O1B    'C3''  . 
 LMT      'H4''  'C4''  .      . 
 LMT      'C3''  'C4''  'C2''  . 
 LMT      'H3''  'C3''  .      . 
 LMT      'O3''  'C3''  'HO3'' . 
 LMT      'HO3'' 'O3''  .      . 
 LMT      'C2''  'C3''  'C1''  . 
 LMT      'H2''  'C2''  .      . 
 LMT      'O2''  'C2''  'HO2'' . 
 LMT      'HO2'' 'O2''  .      . 
 LMT      O1B    C1B    'C4''  . 
 LMT      C1B    C2B    O1B    . 
 LMT      H1B    C1B    .      . 
 LMT      O5B    C5B    .      . 
 LMT      C5B    C4B    O5B    . 
 LMT      H5B    C5B    .      . 
 LMT      C6B    C5B    O6B    . 
 LMT      H6B1   C6B    .      . 
 LMT      H6B2   C6B    .      . 
 LMT      O6B    C6B    HO6B   . 
 LMT      HO6B   O6B    .      . 
 LMT      C4B    C3B    C5B    . 
 LMT      H4B    C4B    .      . 
 LMT      'O4''  C4B    'HO4'' . 
 LMT      'HO4'' 'O4''  .      . 
 LMT      C3B    C2B    C4B    . 
 LMT      H3B    C3B    .      . 
 LMT      O3B    C3B    HO3B   . 
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 LMT      HO3B   O3B    .      . 
 LMT      C2B    O2B    C1B    . 
 LMT      H2B    C2B    .      . 
 LMT      O2B    n/a    C2B    START 
 LMT      HO2B   O2B    .      . 
 LMT      'O5''  'C1''  'C5''  . 
 LMT      'C1''  'C2''  'O1''  . 
 LMT      'H1''  'C1''  .      . 
 LMT      'O1''  'C1''  C1     . 
 LMT      C1     'O1''  C2     . 
 LMT      H11    C1     .      . 
 LMT      H12    C1     .      . 
 LMT      C2     C1     C3     . 
 LMT      H21    C2     .      . 
 LMT      H22    C2     .      . 
 LMT      C3     C2     C4     . 
 LMT      H31    C3     .      . 
 LMT      H32    C3     .      . 
 LMT      C4     C3     C5     . 
 LMT      H41    C4     .      . 
 LMT      H42    C4     .      . 
 LMT      C5     C4     C6     . 
 LMT      H51    C5     .      . 
 LMT      H52    C5     .      . 
 LMT      C6     C5     C7     . 
 LMT      H61    C6     .      . 
 LMT      H62    C6     .      . 
 LMT      C7     C6     C8     . 
 LMT      H71    C7     .      . 
 LMT      H72    C7     .      . 
 LMT      C8     C7     C9     . 
 LMT      H81    C8     .      . 
 LMT      H82    C8     .      . 
 LMT      C9     C8     C10    . 
 LMT      H91    C9     .      . 
 LMT      H92    C9     .      . 
 LMT      C10    C9     C11    . 
 LMT      H101   C10    .      . 
 LMT      H102   C10    .      . 
 LMT      C11    C10    C12    . 
 LMT      H111   C11    .      . 
 LMT      H112   C11    .      . 
 LMT      C12    C11    H123   . 
 LMT      H123   C12    .      END 
 LMT      H122   C12    .      . 
 LMT      H121   C12    .      . 
 LMT      'C5''  'C4''  .    ADD 
 LMT      C1B    O5B    .    ADD 
loop_ 
_chem_comp_bond.comp_id 
_chem_comp_bond.atom_id_1 
_chem_comp_bond.atom_id_2 
_chem_comp_bond.type 
_chem_comp_bond.value_dist 
_chem_comp_bond.value_dist_esd 
 LMT      C1B    C2B       single      1.524    0.020 
 LMT      C1B    O1B       single      1.426    0.020 
 LMT      O5B    C1B       single      1.426    0.020 
 LMT      C2B    C3B       single      1.524    0.020 
 LMT      O2B    C2B       single      1.432    0.020 
 LMT      C3B    C4B       single      1.524    0.020 
 LMT      O3B    C3B       single      1.432    0.020 
 LMT      C4B    C5B       single      1.524    0.020 
 LMT      'O4''  C4B       single      1.432    0.020 
 LMT      C6B    C5B       single      1.524    0.020 
 LMT      C5B    O5B       single      1.426    0.020 
 LMT      O6B    C6B       single      1.432    0.020 
 LMT      O1B    'C4''     single      1.426    0.020 
 LMT      'C1''  'C2''     single      1.524    0.020 
 LMT      'O1''  'C1''     single      1.426    0.020 
 LMT      'C1''  'O5''     single      1.426    0.020 
 LMT      'C2''  'C3''     single      1.524    0.020 
 LMT      'O2''  'C2''     single      1.432    0.020 
 LMT      'C3''  'C4''     single      1.524    0.020 
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 LMT      'O3''  'C3''     single      1.432    0.020 
 LMT      'C4''  'C5''     single      1.524    0.020 
 LMT      'C5''  'C6''     single      1.524    0.020 
 LMT      'O5''  'C5''     single      1.426    0.020 
 LMT      'C6''  'O6''     single      1.432    0.020 
 LMT      C1     'O1''     single      1.426    0.020 
 LMT      C2     C1        single      1.524    0.020 
 LMT      C3     C2        single      1.524    0.020 
 LMT      C4     C3        single      1.524    0.020 
 LMT      C5     C4        single      1.524    0.020 
 LMT      C6     C5        single      1.524    0.020 
 LMT      C7     C6        single      1.524    0.020 
 LMT      C8     C7        single      1.524    0.020 
 LMT      C9     C8        single      1.524    0.020 
 LMT      C10    C9        single      1.524    0.020 
 LMT      C11    C10       single      1.524    0.020 
 LMT      C12    C11       single      1.513    0.020 
 LMT      H1B    C1B       single      1.099    0.020 
 LMT      H2B    C2B       single      1.099    0.020 
 LMT      H3B    C3B       single      1.099    0.020 
 LMT      H4B    C4B       single      1.099    0.020 
 LMT      H5B    C5B       single      1.099    0.020 
 LMT      H6B1   C6B       single      1.092    0.020 
 LMT      H6B2   C6B       single      1.092    0.020 
 LMT      HO2B   O2B       single      0.967    0.020 
 LMT      HO3B   O3B       single      0.967    0.020 
 LMT      'HO4'' 'O4''     single      0.967    0.020 
 LMT      HO6B   O6B       single      0.967    0.020 
 LMT      'H1''  'C1''     single      1.099    0.020 
 LMT      'H2''  'C2''     single      1.099    0.020 
 LMT      'H3''  'C3''     single      1.099    0.020 
 LMT      'H4''  'C4''     single      1.099    0.020 
 LMT      'H5''  'C5''     single      1.099    0.020 
 LMT      'H6'1' 'C6''     single      1.092    0.020 
 LMT      'H6'2' 'C6''     single      1.092    0.020 
 LMT      'HO2'' 'O2''     single      0.967    0.020 
 LMT      'HO3'' 'O3''     single      0.967    0.020 
 LMT      'HO6'' 'O6''     single      0.967    0.020 
 LMT      H11    C1        single      1.092    0.020 
 LMT      H12    C1        single      1.092    0.020 
 LMT      H21    C2        single      1.092    0.020 
 LMT      H22    C2        single      1.092    0.020 
 LMT      H31    C3        single      1.092    0.020 
 LMT      H32    C3        single      1.092    0.020 
 LMT      H41    C4        single      1.092    0.020 
 LMT      H42    C4        single      1.092    0.020 
 LMT      H51    C5        single      1.092    0.020 
 LMT      H52    C5        single      1.092    0.020 
 LMT      H61    C6        single      1.092    0.020 
 LMT      H62    C6        single      1.092    0.020 
 LMT      H71    C7        single      1.092    0.020 
 LMT      H72    C7        single      1.092    0.020 
 LMT      H81    C8        single      1.092    0.020 
 LMT      H82    C8        single      1.092    0.020 
 LMT      H91    C9        single      1.092    0.020 
 LMT      H92    C9        single      1.092    0.020 
 LMT      H101   C10       single      1.092    0.020 
 LMT      H102   C10       single      1.092    0.020 
 LMT      H111   C11       single      1.092    0.020 
 LMT      H112   C11       single      1.092    0.020 
 LMT      H121   C12       single      1.059    0.020 
 LMT      H122   C12       single      1.059    0.020 
 LMT      H123   C12       single      1.059    0.020 
loop_ 
_chem_comp_angle.comp_id 
_chem_comp_angle.atom_id_1 
_chem_comp_angle.atom_id_2 
_chem_comp_angle.atom_id_3 
_chem_comp_angle.value_angle 
_chem_comp_angle.value_angle_esd 
 LMT      'HO6'' 'O6''  'C6''   109.470    3.000 
 LMT      'O6''  'C6''  'H6'1'  109.470    3.000 
 LMT      'O6''  'C6''  'H6'2'  109.470    3.000 
 LMT      'O6''  'C6''  'C5''   109.470    3.000 
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 LMT      'H6'1' 'C6''  'H6'2'  107.900    3.000 
 LMT      'H6'1' 'C6''  'C5''   109.470    3.000 
 LMT      'H6'2' 'C6''  'C5''   109.470    3.000 
 LMT      'C6''  'C5''  'H5''   108.340    3.000 
 LMT      'C6''  'C5''  'C4''   111.000    3.000 
 LMT      'C6''  'C5''  'O5''   109.470    3.000 
 LMT      'H5''  'C5''  'C4''   108.340    3.000 
 LMT      'H5''  'C5''  'O5''   109.470    3.000 
 LMT      'C4''  'C5''  'O5''   109.470    3.000 
 LMT      'C5''  'C4''  'H4''   108.340    3.000 
 LMT      'C5''  'C4''  'C3''   111.000    3.000 
 LMT      'C5''  'C4''  O1B     109.470    3.000 
 LMT      'H4''  'C4''  'C3''   108.340    3.000 
 LMT      'H4''  'C4''  O1B     109.470    3.000 
 LMT      'C3''  'C4''  O1B     109.470    3.000 
 LMT      'C4''  'C3''  'H3''   108.340    3.000 
 LMT      'C4''  'C3''  'O3''   109.470    3.000 
 LMT      'C4''  'C3''  'C2''   111.000    3.000 
 LMT      'H3''  'C3''  'O3''   109.470    3.000 
 LMT      'H3''  'C3''  'C2''   108.340    3.000 
 LMT      'O3''  'C3''  'C2''   109.470    3.000 
 LMT      'C3''  'O3''  'HO3''  109.470    3.000 
 LMT      'C3''  'C2''  'H2''   108.340    3.000 
 LMT      'C3''  'C2''  'O2''   109.470    3.000 
 LMT      'C3''  'C2''  'C1''   111.000    3.000 
 LMT      'H2''  'C2''  'O2''   109.470    3.000 
 LMT      'H2''  'C2''  'C1''   108.340    3.000 
 LMT      'O2''  'C2''  'C1''   109.470    3.000 
 LMT      'C2''  'O2''  'HO2''  109.470    3.000 
 LMT      'C4''  O1B    C1B     111.800    3.000 
 LMT      O1B    C1B    H1B     109.470    3.000 
 LMT      O1B    C1B    O5B     109.470    3.000 
 LMT      O1B    C1B    C2B     109.470    3.000 
 LMT      H1B    C1B    O5B     109.470    3.000 
 LMT      H1B    C1B    C2B     108.340    3.000 
 LMT      O5B    C1B    C2B     109.470    3.000 
 LMT      C1B    O5B    C5B     111.800    3.000 
 LMT      O5B    C5B    H5B     109.470    3.000 
 LMT      O5B    C5B    C6B     109.470    3.000 
 LMT      O5B    C5B    C4B     109.470    3.000 
 LMT      H5B    C5B    C6B     108.340    3.000 
 LMT      H5B    C5B    C4B     108.340    3.000 
 LMT      C6B    C5B    C4B     111.000    3.000 
 LMT      C5B    C6B    H6B1    109.470    3.000 
 LMT      C5B    C6B    H6B2    109.470    3.000 
 LMT      C5B    C6B    O6B     109.470    3.000 
 LMT      H6B1   C6B    H6B2    107.900    3.000 
 LMT      H6B1   C6B    O6B     109.470    3.000 
 LMT      H6B2   C6B    O6B     109.470    3.000 
 LMT      C6B    O6B    HO6B    109.470    3.000 
 LMT      C5B    C4B    H4B     108.340    3.000 
 LMT      C5B    C4B    'O4''   109.470    3.000 
 LMT      C5B    C4B    C3B     111.000    3.000 
 LMT      H4B    C4B    'O4''   109.470    3.000 
 LMT      H4B    C4B    C3B     108.340    3.000 
 LMT      'O4''  C4B    C3B     109.470    3.000 
 LMT      C4B    'O4''  'HO4''  109.470    3.000 
 LMT      C4B    C3B    H3B     108.340    3.000 
 LMT      C4B    C3B    O3B     109.470    3.000 
 LMT      C4B    C3B    C2B     111.000    3.000 
 LMT      H3B    C3B    O3B     109.470    3.000 
 LMT      H3B    C3B    C2B     108.340    3.000 
 LMT      O3B    C3B    C2B     109.470    3.000 
 LMT      C3B    O3B    HO3B    109.470    3.000 
 LMT      C3B    C2B    H2B     108.340    3.000 
 LMT      C3B    C2B    O2B     109.470    3.000 
 LMT      C3B    C2B    C1B     111.000    3.000 
 LMT      H2B    C2B    O2B     109.470    3.000 
 LMT      H2B    C2B    C1B     108.340    3.000 
 LMT      O2B    C2B    C1B     109.470    3.000 
 LMT      C2B    O2B    HO2B    109.470    3.000 
 LMT      'C5''  'O5''  'C1''   111.800    3.000 
 LMT      'O5''  'C1''  'H1''   109.470    3.000 
 LMT      'O5''  'C1''  'O1''   109.470    3.000 
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 LMT      'O5''  'C1''  'C2''   109.470    3.000 
 LMT      'H1''  'C1''  'O1''   109.470    3.000 
 LMT      'H1''  'C1''  'C2''   108.340    3.000 
 LMT      'O1''  'C1''  'C2''   109.470    3.000 
 LMT      'C1''  'O1''  C1      111.800    3.000 
 LMT      'O1''  C1     H11     109.470    3.000 
 LMT      'O1''  C1     H12     109.470    3.000 
 LMT      'O1''  C1     C2      109.470    3.000 
 LMT      H11    C1     H12     107.900    3.000 
 LMT      H11    C1     C2      109.470    3.000 
 LMT      H12    C1     C2      109.470    3.000 
 LMT      C1     C2     H21     109.470    3.000 
 LMT      C1     C2     H22     109.470    3.000 
 LMT      C1     C2     C3      111.000    3.000 
 LMT      H21    C2     H22     107.900    3.000 
 LMT      H21    C2     C3      109.470    3.000 
 LMT      H22    C2     C3      109.470    3.000 
 LMT      C2     C3     H31     109.470    3.000 
 LMT      C2     C3     H32     109.470    3.000 
 LMT      C2     C3     C4      111.000    3.000 
 LMT      H31    C3     H32     107.900    3.000 
 LMT      H31    C3     C4      109.470    3.000 
 LMT      H32    C3     C4      109.470    3.000 
 LMT      C3     C4     H41     109.470    3.000 
 LMT      C3     C4     H42     109.470    3.000 
 LMT      C3     C4     C5      111.000    3.000 
 LMT      H41    C4     H42     107.900    3.000 
 LMT      H41    C4     C5      109.470    3.000 
 LMT      H42    C4     C5      109.470    3.000 
 LMT      C4     C5     H51     109.470    3.000 
 LMT      C4     C5     H52     109.470    3.000 
 LMT      C4     C5     C6      111.000    3.000 
 LMT      H51    C5     H52     107.900    3.000 
 LMT      H51    C5     C6      109.470    3.000 
 LMT      H52    C5     C6      109.470    3.000 
 LMT      C5     C6     H61     109.470    3.000 
 LMT      C5     C6     H62     109.470    3.000 
 LMT      C5     C6     C7      111.000    3.000 
 LMT      H61    C6     H62     107.900    3.000 
 LMT      H61    C6     C7      109.470    3.000 
 LMT      H62    C6     C7      109.470    3.000 
 LMT      C6     C7     H71     109.470    3.000 
 LMT      C6     C7     H72     109.470    3.000 
 LMT      C6     C7     C8      111.000    3.000 
 LMT      H71    C7     H72     107.900    3.000 
 LMT      H71    C7     C8      109.470    3.000 
 LMT      H72    C7     C8      109.470    3.000 
 LMT      C7     C8     H81     109.470    3.000 
 LMT      C7     C8     H82     109.470    3.000 
 LMT      C7     C8     C9      111.000    3.000 
 LMT      H81    C8     H82     107.900    3.000 
 LMT      H81    C8     C9      109.470    3.000 
 LMT      H82    C8     C9      109.470    3.000 
 LMT      C8     C9     H91     109.470    3.000 
 LMT      C8     C9     H92     109.470    3.000 
 LMT      C8     C9     C10     111.000    3.000 
 LMT      H91    C9     H92     107.900    3.000 
 LMT      H91    C9     C10     109.470    3.000 
 LMT      H92    C9     C10     109.470    3.000 
 LMT      C9     C10    H101    109.470    3.000 
 LMT      C9     C10    H102    109.470    3.000 
 LMT      C9     C10    C11     111.000    3.000 
 LMT      H101   C10    H102    107.900    3.000 
 LMT      H101   C10    C11     109.470    3.000 
 LMT      H102   C10    C11     109.470    3.000 
 LMT      C10    C11    H111    109.470    3.000 
 LMT      C10    C11    H112    109.470    3.000 
 LMT      C10    C11    C12     111.000    3.000 
 LMT      H111   C11    H112    107.900    3.000 
 LMT      H111   C11    C12     109.470    3.000 
 LMT      H112   C11    C12     109.470    3.000 
 LMT      C11    C12    H123    109.470    3.000 
 LMT      C11    C12    H122    109.470    3.000 
 LMT      C11    C12    H121    109.470    3.000 
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 LMT      H123   C12    H122    109.470    3.000 
 LMT      H123   C12    H121    109.470    3.000 
 LMT      H122   C12    H121    109.470    3.000 
loop_ 
_chem_comp_tor.comp_id 
_chem_comp_tor.id 
_chem_comp_tor.atom_id_1 
_chem_comp_tor.atom_id_2 
_chem_comp_tor.atom_id_3 
_chem_comp_tor.atom_id_4 
_chem_comp_tor.value_angle 
_chem_comp_tor.value_angle_esd 
_chem_comp_tor.period 
 LMT      var_1    'HO6'' 'O6''  'C6''  'C5''    175.000   20.000   1 
 LMT      var_2    'O6''  'C6''  'C5''  'O5''    175.000   20.000   3 
 LMT      var_3    'C6''  'C5''  'C4''  O1B       60.000   20.000   3 
 LMT      var_4    'C5''  'C4''  'C3''  'C2''      0.000   20.000   3 
 LMT      var_5    'C4''  'C3''  'O3''  'HO3''   175.000   20.000   1 
 LMT      var_6    'C4''  'C3''  'C2''  'O2''    180.000   20.000   3 
 LMT      var_7    'C3''  'C2''  'O2''  'HO2''   175.000   20.000   1 
 LMT      var_8    'C5''  'C4''  O1B    C1B      175.000   20.000   1 
 LMT      var_9    'C4''  O1B    C1B    O5B      175.000   20.000   1 
 LMT      var_10   O1B    C1B    C2B    C3B      180.000   20.000   3 
 LMT      var_11   O1B    C1B    O5B    C5B     -120.000   20.000   1 
 LMT      var_12   C1B    O5B    C5B    C4B      -60.000   20.000   1 
 LMT      var_13   O5B    C5B    C6B    O6B      175.000   20.000   3 
 LMT      var_14   C5B    C6B    O6B    HO6B     175.000   20.000   1 
 LMT      var_15   O5B    C5B    C4B    C3B       60.000   20.000   3 
 LMT      var_16   C5B    C4B    'O4''  'HO4''   175.000   20.000   1 
 LMT      var_17   C5B    C4B    C3B    C2B        0.000   20.000   3 
 LMT      var_18   C4B    C3B    O3B    HO3B     175.000   20.000   1 
 LMT      var_19   C4B    C3B    C2B    O2B      180.000   20.000   3 
 LMT      var_20   C3B    C2B    O2B    HO2B     175.000   20.000   1 
 LMT      var_21   'C6''  'C5''  'O5''  'C1''    180.000   20.000   1 
 LMT      var_22   'C5''  'O5''  'C1''  'O1''   -120.000   20.000   1 
 LMT      var_23   'O5''  'C1''  'C2''  'C3''     60.000   20.000   3 
 LMT      var_24   'O5''  'C1''  'O1''  C1       175.000   20.000   1 
 LMT      var_25   'C1''  'O1''  C1     C2       175.000   20.000   1 
 LMT      var_26   'O1''  C1     C2     C3       175.000   20.000   3 
 LMT      var_27   C1     C2     C3     C4       175.000   20.000   3 
 LMT      var_28   C2     C3     C4     C5       175.000   20.000   3 
 LMT      var_29   C3     C4     C5     C6       175.000   20.000   3 
 LMT      var_30   C4     C5     C6     C7       175.000   20.000   3 
 LMT      var_31   C5     C6     C7     C8       175.000   20.000   3 
 LMT      var_32   C6     C7     C8     C9       175.000   20.000   3 
 LMT      var_33   C7     C8     C9     C10      175.000   20.000   3 
 LMT      var_34   C8     C9     C10    C11      175.000   20.000   3 
 LMT      var_35   C9     C10    C11    C12      175.000   20.000   3 
 LMT      var_36   C10    C11    C12    H121     175.000   20.000   3 
loop_ 
_chem_comp_chir.comp_id 
_chem_comp_chir.id 
_chem_comp_chir.atom_id_centre 
_chem_comp_chir.atom_id_1 
_chem_comp_chir.atom_id_2 
_chem_comp_chir.atom_id_3 
_chem_comp_chir.volume_sign 
 LMT      chir_01  C1B    C2B    O1B    O5B       negativ 
 LMT      chir_02  C2B    C1B    C3B    O2B       negativ 
 LMT      chir_03  C3B    C2B    C4B    O3B       positiv 
 LMT      chir_04  C4B    C3B    C5B    'O4''     negativ 
 LMT      chir_05  C5B    C4B    C6B    O5B       negativ 
 LMT      chir_06  'C1''  'C2''  'O1''  'O5''     positiv 
 LMT      chir_07  'C2''  'C1''  'C3''  'O2''     negativ 
 LMT      chir_08  'C3''  'C2''  'C4''  'O3''     positiv 
 LMT      chir_09  'C4''  O1B    'C3''  'C5''     negativ 
 LMT      chir_10  'C5''  'C4''  'C6''  'O5''     negativ 
# 
data_comp_FAD 
# 
loop_ 
_chem_comp_atom.comp_id 
_chem_comp_atom.atom_id 
_chem_comp_atom.type_symbol 
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_chem_comp_atom.type_energy 
_chem_comp_atom.partial_charge 
_chem_comp_atom.x 
_chem_comp_atom.y 
_chem_comp_atom.z 
 FAD           O2P    O    OP       -0.500      0.000    0.000    0.000 
 FAD           P      P    P         0.000      1.068    1.068    0.000 
 FAD           O1P    O    OP       -0.500      2.063    1.137    1.134 
 FAD           'O5''  O    O2        0.000      1.964    0.883   -1.325 
 FAD           'C5''  C    CH2       0.000      2.988    1.822   -1.642 
 FAD           'H5'1' H    H         0.000      3.673    1.914   -0.797 
 FAD           'H5'2' H    H         0.000      2.538    2.795   -1.851 
 FAD           'C4''  C    CH1       0.000      3.755    1.342   -2.869 
 FAD           'H4''  H    H         0.000      4.273    0.404   -2.628 
 FAD           'O4''  O    OH1       0.000      2.838    1.111   -3.945 
 FAD           'HO4'' H    H         0.000      3.331    0.883   -4.745 
 FAD           'C3''  C    CH1       0.000      4.779    2.380   -3.314 
 FAD           'H3''  H    H         0.000      4.254    3.289   -3.641 
 FAD           'O3''  O    OH1       0.000      5.640    2.702   -2.216 
 FAD           'HO3'' H    H         0.000      6.337    3.300   -2.518 
 FAD           'C2''  C    CH1       0.000      5.629    1.851   -4.463 
 FAD           'H2''  H    H         0.000      4.970    1.517   -5.276 
 FAD           'O2''  O    OH1       0.000      6.412    0.743   -4.006 
 FAD           'HO2'' H    H         0.000      6.892    0.358   -4.752 
 FAD           'C1''  C    CH2       0.000      6.568    2.930   -4.989 
 FAD           'H1'1' H    H         0.000      7.168    3.322   -4.165 
 FAD           'H1'2' H    H         0.000      5.982    3.740   -5.428 
 FAD           N10    N    NR6       0.000      7.450    2.355   -6.008 
 FAD           C9A    C    CR66      0.000      7.411    1.043   -6.263 
 FAD           C9     C    CR16      0.000      6.534    0.225   -5.561 
 FAD           H9     H    H         0.000      5.882    0.650   -4.808 
 FAD           C8     C    CR6       0.000      6.493   -1.139   -5.826 
 FAD           C8M    C    CH3       0.000      5.543   -2.026   -5.065 
 FAD           H8M3   H    H         0.000      5.815   -2.040   -4.042 
 FAD           H8M2   H    H         0.000      4.557   -1.652   -5.163 
 FAD           H8M1   H    H         0.000      5.588   -3.009   -5.456 
 FAD           C7     C    CR6       0.000      7.326   -1.682   -6.788 
 FAD           C7M    C    CH3       0.000      7.282   -3.160   -7.075 
 FAD           H7M3   H    H         0.000      7.607   -3.695   -6.221 
 FAD           H7M2   H    H         0.000      6.290   -3.444   -7.314 
 FAD           H7M1   H    H         0.000      7.919   -3.380   -7.893 
 FAD           C6     C    CR16      0.000      8.203   -0.864   -7.490 
 FAD           H6     H    H         0.000      8.854   -1.290   -8.243 
 FAD           C5X    C    CR66      0.000      8.247    0.498   -7.229 
 FAD           N5     N    NRD6      0.000      9.099    1.293   -7.911 
 FAD           C10    C    CR66      0.000      8.293    3.143   -6.683 
 FAD           C4X    C    CR66      0.000      9.130    2.597   -7.650 
 FAD           C4     C    CR6       0.000     10.007    3.416   -8.352 
 FAD           O4     O    OH1       0.000     10.827    2.881   -9.299 
 FAD           HO4    H    H         0.000     11.312    3.591   -9.743 
 FAD           N3     N    NRD6      0.000     10.047    4.741   -8.094 
 FAD           C2     C    CR6       0.000      9.234    5.270   -7.155 
 FAD           O2     O    O         0.000      9.271    6.497   -6.917 
 FAD           N1     N    NRD6      0.000      8.333    4.467   -6.426 
 FAD           O3P    O    O2        0.000      0.342    2.505    0.000 
 FAD           PA     P    P         0.000      1.207    3.857    0.121 
 FAD           O1A    O    OP       -0.500      1.868    3.874    1.478 
 FAD           O2A    O    OP       -0.500      2.243    3.854   -0.978 
 FAD           O5B    O    O2        0.000      0.092    5.005   -0.058 
 FAD           C5B    C    CH2       0.000      0.438    6.380    0.092 
 FAD           H5B1   H    H         0.000      1.264    6.622   -0.580 
 FAD           H5B2   H    H         0.000      0.742    6.568    1.123 
 FAD           C4B    C    CH1       0.000     -0.768    7.247   -0.251 
 FAD           H4B    H    H         0.000     -1.651    6.921    0.316 
 FAD           C3B    C    CH1       0.000     -0.475    8.719    0.016 
 FAD           H3B    H    H         0.000     -1.162    9.090    0.788 
 FAD           O3B    O    OH1       0.000      0.873    8.862    0.476 
 FAD           HO3B   H    H         0.000      1.084    9.801    0.570 
 FAD           C2B    C    CH1       0.000     -0.649    9.548   -1.251 
 FAD           H2B    H    H         0.000      0.290   10.076   -1.470 
 FAD           O2B    O    OH1       0.000     -1.694   10.508   -1.053 
 FAD           HO2B   H    H         0.000     -1.751   11.085   -1.827 
 FAD           C1B    C    CH1       0.000     -1.016    8.664   -2.437 
 FAD           H1B    H    H         0.000     -0.233    8.737   -3.204 
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 FAD           O4B    O    O2        0.000     -1.132    7.311   -2.003 
 FAD           N9A    N    NR5       0.000     -2.311    9.114   -3.008 
 FAD           C4A    C    CR56      0.000     -2.894    8.632   -4.110 
 FAD           C5A    C    CR56      0.000     -4.087    9.318   -4.301 
 FAD           N7A    N    NRD5      0.000     -4.216   10.217   -3.301 
 FAD           C8A    C    CR15      0.000     -3.136   10.106   -2.499 
 FAD           H8A    H    H         0.000     -2.946   10.692   -1.608 
 FAD           N3A    N    NRD6      0.000     -2.522    7.665   -4.983 
 FAD           C2A    C    CR16      0.000     -3.303    7.370   -6.027 
 FAD           H2A    H    H         0.000     -3.006    6.597   -6.725 
 FAD           N1A    N    NRD6      0.000     -4.451    8.030   -6.210 
 FAD           C6A    C    CR6       0.000     -4.822    8.994   -5.341 
 FAD           N6A    N    N         0.000     -5.986    9.663   -5.526 
 FAD           HN6A   H    H         0.000     -6.247   10.344   -4.912 
loop_ 
_chem_comp_tree.comp_id 
_chem_comp_tree.atom_id 
_chem_comp_tree.atom_back 
_chem_comp_tree.atom_forward 
_chem_comp_tree.connect_type 
 FAD      O2P    P      .      . 
 FAD      P      O3P    'O5''  . 
 FAD      O1P    P      .      . 
 FAD      'O5''  P      'C5''  . 
 FAD      'C5''  'O5''  'C4''  . 
 FAD      'H5'1' 'C5''  .      . 
 FAD      'H5'2' 'C5''  .      . 
 FAD      'C4''  'C5''  'C3''  . 
 FAD      'H4''  'C4''  .      . 
 FAD      'O4''  'C4''  'HO4'' . 
 FAD      'HO4'' 'O4''  .      . 
 FAD      'C3''  'C4''  'C2''  . 
 FAD      'H3''  'C3''  .      . 
 FAD      'O3''  'C3''  'HO3'' . 
 FAD      'HO3'' 'O3''  .      . 
 FAD      'C2''  'C3''  'C1''  . 
 FAD      'H2''  'C2''  .      . 
 FAD      'O2''  'C2''  'HO2'' . 
 FAD      'HO2'' 'O2''  .      . 
 FAD      'C1''  'C2''  N10    . 
 FAD      'H1'1' 'C1''  .      . 
 FAD      'H1'2' 'C1''  .      . 
 FAD      N10    'C1''  C10    . 
 FAD      C9A    C5X    .      . 
 FAD      C9     C8     H9     . 
 FAD      H9     C9     .      END 
 FAD      C8     C7     C9     . 
 FAD      C8M    C8     H8M3   . 
 FAD      H8M3   C8M    .      . 
 FAD      H8M2   C8M    .      . 
 FAD      H8M1   C8M    .      . 
 FAD      C7     C6     C8     . 
 FAD      C7M    C7     H7M3   . 
 FAD      H7M3   C7M    .      . 
 FAD      H7M2   C7M    .      . 
 FAD      H7M1   C7M    .      . 
 FAD      C6     C5X    C7     . 
 FAD      H6     C6     .      . 
 FAD      C5X    N5     C6     . 
 FAD      N5     C4X    C5X    . 
 FAD      C10    N10    N1     . 
 FAD      C4X    C4     N5     . 
 FAD      C4     N3     C4X    . 
 FAD      O4     C4     HO4    . 
 FAD      HO4    O4     .      . 
 FAD      N3     C2     C4     . 
 FAD      C2     N1     N3     . 
 FAD      O2     C2     .      . 
 FAD      N1     C10    C2     . 
 FAD      O3P    PA     P      . 
 FAD      PA     O2A    O3P    . 
 FAD      O1A    PA     .      . 
 FAD      O2A    n/a    PA     START 
 FAD      O5B    PA     C5B    . 
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 FAD      C5B    O5B    C4B    . 
 FAD      H5B1   C5B    .      . 
 FAD      H5B2   C5B    .      . 
 FAD      C4B    C5B    O4B    . 
 FAD      H4B    C4B    .      . 
 FAD      C3B    C2B    O3B    . 
 FAD      H3B    C3B    .      . 
 FAD      O3B    C3B    HO3B   . 
 FAD      HO3B   O3B    .      . 
 FAD      C2B    C1B    C3B    . 
 FAD      H2B    C2B    .      . 
 FAD      O2B    C2B    HO2B   . 
 FAD      HO2B   O2B    .      . 
 FAD      C1B    O4B    C2B    . 
 FAD      H1B    C1B    .      . 
 FAD      O4B    C4B    C1B    . 
 FAD      N9A    C1B    C8A    . 
 FAD      C4A    N3A    .      . 
 FAD      C5A    N7A    C6A    . 
 FAD      N7A    C8A    C5A    . 
 FAD      C8A    N9A    N7A    . 
 FAD      H8A    C8A    .      . 
 FAD      N3A    C2A    C4A    . 
 FAD      C2A    N1A    N3A    . 
 FAD      H2A    C2A    .      . 
 FAD      N1A    C6A    C2A    . 
 FAD      C6A    C5A    N1A    . 
 FAD      N6A    C6A    HN6A   . 
 FAD      HN6A   N6A    .      . 
 FAD      N10    C9A    .    ADD 
 FAD      C9A    C9     .    ADD 
 FAD      C10    C4X    .    ADD 
 FAD      C4B    C3B    .    ADD 
 FAD      N9A    C4A    .    ADD 
 FAD      C4A    C5A    .    ADD 
loop_ 
_chem_comp_bond.comp_id 
_chem_comp_bond.atom_id_1 
_chem_comp_bond.atom_id_2 
_chem_comp_bond.type 
_chem_comp_bond.value_dist 
_chem_comp_bond.value_dist_esd 
 FAD      O1A    PA        deloc       1.510    0.020 
 FAD      O2A    PA        deloc       1.510    0.020 
 FAD      O5B    PA        single      1.610    0.020 
 FAD      PA     O3P       single      1.610    0.020 
 FAD      C5B    O5B       single      1.426    0.020 
 FAD      C4B    C5B       single      1.524    0.020 
 FAD      C4B    O4B       single      1.426    0.020 
 FAD      C3B    C4B       single      1.524    0.020 
 FAD      O4B    C1B       single      1.426    0.020 
 FAD      O3B    C3B       single      1.432    0.020 
 FAD      C2B    C3B       single      1.524    0.020 
 FAD      O2B    C2B       single      1.432    0.020 
 FAD      C1B    C2B       single      1.524    0.020 
 FAD      N9A    C1B       single      1.485    0.020 
 FAD      N9A    C8A       aromatic    1.337    0.020 
 FAD      C4A    N9A       aromatic    1.337    0.020 
 FAD      C8A    N7A       aromatic    1.350    0.020 
 FAD      N7A    C5A       aromatic    1.350    0.020 
 FAD      C5A    C6A       aromatic    1.390    0.020 
 FAD      C5A    C4A       aromatic    1.390    0.020 
 FAD      N6A    C6A       double      1.355    0.020 
 FAD      C6A    N1A       aromatic    1.350    0.020 
 FAD      N1A    C2A       aromatic    1.337    0.020 
 FAD      C2A    N3A       aromatic    1.337    0.020 
 FAD      N3A    C4A       aromatic    1.355    0.020 
 FAD      N1     C2        aromatic    1.350    0.020 
 FAD      N1     C10       aromatic    1.350    0.020 
 FAD      O2     C2        double      1.250    0.020 
 FAD      C2     N3        aromatic    1.350    0.020 
 FAD      N3     C4        aromatic    1.350    0.020 
 FAD      O4     C4        single      1.362    0.020 
 FAD      C4     C4X       aromatic    1.390    0.020 
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 FAD      C4X    N5        aromatic    1.350    0.020 
 FAD      C4X    C10       aromatic    1.390    0.020 
 FAD      N5     C5X       deloc       1.350    0.020 
 FAD      C5X    C6        aromatic    1.390    0.020 
 FAD      C5X    C9A       aromatic    1.390    0.020 
 FAD      C6     C7        aromatic    1.390    0.020 
 FAD      C7M    C7        single      1.506    0.020 
 FAD      C7     C8        aromatic    1.384    0.020 
 FAD      C8M    C8        single      1.506    0.020 
 FAD      C8     C9        aromatic    1.390    0.020 
 FAD      C9     C9A       aromatic    1.390    0.020 
 FAD      C9A    N10       aromatic    1.337    0.020 
 FAD      C10    N10       deloc       1.337    0.020 
 FAD      N10    'C1''     single      1.465    0.020 
 FAD      'C1''  'C2''     single      1.524    0.020 
 FAD      'O2''  'C2''     single      1.432    0.020 
 FAD      'C2''  'C3''     single      1.524    0.020 
 FAD      'O3''  'C3''     single      1.432    0.020 
 FAD      'C3''  'C4''     single      1.524    0.020 
 FAD      'O4''  'C4''     single      1.432    0.020 
 FAD      'C4''  'C5''     single      1.524    0.020 
 FAD      'C5''  'O5''     single      1.426    0.020 
 FAD      'O5''  P         single      1.610    0.020 
 FAD      O1P    P         deloc       1.510    0.020 
 FAD      P      O2P       deloc       1.510    0.020 
 FAD      O3P    P         single      1.610    0.020 
 FAD      H5B1   C5B       single      1.092    0.020 
 FAD      H5B2   C5B       single      1.092    0.020 
 FAD      H4B    C4B       single      1.099    0.020 
 FAD      H3B    C3B       single      1.099    0.020 
 FAD      HO3B   O3B       single      0.967    0.020 
 FAD      H2B    C2B       single      1.099    0.020 
 FAD      HO2B   O2B       single      0.967    0.020 
 FAD      H1B    C1B       single      1.099    0.020 
 FAD      H8A    C8A       single      1.083    0.020 
 FAD      HN6A   N6A       single      0.954    0.020 
 FAD      H2A    C2A       single      1.083    0.020 
 FAD      HO4    O4        single      0.967    0.020 
 FAD      H6     C6        single      1.083    0.020 
 FAD      H7M1   C7M       single      1.059    0.020 
 FAD      H7M2   C7M       single      1.059    0.020 
 FAD      H7M3   C7M       single      1.059    0.020 
 FAD      H8M1   C8M       single      1.059    0.020 
 FAD      H8M2   C8M       single      1.059    0.020 
 FAD      H8M3   C8M       single      1.059    0.020 
 FAD      H9     C9        single      1.083    0.020 
 FAD      'H1'1' 'C1''     single      1.092    0.020 
 FAD      'H1'2' 'C1''     single      1.092    0.020 
 FAD      'H2''  'C2''     single      1.099    0.020 
 FAD      'HO2'' 'O2''     single      0.967    0.020 
 FAD      'H3''  'C3''     single      1.099    0.020 
 FAD      'HO3'' 'O3''     single      0.967    0.020 
 FAD      'H4''  'C4''     single      1.099    0.020 
 FAD      'HO4'' 'O4''     single      0.967    0.020 
 FAD      'H5'1' 'C5''     single      1.092    0.020 
 FAD      'H5'2' 'C5''     single      1.092    0.020 
loop_ 
_chem_comp_angle.comp_id 
_chem_comp_angle.atom_id_1 
_chem_comp_angle.atom_id_2 
_chem_comp_angle.atom_id_3 
_chem_comp_angle.value_angle 
_chem_comp_angle.value_angle_esd 
 FAD      O2P    P      O1P     119.900    3.000 
 FAD      O2P    P      'O5''   108.200    3.000 
 FAD      O2P    P      O3P     108.200    3.000 
 FAD      O1P    P      'O5''   108.200    3.000 
 FAD      O1P    P      O3P     108.200    3.000 
 FAD      'O5''  P      O3P     102.600    3.000 
 FAD      P      'O5''  'C5''   120.500    3.000 
 FAD      'O5''  'C5''  'H5'1'  109.470    3.000 
 FAD      'O5''  'C5''  'H5'2'  109.470    3.000 
 FAD      'O5''  'C5''  'C4''   109.470    3.000 
 FAD      'H5'1' 'C5''  'H5'2'  107.900    3.000 
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 FAD      'H5'1' 'C5''  'C4''   109.470    3.000 
 FAD      'H5'2' 'C5''  'C4''   109.470    3.000 
 FAD      'C5''  'C4''  'H4''   108.340    3.000 
 FAD      'C5''  'C4''  'O4''   109.470    3.000 
 FAD      'C5''  'C4''  'C3''   111.000    3.000 
 FAD      'H4''  'C4''  'O4''   109.470    3.000 
 FAD      'H4''  'C4''  'C3''   108.340    3.000 
 FAD      'O4''  'C4''  'C3''   109.470    3.000 
 FAD      'C4''  'O4''  'HO4''  109.470    3.000 
 FAD      'C4''  'C3''  'H3''   108.340    3.000 
 FAD      'C4''  'C3''  'O3''   109.470    3.000 
 FAD      'C4''  'C3''  'C2''   111.000    3.000 
 FAD      'H3''  'C3''  'O3''   109.470    3.000 
 FAD      'H3''  'C3''  'C2''   108.340    3.000 
 FAD      'O3''  'C3''  'C2''   109.470    3.000 
 FAD      'C3''  'O3''  'HO3''  109.470    3.000 
 FAD      'C3''  'C2''  'H2''   108.340    3.000 
 FAD      'C3''  'C2''  'O2''   109.470    3.000 
 FAD      'C3''  'C2''  'C1''   111.000    3.000 
 FAD      'H2''  'C2''  'O2''   109.470    3.000 
 FAD      'H2''  'C2''  'C1''   108.340    3.000 
 FAD      'O2''  'C2''  'C1''   109.470    3.000 
 FAD      'C2''  'O2''  'HO2''  109.470    3.000 
 FAD      'C2''  'C1''  'H1'1'  109.470    3.000 
 FAD      'C2''  'C1''  'H1'2'  109.470    3.000 
 FAD      'C2''  'C1''  N10     109.470    3.000 
 FAD      'H1'1' 'C1''  'H1'2'  107.900    3.000 
 FAD      'H1'1' 'C1''  N10     109.470    3.000 
 FAD      'H1'2' 'C1''  N10     109.470    3.000 
 FAD      'C1''  N10    C9A     120.000    3.000 
 FAD      'C1''  N10    C10     120.000    3.000 
 FAD      C9A    N10    C10     120.000    3.000 
 FAD      N10    C9A    C9      120.000    3.000 
 FAD      N10    C9A    C5X     120.000    3.000 
 FAD      C9     C9A    C5X     120.000    3.000 
 FAD      C9A    C9     H9      120.000    3.000 
 FAD      C9A    C9     C8      120.000    3.000 
 FAD      H9     C9     C8      120.000    3.000 
 FAD      C9     C8     C8M     120.000    3.000 
 FAD      C9     C8     C7      120.000    3.000 
 FAD      C8M    C8     C7      120.000    3.000 
 FAD      C8     C8M    H8M3    109.470    3.000 
 FAD      C8     C8M    H8M2    109.470    3.000 
 FAD      C8     C8M    H8M1    109.470    3.000 
 FAD      H8M3   C8M    H8M2    109.470    3.000 
 FAD      H8M3   C8M    H8M1    109.470    3.000 
 FAD      H8M2   C8M    H8M1    109.470    3.000 
 FAD      C8     C7     C7M     120.000    3.000 
 FAD      C8     C7     C6      120.000    3.000 
 FAD      C7M    C7     C6      120.000    3.000 
 FAD      C7     C7M    H7M3    109.470    3.000 
 FAD      C7     C7M    H7M2    109.470    3.000 
 FAD      C7     C7M    H7M1    109.470    3.000 
 FAD      H7M3   C7M    H7M2    109.470    3.000 
 FAD      H7M3   C7M    H7M1    109.470    3.000 
 FAD      H7M2   C7M    H7M1    109.470    3.000 
 FAD      C7     C6     H6      120.000    3.000 
 FAD      C7     C6     C5X     120.000    3.000 
 FAD      H6     C6     C5X     120.000    3.000 
 FAD      C9A    C5X    N5      120.000    3.000 
 FAD      C9A    C5X    C6      120.000    3.000 
 FAD      N5     C5X    C6      120.000    3.000 
 FAD      C5X    N5     C4X     120.000    3.000 
 FAD      N10    C10    C4X     120.000    3.000 
 FAD      N10    C10    N1      120.000    3.000 
 FAD      C4X    C10    N1      120.000    3.000 
 FAD      C10    C4X    C4      120.000    3.000 
 FAD      C10    C4X    N5      120.000    3.000 
 FAD      C4     C4X    N5      120.000    3.000 
 FAD      C4X    C4     O4      120.000    3.000 
 FAD      C4X    C4     N3      120.000    3.000 
 FAD      O4     C4     N3      120.000    3.000 
 FAD      C4     O4     HO4     109.470    3.000 
 FAD      C4     N3     C2      120.000    3.000 
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 FAD      N3     C2     O2      120.000    3.000 
 FAD      N3     C2     N1      120.000    3.000 
 FAD      O2     C2     N1      120.000    3.000 
 FAD      C10    N1     C2      120.000    3.000 
 FAD      P      O3P    PA      120.500    3.000 
 FAD      O3P    PA     O1A     108.200    3.000 
 FAD      O3P    PA     O2A     108.200    3.000 
 FAD      O3P    PA     O5B     102.600    3.000 
 FAD      O1A    PA     O2A     119.900    3.000 
 FAD      O1A    PA     O5B     108.200    3.000 
 FAD      O2A    PA     O5B     108.200    3.000 
 FAD      PA     O5B    C5B     120.500    3.000 
 FAD      O5B    C5B    H5B1    109.470    3.000 
 FAD      O5B    C5B    H5B2    109.470    3.000 
 FAD      O5B    C5B    C4B     109.470    3.000 
 FAD      H5B1   C5B    H5B2    107.900    3.000 
 FAD      H5B1   C5B    C4B     109.470    3.000 
 FAD      H5B2   C5B    C4B     109.470    3.000 
 FAD      C5B    C4B    H4B     108.340    3.000 
 FAD      C5B    C4B    C3B     111.000    3.000 
 FAD      C5B    C4B    O4B     109.470    3.000 
 FAD      H4B    C4B    C3B     108.340    3.000 
 FAD      H4B    C4B    O4B     109.470    3.000 
 FAD      C3B    C4B    O4B     109.470    3.000 
 FAD      C4B    C3B    H3B     108.340    3.000 
 FAD      C4B    C3B    O3B     109.470    3.000 
 FAD      C4B    C3B    C2B     111.000    3.000 
 FAD      H3B    C3B    O3B     109.470    3.000 
 FAD      H3B    C3B    C2B     108.340    3.000 
 FAD      O3B    C3B    C2B     109.470    3.000 
 FAD      C3B    O3B    HO3B    109.470    3.000 
 FAD      C3B    C2B    H2B     108.340    3.000 
 FAD      C3B    C2B    O2B     109.470    3.000 
 FAD      C3B    C2B    C1B     111.000    3.000 
 FAD      H2B    C2B    O2B     109.470    3.000 
 FAD      H2B    C2B    C1B     108.340    3.000 
 FAD      O2B    C2B    C1B     109.470    3.000 
 FAD      C2B    O2B    HO2B    109.470    3.000 
 FAD      C2B    C1B    H1B     108.340    3.000 
 FAD      C2B    C1B    O4B     109.470    3.000 
 FAD      C2B    C1B    N9A     109.470    3.000 
 FAD      H1B    C1B    O4B     109.470    3.000 
 FAD      H1B    C1B    N9A     109.470    3.000 
 FAD      O4B    C1B    N9A     109.470    3.000 
 FAD      C1B    O4B    C4B     111.800    3.000 
 FAD      C1B    N9A    C4A     126.000    3.000 
 FAD      C1B    N9A    C8A     126.000    3.000 
 FAD      C4A    N9A    C8A     108.000    3.000 
 FAD      N9A    C4A    C5A     108.000    3.000 
 FAD      N9A    C4A    N3A     132.000    3.000 
 FAD      C5A    C4A    N3A     120.000    3.000 
 FAD      C4A    C5A    N7A     108.000    3.000 
 FAD      C4A    C5A    C6A     120.000    3.000 
 FAD      N7A    C5A    C6A     132.000    3.000 
 FAD      C5A    N7A    C8A     108.000    3.000 
 FAD      N7A    C8A    H8A     126.000    3.000 
 FAD      N7A    C8A    N9A     108.000    3.000 
 FAD      H8A    C8A    N9A     126.000    3.000 
 FAD      C4A    N3A    C2A     120.000    3.000 
 FAD      N3A    C2A    H2A     120.000    3.000 
 FAD      N3A    C2A    N1A     120.000    3.000 
 FAD      H2A    C2A    N1A     120.000    3.000 
 FAD      C2A    N1A    C6A     120.000    3.000 
 FAD      N1A    C6A    N6A     120.000    3.000 
 FAD      N1A    C6A    C5A     120.000    3.000 
 FAD      N6A    C6A    C5A     120.000    3.000 
 FAD      C6A    N6A    HN6A    120.000    3.000 
loop_ 
_chem_comp_tor.comp_id 
_chem_comp_tor.id 
_chem_comp_tor.atom_id_1 
_chem_comp_tor.atom_id_2 
_chem_comp_tor.atom_id_3 
_chem_comp_tor.atom_id_4 
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_chem_comp_tor.value_angle 
_chem_comp_tor.value_angle_esd 
_chem_comp_tor.period 
 FAD      var_1    O2P    P      'O5''  'C5''    175.000   20.000   1 
 FAD      var_2    P      'O5''  'C5''  'C4''    175.000   20.000   1 
 FAD      var_3    'O5''  'C5''  'C4''  'C3''    175.000   20.000   3 
 FAD      var_4    'C5''  'C4''  'O4''  'HO4''   175.000   20.000   1 
 FAD      var_5    'C5''  'C4''  'C3''  'C2''    175.000   20.000   3 
 FAD      var_6    'C4''  'C3''  'O3''  'HO3''   175.000   20.000   1 
 FAD      var_7    'C4''  'C3''  'C2''  'C1''    175.000   20.000   3 
 FAD      var_8    'C3''  'C2''  'O2''  'HO2''   175.000   20.000   1 
 FAD      var_9    'C3''  'C2''  'C1''  N10      175.000   20.000   3 
 FAD      var_10   'C2''  'C1''  N10    C10      175.000   20.000   1 
 FAD      CONST_1  'C1''  N10    C9A    C5X      180.000    0.000   0 
 FAD      CONST_2  N10    C9A    C9     C8       180.000    0.000   0 
 FAD      CONST_3  C9A    C9     C8     C7         0.000    0.000   0 
 FAD      var_11   C9     C8     C8M    H8M1     175.000   20.000   1 
 FAD      CONST_4  C9     C8     C7     C6         0.000    0.000   0 
 FAD      var_12   C8     C7     C7M    H7M1     175.000   20.000   1 
 FAD      CONST_5  C8     C7     C6     C5X        0.000    0.000   0 
 FAD      CONST_6  N10    C9A    C5X    N5         0.000    0.000   0 
 FAD      CONST_7  C9A    C5X    C6     C7         0.000    0.000   0 
 FAD      CONST_8  C9A    C5X    N5     C4X        0.000    0.000   0 
 FAD      CONST_9  'C1''  N10    C10    N1         0.000    0.000   0 
 FAD      CONST_10 N10    C10    C4X    C4       180.000    0.000   0 
 FAD      CONST_11 C10    C4X    N5     C5X        0.000    0.000   0 
 FAD      CONST_12 C10    C4X    C4     N3         0.000    0.000   0 
 FAD      var_13   C4X    C4     O4     HO4      175.000   20.000   1 
 FAD      CONST_13 C4X    C4     N3     C2         0.000    0.000   0 
 FAD      CONST_14 C4     N3     C2     O2       180.000    0.000   0 
 FAD      CONST_15 N10    C10    N1     C2       180.000    0.000   0 
 FAD      CONST_16 C10    N1     C2     N3         0.000    0.000   0 
 FAD      var_14   O2P    P      O3P    PA       175.000   20.000   1 
 FAD      var_15   P      O3P    PA     O5B      175.000   20.000   1 
 FAD      var_16   O3P    PA     O5B    C5B      175.000   20.000   1 
 FAD      var_17   PA     O5B    C5B    C4B      175.000   20.000   1 
 FAD      var_18   O5B    C5B    C4B    C3B      175.000   20.000   3 
 FAD      var_19   C5B    C4B    O4B    C1B     -150.000   20.000   1 
 FAD      var_20   C5B    C4B    C3B    C2B      180.000   20.000   3 
 FAD      var_21   C4B    C3B    O3B    HO3B     175.000   20.000   1 
 FAD      var_22   C4B    C3B    C2B    C1B      -60.000   20.000   3 
 FAD      var_23   C3B    C2B    O2B    HO2B     175.000   20.000   1 
 FAD      var_24   C3B    C2B    C1B    N9A      150.000   20.000   3 
 FAD      var_25   C2B    C1B    O4B    C4B        0.000   20.000   1 
 FAD      var_26   C2B    C1B    N9A    C4A      175.000   20.000   1 
 FAD      CONST_17 C1B    N9A    C8A    N7A      180.000    0.000   0 
 FAD      CONST_18 C1B    N9A    C4A    N3A        0.000    0.000   0 
 FAD      CONST_19 N9A    C4A    C5A    N7A        0.000    0.000   0 
 FAD      CONST_20 C4A    C5A    C6A    N1A        0.000    0.000   0 
 FAD      CONST_21 C4A    C5A    N7A    C8A        0.000    0.000   0 
 FAD      CONST_22 C5A    N7A    C8A    N9A        0.000    0.000   0 
 FAD      CONST_23 N9A    C4A    N3A    C2A      180.000    0.000   0 
 FAD      CONST_24 C4A    N3A    C2A    N1A        0.000    0.000   0 
 FAD      CONST_25 N3A    C2A    N1A    C6A        0.000    0.000   0 
 FAD      CONST_26 C2A    N1A    C6A    N6A      180.000    0.000   0 
 FAD      CONST_27 N1A    C6A    N6A    HN6A     180.000    0.000   0 
loop_ 
_chem_comp_chir.comp_id 
_chem_comp_chir.id 
_chem_comp_chir.atom_id_centre 
_chem_comp_chir.atom_id_1 
_chem_comp_chir.atom_id_2 
_chem_comp_chir.atom_id_3 
_chem_comp_chir.volume_sign 
 FAD      chir_01  C4B    C5B    O4B    C3B       negativ 
 FAD      chir_02  C3B    C4B    O3B    C2B       negativ 
 FAD      chir_03  C2B    C3B    O2B    C1B       negativ 
 FAD      chir_04  C1B    O4B    C2B    N9A       positiv 
 FAD      chir_05  'C2''  'C1''  'O2''  'C3''     positiv 
 FAD      chir_06  'C3''  'C2''  'O3''  'C4''     positiv 
 FAD      chir_07  'C4''  'C3''  'O4''  'C5''     positiv 
loop_ 
_chem_comp_plane_atom.comp_id 
_chem_comp_plane_atom.plane_id 
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_chem_comp_plane_atom.atom_id 
_chem_comp_plane_atom.dist_esd 
 FAD      plan-1    N9A       0.020 
 FAD      plan-1    C1B       0.020 
 FAD      plan-1    C8A       0.020 
 FAD      plan-1    C4A       0.020 
 FAD      plan-1    N7A       0.020 
 FAD      plan-1    H8A       0.020 
 FAD      plan-1    C5A       0.020 
 FAD      plan-1    C6A       0.020 
 FAD      plan-1    N1A       0.020 
 FAD      plan-1    C2A       0.020 
 FAD      plan-1    N3A       0.020 
 FAD      plan-1    N6A       0.020 
 FAD      plan-1    HN6A      0.020 
 FAD      plan-1    H2A       0.020 
 FAD      plan-2    N1        0.020 
 FAD      plan-2    C2        0.020 
 FAD      plan-2    C10       0.020 
 FAD      plan-2    N3        0.020 
 FAD      plan-2    C4        0.020 
 FAD      plan-2    O2        0.020 
 FAD      plan-2    O4        0.020 
 FAD      plan-2    C4X       0.020 
 FAD      plan-2    N5        0.020 
 FAD      plan-2    N10       0.020 
 FAD      plan-2    C5X       0.020 
 FAD      plan-2    C6        0.020 
 FAD      plan-2    C9A       0.020 
 FAD      plan-2    C7        0.020 
 FAD      plan-2    C8        0.020 
 FAD      plan-2    C9        0.020 
 FAD      plan-2    H6        0.020 
 FAD      plan-2    C7M       0.020 
 FAD      plan-2    C8M       0.020 
 FAD      plan-2    H9        0.020 
 FAD      plan-2    'C1''     0.020 
# 
data_comp_CSS 
# 
loop_ 
_chem_comp_atom.comp_id 
_chem_comp_atom.atom_id 
_chem_comp_atom.type_symbol 
_chem_comp_atom.type_energy 
_chem_comp_atom.partial_charge 
 CSS           OXT    O    OC       -0.500 
 CSS           C      C    C         0.000 
 CSS           O      O    OC       -0.500 
 CSS           CA     C    CH1       0.000 
 CSS           HA     H    H         0.000 
 CSS           N      N    NH2       0.000 
 CSS           HN2    H    H         0.000 
 CSS           HN1    H    H         0.000 
 CSS           CB     C    CH2       0.000 
 CSS           HB1    H    H         0.000 
 CSS           HB2    H    H         0.000 
 CSS           SG     S    S2        0.000 
 CSS           SD     S    SH1       0.000 
 CSS           HD     H    H         0.000 
loop_ 
_chem_comp_tree.comp_id 
_chem_comp_tree.atom_id 
_chem_comp_tree.atom_back 
_chem_comp_tree.atom_forward 
_chem_comp_tree.connect_type 
 CSS      OXT    n/a    C      START 
 CSS      C      OXT    CA     . 
 CSS      O      C      .      . 
 CSS      CA     C      CB     . 
 CSS      HA     CA     .      . 
 CSS      N      CA     HN1    . 
 CSS      HN2    N      .      . 
 CSS      HN1    N      .      . 
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 CSS      CB     CA     SG     . 
 CSS      HB1    CB     .      . 
 CSS      HB2    CB     .      . 
 CSS      SG     CB     SD     . 
 CSS      SD     SG     HD     . 
 CSS      HD     SD     .      END 
loop_ 
_chem_comp_bond.comp_id 
_chem_comp_bond.atom_id_1 
_chem_comp_bond.atom_id_2 
_chem_comp_bond.type 
_chem_comp_bond.value_dist 
_chem_comp_bond.value_dist_esd 
 CSS      N      CA        single      1.450    0.020 
 CSS      HN1    N         single      1.010    0.020 
 CSS      HN2    N         single      1.010    0.020 
 CSS      CB     CA        single      1.524    0.020 
 CSS      CA     C         single      1.500    0.020 
 CSS      HA     CA        single      1.099    0.020 
 CSS      SG     CB        single      1.762    0.020 
 CSS      HB1    CB        single      1.092    0.020 
 CSS      HB2    CB        single      1.092    0.020 
 CSS      SD     SG        single      2.025    0.020 
 CSS      HD     SD        single      1.330    0.020 
 CSS      O      C         deloc       1.250    0.020 
 CSS      C      OXT       deloc       1.250    0.020 
loop_ 
_chem_comp_angle.comp_id 
_chem_comp_angle.atom_id_1 
_chem_comp_angle.atom_id_2 
_chem_comp_angle.atom_id_3 
_chem_comp_angle.value_angle 
_chem_comp_angle.value_angle_esd 
 CSS      OXT    C      O       123.000    3.000 
 CSS      OXT    C      CA      118.500    3.000 
 CSS      O      C      CA      118.500    3.000 
 CSS      C      CA     HA      108.810    3.000 
 CSS      C      CA     N       109.470    3.000 
 CSS      C      CA     CB      109.470    3.000 
 CSS      HA     CA     N       109.470    3.000 
 CSS      HA     CA     CB      108.340    3.000 
 CSS      N      CA     CB      109.470    3.000 
 CSS      CA     N      HN2     120.000    3.000 
 CSS      CA     N      HN1     120.000    3.000 
 CSS      HN2    N      HN1     120.000    3.000 
 CSS      CA     CB     HB1     109.470    3.000 
 CSS      CA     CB     HB2     109.470    3.000 
 CSS      CA     CB     SG      109.500    3.000 
 CSS      HB1    CB     HB2     107.900    3.000 
 CSS      HB1    CB     SG      109.500    3.000 
 CSS      HB2    CB     SG      109.500    3.000 
 CSS      CB     SG     SD      104.454    3.000 
 CSS      SG     SD     HD      109.500    3.000 
loop_ 
_chem_comp_tor.comp_id 
_chem_comp_tor.id 
_chem_comp_tor.atom_id_1 
_chem_comp_tor.atom_id_2 
_chem_comp_tor.atom_id_3 
_chem_comp_tor.atom_id_4 
_chem_comp_tor.value_angle 
_chem_comp_tor.value_angle_esd 
_chem_comp_tor.period 
 CSS      var_1    OXT    C      CA     CB       175.000   20.000   3 
 CSS      var_2    C      CA     N      HN1      175.000   20.000   1 
 CSS      var_3    C      CA     CB     SG        62.578   20.000   3 
 CSS      var_4    CA     CB     SG     SD        58.719   20.000   1 
 CSS      var_5    CB     SG     SD     HD       175.000   20.000   1 
loop_ 
_chem_comp_chir.comp_id 
_chem_comp_chir.id 
_chem_comp_chir.atom_id_centre 
_chem_comp_chir.atom_id_1 
_chem_comp_chir.atom_id_2 
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_chem_comp_chir.atom_id_3 
_chem_comp_chir.volume_sign 
 CSS      chir_01  CA     N      CB     C         negativ 
loop_ 
_chem_comp_plane_atom.comp_id 
_chem_comp_plane_atom.plane_id 
_chem_comp_plane_atom.atom_id 
_chem_comp_plane_atom.dist_esd 
 CSS      plan-1    N         0.020 
 CSS      plan-1    CA        0.020 
 CSS      plan-1    HN1       0.020 
 CSS      plan-1    HN2       0.020 
 CSS      plan-2    C         0.020 
 CSS      plan-2    CA        0.020 
 CSS      plan-2    O         0.020 
 CSS      plan-2    OXT       0.020 
# ------------------------------------------------------ 
# ------------------------------------------------------ 
# 
# --- DESCRIPTION OF LINKS --- 
# 
data_link_  1.61 
# 
loop_ 
_chem_link_bond.link_id 
_chem_link_bond.atom_1_comp_id 
_chem_link_bond.atom_id_1 
_chem_link_bond.atom_2_comp_id 
_chem_link_bond.atom_id_2 
_chem_link_bond.type 
_chem_link_bond.value_dist 
_chem_link_bond.value_dist_esd 
   1.61   1 C8M     2 S         .           1.610    0.020 
# 
data_link_  1.62 
# 
loop_ 
_chem_link_bond.link_id 
_chem_link_bond.atom_1_comp_id 
_chem_link_bond.atom_id_1 
_chem_link_bond.atom_2_comp_id 
_chem_link_bond.atom_id_2 
_chem_link_bond.type 
_chem_link_bond.value_dist 
_chem_link_bond.value_dist_esd 
   1.62   1 C8M     2 S         .           1.610    0.020 
# 
data_link_  2.04 
# 
loop_ 
_chem_link_bond.link_id 
_chem_link_bond.atom_1_comp_id 
_chem_link_bond.atom_id_1 
_chem_link_bond.atom_2_comp_id 
_chem_link_bond.atom_id_2 
_chem_link_bond.type 
_chem_link_bond.value_dist 
_chem_link_bond.value_dist_esd 
   2.04   1 SG      2 S         .           2.036    0.020 
# 
data_link_  1.94 
# 
loop_ 
_chem_link_bond.link_id 
_chem_link_bond.atom_1_comp_id 
_chem_link_bond.atom_id_1 
_chem_link_bond.atom_2_comp_id 
_chem_link_bond.atom_id_2 
_chem_link_bond.type 
_chem_link_bond.value_dist 
_chem_link_bond.value_dist_esd 
   1.94   1 SD      2 S2        .           2.036    0.020 
# 
data_link_  1.93 
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# 
loop_ 
_chem_link_bond.link_id 
_chem_link_bond.atom_1_comp_id 
_chem_link_bond.atom_id_1 
_chem_link_bond.atom_2_comp_id 
_chem_link_bond.atom_id_2 
_chem_link_bond.type 
_chem_link_bond.value_dist 
_chem_link_bond.value_dist_esd 
   1.93   1 SD      2 S2        .           2.036    0.020 
# 
data_link_  1.33 
# 
loop_ 
_chem_link_bond.link_id 
_chem_link_bond.atom_1_comp_id 
_chem_link_bond.atom_id_1 
_chem_link_bond.atom_2_comp_id 
_chem_link_bond.atom_id_2 
_chem_link_bond.type 
_chem_link_bond.value_dist 
_chem_link_bond.value_dist_esd 
   1.33   1 C       2 N         .           1.260    0.020 
# 
data_link_  1.34 
# 
loop_ 
_chem_link_bond.link_id 
_chem_link_bond.atom_1_comp_id 
_chem_link_bond.atom_id_1 
_chem_link_bond.atom_2_comp_id 
_chem_link_bond.atom_id_2 
_chem_link_bond.type 
_chem_link_bond.value_dist 
_chem_link_bond.value_dist_esd 
   1.34   1 C       2 N         .           1.260    0.020 
# ------------------------------------------------------ 
 
 
Appendix table 33: Ramachandran plot
a 
 
 
 
a for the “as-purified” SQR structure (PDB id.: 3HYV). 
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Appendix table 34: sponge phase crystallization screen
a 
Precipitant 1 (% 
w/V) 
Precipitant 2 
(M) 
Buffer (mM)  pH  Additive (%)  notes 
Jeffamine               
Jeffamine M600  20  (NH4)2SO4 0.7  HEPES    100  8.1  1.2.3-
heptanetriol 
2.5  
Jeffamine ED600  12      MES   100  6.0     
b 
Jeffamine ED600  14      MES   100  6.0     
b 
Jeffamine  ED600 14    Tris  100 8.0    
b 
Jeffamine ED600  16      MES   100  6.0     
b 
Jeffamine  ED600 16    Tris  100 8.0    
b 
Jeffamine ED600  18      MES   100  6.0     
b 
Jeffamine ED600  18      HEPES   100  7.0     
b 
Jeffamine  ED600 18    Tris  100 8.0    
b 
Jeffamine ED600  20      MES   100  6.0     
b 
Jeffamine  ED600 20    Tris  100 8.0    
b 
Jeffamine ED900  12      MES   100  6.0     
b 
Jeffamine ED900  14      MES   100  6.0     
b 
Jeffamine ED900  16      MES   100  6.0     
b 
Jeffamine ED900  18      MES   100  6.0     
b 
Jeffamine ED900  20      MES   100  6.0     
b 
               
PEG               
PEG 400  40      MES   100  6.5      
PEG 400  40  MgCl2 0.45            
PEG 400  42  MgCl2 0.2            
PEG 400  42  MgCl2 0.25            
PEG 400  42  MgCl2 0.3            
PEG 400  42  MgCl2 0.4            
PEG 400  45  MgCl2 0.2            
PEG 400  45  MgCl2 0.25            
PEG 400  45  MgCl2 0.3            
PEG  400  48    HEPES    100 7.5 CaCl2 200  JBM1_A5
c 
PEG 550 MME  40  MgCl2  0.4          
PEG 550 MME  40  MgCl2  0.8          
PEG 550 MME  50  MgCl2  0.4          
               
MPD               
MPD  5  Ethanol   5  HEPES   100  7.5      JB8_B5 
MPD  10    HEPES    100 7.5 Na-citrate  100 JB7_A1 
MPD  12    Tris  100 8.5 MgCl2 50  JB7_A2 
MPD 15      Na-
acetate 
100 4.6 CaCl2 20  JB7_A3 
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MPD  15    Na-citrate 100 5.6 (NH4)CH3COO 200  JB7_A5 
MPD  15    MES    100 6.5 Mg-acetate  200 JB7_A6 
MPD  15    HEPES    100 7.5 Na-citrate  200 JB7_B1 
MPD  20    HEPES    100 7.5 Na-citrate  100 JB7_B2 
MPD  20    Imidazole 100 8.0    JB7_B3 
MPD  20 Glycerol  4      NaCl  200 JB7_B4 
MPD  30    Na-citrate 100 5.6 (NH4)-acetate 200  JB7_B6 
MPD  30    HEPES    100 7.5 (NH4)2SO4 500  JB7_C2 
MPD  30    HEPES    100 7.5 Na-citrate  200 JB7_C3 
MPD  30 PEG  4000  5 HEPES    100 7.5    JB7_C4 
MPD  50    Tris  100 8.5 NH4H2PO4 100  JB8_A3 
a the screen was optimized in collaboration with Sabine Buschmann and Dr. Chitra Rajendran (Max Planck 
Institute of Biophysics, Frankfurt am Main, Germany). 
b the buffer used to prepare the lipidic cubic phase was not MES 20 mM, pH 6.5, DDM 0.02 %, but MES 20 
mM, pH 6.5, DDM 0.02 %, NaCl 100 mM. 
c JBM stands for Jena Bioscience Membrane Screen, JB for Jena Bioscience Classic Screen. 
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Appendix table 35: command line for T-COFFEE
a 
 
t_coffee  -pdb_db pdb  
          -protein_db UniRef100  
          -blast LOCAL  
          -mode expresso  
          -in  sequences_fasta.in0   
          -evaluate_mode t_coffee_slow  
          -output clustalw_aln fasta_aln phylip score_html score_pdf  
          -maxnseq 50  
          -maxlen 2000  
          -tree     
          -run_name=tcfEXPR63893_7734     
          -check_pdb_status   
          -cache=no  
          -remove_template_file=1  
          -quiet=stdout  
          >tcfEXPR63893_7734.tc_LOG 
 
a the run was performed online at http://tcoffee.vital-it.ch/cgi-bin/Tcoffee/tcoffee_cgi/index.cgi. 
 
Appendix table 36: template file used by T-COFFEE 
 
>gi153872492__Beggiatoa _P_ 1fcdA mol:protein length:401  FCSD 
>gi|255021328_Acaldus 
>gi21673852___Ctepidum 
>gi13542037___Tvolcanium _P_ 3h8iA mol:protein length:409  NADH oxidase 
>gi15922815___Stokodaii _P_ 3h8iA mol:protein length:409  NADH oxidase 
>gi16082149___Tacidophilum _P_ 3h8iA mol:protein length:409  NADH oxidase 
>gi24657386___Dmelanogaster 
>gi21673913___Ctepidum 
>gi157092622__Amarina 
>gi15899356___Ssolfataricus 
>gi15607118___Aaeolicus _P_ 3hyvA mol:protein length:430  Sulfide-quinone reductase 
>gi192289979__Rpalustris _P_ 1fcdA mol:protein length:401  FCSD 
>gi15920835___Stokodaii 
>gi8118249____Olimnetica _P_ 3hyvA mol:protein length:430  Sulfide-quinone reductase 
>gi17546261___Rsolanacearum 
>gi86748177___Rpalustris 
>gi19112859___Spombe 
>gi193211736__Cparvum 
>gi21436536___Pdenitrificans _P_ 1fcdA mol:protein length:401  FCSD 
>gi145218949__Pvibrioformis 
>gi21672958___Ctepidum 
>gi78364011___Tcrunogena 
>gi38505571___SynechocystisPCC6803 
>gi15605781___Aaeolicus 
>gi17232004___NostocPCC7120 _P_ 3hyvA mol:protein length:430  Sulfide-quinone reductase 
>gi8118252____Ahalophytica _P_ 3hyvA mol:protein length:430  Sulfide-quinone reductase 
>gi19879585___Climicola _P_ 1fcdA mol:protein length:401  FCSD 
>gi|21673704__Ctepidum 
>gi241777285__Avinosum _P_ 1fcdA mol:protein length:401  FCSD 
>gi225850055__Pmarina 
>gi23015306___Mmagnetotacticum 
>gi2385380____Rcapsulatus _P_ 3hyvA mol:protein length:430  Sulfide-quinone reductase 
>gi78776818___Sdenitrificans 
>gi15606162___Aaeolicus 
>gi|193212535_Cparvum 
>gi82749809___Saureus 
>gi148696168__Mmusculus 
>gi21464540___Tdenitrificans _P_ 3hyvA mol:protein length:430  Sulfide-quinone reductase 
>gi15597541___Paeruginosa 
>gi238828305__Aambivalens _P_ 3h8iA mol:protein length:409  NADH oxidase 
>gi78186989___Pluteolum 
>gi18313472___Paerophilum 
>gi|256759353_Tintermedia 
>gi62896485___Hsapiens 
>gi241775880__Avinosum 
>gi11498167___Afulgidus 
>gi15899031___Ssolfataricus _P_ 3h8iA mol:protein length:409  NADH oxidase 
>gi103492069__Aferrooxidans _P_ 3hyvA mol:protein length:430  Sulfide-quinone reductase 
>gi229580793__Sislandicus _P_ 3h8iA mol:protein length:409  NADH oxidase 
>gi78185961___Pluteolum  
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Appendix table 37: full sequence alignment generated by T-COFFEE 
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Appendix table 38: the structure of Acidithiobacillus ferrooxidans SQR 
a 
 
During revision of this thesis, the anticipated structure of Acidithiobacillus ferrooxidans 
SQR overexpressed in E. coli (see Chapter 3.9) has become available. It was solved at 2.30, 
2.30 and 2.05 Å resolution in an “as-purified”, quinone-bound and C160A-mutant forms, 
respectively, using the A. aeolicus SQR structure described in this thesis as a molecular 
replacement model. 
A. ferrooxidans SQR is characterized by the following properties: 
1.  it is dimeric; 
2.  its overall monomeric architecture is closely related to A. aeolicus SQR, confirming 
the sequence fingerprints for type I SQRs described in Chapter 3.8; 
3.  it is an integral monotopic membrane protein inserted about 20 Å into the lipidic 
bilayer; 
4.  it harbours a non-covalently bound FAD, whose C8M atom is positioned at a distance 
of 3.86 Å from Cys 128 Sγ atom. A sulfide ion is found in the electron density 4 Å 
apart from Cys 128 Sγ atom. The authors propose that sulfide may S-sulphydrate Cys 
128. They additionally propose that the Cys128-Sγ-SH species could act as 
nucleophile on Cys 160 for product release;  
5.  Cys 160 and Cys 356 in the “as-purified” structure are connected through a branched 
polysulfur chain of 4 or 5 S atoms. The C160A and C356A mutants have no 
sulfide:quinone oxidoreduction activity. The structure of the C160A mutant shows 
sulfhydration of Cys 356 (Cys356-Sγ-SH). Cys 356 is also the closest cysteine near 
FAD atom C4A (3.2 Å between the SH group of Cys356-Sγ-SH and FAD atom C4A in the 
“as-purified” structure). Based on these observations, the authors propose that Cys 
160 and Cys 356 form the redox active centre of A. ferrooxidans SQR and in 
particular that Cys 356 is involved in forming the covalent adduct with FAD atom C4A 
while Cys 160 harbours the growing polysulfur chain. However, the structure of A. 
ferrooxidans SQR does not contradict the mechanistic hypotheses presented in this 
thesis (see Chapter 3.7); 
6.  the product of sulfide oxidation may be released through a hydrophobic channel 
directly into the membrane bilayer, as suggested in this thesis (see Chapter 3.7 and 
Figure 3.7); 
7.  the position of the quinone binding site corresponds to that of A. aeolicus SQR as 
described in this thesis, but in A. ferrooxidans SQR one amphipatic helix may 
undergo a conformational change upon quinone binding (see Chapter 2.10.5 and 3.6). 
 
a based on PDB entries 3KPI, 3KPG and 3KPK and on the following reference: Cherney M. M., Zhang Y., 
Solomonson M., Weiner J. H., James M. N. G. (2010) Crystal structure of sulfide:quinone oxidoreductase 
from  Acidithiobacillus ferrooxidans: insights into sulfidotropic respiration and detoxification. Journal of 
Molecular Biology 398:292-305. 
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